GS	SIZE	SOURCE	ES	NES	NOM p-val	FDR q-val	FWER p-val	Tag %	Gene %	Signal	FDR (median)	glob.p.val
MACLACHLAN_BRCA1_TARGETS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/MACLACHLAN_BRCA1_TARGETS_UP	-0.68766	-1.9779	0	0.29596	0.146	0.6	0.209	0.475	0	0.136
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-0.58206	-1.9426	0	0.2417	0.216	0.271	0.12	0.239	0	0.08
LAMB_CCND1_TARGETS	19	http://www.broadinstitute.org/gsea/msigdb/cards/LAMB_CCND1_TARGETS	-0.55684	-1.8954	0.02196	0.34717	0.334	0.474	0.27	0.346	0	0.111
THILLAINADESAN_ZNF217_TARGETS_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/THILLAINADESAN_ZNF217_TARGETS_UP	-0.63394	-1.8887	0	0.28616	0.353	0.357	0.099	0.322	0	0.081
REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION	-0.61493	-1.8764	0	0.27198	0.381	0.412	0.179	0.338	0	0.077
FAELT_B_CLL_WITH_VH3_21_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH3_21_UP	-0.49212	-1.8615	0.01793	0.27784	0.429	0.381	0.251	0.286	0	0.074
SESTO_RESPONSE_TO_UV_C7	68	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C7	-0.5474	-1.8528	0	0.27151	0.455	0.485	0.219	0.38	0	0.066
GAL_LEUKEMIC_STEM_CELL_DN	233	http://www.broadinstitute.org/gsea/msigdb/cards/GAL_LEUKEMIC_STEM_CELL_DN	-0.48083	-1.8089	0	0.42791	0.6	0.266	0.13	0.234	0.19983	0.111
REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_THE_ROLE_OF_NEF_IN_HIV1_REPLICATION_AND_DISEASE_PATHOGENESIS	-0.50058	-1.7931	0.01186	0.46525	0.646	0.462	0.268	0.338	0.22782	0.131
HINATA_NFKB_TARGETS_KERATINOCYTE_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/HINATA_NFKB_TARGETS_KERATINOCYTE_DN	-0.71334	-1.7873	0.00759	0.4576	0.671	0.409	0.105	0.367	0.22063	0.122
MATTIOLI_MGUS_VS_PCL	93	http://www.broadinstitute.org/gsea/msigdb/cards/MATTIOLI_MGUS_VS_PCL	-0.53216	-1.7838	0.004	0.43436	0.682	0.505	0.257	0.377	0.20595	0.114
SHEPARD_BMYB_MORPHOLINO_DN	192	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_MORPHOLINO_DN	-0.50569	-1.7813	0.006048	0.4115	0.694	0.292	0.16	0.247	0.19615	0.102
LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	360	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_1_DN	-0.52819	-1.779	0.006036	0.39213	0.699	0.4	0.192	0.328	0.18395	0.089
MARSHALL_VIRAL_INFECTION_RESPONSE_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/MARSHALL_VIRAL_INFECTION_RESPONSE_DN	-0.57289	-1.7787	0.001938	0.36549	0.7	0.448	0.257	0.333	0.17158	0.079
BIOCARTA_CELLCYCLE_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CELLCYCLE_PATHWAY	-0.67368	-1.7762	0.005703	0.35256	0.706	0.435	0.0909	0.396	0.17309	0.074
NIELSEN_LIPOSARCOMA_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LIPOSARCOMA_UP	-0.60757	-1.7742	0.002037	0.33875	0.712	0.588	0.22	0.459	0.16525	0.071
MORI_PRE_BI_LYMPHOCYTE_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PRE_BI_LYMPHOCYTE_UP	-0.70864	-1.7731	0.00202	0.32333	0.712	0.412	0.122	0.363	0.15583	0.062
SUNG_METASTASIS_STROMA_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/SUNG_METASTASIS_STROMA_DN	-0.59952	-1.7696	0.003831	0.31931	0.72	0.66	0.273	0.481	0.15786	0.063
SMITH_TERT_TARGETS_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/SMITH_TERT_TARGETS_DN	-0.40594	-1.7692	0	0.3044	0.721	0.253	0.154	0.215	0.14955	0.058
KIM_TIAL1_TARGETS	30	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_TIAL1_TARGETS	-0.52207	-1.7644	0.01594	0.30824	0.733	0.267	0.0998	0.24	0.15121	0.057
AUNG_GASTRIC_CANCER	50	http://www.broadinstitute.org/gsea/msigdb/cards/AUNG_GASTRIC_CANCER	-0.54749	-1.7609	0.002004	0.30654	0.747	0.44	0.198	0.354	0.1576	0.058
JEON_SMAD6_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/JEON_SMAD6_TARGETS_DN	-0.73635	-1.7597	0.0161	0.29713	0.751	0.263	0.0272	0.256	0.15105	0.057
CHUNG_BLISTER_CYTOTOXICITY_UP	126	http://www.broadinstitute.org/gsea/msigdb/cards/CHUNG_BLISTER_CYTOTOXICITY_UP	-0.46946	-1.7573	0	0.2935	0.767	0.349	0.21	0.277	0.14977	0.052
HUMMERICH_BENIGN_SKIN_TUMOR_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_BENIGN_SKIN_TUMOR_UP	-0.54768	-1.7528	0.003945	0.29797	0.774	0.278	0.133	0.241	0.15387	0.056
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN	-0.59836	-1.7502	0.01765	0.29608	0.78	0.375	0.165	0.313	0.16161	0.056
HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/HOEGERKORP_CD44_TARGETS_TEMPORAL_DN	-0.54406	-1.7461	0.009747	0.30012	0.798	0.36	0.212	0.284	0.16928	0.057
BOSCO_TH1_CYTOTOXIC_MODULE	106	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_TH1_CYTOTOXIC_MODULE	-0.49723	-1.7437	0.001822	0.29719	0.806	0.283	0.158	0.239	0.16856	0.056
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	43	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	-0.5614	-1.7411	0.001901	0.29515	0.81	0.279	0.0896	0.254	0.16367	0.054
NADERI_BREAST_CANCER_PROGNOSIS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/NADERI_BREAST_CANCER_PROGNOSIS_UP	-0.7405	-1.7367	0	0.30226	0.825	0.435	0.0998	0.392	0.16566	0.057
HALMOS_CEBPA_TARGETS_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/HALMOS_CEBPA_TARGETS_DN	-0.51403	-1.7359	0.01389	0.29502	0.826	0.244	0.147	0.209	0.16032	0.053
HAHTOLA_SEZARY_SYNDROM_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_SEZARY_SYNDROM_UP	-0.5653	-1.7302	0.008048	0.30457	0.834	0.379	0.129	0.331	0.16984	0.055
CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	33	http://www.broadinstitute.org/gsea/msigdb/cards/CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE	-0.51116	-1.7297	0	0.29681	0.836	0.303	0.109	0.27	0.16541	0.055
NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	38	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON	-0.49607	-1.7291	0.01887	0.28951	0.838	0.395	0.236	0.302	0.16111	0.054
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP	-0.69526	-1.7284	0.002004	0.28346	0.838	0.433	0.114	0.384	0.16138	0.053
SHEPARD_BMYB_TARGETS	67	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_TARGETS	-0.71734	-1.7271	0.006073	0.27926	0.839	0.269	0.0152	0.265	0.16011	0.05
PARK_APL_PATHOGENESIS_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_APL_PATHOGENESIS_DN	-0.52471	-1.7214	0.03083	0.29186	0.854	0.468	0.267	0.344	0.16984	0.053
ZHENG_GLIOBLASTOMA_PLASTICITY_UP	241	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_GLIOBLASTOMA_PLASTICITY_UP	-0.55013	-1.7175	0.003984	0.29603	0.86	0.232	0.0694	0.218	0.1742	0.055
TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP	-0.63002	-1.7169	0	0.29069	0.86	0.158	0.00938	0.157	0.17907	0.055
GRADE_METASTASIS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_METASTASIS_DN	-0.54067	-1.7165	0.02564	0.28496	0.86	0.595	0.283	0.427	0.17447	0.049
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	16	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL	-0.62742	-1.7141	0.009709	0.28546	0.864	0.375	0.113	0.333	0.17495	0.049
PID_PRL_SIGNALING_EVENTS_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PRL_SIGNALING_EVENTS_PATHWAY	-0.59021	-1.7139	0.01375	0.27913	0.864	0.609	0.268	0.446	0.17092	0.044
AMUNDSON_GENOTOXIC_SIGNATURE	99	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GENOTOXIC_SIGNATURE	-0.45557	-1.7098	0	0.28559	0.867	0.283	0.159	0.239	0.17272	0.046
GOLDRATH_ANTIGEN_RESPONSE	327	http://www.broadinstitute.org/gsea/msigdb/cards/GOLDRATH_ANTIGEN_RESPONSE	-0.53238	-1.7083	0	0.28472	0.869	0.297	0.126	0.263	0.17414	0.046
GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_ONLY_DN	-0.48977	-1.7071	0.03131	0.28184	0.871	0.425	0.263	0.314	0.1703	0.043
PID_CD8_TCR_PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CD8_TCR_PATHWAY	-0.4448	-1.7057	0.01346	0.28011	0.872	0.442	0.301	0.31	0.16651	0.043
LEE_LIVER_CANCER_MYC_E2F1_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_E2F1_UP	-0.59597	-1.7035	0.01408	0.28174	0.875	0.411	0.178	0.338	0.16921	0.043
SERVITJA_LIVER_HNF1A_TARGETS_UP	131	http://www.broadinstitute.org/gsea/msigdb/cards/SERVITJA_LIVER_HNF1A_TARGETS_UP	-0.50503	-1.7032	0.007767	0.27682	0.875	0.29	0.117	0.258	0.16696	0.043
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP	-0.72012	-1.7028	0	0.27225	0.875	0.444	0.122	0.39	0.16487	0.04
HU_GENOTOXIC_DAMAGE_24HR	32	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIC_DAMAGE_24HR	-0.48268	-1.7006	0.02642	0.27367	0.877	0.281	0.142	0.242	0.16765	0.041
SHEPARD_CRUSH_AND_BURN_MUTANT_DN	174	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_CRUSH_AND_BURN_MUTANT_DN	-0.53484	-1.6993	0.01403	0.27233	0.88	0.316	0.16	0.267	0.16587	0.039
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	-0.51295	-1.6987	0	0.26395	0.881	0.51	0.244	0.386	0.15992	0.038
BROWNE_HCMV_INFECTION_6HR_UP	66	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_6HR_UP	-0.37351	-1.6987	0.02637	0.26907	0.881	0.212	0.161	0.178	0.16306	0.039
BIOCARTA_ETS_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ETS_PATHWAY	-0.62302	-1.693	0.02729	0.27545	0.89	0.444	0.196	0.358	0.16225	0.04
TSENG_ADIPOGENIC_POTENTIAL_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_ADIPOGENIC_POTENTIAL_UP	-0.49741	-1.6921	0.003922	0.27392	0.89	0.367	0.213	0.289	0.16149	0.04
MATZUK_SPERMATOCYTE	70	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATOCYTE	-0.47303	-1.6917	0.005714	0.27052	0.89	0.257	0.114	0.228	0.15905	0.039
RIZ_ERYTHROID_DIFFERENTIATION_HBZ	41	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_HBZ	-0.48422	-1.691	0.00994	0.26772	0.89	0.268	0.146	0.23	0.16033	0.036
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP	-0.56302	-1.6904	0.01833	0.26473	0.891	0.45	0.246	0.339	0.15752	0.036
REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_S_SPECIFIC_TRANSCRIPTION	-0.78451	-1.6894	0.01212	0.26332	0.894	0.706	0.14	0.608	0.15624	0.039
LE_NEURONAL_DIFFERENTIATION_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/LE_NEURONAL_DIFFERENTIATION_DN	-0.69775	-1.686	0.0137	0.27019	0.894	0.474	0.114	0.42	0.16543	0.04
KOBAYASHI_EGFR_SIGNALING_24HR_DN	244	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_24HR_DN	-0.70682	-1.6833	0.007952	0.27395	0.902	0.496	0.126	0.438	0.16851	0.04
MARKEY_RB1_CHRONIC_LOF_UP	110	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_CHRONIC_LOF_UP	-0.52874	-1.6757	0	0.29479	0.915	0.391	0.162	0.329	0.18001	0.045
REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX	-0.5524	-1.6756	0.009506	0.2905	0.915	0.261	0.107	0.233	0.17711	0.045
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN	-0.52743	-1.6741	0.01266	0.29102	0.916	0.345	0.198	0.277	0.17749	0.043
STEARMAN_TUMOR_FIELD_EFFECT_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/STEARMAN_TUMOR_FIELD_EFFECT_UP	-0.57608	-1.6716	0.01165	0.29412	0.921	0.382	0.165	0.32	0.177	0.043
ZHANG_RESPONSE_TO_CANTHARIDIN_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_CANTHARIDIN_UP	-0.57932	-1.6709	0.005736	0.29175	0.921	0.211	0.0524	0.2	0.17513	0.042
CHEN_ETV5_TARGETS_TESTIS	22	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_ETV5_TARGETS_TESTIS	-0.72281	-1.6701	0.001916	0.28949	0.923	0.455	0.0788	0.419	0.1744	0.043
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	128	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	-0.52748	-1.6692	0.001848	0.28758	0.923	0.344	0.157	0.291	0.17289	0.043
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	165	http://www.broadinstitute.org/gsea/msigdb/cards/GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-0.46275	-1.6691	0	0.28373	0.923	0.394	0.219	0.31	0.17035	0.043
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	86	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	-0.71962	-1.6658	0.006048	0.29052	0.927	0.349	0.0282	0.34	0.17207	0.043
OXFORD_RALA_OR_RALB_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/OXFORD_RALA_OR_RALB_TARGETS_UP	-0.66855	-1.6655	0.02964	0.28726	0.928	0.404	0.122	0.355	0.16972	0.043
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN	-0.5015	-1.6631	0.03891	0.29024	0.932	0.783	0.382	0.484	0.17283	0.043
GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP	-0.61143	-1.6624	0.008403	0.28905	0.932	0.28	0.0552	0.266	0.17528	0.043
BASAKI_YBX1_TARGETS_UP	274	http://www.broadinstitute.org/gsea/msigdb/cards/BASAKI_YBX1_TARGETS_UP	-0.59542	-1.662	0.01389	0.28601	0.932	0.347	0.125	0.307	0.17327	0.042
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN	-0.47781	-1.661	0.02896	0.2854	0.932	0.386	0.23	0.298	0.17279	0.042
REACTOME_MEIOTIC_RECOMBINATION	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEIOTIC_RECOMBINATION	-0.62285	-1.6607	0.01331	0.28262	0.932	0.476	0.137	0.412	0.17147	0.041
CHICAS_RB1_TARGETS_LOW_SERUM	89	http://www.broadinstitute.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_LOW_SERUM	-0.5151	-1.6605	0.01029	0.2798	0.935	0.303	0.145	0.26	0.16921	0.041
BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	29	http://www.broadinstitute.org/gsea/msigdb/cards/BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.78056	-1.6602	0.02386	0.27691	0.935	0.621	0.146	0.531	0.16823	0.041
LE_EGR2_TARGETS_UP	106	http://www.broadinstitute.org/gsea/msigdb/cards/LE_EGR2_TARGETS_UP	-0.66659	-1.66	0.004107	0.27419	0.935	0.491	0.16	0.414	0.16911	0.039
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP	-0.44896	-1.6593	0.001916	0.27247	0.935	0.421	0.262	0.311	0.16914	0.041
TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	100	http://www.broadinstitute.org/gsea/msigdb/cards/TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA	-0.37371	-1.6592	0	0.2693	0.935	0.13	0.094	0.118	0.16703	0.039
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	63	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	-0.49056	-1.6583	0.008403	0.26923	0.937	0.397	0.217	0.312	0.16827	0.039
REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ABORTIVE_ELONGATION_OF_HIV1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT	-0.53406	-1.6581	0.01807	0.26638	0.937	0.474	0.238	0.361	0.16622	0.039
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	68	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3	-0.48425	-1.6565	0.02686	0.26715	0.938	0.353	0.181	0.29	0.16585	0.039
WHITFIELD_CELL_CYCLE_G2	172	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2	-0.6053	-1.6562	0.005906	0.26489	0.938	0.419	0.153	0.357	0.16387	0.039
ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP	-0.6477	-1.6551	0.03846	0.26532	0.942	0.586	0.233	0.45	0.16667	0.039
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP	-0.54823	-1.655	0.00409	0.26245	0.942	0.481	0.257	0.358	0.16581	0.039
CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_T_ALL_RELAPSE_PROGNOSIS	-0.81094	-1.654	0.01923	0.26232	0.943	0.316	0.0136	0.312	0.16436	0.039
JAZAG_TGFB1_SIGNALING_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_DN	-0.48302	-1.6486	0.02419	0.27473	0.949	0.324	0.193	0.261	0.17289	0.041
TSENG_IRS1_TARGETS_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_IRS1_TARGETS_UP	-0.43528	-1.6477	0.003937	0.2741	0.949	0.376	0.219	0.295	0.17332	0.042
PID_NFKAPPAB_ATYPICAL_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NFKAPPAB_ATYPICAL_PATHWAY	-0.55478	-1.6474	0.003992	0.27199	0.955	0.188	0.0813	0.172	0.17183	0.042
DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	313	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP	-0.66081	-1.6456	0.0159	0.27402	0.957	0.454	0.127	0.401	0.17447	0.041
BURTON_ADIPOGENESIS_PEAK_AT_24HR	42	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_24HR	-0.77065	-1.6448	0.004115	0.27371	0.957	0.381	0.0496	0.363	0.1737	0.041
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	157	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-0.67756	-1.6447	0.012	0.27105	0.957	0.522	0.171	0.436	0.17207	0.041
VECCHI_GASTRIC_CANCER_EARLY_UP	395	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_EARLY_UP	-0.59337	-1.6426	0.003906	0.27489	0.965	0.347	0.129	0.307	0.17701	0.042
CHEN_ETV5_TARGETS_SERTOLI	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_ETV5_TARGETS_SERTOLI	-0.63082	-1.6421	0.03239	0.2735	0.965	0.368	0.194	0.297	0.17516	0.042
MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN	-0.58456	-1.6418	0.001845	0.27153	0.965	0.458	0.2	0.367	0.17333	0.042
REACTOME_KINESINS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_KINESINS	-0.69831	-1.6417	0.01992	0.26885	0.965	0.292	0.0694	0.272	0.17155	0.042
ZHAN_V2_LATE_DIFFERENTIATION_GENES	41	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_V2_LATE_DIFFERENTIATION_GENES	-0.43877	-1.6412	0.02976	0.2675	0.965	0.415	0.249	0.312	0.1698	0.041
REACTOME_MEIOSIS	91	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEIOSIS	-0.57141	-1.6409	0.01147	0.26554	0.965	0.418	0.142	0.36	0.16808	0.041
BENPORATH_ES_CORE_NINE_CORRELATED	100	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_CORE_NINE_CORRELATED	-0.49588	-1.6396	0.03414	0.26736	0.967	0.52	0.276	0.378	0.16846	0.042
BLUM_RESPONSE_TO_SALIRASIB_DN	339	http://www.broadinstitute.org/gsea/msigdb/cards/BLUM_RESPONSE_TO_SALIRASIB_DN	-0.57265	-1.6384	0.0122	0.26772	0.967	0.369	0.145	0.32	0.16703	0.042
WANG_CISPLATIN_RESPONSE_AND_XPC_UP	196	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CISPLATIN_RESPONSE_AND_XPC_UP	-0.49331	-1.6377	0.008475	0.26731	0.967	0.311	0.13	0.273	0.1685	0.042
STANELLE_E2F1_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/STANELLE_E2F1_TARGETS	-0.55375	-1.637	0.02935	0.26664	0.971	0.207	0.0606	0.195	0.1696	0.042
WATANABE_COLON_CANCER_MSI_VS_MSS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_COLON_CANCER_MSI_VS_MSS_UP	-0.43586	-1.6355	0.003846	0.26815	0.971	0.4	0.197	0.321	0.16973	0.042
LEIN_CEREBELLUM_MARKERS	79	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_CEREBELLUM_MARKERS	-0.3391	-1.632	0.006276	0.27488	0.972	0.19	0.151	0.162	0.17531	0.042
VIETOR_IFRD1_TARGETS	23	http://www.broadinstitute.org/gsea/msigdb/cards/VIETOR_IFRD1_TARGETS	-0.62416	-1.6316	0.01636	0.27291	0.972	0.261	0.0503	0.248	0.17617	0.042
DAZARD_UV_RESPONSE_CLUSTER_G24	26	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G24	-0.6072	-1.6315	0.007353	0.27088	0.972	0.423	0.119	0.373	0.17452	0.042
SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP	-0.57527	-1.6307	0.02161	0.27041	0.972	0.308	0.112	0.274	0.17489	0.041
KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	116	http://www.broadinstitute.org/gsea/msigdb/cards/KAN_RESPONSE_TO_ARSENIC_TRIOXIDE	-0.44826	-1.6304	0.01581	0.26878	0.975	0.216	0.0967	0.196	0.17328	0.041
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN	-0.57418	-1.6294	0.025	0.26898	0.978	0.714	0.306	0.496	0.17275	0.041
REACTOME_AMYLOIDS	61	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMYLOIDS	-0.56254	-1.6293	0.03025	0.26682	0.978	0.377	0.137	0.326	0.1712	0.041
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN	-0.40538	-1.6292	0.02124	0.26465	0.978	0.548	0.32	0.373	0.16967	0.041
MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	24	http://www.broadinstitute.org/gsea/msigdb/cards/MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP	-0.48421	-1.6264	0.03422	0.27016	0.979	0.333	0.202	0.266	0.17487	0.041
ROY_WOUND_BLOOD_VESSEL_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/ROY_WOUND_BLOOD_VESSEL_DN	-0.59049	-1.6263	0.009842	0.26843	0.979	0.364	0.138	0.314	0.17334	0.041
REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	117	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	-0.44558	-1.6251	0.01205	0.26921	0.979	0.325	0.185	0.266	0.17441	0.041
NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST_AND_SYNOVIAL_SARCOMA_DN	-0.63887	-1.6244	0.05469	0.2688	0.979	0.35	0.165	0.292	0.17365	0.041
GROSS_HYPOXIA_VIA_ELK3_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_UP	-0.38579	-1.6235	0.01383	0.26907	0.979	0.305	0.216	0.241	0.17354	0.041
CUI_GLUCOSE_DEPRIVATION	57	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_GLUCOSE_DEPRIVATION	-0.48296	-1.6234	0.03495	0.26697	0.979	0.316	0.166	0.264	0.17207	0.041
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	97	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	-0.62413	-1.6233	0.03644	0.26508	0.979	0.433	0.164	0.364	0.17063	0.041
KENNY_CTNNB1_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/KENNY_CTNNB1_TARGETS_UP	-0.56279	-1.6223	0.02028	0.26553	0.979	0.234	0.0609	0.22	0.1717	0.041
RUIZ_TNC_TARGETS_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/RUIZ_TNC_TARGETS_DN	-0.60856	-1.622	0.012	0.26393	0.979	0.438	0.127	0.384	0.17028	0.041
PID_AJDISS_2PATHWAY	48	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AJDISS_2PATHWAY	-0.50636	-1.6212	0.01174	0.2639	0.979	0.396	0.185	0.323	0.17079	0.041
RASHI_RESPONSE_TO_IONIZING_RADIATION_6	79	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_6	-0.42522	-1.6211	0.005906	0.26226	0.979	0.354	0.226	0.275	0.16952	0.041
SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN	-0.74573	-1.6201	0.006383	0.26246	0.98	0.524	0.091	0.477	0.16862	0.041
DER_IFN_GAMMA_RESPONSE_UP	69	http://www.broadinstitute.org/gsea/msigdb/cards/DER_IFN_GAMMA_RESPONSE_UP	-0.5418	-1.6197	0.08175	0.26117	0.98	0.449	0.225	0.349	0.16727	0.041
PID_FOXM1_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FOXM1_PATHWAY	-0.65869	-1.6192	0.01461	0.26067	0.98	0.59	0.216	0.463	0.16785	0.041
RADAEVA_RESPONSE_TO_IFNA1_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/RADAEVA_RESPONSE_TO_IFNA1_UP	-0.63705	-1.6189	0.02941	0.25923	0.98	0.442	0.134	0.384	0.16703	0.041
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	171	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-0.70803	-1.6183	0.009881	0.25922	0.98	0.444	0.119	0.394	0.16776	0.041
HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN	-0.42709	-1.6179	0.02806	0.25807	0.98	0.468	0.311	0.323	0.16645	0.038
REACTOME_MEIOTIC_SYNAPSIS	59	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEIOTIC_SYNAPSIS	-0.58044	-1.6148	0.01569	0.2645	0.98	0.525	0.196	0.423	0.17126	0.041
GENTLES_LEUKEMIC_STEM_CELL_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/GENTLES_LEUKEMIC_STEM_CELL_DN	-0.74182	-1.6137	0.005628	0.26538	0.98	0.368	0.0332	0.356	0.17384	0.041
VANTVEER_BREAST_CANCER_ESR1_DN	223	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_ESR1_DN	-0.5067	-1.6133	0.02335	0.26426	0.981	0.368	0.184	0.303	0.17295	0.041
HORIUCHI_WTAP_TARGETS_DN	294	http://www.broadinstitute.org/gsea/msigdb/cards/HORIUCHI_WTAP_TARGETS_DN	-0.60502	-1.6114	0.009747	0.26507	0.981	0.425	0.161	0.361	0.17215	0.041
AFFAR_YY1_TARGETS_DN	228	http://www.broadinstitute.org/gsea/msigdb/cards/AFFAR_YY1_TARGETS_DN	-0.52129	-1.6114	0.01581	0.26691	0.981	0.364	0.159	0.309	0.17345	0.041
VANASSE_BCL2_TARGETS_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/VANASSE_BCL2_TARGETS_DN	-0.4533	-1.6096	0.008197	0.26734	0.984	0.304	0.185	0.249	0.17348	0.042
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN	-0.41859	-1.6092	0.02	0.26639	0.984	0.167	0.125	0.146	0.17314	0.042
KIM_MYCL1_AMPLIFICATION_TARGETS_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_MYCL1_AMPLIFICATION_TARGETS_DN	-0.66191	-1.608	0.007678	0.26767	0.984	0.3	0.0555	0.284	0.17588	0.042
JIANG_VHL_TARGETS	130	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_VHL_TARGETS	-0.37391	-1.6075	0.03532	0.26679	0.984	0.346	0.247	0.262	0.1751	0.042
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP	-0.40524	-1.607	0.0142	0.26605	0.984	0.367	0.267	0.269	0.17443	0.042
PID_P73PATHWAY	76	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P73PATHWAY	-0.45177	-1.606	0.01912	0.26703	0.984	0.211	0.101	0.19	0.17369	0.042
VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN	-0.56314	-1.6042	0.03206	0.26992	0.984	0.171	0.0614	0.161	0.17413	0.042
PEART_HDAC_PROLIFERATION_CLUSTER_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/PEART_HDAC_PROLIFERATION_CLUSTER_DN	-0.54226	-1.6026	0.01018	0.2723	0.984	0.534	0.212	0.422	0.17865	0.043
REACTOME_METABOLISM_OF_NUCLEOTIDES	67	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_NUCLEOTIDES	-0.39324	-1.6022	0.01714	0.27137	0.984	0.388	0.234	0.298	0.17824	0.043
KYNG_NORMAL_AGING_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_NORMAL_AGING_DN	-0.48259	-1.6019	0	0.2703	0.984	0.214	0.0719	0.199	0.17857	0.043
BURTON_ADIPOGENESIS_3	99	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_3	-0.75028	-1.6007	0.008048	0.2719	0.984	0.606	0.157	0.513	0.1797	0.043
BIOCARTA_ARAP_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ARAP_PATHWAY	-0.61141	-1.5996	0.03976	0.27285	0.984	0.588	0.239	0.448	0.17951	0.043
FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN	-0.61208	-1.5995	0.05534	0.27127	0.984	0.54	0.206	0.43	0.17829	0.043
HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP	-0.5039	-1.5975	0.00789	0.27477	0.984	0.235	0.0908	0.214	0.17899	0.043
WONG_IFNA2_RESISTANCE_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_IFNA2_RESISTANCE_DN	-0.50152	-1.5966	0.03578	0.27533	0.984	0.515	0.294	0.364	0.18009	0.043
KONG_E2F3_TARGETS	93	http://www.broadinstitute.org/gsea/msigdb/cards/KONG_E2F3_TARGETS	-0.77683	-1.595	0.01008	0.27791	0.984	0.495	0.0788	0.457	0.18294	0.043
DURCHDEWALD_SKIN_CARCINOGENESIS_UP	85	http://www.broadinstitute.org/gsea/msigdb/cards/DURCHDEWALD_SKIN_CARCINOGENESIS_UP	-0.38767	-1.5947	0.01012	0.27698	0.984	0.282	0.183	0.232	0.18173	0.043
PETROVA_PROX1_TARGETS_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_PROX1_TARGETS_UP	-0.75376	-1.5929	0.004107	0.28044	0.987	0.444	0.091	0.404	0.183	0.043
WHITFIELD_CELL_CYCLE_G2_M	204	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G2_M	-0.5591	-1.5921	0.00996	0.28119	0.988	0.338	0.171	0.283	0.18619	0.043
FURUKAWA_DUSP6_TARGETS_PCI35_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/FURUKAWA_DUSP6_TARGETS_PCI35_DN	-0.70787	-1.5914	0.01188	0.281	0.988	0.377	0.0566	0.356	0.18715	0.043
NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/NATSUME_RESPONSE_TO_INTERFERON_BETA_UP	-0.47551	-1.591	0.004	0.28008	0.989	0.239	0.0972	0.217	0.18774	0.043
SASAKI_ADULT_T_CELL_LEUKEMIA	169	http://www.broadinstitute.org/gsea/msigdb/cards/SASAKI_ADULT_T_CELL_LEUKEMIA	-0.53849	-1.5905	0.02032	0.27962	0.989	0.325	0.141	0.282	0.18704	0.043
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	168	http://www.broadinstitute.org/gsea/msigdb/cards/SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-0.63038	-1.5901	0.01829	0.2789	0.989	0.375	0.0917	0.343	0.18585	0.043
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP	-0.57322	-1.5901	0.032	0.27714	0.989	0.37	0.144	0.317	0.18467	0.043
BIOCARTA_IL22BP_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL22BP_PATHWAY	-0.45023	-1.5896	0.02066	0.27671	0.989	0.267	0.216	0.209	0.18376	0.043
DORN_ADENOVIRUS_INFECTION_12HR_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_12HR_DN	-0.48615	-1.5895	0.04427	0.2751	0.989	0.515	0.232	0.396	0.18285	0.043
POOLA_INVASIVE_BREAST_CANCER_UP	267	http://www.broadinstitute.org/gsea/msigdb/cards/POOLA_INVASIVE_BREAST_CANCER_UP	-0.57613	-1.5894	0.006224	0.27368	0.989	0.352	0.16	0.299	0.18254	0.043
LIAO_HAVE_SOX4_BINDING_SITES	39	http://www.broadinstitute.org/gsea/msigdb/cards/LIAO_HAVE_SOX4_BINDING_SITES	-0.55514	-1.5876	0.03095	0.27662	0.99	0.538	0.197	0.433	0.18592	0.043
FERRANDO_HOX11_NEIGHBORS	23	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_HOX11_NEIGHBORS	-0.56213	-1.5872	0.02692	0.27581	0.99	0.565	0.234	0.434	0.18604	0.043
REACTOME_RNA_POL_I_TRANSCRIPTION	65	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_TRANSCRIPTION	-0.56835	-1.5871	0.02868	0.27453	0.99	0.385	0.137	0.333	0.18623	0.043
GAVIN_FOXP3_TARGETS_CLUSTER_P6	89	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P6	-0.64769	-1.5864	0.01581	0.27454	0.99	0.449	0.124	0.395	0.18701	0.043
HU_GENOTOXIC_DAMAGE_4HR	34	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIC_DAMAGE_4HR	-0.67958	-1.5861	0.008032	0.27388	0.99	0.382	0.0901	0.348	0.1865	0.043
MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN	-0.43226	-1.5858	0.0377	0.27275	0.99	0.174	0.104	0.156	0.18608	0.043
REACTOME_RNA_POL_I_PROMOTER_OPENING	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_PROMOTER_OPENING	-0.6653	-1.5857	0.03095	0.27139	0.99	0.537	0.137	0.464	0.18548	0.043
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-0.45561	-1.5844	0.05098	0.27348	0.99	0.318	0.221	0.248	0.18592	0.043
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP	-0.4023	-1.5843	0.02386	0.27192	0.99	0.305	0.189	0.249	0.18482	0.043
REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS	-0.51027	-1.5812	0.05315	0.27882	0.993	0.474	0.268	0.347	0.18846	0.043
JACKSON_DNMT1_TARGETS_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/JACKSON_DNMT1_TARGETS_UP	-0.48837	-1.581	0.05242	0.27763	0.993	0.333	0.224	0.259	0.18736	0.043
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-0.64632	-1.5802	0.032	0.27789	0.993	0.396	0.122	0.349	0.18773	0.043
WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	343	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN	-0.51442	-1.5802	0.01172	0.27651	0.993	0.3	0.126	0.266	0.18665	0.043
DORN_ADENOVIRUS_INFECTION_24HR_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_24HR_DN	-0.48368	-1.58	0.04826	0.27553	0.993	0.419	0.233	0.322	0.1862	0.043
REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS	-0.39556	-1.5791	0.03516	0.27619	0.993	0.26	0.176	0.215	0.1875	0.043
PID_PLK1_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PLK1_PATHWAY	-0.76134	-1.579	0.01623	0.27506	0.993	0.442	0.0836	0.406	0.18676	0.043
REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING	-0.40339	-1.5783	0.04143	0.275	0.993	0.452	0.241	0.343	0.18619	0.043
RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	37	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_CCNE1	-0.41325	-1.5778	0.03366	0.27464	0.993	0.405	0.253	0.303	0.18594	0.043
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	177	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-0.65061	-1.5768	0.01403	0.27548	0.993	0.48	0.148	0.412	0.18705	0.043
MARKEY_RB1_ACUTE_LOF_DN	220	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_DN	-0.56873	-1.5759	0.01205	0.27639	0.993	0.436	0.162	0.369	0.18663	0.043
REACTOME_CHROMOSOME_MAINTENANCE	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHROMOSOME_MAINTENANCE	-0.55487	-1.5758	0.01807	0.27509	0.993	0.429	0.183	0.352	0.18572	0.043
DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	296	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_UP	-0.31065	-1.5752	0.0668	0.27509	0.993	0.351	0.287	0.253	0.18516	0.043
HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	49	http://www.broadinstitute.org/gsea/msigdb/cards/HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR	-0.42899	-1.5747	0.01837	0.27498	0.993	0.429	0.267	0.315	0.18501	0.043
PID_E2F_PATHWAY	72	http://www.broadinstitute.org/gsea/msigdb/cards/PID_E2F_PATHWAY	-0.51945	-1.5738	0.02724	0.27574	0.993	0.5	0.225	0.389	0.18581	0.043
BROWNE_HCMV_INFECTION_8HR_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_8HR_DN	-0.49613	-1.5727	0.01758	0.27709	0.994	0.326	0.216	0.256	0.18501	0.043
CHANG_CYCLING_GENES	143	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CYCLING_GENES	-0.73689	-1.5723	0.01195	0.27675	0.994	0.51	0.0947	0.465	0.1863	0.043
MULLIGHAN_MLL_SIGNATURE_1_UP	352	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_1_UP	-0.29209	-1.5722	0.01804	0.27535	0.994	0.344	0.29	0.247	0.18531	0.043
LINDSTEDT_DENDRITIC_CELL_MATURATION_B	49	http://www.broadinstitute.org/gsea/msigdb/cards/LINDSTEDT_DENDRITIC_CELL_MATURATION_B	-0.52742	-1.5715	0.07087	0.27562	0.994	0.429	0.196	0.345	0.18807	0.043
LU_TUMOR_VASCULATURE_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_VASCULATURE_UP	-0.56247	-1.5713	0.02692	0.27503	0.994	0.286	0.107	0.255	0.18708	0.043
YE_METASTATIC_LIVER_CANCER	26	http://www.broadinstitute.org/gsea/msigdb/cards/YE_METASTATIC_LIVER_CANCER	-0.50984	-1.571	0.006012	0.27404	0.994	0.115	0.00413	0.115	0.18616	0.043
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	30	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-0.48146	-1.5708	0.0593	0.27298	0.994	0.6	0.274	0.436	0.18526	0.043
REN_BOUND_BY_E2F	60	http://www.broadinstitute.org/gsea/msigdb/cards/REN_BOUND_BY_E2F	-0.73942	-1.5708	0.01639	0.27026	0.994	0.533	0.0944	0.484	0.18335	0.043
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	111	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	-0.36461	-1.5708	0.01597	0.27162	0.994	0.27	0.197	0.218	0.1843	0.043
KORKOLA_TERATOMA	39	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_TERATOMA	-0.59929	-1.5683	0.01174	0.2754	0.994	0.282	0.0609	0.265	0.18666	0.046
VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	49	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_POOR_PROGNOSIS	-0.64415	-1.5682	0.02353	0.27414	0.994	0.306	0.0527	0.291	0.18571	0.043
ZAMORA_NOS2_TARGETS_DN	94	http://www.broadinstitute.org/gsea/msigdb/cards/ZAMORA_NOS2_TARGETS_DN	-0.31385	-1.5676	0.03269	0.27433	0.996	0.404	0.311	0.28	0.1854	0.043
YAMAZAKI_TCEB3_TARGETS_DN	208	http://www.broadinstitute.org/gsea/msigdb/cards/YAMAZAKI_TCEB3_TARGETS_DN	-0.48983	-1.5671	0.007984	0.27402	0.996	0.264	0.134	0.231	0.18446	0.043
REACTOME_PACKAGING_OF_TELOMERE_ENDS	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PACKAGING_OF_TELOMERE_ENDS	-0.6398	-1.5665	0.03119	0.27405	0.996	0.639	0.208	0.507	0.18384	0.046
JACKSON_DNMT1_TARGETS_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/JACKSON_DNMT1_TARGETS_DN	-0.5327	-1.5665	0.05234	0.27282	0.996	0.36	0.0925	0.327	0.18292	0.043
LI_AMPLIFIED_IN_LUNG_CANCER	172	http://www.broadinstitute.org/gsea/msigdb/cards/LI_AMPLIFIED_IN_LUNG_CANCER	-0.39514	-1.5658	0.05653	0.27315	0.996	0.32	0.192	0.26	0.18417	0.046
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	180	http://www.broadinstitute.org/gsea/msigdb/cards/ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-0.4516	-1.5655	0.02339	0.27265	0.996	0.306	0.172	0.255	0.1838	0.043
JISON_SICKLE_CELL_DISEASE_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/JISON_SICKLE_CELL_DISEASE_UP	-0.41688	-1.5644	0.03125	0.27413	0.996	0.308	0.17	0.258	0.18382	0.043
REACTOME_ELONGATION_ARREST_AND_RECOVERY	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ELONGATION_ARREST_AND_RECOVERY	-0.52672	-1.5637	0.02429	0.27452	0.996	0.429	0.239	0.327	0.1831	0.043
EINAV_INTERFERON_SIGNATURE_IN_CANCER	26	http://www.broadinstitute.org/gsea/msigdb/cards/EINAV_INTERFERON_SIGNATURE_IN_CANCER	-0.74813	-1.5629	0.07157	0.27399	0.996	0.538	0.116	0.477	0.18601	0.043
LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	15	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES	-0.50615	-1.5629	0.03543	0.27506	0.996	0.4	0.238	0.305	0.18634	0.043
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	61	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_4NQO_OR_UV	-0.39616	-1.5627	0.02669	0.27322	0.996	0.459	0.258	0.342	0.18637	0.043
REACTOME_G0_AND_EARLY_G1	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G0_AND_EARLY_G1	-0.7585	-1.5625	0.01772	0.27246	0.996	0.591	0.101	0.532	0.18547	0.043
KAMMINGA_SENESCENCE	37	http://www.broadinstitute.org/gsea/msigdb/cards/KAMMINGA_SENESCENCE	-0.44961	-1.5624	0.06522	0.27143	0.996	0.243	0.151	0.207	0.18526	0.043
BIOCARTA_MAL_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MAL_PATHWAY	-0.5343	-1.5623	0.02935	0.27042	0.996	0.579	0.324	0.392	0.18544	0.043
SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	433	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6	-0.61853	-1.5621	0.03131	0.26945	0.996	0.413	0.127	0.367	0.18473	0.043
APPIERTO_RESPONSE_TO_FENRETINIDE_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/APPIERTO_RESPONSE_TO_FENRETINIDE_UP	-0.52662	-1.562	0.04268	0.26826	0.996	0.263	0.0953	0.238	0.18386	0.04
SHIN_B_CELL_LYMPHOMA_CLUSTER_9	19	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_9	-0.60436	-1.5614	0.03992	0.26857	0.996	0.211	0.041	0.202	0.18336	0.043
REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE	-0.62583	-1.5612	0.0293	0.26795	0.996	0.469	0.135	0.407	0.18564	0.04
PID_INTEGRIN_A4B1_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN_A4B1_PATHWAY	-0.5225	-1.5611	0.02935	0.26574	0.996	0.242	0.115	0.215	0.18392	0.039
WHITEFORD_PEDIATRIC_CANCER_MARKERS	113	http://www.broadinstitute.org/gsea/msigdb/cards/WHITEFORD_PEDIATRIC_CANCER_MARKERS	-0.72246	-1.5611	0.02434	0.26691	0.996	0.496	0.0917	0.452	0.18477	0.04
SMIRNOV_RESPONSE_TO_IR_6HR_DN	109	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_RESPONSE_TO_IR_6HR_DN	-0.51204	-1.5595	0.04062	0.26846	0.996	0.202	0.0721	0.188	0.18461	0.043
DELPUECH_FOXO3_TARGETS_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/DELPUECH_FOXO3_TARGETS_DN	-0.6278	-1.5594	0.02376	0.26783	0.996	0.447	0.168	0.373	0.18376	0.043
REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAF6_MEDIATED_NFKB_ACTIVATION	-0.54563	-1.5583	0.0203	0.2689	0.998	0.238	0.107	0.213	0.18428	0.043
TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN	-0.5184	-1.5582	0.04365	0.26788	0.998	0.438	0.197	0.351	0.18344	0.042
GOLUB_ALL_VS_AML_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/GOLUB_ALL_VS_AML_DN	-0.48935	-1.5582	0.0701	0.2667	0.998	0.455	0.321	0.309	0.18261	0.038
CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP	-0.54463	-1.5579	0.009108	0.26622	0.998	0.731	0.282	0.525	0.18207	0.035
CUI_TCF21_TARGETS_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_UP	-0.53241	-1.5574	0.01676	0.26618	0.998	0.162	0.0251	0.158	0.18195	0.038
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	98	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP	-0.4549	-1.557	0.01751	0.26588	0.998	0.296	0.182	0.243	0.18134	0.038
BENPORATH_ES_2	39	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_2	-0.50692	-1.5569	0.05098	0.26502	0.998	0.282	0.115	0.25	0.18142	0.035
LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN	-0.57006	-1.5566	0.009766	0.26464	0.998	0.312	0.119	0.275	0.18062	0.038
BIOCARTA_STATHMIN_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_STATHMIN_PATHWAY	-0.57549	-1.5565	0.01698	0.26384	0.998	0.263	0.0931	0.239	0.17982	0.038
BIOCARTA_IL10_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL10_PATHWAY	-0.48342	-1.5564	0.02449	0.26285	0.998	0.125	0.0138	0.123	0.17904	0.038
ODONNELL_TFRC_TARGETS_DN	129	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TFRC_TARGETS_DN	-0.66217	-1.5561	0.02335	0.26228	0.998	0.395	0.0836	0.364	0.17825	0.038
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-0.67216	-1.5561	0.0551	0.26117	0.998	0.56	0.159	0.472	0.17748	0.038
MISSIAGLIA_REGULATED_BY_METHYLATION_DN	116	http://www.broadinstitute.org/gsea/msigdb/cards/MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-0.67281	-1.556	0.03292	0.2601	0.998	0.638	0.219	0.5	0.17671	0.035
MORI_MATURE_B_LYMPHOCYTE_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_MATURE_B_LYMPHOCYTE_DN	-0.46965	-1.5557	0.02213	0.25996	0.998	0.438	0.213	0.346	0.17756	0.035
REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	96	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_RNA_POL_III_AND_MITOCHONDRIAL_TRANSCRIPTION	-0.49743	-1.5556	0.04356	0.25894	0.998	0.479	0.263	0.354	0.1768	0.033
PID_ATR_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATR_PATHWAY	-0.64415	-1.5555	0.005703	0.25815	0.998	0.41	0.0813	0.377	0.17622	0.033
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	123	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-0.52866	-1.5551	0.02976	0.25791	0.998	0.35	0.159	0.295	0.17748	0.033
CHEOK_RESPONSE_TO_HD_MTX_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHEOK_RESPONSE_TO_HD_MTX_UP	-0.57494	-1.554	0.03018	0.25938	0.998	0.211	0.0543	0.199	0.17897	0.033
CROONQUIST_NRAS_SIGNALING_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_SIGNALING_DN	-0.77036	-1.5535	0.01629	0.25966	0.998	0.569	0.118	0.504	0.18089	0.033
CROMER_TUMORIGENESIS_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_TUMORIGENESIS_DN	-0.44309	-1.553	0.03043	0.25984	0.998	0.367	0.246	0.278	0.18032	0.033
FUJII_YBX1_TARGETS_DN	195	http://www.broadinstitute.org/gsea/msigdb/cards/FUJII_YBX1_TARGETS_DN	-0.59443	-1.5521	0.02032	0.2608	0.999	0.431	0.162	0.364	0.17995	0.033
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	161	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-0.6197	-1.5514	0.02041	0.26154	0.999	0.466	0.157	0.395	0.18178	0.036
CROONQUIST_IL6_DEPRIVATION_DN	97	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_IL6_DEPRIVATION_DN	-0.75374	-1.5513	0.02675	0.26071	0.999	0.454	0.0652	0.426	0.18102	0.036
MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN	-0.52371	-1.551	0.03762	0.26027	0.999	0.346	0.169	0.288	0.18028	0.036
TERAMOTO_OPN_TARGETS_CLUSTER_7	16	http://www.broadinstitute.org/gsea/msigdb/cards/TERAMOTO_OPN_TARGETS_CLUSTER_7	-0.53703	-1.5509	0.03785	0.25932	0.999	0.562	0.316	0.385	0.17953	0.036
LEE_EARLY_T_LYMPHOCYTE_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_EARLY_T_LYMPHOCYTE_UP	-0.74955	-1.5506	0.0193	0.25896	0.999	0.392	0.0238	0.384	0.17922	0.036
UROSEVIC_RESPONSE_TO_IMIQUIMOD	23	http://www.broadinstitute.org/gsea/msigdb/cards/UROSEVIC_RESPONSE_TO_IMIQUIMOD	-0.66768	-1.549	0.08187	0.2614	0.999	0.522	0.152	0.443	0.18214	0.036
CAFFAREL_RESPONSE_TO_THC_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_DN	-0.54553	-1.5477	0.04234	0.26378	0.999	0.3	0.122	0.264	0.18364	0.036
BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	74	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE	-0.60361	-1.5471	0.05837	0.2643	0.999	0.541	0.2	0.434	0.18437	0.036
PID_TNF_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TNF_PATHWAY	-0.51418	-1.5464	0.06526	0.26509	0.999	0.378	0.191	0.306	0.18363	0.036
ZHU_CMV_24_HR_UP	93	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_24_HR_UP	-0.55349	-1.5463	0.04918	0.26408	0.999	0.484	0.198	0.389	0.18289	0.036
ROESSLER_LIVER_CANCER_METASTASIS_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/ROESSLER_LIVER_CANCER_METASTASIS_UP	-0.37782	-1.5459	0.02218	0.26381	0.999	0.225	0.16	0.19	0.18216	0.036
NABA_PROTEOGLYCANS	35	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_PROTEOGLYCANS	-0.517	-1.5449	0.06844	0.26508	0.999	0.314	0.168	0.262	0.18269	0.036
REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OTHER_SEMAPHORIN_INTERACTIONS	-0.56043	-1.5442	0.04582	0.26551	0.999	0.4	0.189	0.324	0.18531	0.038
BENPORATH_PROLIFERATION	137	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_PROLIFERATION	-0.72323	-1.5435	0.008016	0.26636	0.999	0.54	0.126	0.474	0.18649	0.036
REACTOME_TELOMERE_MAINTENANCE	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TELOMERE_MAINTENANCE	-0.57605	-1.5431	0.04356	0.26646	0.999	0.333	0.0892	0.304	0.18608	0.036
BURTON_ADIPOGENESIS_PEAK_AT_16HR	40	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_16HR	-0.64341	-1.5427	0.02817	0.26615	0.999	0.6	0.201	0.48	0.18719	0.036
LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	306	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_3_UP	-0.58564	-1.5417	0.02734	0.26765	0.999	0.369	0.128	0.326	0.18692	0.037
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	136	http://www.broadinstitute.org/gsea/msigdb/cards/ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-0.7882	-1.5411	0.03239	0.26795	0.999	0.64	0.127	0.561	0.18698	0.037
YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN	-0.54845	-1.5405	0.05503	0.26848	0.999	0.706	0.311	0.486	0.18793	0.037
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN	-0.72371	-1.5402	0.01372	0.26799	0.999	0.45	0.0963	0.407	0.1872	0.037
TANG_SENESCENCE_TP53_TARGETS_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/TANG_SENESCENCE_TP53_TARGETS_DN	-0.77629	-1.5399	0.01031	0.26765	0.999	0.571	0.091	0.521	0.18648	0.037
REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSCRIPTION_COUPLED_NER_TC_NER	-0.45934	-1.5394	0.06814	0.26796	0.999	0.233	0.14	0.2	0.18769	0.036
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	-0.75403	-1.5378	0.03482	0.27085	1	0.4	0.0238	0.391	0.18993	0.037
MISSIAGLIA_REGULATED_BY_METHYLATION_UP	122	http://www.broadinstitute.org/gsea/msigdb/cards/MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-0.43481	-1.5373	0.08721	0.271	1	0.32	0.177	0.264	0.19014	0.036
ZHU_CMV_8_HR_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_8_HR_UP	-0.55884	-1.5371	0.07129	0.27033	1	0.37	0.116	0.327	0.19073	0.036
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	53	http://www.broadinstitute.org/gsea/msigdb/cards/MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-0.77103	-1.5358	0.007782	0.27208	1	0.566	0.0947	0.513	0.1923	0.037
SABATES_COLORECTAL_ADENOMA_UP	125	http://www.broadinstitute.org/gsea/msigdb/cards/SABATES_COLORECTAL_ADENOMA_UP	-0.42715	-1.5354	0.02761	0.27175	1	0.264	0.169	0.221	0.1918	0.037
RIZ_ERYTHROID_DIFFERENTIATION	72	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION	-0.51084	-1.5352	0.06324	0.27117	1	0.486	0.253	0.364	0.19108	0.037
LY_AGING_OLD_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_OLD_DN	-0.61222	-1.5347	0.03953	0.27127	1	0.564	0.184	0.461	0.19119	0.037
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	-0.48764	-1.5345	0.05098	0.27088	1	0.286	0.168	0.238	0.19108	0.037
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	73	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE	-0.40637	-1.5337	0.01606	0.27147	1	0.425	0.28	0.306	0.19081	0.037
MURAKAMI_UV_RESPONSE_6HR_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_6HR_UP	-0.43571	-1.5335	0.05871	0.27097	1	0.389	0.191	0.315	0.19027	0.037
BROWNE_INTERFERON_RESPONSIVE_GENES	64	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_INTERFERON_RESPONSIVE_GENES	-0.64363	-1.5328	0.08238	0.27168	1	0.531	0.172	0.441	0.19034	0.037
DER_IFN_ALPHA_RESPONSE_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/DER_IFN_ALPHA_RESPONSE_UP	-0.54042	-1.5325	0.1059	0.27126	1	0.338	0.136	0.293	0.19205	0.036
WANG_BARRETTS_ESOPHAGUS_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_DN	-0.58571	-1.5312	0.03808	0.27362	1	0.32	0.0752	0.296	0.19387	0.037
NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/NEMETH_INFLAMMATORY_RESPONSE_LPS_DN	-0.58361	-1.5311	0.03282	0.27294	1	0.219	0.00775	0.217	0.19316	0.037
REACTOME_EGFR_DOWNREGULATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EGFR_DOWNREGULATION	-0.4028	-1.5305	0.05198	0.27336	1	0.583	0.339	0.386	0.19463	0.036
VERNELL_RETINOBLASTOMA_PATHWAY_UP	69	http://www.broadinstitute.org/gsea/msigdb/cards/VERNELL_RETINOBLASTOMA_PATHWAY_UP	-0.62817	-1.5304	0.02569	0.27175	1	0.377	0.0836	0.346	0.19323	0.036
RHODES_UNDIFFERENTIATED_CANCER	68	http://www.broadinstitute.org/gsea/msigdb/cards/RHODES_UNDIFFERENTIATED_CANCER	-0.70554	-1.5304	0.02484	0.27261	1	0.632	0.184	0.518	0.19393	0.036
BIOCARTA_BCELLSURVIVAL_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BCELLSURVIVAL_PATHWAY	-0.5821	-1.5298	0.0451	0.27229	1	0.375	0.155	0.317	0.19388	0.036
CHANG_POU5F1_TARGETS_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_POU5F1_TARGETS_UP	-0.63244	-1.5295	0.07514	0.27207	1	0.6	0.237	0.458	0.19424	0.036
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	70	http://www.broadinstitute.org/gsea/msigdb/cards/ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	-0.40189	-1.5288	0.06814	0.27276	1	0.343	0.224	0.267	0.19648	0.036
SESTO_RESPONSE_TO_UV_C4	20	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C4	-0.54628	-1.5286	0.02687	0.27231	1	0.4	0.123	0.351	0.19591	0.036
JAEGER_METASTASIS_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/JAEGER_METASTASIS_UP	-0.69479	-1.5284	0.02767	0.27186	1	0.564	0.181	0.463	0.19521	0.036
ZHU_CMV_ALL_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_ALL_UP	-0.5242	-1.528	0.04704	0.27174	1	0.42	0.178	0.347	0.19618	0.036
GRUETZMANN_PANCREATIC_CANCER_UP	347	http://www.broadinstitute.org/gsea/msigdb/cards/GRUETZMANN_PANCREATIC_CANCER_UP	-0.46041	-1.5276	0.058	0.27186	1	0.34	0.17	0.286	0.19616	0.036
PID_FGF_PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FGF_PATHWAY	-0.42011	-1.5271	0.04037	0.27117	1	0.0926	0.0165	0.0913	0.19542	0.036
ZHAN_MULTIPLE_MYELOMA_HP_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_HP_DN	-0.51645	-1.5271	0.0835	0.2719	1	0.381	0.159	0.321	0.19575	0.036
SA_B_CELL_RECEPTOR_COMPLEXES	24	http://www.broadinstitute.org/gsea/msigdb/cards/SA_B_CELL_RECEPTOR_COMPLEXES	-0.50071	-1.527	0.05812	0.27039	1	0.583	0.322	0.396	0.19474	0.036
ZAMORA_NOS2_TARGETS_UP	66	http://www.broadinstitute.org/gsea/msigdb/cards/ZAMORA_NOS2_TARGETS_UP	-0.47467	-1.5259	0.03232	0.27177	1	0.53	0.253	0.397	0.195	0.036
LEE_AGING_CEREBELLUM_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_CEREBELLUM_UP	-0.39679	-1.5246	0.0749	0.27412	1	0.183	0.124	0.161	0.19785	0.036
JIANG_TIP30_TARGETS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_TIP30_TARGETS_DN	-0.52563	-1.5241	0.08713	0.27422	1	0.391	0.199	0.314	0.19717	0.037
WIERENGA_STAT5A_TARGETS_GROUP2	57	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_GROUP2	-0.50173	-1.5238	0.05058	0.27409	1	0.333	0.153	0.283	0.19678	0.037
JAEGER_METASTASIS_DN	252	http://www.broadinstitute.org/gsea/msigdb/cards/JAEGER_METASTASIS_DN	-0.37306	-1.5237	0.01515	0.27249	1	0.234	0.14	0.203	0.19544	0.037
KAMMINGA_EZH2_TARGETS	41	http://www.broadinstitute.org/gsea/msigdb/cards/KAMMINGA_EZH2_TARGETS	-0.78808	-1.5237	0.02395	0.27342	1	0.537	0.0892	0.49	0.19611	0.037
XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	19	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR	-0.64201	-1.5235	0.06707	0.27196	1	0.684	0.275	0.496	0.19478	0.037
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.48224	-1.5227	0.07968	0.27228	1	0.441	0.254	0.33	0.19776	0.036
KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP	-0.54493	-1.5227	0.01676	0.27314	1	0.273	0.0849	0.25	0.19843	0.037
CHESLER_BRAIN_QTL_CIS	71	http://www.broadinstitute.org/gsea/msigdb/cards/CHESLER_BRAIN_QTL_CIS	-0.43086	-1.5226	0.02584	0.27159	1	0.324	0.156	0.274	0.1971	0.035
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP	-0.46779	-1.522	0.09751	0.27182	1	0.375	0.237	0.287	0.1965	0.036
REACTOME_G2_M_CHECKPOINTS	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G2_M_CHECKPOINTS	-0.76799	-1.5212	0.006073	0.27293	1	0.561	0.106	0.502	0.19658	0.036
KYNG_RESPONSE_TO_H2O2	70	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2	-0.40044	-1.5209	0.04852	0.2726	1	0.329	0.227	0.255	0.19592	0.036
PID_IL8_CXCR2_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL8_CXCR2_PATHWAY	-0.36627	-1.5206	0.03049	0.2723	1	0.455	0.29	0.323	0.19605	0.036
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	146	http://www.broadinstitute.org/gsea/msigdb/cards/SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-0.74613	-1.5204	0.0396	0.27188	1	0.589	0.123	0.52	0.19541	0.036
REACTOME_DNA_REPLICATION	183	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_REPLICATION	-0.60264	-1.5197	0.046	0.27265	1	0.426	0.163	0.359	0.19718	0.036
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	-0.48789	-1.5195	0.03622	0.27224	1	0.457	0.211	0.361	0.19654	0.036
PENG_RAPAMYCIN_RESPONSE_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_RAPAMYCIN_RESPONSE_UP	-0.2994	-1.5183	0.02312	0.2737	1	0.0785	0.0398	0.076	0.19871	0.036
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN	-0.63732	-1.5174	0.05762	0.27523	1	0.4	0.147	0.341	0.19861	0.036
JIANG_HYPOXIA_CANCER	78	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_HYPOXIA_CANCER	-0.45016	-1.5162	0.04208	0.27697	1	0.346	0.202	0.277	0.19998	0.036
LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	104	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT	-0.46956	-1.5154	0.07525	0.27813	1	0.346	0.161	0.292	0.20006	0.036
PRAMOONJAGO_SOX4_TARGETS_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/PRAMOONJAGO_SOX4_TARGETS_DN	-0.50555	-1.515	0.06786	0.27811	1	0.28	0.118	0.248	0.1997	0.036
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	-0.47155	-1.5148	0.04348	0.27766	1	0.449	0.219	0.351	0.2015	0.036
JOHNSTONE_PARVB_TARGETS_2_UP	129	http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_2_UP	-0.38629	-1.5147	0.09553	0.27685	1	0.364	0.25	0.274	0.20086	0.036
REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS	-0.74929	-1.5139	0.03953	0.27712	1	0.514	0.0991	0.464	0.20065	0.036
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	280	http://www.broadinstitute.org/gsea/msigdb/cards/DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN	-0.31634	-1.5139	0.04781	0.27624	1	0.232	0.191	0.19	0.20001	0.036
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	63	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM	-0.46825	-1.5139	0.08087	0.27794	1	0.333	0.191	0.27	0.20129	0.036
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN	-0.59728	-1.5137	0.05048	0.27586	1	0.389	0.139	0.335	0.19938	0.036
WHITFIELD_CELL_CYCLE_LITERATURE	44	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_LITERATURE	-0.7782	-1.5136	0.02414	0.27532	1	0.705	0.159	0.593	0.19875	0.036
PENG_GLUCOSE_DEPRIVATION_DN	162	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUCOSE_DEPRIVATION_DN	-0.43013	-1.5131	0.04032	0.27544	1	0.364	0.232	0.281	0.19892	0.036
REACTOME_CELL_CYCLE	380	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE	-0.52986	-1.5129	0.03823	0.27518	1	0.395	0.173	0.331	0.19829	0.036
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	86	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-0.73295	-1.5127	0.03945	0.27466	1	0.477	0.0616	0.449	0.19807	0.036
ISHIDA_E2F_TARGETS	51	http://www.broadinstitute.org/gsea/msigdb/cards/ISHIDA_E2F_TARGETS	-0.81951	-1.5121	0.01633	0.27506	1	0.608	0.0699	0.566	0.19785	0.036
SCIBETTA_KDM5B_TARGETS_DN	76	http://www.broadinstitute.org/gsea/msigdb/cards/SCIBETTA_KDM5B_TARGETS_DN	-0.57932	-1.5118	0.02834	0.27495	1	0.447	0.164	0.375	0.19723	0.036
SMID_BREAST_CANCER_LUMINAL_A_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_LUMINAL_A_DN	-0.78747	-1.5118	0.0503	0.27421	1	0.556	0.117	0.491	0.19662	0.035
MAHADEVAN_RESPONSE_TO_MP470_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_RESPONSE_TO_MP470_UP	-0.7001	-1.5116	0.07551	0.27375	1	0.368	0.077	0.34	0.19602	0.035
ZHAN_MULTIPLE_MYELOMA_SPIKED	21	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_SPIKED	-0.60097	-1.5115	0.03918	0.27332	1	0.333	0.101	0.3	0.19541	0.035
DEMAGALHAES_AGING_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/DEMAGALHAES_AGING_DN	-0.70172	-1.5112	0.01957	0.273	1	0.467	0.147	0.398	0.19529	0.035
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-0.5335	-1.5094	0.06352	0.27558	1	0.525	0.228	0.407	0.19836	0.035
SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP	-0.4782	-1.5094	0.0651	0.27621	1	0.28	0.163	0.234	0.19897	0.036
AMUNDSON_GAMMA_RADIATION_RESPONSE	39	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GAMMA_RADIATION_RESPONSE	-0.77816	-1.5087	0.004219	0.27624	1	0.513	0.091	0.467	0.1991	0.036
CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	30	http://www.broadinstitute.org/gsea/msigdb/cards/CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN	-0.45378	-1.5077	0.003945	0.2776	1	0.2	0.0788	0.184	0.19911	0.036
YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP	-0.46256	-1.5068	0.07393	0.27864	1	0.524	0.251	0.393	0.19904	0.036
NAKAMURA_CANCER_MICROENVIRONMENT_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_CANCER_MICROENVIRONMENT_DN	-0.64977	-1.5066	0.0336	0.27829	1	0.535	0.177	0.441	0.19941	0.036
REACTOME_CHOLESTEROL_BIOSYNTHESIS	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHOLESTEROL_BIOSYNTHESIS	-0.66043	-1.5064	0.03955	0.27812	1	0.476	0.163	0.399	0.19983	0.036
KANG_DOXORUBICIN_RESISTANCE_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_DOXORUBICIN_RESISTANCE_UP	-0.8567	-1.5056	0.01025	0.27891	1	0.712	0.0694	0.663	0.20101	0.036
FOURNIER_ACINAR_DEVELOPMENT_LATE_2	265	http://www.broadinstitute.org/gsea/msigdb/cards/FOURNIER_ACINAR_DEVELOPMENT_LATE_2	-0.56395	-1.5034	0.04536	0.28318	1	0.4	0.147	0.345	0.20522	0.039
REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS	-0.52872	-1.5033	0.03414	0.28279	1	0.312	0.129	0.272	0.20506	0.039
REACTOME_DNA_STRAND_ELONGATION	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_STRAND_ELONGATION	-0.71062	-1.5025	0.05368	0.28385	1	0.4	0.0801	0.368	0.2065	0.039
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	98	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	-0.51592	-1.502	0.04449	0.28418	1	0.357	0.174	0.296	0.20589	0.039
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	-0.51087	-1.5011	0.0391	0.28539	1	0.269	0.101	0.242	0.20596	0.039
BYSTROEM_CORRELATED_WITH_IL5_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTROEM_CORRELATED_WITH_IL5_UP	-0.40474	-1.5002	0.02896	0.28672	1	0.468	0.333	0.313	0.2072	0.039
ZHANG_INTERFERON_RESPONSE	23	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_INTERFERON_RESPONSE	-0.71036	-1.4988	0.1096	0.28911	1	0.696	0.199	0.558	0.20974	0.039
MORI_IMMATURE_B_LYMPHOCYTE_DN	90	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_IMMATURE_B_LYMPHOCYTE_DN	-0.67581	-1.4975	0.06491	0.2911	1	0.522	0.14	0.451	0.21111	0.039
KEGG_HOMOLOGOUS_RECOMBINATION	28	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HOMOLOGOUS_RECOMBINATION	-0.59053	-1.4971	0.05315	0.29113	1	0.393	0.173	0.325	0.21076	0.039
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	163	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	-0.41002	-1.4971	0.05556	0.29044	1	0.307	0.172	0.255	0.21014	0.039
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-0.73382	-1.4952	0.026	0.29379	1	0.523	0.0794	0.482	0.21232	0.043
ST_GA12_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/ST_GA12_PATHWAY	-0.46255	-1.4948	0.03301	0.29394	1	0.304	0.181	0.249	0.21418	0.043
ZHENG_RESPONSE_TO_ARSENITE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_RESPONSE_TO_ARSENITE_DN	-0.55138	-1.4934	0.03307	0.29661	1	0.25	0.0346	0.242	0.21611	0.043
STEIN_ESR1_TARGETS	83	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESR1_TARGETS	-0.45152	-1.4922	0.05159	0.29869	1	0.289	0.144	0.248	0.21755	0.043
WALLACE_PROSTATE_CANCER_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_PROSTATE_CANCER_UP	-0.49649	-1.4918	0.06291	0.29863	1	0.421	0.207	0.334	0.21714	0.043
OLSSON_E2F3_TARGETS_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/OLSSON_E2F3_TARGETS_DN	-0.61962	-1.491	0.06681	0.29989	1	0.533	0.148	0.455	0.21681	0.043
REACTOME_MITOTIC_PROMETAPHASE	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_PROMETAPHASE	-0.60011	-1.4906	0.04697	0.2998	1	0.432	0.159	0.364	0.21834	0.043
WILLERT_WNT_SIGNALING	22	http://www.broadinstitute.org/gsea/msigdb/cards/WILLERT_WNT_SIGNALING	-0.52912	-1.4905	0.05233	0.29845	1	0.455	0.182	0.372	0.21978	0.043
SONG_TARGETS_OF_IE86_CMV_PROTEIN	59	http://www.broadinstitute.org/gsea/msigdb/cards/SONG_TARGETS_OF_IE86_CMV_PROTEIN	-0.65813	-1.4905	0.07415	0.29916	1	0.627	0.197	0.505	0.2204	0.043
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	152	http://www.broadinstitute.org/gsea/msigdb/cards/FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-0.63143	-1.4899	0.03476	0.29888	1	0.355	0.0776	0.33	0.21938	0.043
DOANE_BREAST_CANCER_ESR1_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_BREAST_CANCER_ESR1_DN	-0.45829	-1.4892	0.05078	0.29967	1	0.234	0.0727	0.217	0.21974	0.043
PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/PACHER_TARGETS_OF_IGF1_AND_IGF2_UP	-0.47582	-1.4891	0.05882	0.29894	1	0.441	0.219	0.345	0.21912	0.043
YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	53	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_METHYLATED_IN_PROSTATE_CANCER	-0.50188	-1.4882	0.02692	0.30025	1	0.208	0.0609	0.195	0.22106	0.04
LANDIS_ERBB2_BREAST_TUMORS_324_DN	146	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_324_DN	-0.34347	-1.4881	0.06844	0.29967	1	0.281	0.195	0.227	0.22102	0.04
ROY_WOUND_BLOOD_VESSEL_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/ROY_WOUND_BLOOD_VESSEL_UP	-0.54969	-1.488	0.09054	0.29823	1	0.391	0.185	0.319	0.21979	0.04
FRIDMAN_SENESCENCE_UP	77	http://www.broadinstitute.org/gsea/msigdb/cards/FRIDMAN_SENESCENCE_UP	-0.42257	-1.488	0.09823	0.29897	1	0.299	0.18	0.246	0.2204	0.04
WILCOX_RESPONSE_TO_PROGESTERONE_UP	144	http://www.broadinstitute.org/gsea/msigdb/cards/WILCOX_RESPONSE_TO_PROGESTERONE_UP	-0.57553	-1.4879	0.03755	0.29762	1	0.424	0.169	0.354	0.21918	0.04
REACTOME_MITOTIC_G1_G1_S_PHASES	128	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_G1_G1_S_PHASES	-0.57338	-1.4876	0.05317	0.29746	1	0.352	0.101	0.318	0.2193	0.04
KEGG_ACUTE_MYELOID_LEUKEMIA	57	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ACUTE_MYELOID_LEUKEMIA	-0.42024	-1.487	0.0142	0.29802	1	0.333	0.213	0.263	0.21879	0.04
LABBE_WNT3A_TARGETS_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_WNT3A_TARGETS_UP	-0.45534	-1.487	0.03633	0.29733	1	0.202	0.0808	0.186	0.21858	0.04
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	-0.52648	-1.4865	0.05709	0.29752	1	0.356	0.168	0.297	0.21957	0.04
LEE_LIVER_CANCER_E2F1_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_E2F1_DN	-0.37974	-1.4863	0.02767	0.29622	1	0.393	0.277	0.285	0.21837	0.04
GUO_HEX_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/GUO_HEX_TARGETS_DN	-0.37274	-1.4863	0.03985	0.29693	1	0.177	0.11	0.158	0.21897	0.04
LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_NEOCORTEX_UP	-0.32132	-1.4851	0.03455	0.29796	1	0.2	0.141	0.172	0.21895	0.04
REACTOME_MITOTIC_M_M_G1_PHASES	163	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_M_M_G1_PHASES	-0.59494	-1.485	0.07451	0.29738	1	0.429	0.163	0.362	0.21836	0.04
MOOTHA_GLYCOLYSIS	20	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_GLYCOLYSIS	-0.54018	-1.485	0.09369	0.29664	1	0.7	0.335	0.466	0.21777	0.04
REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX	-0.4411	-1.4849	0.08398	0.29593	1	0.214	0.112	0.19	0.21718	0.04
RUAN_RESPONSE_TO_TNF_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_DN	-0.28858	-1.4845	0.0224	0.29613	1	0.119	0.125	0.104	0.21669	0.04
PID_SYNDECAN_1_PATHWAY	46	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_1_PATHWAY	-0.46654	-1.4827	0.09242	0.29961	1	0.283	0.178	0.233	0.21915	0.04
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	73	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	-0.36313	-1.4816	0.08765	0.30154	1	0.452	0.32	0.308	0.22082	0.04
MUELLER_METHYLATED_IN_GLIOBLASTOMA	38	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_METHYLATED_IN_GLIOBLASTOMA	-0.4728	-1.4814	0.04898	0.3012	1	0.368	0.218	0.289	0.22057	0.04
DORMOY_ELAVL1_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/DORMOY_ELAVL1_TARGETS	-0.67671	-1.4809	0.04049	0.30136	1	0.375	0.102	0.337	0.22062	0.04
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN	-0.58521	-1.4806	0.06718	0.30139	1	0.278	0.154	0.235	0.2205	0.04
REACTOME_PURINE_METABOLISM	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PURINE_METABOLISM	-0.44841	-1.4802	0.0735	0.30142	1	0.424	0.234	0.326	0.21992	0.04
PLASARI_NFIC_TARGETS_BASAL_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_NFIC_TARGETS_BASAL_DN	-0.53316	-1.4802	0.04167	0.3007	1	0.588	0.294	0.416	0.21934	0.04
DELACROIX_RAR_BOUND_ES	434	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RAR_BOUND_ES	-0.26219	-1.4799	0.01584	0.30042	1	0.23	0.201	0.187	0.21886	0.04
KORKOLA_YOLK_SAC_TUMOR_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_YOLK_SAC_TUMOR_UP	-0.64962	-1.4798	0.09881	0.29989	1	0.632	0.214	0.497	0.21828	0.04
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	21	http://www.broadinstitute.org/gsea/msigdb/cards/DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	-0.45138	-1.4798	0.07312	0.29923	1	0.333	0.248	0.251	0.21771	0.04
REACTOME_SIGNALLING_TO_RAS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_TO_RAS	-0.49504	-1.4792	0.09619	0.29975	1	0.333	0.235	0.255	0.21766	0.04
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	161	http://www.broadinstitute.org/gsea/msigdb/cards/CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN	-0.40156	-1.4792	0.03968	0.299	1	0.311	0.213	0.246	0.2171	0.04
PID_AURORA_A_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AURORA_A_PATHWAY	-0.50161	-1.4788	0.06154	0.29916	1	0.167	0.0307	0.162	0.21693	0.04
PID_A6B1_A6B4_INTEGRIN_PATHWAY	46	http://www.broadinstitute.org/gsea/msigdb/cards/PID_A6B1_A6B4_INTEGRIN_PATHWAY	-0.45142	-1.4787	0.04234	0.29871	1	0.326	0.165	0.273	0.21637	0.04
WORSCHECH_TUMOR_REJECTION_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/WORSCHECH_TUMOR_REJECTION_UP	-0.45186	-1.4785	0.05788	0.2983	1	0.302	0.167	0.252	0.21581	0.04
REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION	-0.66581	-1.4776	0.06349	0.29969	1	0.594	0.14	0.511	0.21821	0.04
GRANDVAUX_IRF3_TARGETS_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/GRANDVAUX_IRF3_TARGETS_UP	-0.76145	-1.477	0.1056	0.30038	1	0.467	0.0404	0.448	0.21814	0.04
KORKOLA_EMBRYONAL_CARCINOMA_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_EMBRYONAL_CARCINOMA_UP	-0.58061	-1.4769	0.0497	0.29966	1	0.5	0.205	0.398	0.21758	0.04
CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_PML_TARGETS_BOUND_BY_MYC_UP	-0.51737	-1.4765	0.05758	0.29986	1	0.478	0.236	0.366	0.21752	0.04
WENG_POR_TARGETS_LIVER_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/WENG_POR_TARGETS_LIVER_UP	-0.4437	-1.4763	0.02988	0.29966	1	0.25	0.134	0.217	0.218	0.04
TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	301	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_PLASMABLAST_DN	-0.53712	-1.4755	0.07831	0.30049	1	0.449	0.215	0.356	0.21842	0.04
YANG_BCL3_TARGETS_UP	348	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BCL3_TARGETS_UP	-0.42956	-1.4753	0.03945	0.30042	1	0.307	0.181	0.255	0.21803	0.04
YU_MYC_TARGETS_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/YU_MYC_TARGETS_UP	-0.77323	-1.475	0.03386	0.30031	1	0.525	0.0588	0.495	0.21748	0.04
REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	106	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOSAMINOGLYCAN_METABOLISM	-0.34564	-1.4749	0.05895	0.2997	1	0.283	0.202	0.227	0.21693	0.04
BAE_BRCA1_TARGETS_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/BAE_BRCA1_TARGETS_UP	-0.40478	-1.4749	0.01547	0.29904	1	0.437	0.221	0.341	0.21639	0.04
HASLINGER_B_CLL_WITH_6Q21_DELETION	17	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_6Q21_DELETION	-0.63868	-1.4746	0.05	0.29881	1	0.647	0.236	0.495	0.21616	0.04
KEGG_LYSOSOME	116	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LYSOSOME	-0.31845	-1.4743	0.03614	0.29865	1	0.233	0.155	0.198	0.21607	0.04
REACTOME_LYSOSOME_VESICLE_BIOGENESIS	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LYSOSOME_VESICLE_BIOGENESIS	-0.43287	-1.4743	0.04464	0.29794	1	0.409	0.282	0.294	0.21553	0.04
SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP	-0.53372	-1.4742	0.0978	0.29736	1	0.182	0.0552	0.172	0.21499	0.04
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	122	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-0.67418	-1.4741	0.02846	0.29686	1	0.475	0.119	0.421	0.21446	0.039
GREENBAUM_E2A_TARGETS_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/GREENBAUM_E2A_TARGETS_UP	-0.77148	-1.4737	0.03647	0.2971	1	0.576	0.0699	0.536	0.21517	0.039
REACTOME_SIGNALLING_TO_ERKS	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_TO_ERKS	-0.47467	-1.4736	0.08087	0.29653	1	0.25	0.175	0.207	0.21511	0.039
LU_TUMOR_ANGIOGENESIS_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_ANGIOGENESIS_UP	-0.63443	-1.473	0.05469	0.29733	1	0.292	0.0606	0.274	0.2166	0.039
SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN	-0.44219	-1.4723	0.04118	0.29805	1	0.39	0.181	0.32	0.21645	0.039
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	-0.58383	-1.4719	0.03984	0.29809	1	0.375	0.143	0.322	0.21671	0.039
REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN	-0.66469	-1.4711	0.06509	0.29924	1	0.467	0.213	0.367	0.21674	0.039
LEE_LIVER_CANCER_DENA_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_DENA_UP	-0.48462	-1.4708	0.06776	0.29931	1	0.466	0.251	0.35	0.21673	0.039
BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	17	http://www.broadinstitute.org/gsea/msigdb/cards/BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX	-0.75364	-1.4696	0.1184	0.30126	1	0.647	0.17	0.538	0.21808	0.039
WEST_ADRENOCORTICAL_TUMOR_UP	281	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_UP	-0.53397	-1.4693	0.05697	0.30125	1	0.413	0.195	0.336	0.21823	0.039
REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION	-0.42584	-1.4692	0.07816	0.30076	1	0.565	0.338	0.375	0.21929	0.039
BOWIE_RESPONSE_TO_TAMOXIFEN	18	http://www.broadinstitute.org/gsea/msigdb/cards/BOWIE_RESPONSE_TO_TAMOXIFEN	-0.76668	-1.4692	0.1126	0.30003	1	0.722	0.17	0.6	0.21876	0.039
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	-0.42998	-1.469	0.04706	0.29989	1	0.4	0.157	0.338	0.21827	0.039
HELLER_SILENCED_BY_METHYLATION_UP	266	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_SILENCED_BY_METHYLATION_UP	-0.39971	-1.4682	0.08577	0.30087	1	0.211	0.133	0.184	0.21808	0.039
VALK_AML_CLUSTER_12	30	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_12	-0.38936	-1.4675	0.02756	0.30163	1	0.333	0.156	0.282	0.21879	0.039
REACTOME_CELL_CYCLE_MITOTIC	300	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE_MITOTIC	-0.53978	-1.4673	0.05726	0.30152	1	0.4	0.173	0.335	0.21885	0.039
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	54	http://www.broadinstitute.org/gsea/msigdb/cards/WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-0.81139	-1.4662	0.0502	0.30309	1	0.593	0.0566	0.56	0.22158	0.039
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	-0.55139	-1.4657	0.09056	0.30359	1	0.38	0.181	0.312	0.22226	0.039
WINNEPENNINCKX_MELANOMA_METASTASIS_UP	152	http://www.broadinstitute.org/gsea/msigdb/cards/WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-0.66134	-1.4648	0.07252	0.30495	1	0.461	0.145	0.396	0.22191	0.037
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	-0.68565	-1.4641	0.06923	0.30592	1	0.5	0.123	0.439	0.22142	0.037
LIANG_SILENCED_BY_METHYLATION_2	52	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_SILENCED_BY_METHYLATION_2	-0.55421	-1.4638	0.08946	0.30584	1	0.462	0.176	0.381	0.22172	0.037
REACTOME_HEMOSTASIS	439	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HEMOSTASIS	-0.30592	-1.4637	0.02204	0.30524	1	0.308	0.238	0.238	0.2212	0.037
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	87	http://www.broadinstitute.org/gsea/msigdb/cards/NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-0.43382	-1.4637	0.1076	0.30458	1	0.517	0.267	0.381	0.22068	0.037
HECKER_IFNB1_TARGETS	90	http://www.broadinstitute.org/gsea/msigdb/cards/HECKER_IFNB1_TARGETS	-0.55989	-1.4633	0.1346	0.30484	1	0.478	0.176	0.395	0.22038	0.036
BENPORATH_ES_1	366	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_ES_1	-0.4766	-1.463	0.06102	0.30483	1	0.383	0.211	0.306	0.21986	0.036
VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN	-0.52186	-1.4629	0.08704	0.30415	1	0.25	0.178	0.206	0.21953	0.036
ZHAN_MULTIPLE_MYELOMA_CD2_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD2_DN	-0.44913	-1.4628	0.1086	0.30384	1	0.391	0.238	0.299	0.21901	0.036
KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	109	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	-0.47738	-1.4618	0.02698	0.30549	1	0.358	0.135	0.311	0.22107	0.036
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	109	http://www.broadinstitute.org/gsea/msigdb/cards/ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-0.37541	-1.4617	0.08465	0.30482	1	0.312	0.224	0.243	0.22056	0.036
ST_MYOCYTE_AD_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/ST_MYOCYTE_AD_PATHWAY	-0.42123	-1.4611	0.1143	0.3054	1	0.296	0.202	0.237	0.22133	0.036
REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING	-0.49845	-1.4606	0.122	0.30579	1	0.4	0.228	0.309	0.22291	0.036
YAMASHITA_LIVER_CANCER_STEM_CELL_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_LIVER_CANCER_STEM_CELL_UP	-0.43238	-1.4604	0.03614	0.3055	1	0.234	0.0839	0.215	0.2224	0.036
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN	-0.58681	-1.4603	0.08952	0.30488	1	0.514	0.197	0.414	0.22189	0.036
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	86	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-0.42464	-1.4599	0.06085	0.30522	1	0.314	0.197	0.253	0.22186	0.036
MANALO_HYPOXIA_DN	275	http://www.broadinstitute.org/gsea/msigdb/cards/MANALO_HYPOXIA_DN	-0.51501	-1.4598	0.082	0.30477	1	0.422	0.207	0.338	0.22231	0.036
SIMBULAN_PARP1_TARGETS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_PARP1_TARGETS_DN	-0.67834	-1.4595	0.03762	0.30465	1	0.588	0.169	0.489	0.22202	0.036
MURAKAMI_UV_RESPONSE_24HR	20	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_24HR	-0.46698	-1.4593	0.09407	0.30437	1	0.2	0.116	0.177	0.22178	0.036
LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	35	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_TRANSLATION_VIA_FN1_SIGNALING	-0.47926	-1.4589	0.06379	0.30465	1	0.343	0.127	0.3	0.22216	0.036
BIOCARTA_RHO_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RHO_PATHWAY	-0.3641	-1.4582	0.06008	0.30564	1	0.406	0.224	0.316	0.22347	0.036
REACTOME_CELL_CYCLE_CHECKPOINTS	111	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CYCLE_CHECKPOINTS	-0.58746	-1.4579	0.07347	0.30557	1	0.414	0.129	0.363	0.22319	0.036
MOOTHA_GLUCONEOGENESIS	32	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_GLUCONEOGENESIS	-0.40945	-1.457	0.05273	0.30701	1	0.469	0.279	0.339	0.22382	0.036
MARZEC_IL2_SIGNALING_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/MARZEC_IL2_SIGNALING_UP	-0.33658	-1.4565	0.05871	0.30754	1	0.248	0.165	0.208	0.22353	0.036
LEI_MYB_TARGETS	314	http://www.broadinstitute.org/gsea/msigdb/cards/LEI_MYB_TARGETS	-0.36697	-1.4564	0.05383	0.30713	1	0.248	0.16	0.211	0.22347	0.036
ZHANG_TLX_TARGETS_60HR_DN	266	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_60HR_DN	-0.59503	-1.4558	0.06958	0.30779	1	0.444	0.165	0.374	0.22362	0.036
PID_CIRCADIAN_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CIRCADIAN_PATHWAY	-0.54925	-1.4556	0.03863	0.30751	1	0.333	0.204	0.266	0.22354	0.036
NEWMAN_ERCC6_TARGETS_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/NEWMAN_ERCC6_TARGETS_UP	-0.54332	-1.4552	0.08318	0.30757	1	0.458	0.213	0.361	0.22304	0.036
FARMER_BREAST_CANCER_CLUSTER_1	38	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_1	-0.64677	-1.4547	0.1105	0.30798	1	0.421	0.127	0.368	0.22378	0.036
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN	-0.65846	-1.4539	0.094	0.30916	1	0.467	0.137	0.403	0.22487	0.036
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	173	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	-0.47829	-1.4535	0.08647	0.30883	1	0.329	0.146	0.283	0.22466	0.036
NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	15	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON	-0.55093	-1.4535	0.08417	0.30944	1	0.133	0.0705	0.124	0.22516	0.036
YUAN_ZNF143_PARTNERS	21	http://www.broadinstitute.org/gsea/msigdb/cards/YUAN_ZNF143_PARTNERS	-0.56121	-1.4525	0.1064	0.31034	1	0.19	0.0782	0.176	0.22516	0.036
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	-0.39825	-1.4514	0.04356	0.31245	1	0.273	0.123	0.24	0.22744	0.036
BIOCARTA_G2_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_G2_PATHWAY	-0.52704	-1.4501	0.04564	0.31491	1	0.333	0.126	0.292	0.22899	0.036
REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	39	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX_	-0.43257	-1.4496	0.05664	0.31527	1	0.487	0.308	0.338	0.22853	0.036
PID_ER_NONGENOMIC_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ER_NONGENOMIC_PATHWAY	-0.42777	-1.449	0.04339	0.3159	1	0.39	0.238	0.298	0.2289	0.036
LI_WILMS_TUMOR_ANAPLASTIC_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_ANAPLASTIC_UP	-0.78029	-1.4487	0.04251	0.3159	1	0.684	0.159	0.576	0.22839	0.036
KEGG_BASE_EXCISION_REPAIR	32	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BASE_EXCISION_REPAIR	-0.5217	-1.4485	0.104	0.31567	1	0.375	0.195	0.302	0.2279	0.036
ROVERSI_GLIOMA_LOH_REGIONS	43	http://www.broadinstitute.org/gsea/msigdb/cards/ROVERSI_GLIOMA_LOH_REGIONS	-0.44892	-1.4478	0.04255	0.31592	1	0.395	0.221	0.308	0.22739	0.036
KANG_IMMORTALIZED_BY_TERT_DN	99	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_IMMORTALIZED_BY_TERT_DN	-0.3488	-1.4478	0.02103	0.31646	1	0.162	0.0909	0.147	0.22789	0.036
LEIN_OLIGODENDROCYTE_MARKERS	71	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_OLIGODENDROCYTE_MARKERS	-0.37493	-1.4477	0.0505	0.31545	1	0.239	0.142	0.206	0.22722	0.036
KEGG_PROTEASOME	46	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROTEASOME	-0.50996	-1.4471	0.064	0.31607	1	0.37	0.17	0.307	0.22706	0.036
REACTOME_SEMAPHORIN_INTERACTIONS	66	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SEMAPHORIN_INTERACTIONS	-0.365	-1.4465	0.03495	0.31676	1	0.333	0.241	0.254	0.22677	0.036
SHIN_B_CELL_LYMPHOMA_CLUSTER_8	36	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_8	-0.51022	-1.4463	0.09427	0.31649	1	0.222	0.0731	0.206	0.22628	0.036
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	-0.66206	-1.446	0.08485	0.31639	1	0.518	0.159	0.436	0.22763	0.036
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN	-0.62148	-1.4455	0.0946	0.31696	1	0.5	0.168	0.416	0.22811	0.036
CUI_TCF21_TARGETS_2_UP	413	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_2_UP	-0.35003	-1.4454	0.009042	0.31658	1	0.206	0.129	0.182	0.22762	0.036
ZHANG_TLX_TARGETS_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_UP	-0.72394	-1.4451	0.04225	0.31648	1	0.545	0.118	0.483	0.22816	0.036
PAL_PRMT5_TARGETS_UP	196	http://www.broadinstitute.org/gsea/msigdb/cards/PAL_PRMT5_TARGETS_UP	-0.46348	-1.4443	0.07738	0.31765	1	0.352	0.181	0.291	0.22837	0.036
ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	16	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_DOXORUBICIN	-0.48363	-1.4442	0.05313	0.31712	1	0.188	0.0415	0.18	0.22844	0.036
ROSS_AML_WITH_AML1_ETO_FUSION	74	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_AML1_ETO_FUSION	-0.36679	-1.4437	0.06326	0.31759	1	0.149	0.0684	0.139	0.22916	0.036
REACTOME_SYNTHESIS_OF_DNA	90	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_DNA	-0.5703	-1.4436	0.08669	0.31712	1	0.356	0.126	0.312	0.22868	0.036
SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP	-0.53644	-1.4435	0.09714	0.31675	1	0.352	0.117	0.312	0.22819	0.036
TENEDINI_MEGAKARYOCYTE_MARKERS	64	http://www.broadinstitute.org/gsea/msigdb/cards/TENEDINI_MEGAKARYOCYTE_MARKERS	-0.41625	-1.4434	0.07241	0.31652	1	0.359	0.232	0.277	0.22771	0.036
CROMER_METASTASIS_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_METASTASIS_UP	-0.41822	-1.4432	0.07724	0.31608	1	0.227	0.127	0.198	0.22774	0.036
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-0.68649	-1.4427	0.05368	0.31669	1	0.551	0.159	0.464	0.22784	0.036
HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	47	http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_HEREDITARY_VS_SPORADIC	-0.47461	-1.4418	0.09924	0.31733	1	0.447	0.202	0.357	0.22826	0.036
FINETTI_BREAST_CANCER_KINOME_RED	16	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCER_KINOME_RED	-0.93562	-1.4418	0.002041	0.3167	1	0.812	0.0443	0.777	0.22778	0.036
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	88	http://www.broadinstitute.org/gsea/msigdb/cards/BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C	-0.35994	-1.4418	0.08397	0.31791	1	0.284	0.178	0.234	0.22874	0.036
KIM_WT1_TARGETS_UP	207	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_UP	-0.37174	-1.4413	0.09333	0.31702	1	0.353	0.258	0.264	0.23012	0.036
LY_AGING_PREMATURE_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_PREMATURE_DN	-0.44672	-1.4409	0.08527	0.31748	1	0.586	0.219	0.459	0.23164	0.036
ZHANG_RESPONSE_TO_CANTHARIDIN_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-0.44078	-1.4402	0.05653	0.31776	1	0.4	0.256	0.298	0.23294	0.036
RUAN_RESPONSE_TO_TROGLITAZONE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TROGLITAZONE_DN	-0.41007	-1.4402	0.04427	0.31842	1	0.211	0.125	0.184	0.23343	0.036
ALONSO_METASTASIS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_DN	-0.44422	-1.4401	0.09454	0.31738	1	0.333	0.213	0.262	0.23251	0.036
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	81	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-0.63896	-1.44	0.08722	0.31689	1	0.481	0.126	0.422	0.23203	0.036
PID_MAPK_TRK_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MAPK_TRK_PATHWAY	-0.47634	-1.4396	0.06139	0.31726	1	0.412	0.222	0.321	0.23218	0.036
REACTOME_G1_S_TRANSITION	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_S_TRANSITION	-0.57323	-1.4396	0.08589	0.31673	1	0.352	0.0991	0.319	0.23171	0.036
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-0.48132	-1.4392	0.072	0.31695	1	0.357	0.169	0.297	0.23267	0.033
GENTILE_UV_LOW_DOSE_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_LOW_DOSE_UP	-0.46982	-1.439	0.1086	0.3167	1	0.385	0.221	0.3	0.23371	0.033
WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	247	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP	-0.353	-1.4388	0.06643	0.31655	1	0.36	0.263	0.268	0.23323	0.033
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	-0.43221	-1.4385	0.04528	0.31648	1	0.377	0.224	0.293	0.23276	0.033
BIOCARTA_RACCYCD_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RACCYCD_PATHWAY	-0.54633	-1.4384	0.1086	0.3161	1	0.462	0.241	0.351	0.23228	0.033
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	16	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7	-0.57026	-1.4378	0.0713	0.31665	1	0.312	0.092	0.284	0.23182	0.036
FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP	-0.3846	-1.4377	0.04223	0.31644	1	0.213	0.159	0.18	0.23201	0.035
LU_TUMOR_ENDOTHELIAL_MARKERS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/LU_TUMOR_ENDOTHELIAL_MARKERS_UP	-0.54678	-1.4375	0.05848	0.31624	1	0.364	0.197	0.292	0.23154	0.035
LI_LUNG_CANCER	40	http://www.broadinstitute.org/gsea/msigdb/cards/LI_LUNG_CANCER	-0.44748	-1.4353	0.06567	0.32011	1	0.225	0.0746	0.209	0.23313	0.036
YU_BAP1_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/YU_BAP1_TARGETS	-0.65933	-1.4342	0.06846	0.32207	1	0.286	0.039	0.275	0.23536	0.036
REACTOME_S_PHASE	106	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_S_PHASE	-0.55411	-1.4331	0.08907	0.32388	1	0.349	0.126	0.306	0.2363	0.036
DER_IFN_BETA_RESPONSE_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/DER_IFN_BETA_RESPONSE_UP	-0.50046	-1.4327	0.1401	0.32415	1	0.455	0.226	0.353	0.23712	0.038
REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS	-0.54897	-1.4326	0.08048	0.32305	1	0.588	0.192	0.476	0.23617	0.035
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN	-0.44478	-1.4326	0.06796	0.32366	1	0.365	0.216	0.287	0.23665	0.035
BROWNE_HCMV_INFECTION_10HR_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_10HR_UP	-0.40476	-1.4321	0.05693	0.32333	1	0.442	0.292	0.314	0.23621	0.035
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	69	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	-0.52341	-1.432	0.1442	0.32298	1	0.29	0.137	0.251	0.23574	0.035
YIH_RESPONSE_TO_ARSENITE_C2	18	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C2	-0.48006	-1.4309	0.1004	0.3249	1	0.5	0.237	0.382	0.23686	0.038
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP	-0.51864	-1.4301	0.05989	0.32599	1	0.417	0.151	0.354	0.23737	0.038
MUELLER_PLURINET	293	http://www.broadinstitute.org/gsea/msigdb/cards/MUELLER_PLURINET	-0.43952	-1.4288	0.08434	0.32853	1	0.3	0.169	0.252	0.2411	0.038
MARKS_HDAC_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_HDAC_TARGETS_UP	-0.52822	-1.4285	0.08448	0.32845	1	0.304	0.123	0.267	0.24063	0.038
REACTOME_FRS2_MEDIATED_CASCADE	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FRS2_MEDIATED_CASCADE	-0.40476	-1.4283	0.074	0.32811	1	0.222	0.186	0.181	0.24126	0.038
REACTOME_METABOLISM_OF_CARBOHYDRATES	227	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_CARBOHYDRATES	-0.29237	-1.4267	0.01429	0.33107	1	0.374	0.275	0.274	0.24365	0.038
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	171	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-0.31446	-1.4256	0.03774	0.33296	1	0.257	0.189	0.21	0.24526	0.039
WANG_NFKB_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_NFKB_TARGETS	-0.51035	-1.4253	0.09438	0.33314	1	0.333	0.205	0.265	0.24564	0.039
GEORGES_CELL_CYCLE_MIR192_TARGETS	62	http://www.broadinstitute.org/gsea/msigdb/cards/GEORGES_CELL_CYCLE_MIR192_TARGETS	-0.56215	-1.4251	0.0479	0.33279	1	0.371	0.126	0.325	0.24516	0.039
CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_24HR_5_DN	-0.49082	-1.4245	0.09375	0.33369	1	0.482	0.241	0.367	0.24537	0.038
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	72	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP	-0.67955	-1.4244	0.07816	0.33335	1	0.542	0.129	0.473	0.24489	0.038
XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP	-0.38062	-1.4241	0.1047	0.33343	1	0.543	0.352	0.352	0.24441	0.038
WONG_EMBRYONIC_STEM_CELL_CORE	329	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_EMBRYONIC_STEM_CELL_CORE	-0.51503	-1.4229	0.1155	0.33563	1	0.429	0.212	0.342	0.24662	0.039
REACTOME_PROTEIN_FOLDING	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROTEIN_FOLDING	-0.40264	-1.4224	0.1238	0.33613	1	0.32	0.215	0.252	0.24667	0.039
BORLAK_LIVER_CANCER_EGF_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/BORLAK_LIVER_CANCER_EGF_UP	-0.49777	-1.4222	0.1131	0.33576	1	0.193	0.124	0.169	0.24624	0.039
REACTOME_SHC_MEDIATED_CASCADE	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_MEDIATED_CASCADE	-0.4253	-1.422	0.06183	0.33557	1	0.214	0.151	0.182	0.24675	0.039
REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX	-0.73415	-1.4213	0.08415	0.33586	1	0.533	0.0991	0.481	0.24692	0.039
MARKEY_RB1_ACUTE_LOF_UP	204	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_ACUTE_LOF_UP	-0.35797	-1.4213	0.148	0.33645	1	0.324	0.221	0.254	0.24739	0.039
ROSS_AML_WITH_PML_RARA_FUSION	73	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_PML_RARA_FUSION	-0.34305	-1.421	0.07629	0.33588	1	0.26	0.156	0.22	0.24732	0.039
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	281	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP	-0.58742	-1.4209	0.09789	0.33546	1	0.384	0.118	0.343	0.24684	0.039
LEI_HOXC8_TARGETS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/LEI_HOXC8_TARGETS_DN	-0.59841	-1.4206	0.07927	0.33546	1	0.353	0.101	0.317	0.24645	0.039
BAKKER_FOXO3_TARGETS_DN	173	http://www.broadinstitute.org/gsea/msigdb/cards/BAKKER_FOXO3_TARGETS_DN	-0.27898	-1.4203	0.0119	0.33551	1	0.237	0.195	0.192	0.24644	0.039
ZHAN_MULTIPLE_MYELOMA_PR_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_PR_UP	-0.85751	-1.4202	0.01012	0.33518	1	0.857	0.127	0.75	0.24597	0.039
EGUCHI_CELL_CYCLE_RB1_TARGETS	23	http://www.broadinstitute.org/gsea/msigdb/cards/EGUCHI_CELL_CYCLE_RB1_TARGETS	-0.87397	-1.42	0.04546	0.33501	1	0.739	0.0566	0.698	0.2455	0.039
BURTON_ADIPOGENESIS_2	70	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_2	-0.32486	-1.4198	0.09919	0.33472	1	0.471	0.317	0.323	0.24504	0.039
MULLIGHAN_MLL_SIGNATURE_2_UP	387	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_2_UP	-0.25886	-1.4194	0.0202	0.33506	1	0.326	0.279	0.238	0.24654	0.038
REACTOME_TRANSCRIPTION	176	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSCRIPTION	-0.44245	-1.4192	0.09126	0.33489	1	0.403	0.239	0.309	0.24608	0.038
MITSIADES_RESPONSE_TO_APLIDIN_DN	240	http://www.broadinstitute.org/gsea/msigdb/cards/MITSIADES_RESPONSE_TO_APLIDIN_DN	-0.58205	-1.4191	0.146	0.33444	1	0.475	0.197	0.385	0.24561	0.037
POS_HISTAMINE_RESPONSE_NETWORK	32	http://www.broadinstitute.org/gsea/msigdb/cards/POS_HISTAMINE_RESPONSE_NETWORK	-0.35429	-1.419	0.1012	0.33405	1	0.375	0.219	0.293	0.24529	0.037
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP	-0.35809	-1.418	0.04615	0.33576	1	0.125	0.0788	0.116	0.24646	0.037
KARAKAS_TGFB1_SIGNALING	17	http://www.broadinstitute.org/gsea/msigdb/cards/KARAKAS_TGFB1_SIGNALING	-0.59291	-1.4171	0.07617	0.33724	1	0.471	0.189	0.382	0.24797	0.039
MARCHINI_TRABECTEDIN_RESISTANCE_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/MARCHINI_TRABECTEDIN_RESISTANCE_DN	-0.3729	-1.4154	0.1303	0.3405	1	0.543	0.297	0.383	0.2505	0.039
PUJANA_BRCA2_PCC_NETWORK	410	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BRCA2_PCC_NETWORK	-0.51876	-1.4151	0.1287	0.34071	1	0.363	0.16	0.31	0.25003	0.039
TAVOR_CEBPA_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/TAVOR_CEBPA_TARGETS_UP	-0.46694	-1.4144	0.1282	0.34153	1	0.468	0.258	0.348	0.25092	0.039
PID_RHOA_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHOA_PATHWAY	-0.3687	-1.414	0.0759	0.34203	1	0.467	0.313	0.321	0.2507	0.039
PID_P38_MKK3_6PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P38_MKK3_6PATHWAY	-0.37993	-1.4133	0.1166	0.34317	1	0.231	0.179	0.19	0.25153	0.04
REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	189	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES	-0.3061	-1.413	0.04839	0.3432	1	0.291	0.229	0.226	0.25204	0.039
BARRIER_COLON_CANCER_RECURRENCE_UP	41	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_COLON_CANCER_RECURRENCE_UP	-0.56011	-1.4126	0.0754	0.34335	1	0.366	0.167	0.305	0.25223	0.039
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	30	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-0.61345	-1.4126	0.07212	0.34284	1	0.433	0.138	0.374	0.25176	0.037
BOYLAN_MULTIPLE_MYELOMA_C_D_UP	132	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_D_UP	-0.37278	-1.4125	0.0289	0.34243	1	0.235	0.139	0.203	0.25344	0.037
KEGG_DORSO_VENTRAL_AXIS_FORMATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DORSO_VENTRAL_AXIS_FORMATION	-0.51429	-1.4122	0.09486	0.34245	1	0.542	0.302	0.379	0.25306	0.037
FARMER_BREAST_CANCER_CLUSTER_2	32	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_2	-0.89662	-1.4116	0.02718	0.34338	1	0.812	0.0694	0.757	0.25312	0.037
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	149	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	-0.41551	-1.4114	0.1151	0.34299	1	0.289	0.146	0.248	0.25266	0.036
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	34	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15	-0.52204	-1.4104	0.08918	0.3448	1	0.353	0.12	0.311	0.25531	0.038
SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	291	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN	-0.33557	-1.4103	0.06509	0.34424	1	0.234	0.155	0.2	0.25485	0.037
WILLIAMS_ESR1_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WILLIAMS_ESR1_TARGETS_UP	-0.46471	-1.4102	0.08582	0.34384	1	0.423	0.218	0.331	0.25438	0.036
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	64	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS	-0.52914	-1.4098	0.1053	0.34433	1	0.422	0.173	0.35	0.25512	0.037
MATZUK_MEIOTIC_AND_DNA_REPAIR	38	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_MEIOTIC_AND_DNA_REPAIR	-0.43857	-1.4097	0.03688	0.34386	1	0.421	0.249	0.317	0.25466	0.036
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP	-0.561	-1.4089	0.09533	0.34446	1	0.333	0.141	0.286	0.25583	0.036
GAVIN_PDE3B_TARGETS	21	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_PDE3B_TARGETS	-0.56184	-1.4089	0.1218	0.34494	1	0.381	0.142	0.327	0.2563	0.038
LAU_APOPTOSIS_CDKN2A_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/LAU_APOPTOSIS_CDKN2A_UP	-0.38518	-1.4087	0.09888	0.34435	1	0.358	0.203	0.286	0.2558	0.036
DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN	-0.45956	-1.4067	0.1118	0.34839	1	0.407	0.221	0.318	0.25908	0.039
WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	36	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2	-0.322	-1.4062	0.05567	0.34902	1	0.306	0.259	0.227	0.25942	0.039
MARCHINI_TRABECTEDIN_RESISTANCE_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/MARCHINI_TRABECTEDIN_RESISTANCE_UP	-0.52219	-1.4062	0.07377	0.3484	1	0.3	0.116	0.265	0.25896	0.039
KIM_LRRC3B_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_LRRC3B_TARGETS	-0.58757	-1.4053	0.1255	0.3497	1	0.393	0.149	0.335	0.26133	0.039
YAGI_AML_RELAPSE_PROGNOSIS	34	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_RELAPSE_PROGNOSIS	-0.38036	-1.4051	0.1131	0.34954	1	0.5	0.308	0.346	0.261	0.039
BASSO_B_LYMPHOCYTE_NETWORK	139	http://www.broadinstitute.org/gsea/msigdb/cards/BASSO_B_LYMPHOCYTE_NETWORK	-0.43065	-1.404	0.06721	0.35143	1	0.424	0.253	0.319	0.26195	0.039
KAUFFMANN_DNA_REPLICATION_GENES	140	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPLICATION_GENES	-0.49438	-1.4038	0.07307	0.3511	1	0.393	0.203	0.315	0.26148	0.039
SANSOM_APC_MYC_TARGETS	201	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_MYC_TARGETS	-0.30363	-1.4034	0.08415	0.35159	1	0.299	0.242	0.228	0.26144	0.039
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	-0.41372	-1.4025	0.1275	0.35306	1	0.3	0.139	0.259	0.26384	0.039
LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	83	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_VAV3_PROSTATE_CARCINOGENESIS_UP	-0.44936	-1.4022	0.1471	0.35299	1	0.229	0.123	0.201	0.26338	0.039
KORKOLA_SEMINOMA_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_SEMINOMA_UP	-0.55423	-1.402	0.1038	0.35277	1	0.452	0.136	0.392	0.26291	0.039
FRIDMAN_IMMORTALIZATION_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/FRIDMAN_IMMORTALIZATION_DN	-0.43435	-1.4015	0.1284	0.35333	1	0.394	0.275	0.286	0.26329	0.039
VANTVEER_BREAST_CANCER_METASTASIS_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_METASTASIS_DN	-0.64017	-1.4009	0.1219	0.35421	1	0.451	0.126	0.396	0.26481	0.04
KRIGE_AMINO_ACID_DEPRIVATION	28	http://www.broadinstitute.org/gsea/msigdb/cards/KRIGE_AMINO_ACID_DEPRIVATION	-0.4245	-1.4006	0.09785	0.35429	1	0.357	0.259	0.265	0.2644	0.04
HAN_JNK_SINGALING_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_JNK_SINGALING_DN	-0.43749	-1.4005	0.1023	0.35392	1	0.395	0.271	0.288	0.26435	0.04
NADLER_OBESITY_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/NADLER_OBESITY_UP	-0.40515	-1.4001	0.1324	0.35397	1	0.424	0.262	0.313	0.26451	0.04
WONG_ENDMETRIUM_CANCER_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_ENDMETRIUM_CANCER_UP	-0.51633	-1.3998	0.1136	0.3542	1	0.292	0.102	0.262	0.26418	0.04
BIOCARTA_NFKB_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NFKB_PATHWAY	-0.44223	-1.399	0.1297	0.35551	1	0.261	0.196	0.21	0.26546	0.04
CHICAS_RB1_TARGETS_GROWING	233	http://www.broadinstitute.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_GROWING	-0.52622	-1.3984	0.1057	0.35619	1	0.378	0.147	0.325	0.26791	0.04
PID_EPHA2_FWD_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPHA2_FWD_PATHWAY	-0.50652	-1.3981	0.09488	0.35622	1	0.526	0.247	0.397	0.26779	0.04
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN	-0.48783	-1.3981	0.08812	0.35582	1	0.211	0.0685	0.196	0.26733	0.04
WOOD_EBV_EBNA1_TARGETS_UP	106	http://www.broadinstitute.org/gsea/msigdb/cards/WOOD_EBV_EBNA1_TARGETS_UP	-0.37192	-1.3979	0.09728	0.35565	1	0.453	0.298	0.319	0.26686	0.04
PUJANA_BREAST_CANCER_LIT_INT_NETWORK	98	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-0.5044	-1.3979	0.123	0.35507	1	0.48	0.225	0.373	0.2664	0.04
ONDER_CDH1_TARGETS_2_DN	449	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_2_DN	-0.35695	-1.3976	0.08397	0.35504	1	0.252	0.157	0.216	0.2662	0.04
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	15	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4	-0.45937	-1.3958	0.1197	0.35866	1	0.133	0.0468	0.127	0.26863	0.04
ISSAEVA_MLL2_TARGETS	58	http://www.broadinstitute.org/gsea/msigdb/cards/ISSAEVA_MLL2_TARGETS	-0.42106	-1.395	0.1036	0.35981	1	0.431	0.285	0.309	0.27375	0.04
BROWNE_HCMV_INFECTION_2HR_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_2HR_DN	-0.441	-1.3933	0.08958	0.36329	1	0.163	0.091	0.149	0.27728	0.04
MARKS_HDAC_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_HDAC_TARGETS_DN	-0.56158	-1.393	0.09307	0.36326	1	0.2	0.0474	0.191	0.2768	0.04
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP	-0.34502	-1.3926	0.08789	0.36361	1	0.235	0.154	0.199	0.27633	0.04
KEGG_OOCYTE_MEIOSIS	110	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_OOCYTE_MEIOSIS	-0.38905	-1.3925	0.07379	0.36318	1	0.318	0.192	0.258	0.27586	0.04
BURTON_ADIPOGENESIS_PEAK_AT_8HR	37	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_8HR	-0.42676	-1.3923	0.04008	0.36312	1	0.378	0.188	0.308	0.27538	0.04
DARWICHE_PAPILLOMA_RISK_HIGH_DN	166	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_HIGH_DN	-0.28785	-1.392	0.06564	0.3631	1	0.187	0.155	0.159	0.2756	0.04
ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	18	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_VINCRISTINE	-0.52649	-1.3915	0.1302	0.36375	1	0.333	0.103	0.299	0.27577	0.04
ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	124	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST	-0.40948	-1.3914	0.09016	0.3633	1	0.363	0.236	0.279	0.27531	0.04
DOANE_RESPONSE_TO_ANDROGEN_DN	232	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_RESPONSE_TO_ANDROGEN_DN	-0.37154	-1.3912	0.08498	0.36315	1	0.272	0.161	0.23	0.27484	0.04
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP	-0.39026	-1.3912	0.06863	0.36254	1	0.327	0.231	0.251	0.27437	0.04
ZHENG_IL22_SIGNALING_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_IL22_SIGNALING_DN	-0.42788	-1.3909	0.06827	0.3628	1	0.275	0.128	0.24	0.2753	0.04
WIERENGA_STAT5A_TARGETS_UP	204	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_UP	-0.30588	-1.3908	0.06855	0.36234	1	0.216	0.177	0.179	0.27548	0.04
KEGG_CELL_CYCLE	123	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CELL_CYCLE	-0.50736	-1.3905	0.1129	0.36236	1	0.398	0.142	0.343	0.27501	0.04
CHANG_IMMORTALIZED_BY_HPV31_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_IMMORTALIZED_BY_HPV31_DN	-0.47621	-1.3905	0.0946	0.36177	1	0.333	0.101	0.3	0.27455	0.04
CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN	-0.46729	-1.3904	0.1054	0.36133	1	0.391	0.154	0.331	0.27409	0.04
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP	-0.65999	-1.39	0.122	0.36183	1	0.69	0.198	0.554	0.27384	0.04
XU_CREBBP_TARGETS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/XU_CREBBP_TARGETS_DN	-0.31355	-1.3892	0.07273	0.36298	1	0.419	0.285	0.3	0.27355	0.04
HORTON_SREBF_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/HORTON_SREBF_TARGETS	-0.4327	-1.3886	0.1077	0.36371	1	0.417	0.298	0.293	0.27562	0.04
WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/WATTEL_AUTONOMOUS_THYROID_ADENOMA_UP	-0.34846	-1.3885	0.09034	0.36326	1	0.143	0.135	0.124	0.27531	0.04
PID_AVB3_OPN_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AVB3_OPN_PATHWAY	-0.47723	-1.388	0.07185	0.36391	1	0.387	0.209	0.306	0.27487	0.04
HOWLIN_CITED1_TARGETS_2_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_CITED1_TARGETS_2_UP	-0.56397	-1.3878	0.08269	0.36385	1	0.438	0.179	0.359	0.27624	0.04
REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A	-0.54996	-1.3873	0.114	0.36429	1	0.45	0.129	0.392	0.27663	0.04
WANG_TUMOR_INVASIVENESS_DN	201	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TUMOR_INVASIVENESS_DN	-0.40896	-1.3871	0.1	0.36427	1	0.363	0.238	0.279	0.27701	0.04
PID_P53_DOWNSTREAM_PATHWAY	131	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P53_DOWNSTREAM_PATHWAY	-0.34564	-1.3868	0.07863	0.36441	1	0.206	0.146	0.177	0.27656	0.04
PID_AURORA_B_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AURORA_B_PATHWAY	-0.68649	-1.3855	0.1129	0.36662	1	0.359	0.0566	0.339	0.27839	0.04
LEE_LIVER_CANCER_SURVIVAL_DN	166	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_SURVIVAL_DN	-0.515	-1.3853	0.09449	0.36629	1	0.41	0.174	0.34	0.27793	0.04
RIZKI_TUMOR_INVASIVENESS_2D_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_2D_UP	-0.29944	-1.3851	0.07466	0.3661	1	0.147	0.0866	0.135	0.27747	0.04
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	-0.42327	-1.3843	0.06299	0.36755	1	0.292	0.16	0.246	0.27998	0.04
LI_DCP2_BOUND_MRNA	88	http://www.broadinstitute.org/gsea/msigdb/cards/LI_DCP2_BOUND_MRNA	-0.29654	-1.3836	0.1325	0.36861	1	0.25	0.21	0.198	0.2805	0.04
PODAR_RESPONSE_TO_ADAPHOSTIN_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/PODAR_RESPONSE_TO_ADAPHOSTIN_DN	-0.58384	-1.3835	0.07663	0.36813	1	0.389	0.163	0.326	0.28004	0.04
REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERFERON_ALPHA_BETA_SIGNALING	-0.51275	-1.3832	0.1575	0.36843	1	0.429	0.216	0.337	0.27974	0.04
BIOCARTA_TFF_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TFF_PATHWAY	-0.47655	-1.3831	0.112	0.36741	1	0.381	0.209	0.301	0.27883	0.04
REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX	-0.39216	-1.3831	0.1198	0.36789	1	0.393	0.258	0.292	0.27928	0.04
WALLACE_PROSTATE_CANCER_RACE_UP	275	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_PROSTATE_CANCER_RACE_UP	-0.41876	-1.3828	0.1443	0.36744	1	0.338	0.203	0.273	0.28	0.04
PEART_HDAC_PROLIFERATION_CLUSTER_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/PEART_HDAC_PROLIFERATION_CLUSTER_UP	-0.42501	-1.3826	0.05159	0.36723	1	0.291	0.184	0.238	0.28019	0.039
MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	15	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH	-0.61974	-1.3824	0.1341	0.36663	1	0.333	0.0997	0.3	0.27928	0.039
PENG_LEUCINE_DEPRIVATION_DN	182	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_LEUCINE_DEPRIVATION_DN	-0.46294	-1.3824	0.1283	0.36713	1	0.319	0.171	0.266	0.27974	0.039
MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	41	http://www.broadinstitute.org/gsea/msigdb/cards/MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER	-0.42999	-1.3822	0.07692	0.36652	1	0.146	0.0518	0.139	0.27887	0.039
GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP	-0.44288	-1.3821	0.1	0.36607	1	0.211	0.0731	0.195	0.27842	0.039
HINATA_NFKB_TARGETS_FIBROBLAST_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/HINATA_NFKB_TARGETS_FIBROBLAST_UP	-0.43108	-1.3813	0.1173	0.36724	1	0.439	0.259	0.326	0.27797	0.039
REACTOME_LAGGING_STRAND_SYNTHESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LAGGING_STRAND_SYNTHESIS	-0.63268	-1.3812	0.1429	0.36688	1	0.316	0.0801	0.291	0.27752	0.039
RIZKI_TUMOR_INVASIVENESS_3D_DN	255	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_3D_DN	-0.29999	-1.3808	0.024	0.36743	1	0.275	0.202	0.221	0.2777	0.039
MATZUK_IMPLANTATION_AND_UTERINE	22	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_IMPLANTATION_AND_UTERINE	-0.44027	-1.3795	0.05162	0.36959	1	0.227	0.0721	0.211	0.28143	0.039
LANDIS_BREAST_CANCER_PROGRESSION_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_BREAST_CANCER_PROGRESSION_DN	-0.38449	-1.3791	0.1286	0.36988	1	0.449	0.289	0.32	0.28262	0.039
DAIRKEE_TERT_TARGETS_UP	352	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_TERT_TARGETS_UP	-0.26054	-1.3785	0.1	0.37095	1	0.261	0.23	0.204	0.28217	0.04
REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE	-0.33346	-1.3782	0.1021	0.37085	1	0.385	0.226	0.298	0.28249	0.04
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	106	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN	-0.31868	-1.378	0.0748	0.37065	1	0.16	0.117	0.142	0.28254	0.04
SANA_TNF_SIGNALING_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/SANA_TNF_SIGNALING_UP	-0.5151	-1.3774	0.1641	0.37097	1	0.5	0.227	0.387	0.2827	0.04
JI_RESPONSE_TO_FSH_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/JI_RESPONSE_TO_FSH_DN	-0.49323	-1.3774	0.1258	0.37152	1	0.411	0.218	0.322	0.28315	0.04
REICHERT_MITOSIS_LIN9_TARGETS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REICHERT_MITOSIS_LIN9_TARGETS	-0.79913	-1.3769	0.09543	0.37139	1	0.571	0.0608	0.537	0.28243	0.039
ALONSO_METASTASIS_NEURAL_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_NEURAL_UP	-0.56463	-1.3767	0.1607	0.37116	1	0.5	0.21	0.395	0.28227	0.039
ZIRN_TRETINOIN_RESPONSE_WT1_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/ZIRN_TRETINOIN_RESPONSE_WT1_UP	-0.55313	-1.3764	0.136	0.37078	1	0.429	0.155	0.363	0.28194	0.039
TSAI_RESPONSE_TO_IONIZING_RADIATION	144	http://www.broadinstitute.org/gsea/msigdb/cards/TSAI_RESPONSE_TO_IONIZING_RADIATION	-0.31856	-1.3764	0.07308	0.3712	1	0.271	0.215	0.214	0.28238	0.039
RICKMAN_METASTASIS_DN	244	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_METASTASIS_DN	-0.30538	-1.3762	0.1107	0.37076	1	0.279	0.226	0.218	0.28149	0.039
BURTON_ADIPOGENESIS_PEAK_AT_0HR	60	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_0HR	-0.37807	-1.3761	0.0947	0.37031	1	0.45	0.267	0.331	0.28105	0.039
VALK_AML_WITH_FLT3_ITD	39	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_FLT3_ITD	-0.42322	-1.3756	0.09369	0.37084	1	0.333	0.182	0.273	0.28181	0.039
BIOCARTA_MCM_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MCM_PATHWAY	-0.71244	-1.3737	0.1275	0.37479	1	0.611	0.0991	0.551	0.28406	0.041
REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	76	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_MITOTIC_CELL_CYCLE	-0.52474	-1.3737	0.1203	0.37422	1	0.355	0.129	0.31	0.28361	0.041
YEGNASUBRAMANIAN_PROSTATE_CANCER	116	http://www.broadinstitute.org/gsea/msigdb/cards/YEGNASUBRAMANIAN_PROSTATE_CANCER	-0.33725	-1.3732	0.03683	0.37483	1	0.198	0.119	0.175	0.28354	0.041
REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND	-0.58285	-1.373	0.1379	0.37456	1	0.333	0.14	0.287	0.28347	0.04
PID_WNT_NONCANONICAL_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_WNT_NONCANONICAL_PATHWAY	-0.49683	-1.3726	0.09709	0.37479	1	0.5	0.257	0.372	0.2831	0.04
BROWNE_HCMV_INFECTION_24HR_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_24HR_UP	-0.41293	-1.3726	0.08932	0.37422	1	0.411	0.232	0.318	0.28266	0.04
MCCLUNG_COCAIN_REWARD_4WK	74	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_COCAIN_REWARD_4WK	-0.34239	-1.3724	0.07992	0.37412	1	0.297	0.178	0.245	0.28278	0.04
PID_DNA_PK_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_DNA_PK_PATHWAY	-0.45371	-1.3723	0.1235	0.37369	1	0.133	0.0807	0.123	0.28234	0.039
FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/FOURNIER_ACINAR_DEVELOPMENT_LATE_DN	-0.66114	-1.3716	0.07088	0.37493	1	0.619	0.127	0.541	0.2832	0.04
REACTOME_M_G1_TRANSITION	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_M_G1_TRANSITION	-0.58587	-1.371	0.1382	0.3756	1	0.359	0.0991	0.324	0.28317	0.041
PUJANA_XPRSS_INT_NETWORK	165	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_XPRSS_INT_NETWORK	-0.56952	-1.3707	0.1569	0.37572	1	0.43	0.154	0.367	0.28273	0.041
BHATTACHARYA_EMBRYONIC_STEM_CELL	86	http://www.broadinstitute.org/gsea/msigdb/cards/BHATTACHARYA_EMBRYONIC_STEM_CELL	-0.50692	-1.3707	0.1295	0.37516	1	0.442	0.225	0.343	0.28229	0.041
SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	41	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER	-0.37271	-1.3693	0.1132	0.37767	1	0.244	0.185	0.199	0.28549	0.041
BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP	-0.57109	-1.3692	0.1167	0.37746	1	0.6	0.236	0.458	0.28711	0.041
REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI	-0.50276	-1.3682	0.09486	0.37893	1	0.5	0.266	0.367	0.28826	0.041
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN	-0.43244	-1.3677	0.08206	0.37944	1	0.273	0.145	0.234	0.28802	0.042
OSADA_ASCL1_TARGETS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/OSADA_ASCL1_TARGETS_DN	-0.48974	-1.3674	0.1187	0.37952	1	0.417	0.264	0.307	0.28759	0.042
PROVENZANI_METASTASIS_DN	131	http://www.broadinstitute.org/gsea/msigdb/cards/PROVENZANI_METASTASIS_DN	-0.35431	-1.3669	0.1027	0.37997	1	0.321	0.192	0.26	0.28733	0.042
REACTOME_BASIGIN_INTERACTIONS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BASIGIN_INTERACTIONS	-0.38361	-1.3664	0.0888	0.38005	1	0.333	0.28	0.24	0.28851	0.042
HELLER_HDAC_TARGETS_UP	288	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_UP	-0.31344	-1.3664	0.0499	0.38062	1	0.181	0.118	0.161	0.28895	0.042
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	100	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-0.2699	-1.3662	0.123	0.37989	1	0.25	0.236	0.192	0.28807	0.042
WANG_THOC1_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_THOC1_TARGETS_DN	-0.45157	-1.3653	0.1385	0.38142	1	0.316	0.16	0.266	0.28952	0.043
CUI_TCF21_TARGETS_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/CUI_TCF21_TARGETS_DN	-0.44101	-1.3644	0.08055	0.38301	1	0.29	0.178	0.239	0.2904	0.043
PID_TOLL_ENDOGENOUS_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TOLL_ENDOGENOUS_PATHWAY	-0.43483	-1.3639	0.08772	0.38364	1	0.2	0.0573	0.189	0.29149	0.043
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	-0.45536	-1.3638	0.1464	0.3833	1	0.241	0.103	0.217	0.29105	0.043
PID_CERAMIDE_PATHWAY	48	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CERAMIDE_PATHWAY	-0.39893	-1.3634	0.1131	0.38367	1	0.479	0.329	0.322	0.29138	0.043
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN	-0.44813	-1.3633	0.1181	0.38318	1	0.372	0.197	0.299	0.29153	0.043
DORN_ADENOVIRUS_INFECTION_12HR_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_12HR_UP	-0.47137	-1.363	0.1386	0.38344	1	0.345	0.233	0.265	0.29109	0.043
KEGG_PENTOSE_PHOSPHATE_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PENTOSE_PHOSPHATE_PATHWAY	-0.41075	-1.3628	0.1101	0.38332	1	0.346	0.197	0.278	0.29065	0.043
MMS_MOUSE_LYMPH_HIGH_4HRS_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/MMS_MOUSE_LYMPH_HIGH_4HRS_UP	-0.56936	-1.3626	0.1325	0.38302	1	0.5	0.232	0.384	0.29022	0.043
KIM_ALL_DISORDERS_DURATION_CORR_DN	141	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_DURATION_CORR_DN	-0.24293	-1.3618	0.09015	0.38429	1	0.248	0.226	0.193	0.29197	0.043
REACTOME_MICRORNA_MIRNA_BIOGENESIS	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MICRORNA_MIRNA_BIOGENESIS	-0.50854	-1.3615	0.1485	0.38462	1	0.222	0.0933	0.202	0.29199	0.043
STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP	-0.45397	-1.361	0.1012	0.38522	1	0.387	0.211	0.306	0.29185	0.043
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	-0.31694	-1.3608	0.05085	0.38501	1	0.141	0.107	0.126	0.29142	0.043
FERNANDEZ_BOUND_BY_MYC	179	http://www.broadinstitute.org/gsea/msigdb/cards/FERNANDEZ_BOUND_BY_MYC	-0.26123	-1.3602	0.05263	0.38536	1	0.229	0.191	0.187	0.29055	0.043
LEE_LIVER_CANCER_E2F1_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_E2F1_UP	-0.43815	-1.3602	0.1214	0.38589	1	0.35	0.17	0.291	0.29098	0.043
HUANG_GATA2_TARGETS_DN	68	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_GATA2_TARGETS_DN	-0.3445	-1.3599	0.0781	0.3856	1	0.132	0.104	0.119	0.29012	0.043
ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	172	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN	-0.33132	-1.3597	0.03333	0.38542	1	0.203	0.102	0.184	0.29068	0.043
TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP	-0.59652	-1.3594	0.1248	0.38559	1	0.5	0.178	0.412	0.29025	0.043
WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP	-0.52261	-1.3593	0.1137	0.38544	1	0.286	0.192	0.231	0.29103	0.043
PID_DELTA_NP63_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/PID_DELTA_NP63_PATHWAY	-0.40274	-1.3591	0.117	0.38523	1	0.128	0.0401	0.123	0.29077	0.043
FURUKAWA_DUSP6_TARGETS_PCI35_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/FURUKAWA_DUSP6_TARGETS_PCI35_UP	-0.37819	-1.3589	0.05693	0.38497	1	0.314	0.163	0.264	0.29047	0.043
LINDSTEDT_DENDRITIC_CELL_MATURATION_C	66	http://www.broadinstitute.org/gsea/msigdb/cards/LINDSTEDT_DENDRITIC_CELL_MATURATION_C	-0.37877	-1.3589	0.08465	0.38449	1	0.212	0.139	0.183	0.29005	0.043
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	-0.35282	-1.3587	0.1163	0.38436	1	0.248	0.168	0.208	0.29092	0.043
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN	-0.41566	-1.3583	0.1	0.38487	1	0.323	0.175	0.267	0.29111	0.042
JIANG_AGING_HYPOTHALAMUS_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_AGING_HYPOTHALAMUS_DN	-0.36263	-1.3582	0.1488	0.38444	1	0.45	0.28	0.325	0.29068	0.042
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	28	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5	-0.43729	-1.3576	0.1377	0.38512	1	0.464	0.303	0.324	0.29048	0.042
LENAOUR_DENDRITIC_CELL_MATURATION_DN	125	http://www.broadinstitute.org/gsea/msigdb/cards/LENAOUR_DENDRITIC_CELL_MATURATION_DN	-0.37809	-1.3575	0.1526	0.38491	1	0.232	0.155	0.197	0.29062	0.043
VERHAAK_GLIOBLASTOMA_MESENCHYMAL	207	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_MESENCHYMAL	-0.3532	-1.3569	0.1636	0.38578	1	0.343	0.241	0.262	0.29052	0.043
BIOCARTA_BARRESTIN_SRC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BARRESTIN_SRC_PATHWAY	-0.48064	-1.3566	0.131	0.3858	1	0.6	0.356	0.387	0.29114	0.042
REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING	-0.64191	-1.3561	0.1767	0.38665	1	0.467	0.213	0.367	0.29071	0.043
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN	-0.52218	-1.3559	0.169	0.38647	1	0.357	0.154	0.303	0.29091	0.043
HUPER_BREAST_BASAL_VS_LUMINAL_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/HUPER_BREAST_BASAL_VS_LUMINAL_UP	-0.42326	-1.3554	0.09634	0.38706	1	0.346	0.213	0.273	0.29093	0.043
TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	421	http://www.broadinstitute.org/gsea/msigdb/cards/TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	-0.45788	-1.3551	0.0996	0.38715	1	0.278	0.129	0.246	0.2905	0.042
REACTOME_MRNA_CAPPING	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_CAPPING	-0.42366	-1.355	0.112	0.38673	1	0.429	0.258	0.319	0.29097	0.042
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	-0.39843	-1.3539	0.102	0.38882	1	0.133	0.0184	0.131	0.29289	0.044
DARWICHE_PAPILLOMA_RISK_LOW_DN	154	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_LOW_DN	-0.29348	-1.3532	0.09249	0.38981	1	0.175	0.155	0.149	0.29255	0.044
NAKAYAMA_FGF2_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_FGF2_TARGETS	-0.4545	-1.3531	0.0902	0.38945	1	0.379	0.192	0.307	0.29213	0.044
REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	65	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ORC1_REMOVAL_FROM_CHROMATIN	-0.54556	-1.3524	0.147	0.39041	1	0.369	0.126	0.323	0.29201	0.044
PID_FANCONI_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FANCONI_PATHWAY	-0.58583	-1.352	0.1968	0.39073	1	0.356	0.144	0.305	0.29179	0.044
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN	-0.54188	-1.3516	0.1328	0.39127	1	0.286	0.0564	0.27	0.29327	0.044
WEIGEL_OXIDATIVE_STRESS_RESPONSE	34	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_RESPONSE	-0.40392	-1.351	0.1049	0.39206	1	0.206	0.154	0.174	0.29398	0.044
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP	-0.44321	-1.3499	0.1189	0.39398	1	0.682	0.306	0.473	0.29644	0.045
PID_INTEGRIN_A9B1_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN_A9B1_PATHWAY	-0.47405	-1.3496	0.1702	0.39366	1	0.375	0.259	0.278	0.29571	0.044
LINSLEY_MIR16_TARGETS	193	http://www.broadinstitute.org/gsea/msigdb/cards/LINSLEY_MIR16_TARGETS	-0.30907	-1.3496	0.06719	0.39407	1	0.269	0.201	0.217	0.29613	0.045
ZHAN_MULTIPLE_MYELOMA_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_DN	-0.45586	-1.3495	0.1308	0.3933	1	0.25	0.121	0.22	0.29543	0.045
PID_WNT_CANONICAL_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/PID_WNT_CANONICAL_PATHWAY	-0.41997	-1.349	0.1426	0.39392	1	0.4	0.262	0.296	0.29657	0.045
REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	53	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SCFSKP2_MEDIATED_DEGRADATION_OF_P27_P21	-0.51378	-1.3486	0.1326	0.39442	1	0.491	0.229	0.379	0.29701	0.045
ROVERSI_GLIOMA_COPY_NUMBER_UP	96	http://www.broadinstitute.org/gsea/msigdb/cards/ROVERSI_GLIOMA_COPY_NUMBER_UP	-0.31717	-1.3484	0.08802	0.39439	1	0.198	0.169	0.165	0.29904	0.045
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.39846	-1.3481	0.1195	0.39449	1	0.353	0.191	0.286	0.29862	0.045
PAL_PRMT5_TARGETS_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/PAL_PRMT5_TARGETS_DN	-0.40578	-1.348	0.1008	0.3941	1	0.241	0.178	0.199	0.2982	0.044
AIGNER_ZEB1_TARGETS	32	http://www.broadinstitute.org/gsea/msigdb/cards/AIGNER_ZEB1_TARGETS	-0.54829	-1.3477	0.1189	0.39415	1	0.344	0.106	0.308	0.29778	0.044
COLINA_TARGETS_OF_4EBP1_AND_4EBP2	349	http://www.broadinstitute.org/gsea/msigdb/cards/COLINA_TARGETS_OF_4EBP1_AND_4EBP2	-0.3605	-1.3476	0.05426	0.39384	1	0.244	0.175	0.204	0.29759	0.044
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	233	http://www.broadinstitute.org/gsea/msigdb/cards/HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP	-0.38652	-1.3469	0.1563	0.39444	1	0.361	0.236	0.278	0.29866	0.044
LU_EZH2_TARGETS_UP	262	http://www.broadinstitute.org/gsea/msigdb/cards/LU_EZH2_TARGETS_UP	-0.26762	-1.3469	0.1242	0.39475	1	0.435	0.341	0.29	0.29909	0.045
REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ASSEMBLY_OF_THE_PRE_REPLICATIVE_COMPLEX	-0.55607	-1.3468	0.169	0.39398	1	0.381	0.126	0.334	0.29825	0.044
XU_AKT1_TARGETS_6HR	27	http://www.broadinstitute.org/gsea/msigdb/cards/XU_AKT1_TARGETS_6HR	-0.49497	-1.3468	0.1865	0.39353	1	0.444	0.154	0.376	0.29783	0.044
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP	-0.41011	-1.3467	0.1176	0.39302	1	0.409	0.191	0.331	0.29741	0.044
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	-0.38216	-1.3466	0.07804	0.39271	1	0.14	0.0543	0.133	0.29699	0.044
MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	22	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5	-0.46395	-1.3464	0.1207	0.39276	1	0.227	0.0992	0.205	0.29803	0.044
MOSERLE_IFNA_RESPONSE	31	http://www.broadinstitute.org/gsea/msigdb/cards/MOSERLE_IFNA_RESPONSE	-0.75887	-1.3458	0.1682	0.39352	1	0.742	0.142	0.638	0.2998	0.044
SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP	-0.55753	-1.3444	0.1734	0.39587	1	0.333	0.157	0.281	0.29996	0.044
WESTON_VEGFA_TARGETS_3HR	72	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS_3HR	-0.35726	-1.3442	0.1051	0.39586	1	0.417	0.277	0.302	0.29954	0.044
REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	62	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_	-0.47659	-1.3438	0.1286	0.39626	1	0.452	0.229	0.349	0.29914	0.044
WESTON_VEGFA_TARGETS	105	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS	-0.36884	-1.3432	0.1126	0.39704	1	0.419	0.277	0.304	0.30011	0.044
LIM_MAMMARY_LUMINAL_PROGENITOR_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_LUMINAL_PROGENITOR_UP	-0.39447	-1.3431	0.09808	0.39686	1	0.226	0.158	0.191	0.29999	0.044
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	202	http://www.broadinstitute.org/gsea/msigdb/cards/GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-0.33235	-1.3424	0.009901	0.39789	1	0.272	0.197	0.22	0.30162	0.044
REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC	-0.46756	-1.3423	0.1423	0.39748	1	0.25	0.103	0.224	0.3012	0.044
NIELSEN_LEIOMYOSARCOMA_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_UP	-0.47928	-1.3422	0.09414	0.39718	1	0.25	0.111	0.222	0.30078	0.044
LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	23	http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS	-0.49627	-1.3419	0.1534	0.39732	1	0.217	0.127	0.19	0.30123	0.044
WU_CELL_MIGRATION	176	http://www.broadinstitute.org/gsea/msigdb/cards/WU_CELL_MIGRATION	-0.41311	-1.3418	0.1235	0.3971	1	0.318	0.176	0.264	0.30195	0.043
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	90	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	-0.4053	-1.3412	0.1577	0.39785	1	0.333	0.213	0.263	0.30222	0.043
WIELAND_UP_BY_HBV_INFECTION	95	http://www.broadinstitute.org/gsea/msigdb/cards/WIELAND_UP_BY_HBV_INFECTION	-0.52794	-1.3408	0.1807	0.39765	1	0.337	0.168	0.281	0.30169	0.044
ABRAMSON_INTERACT_WITH_AIRE	44	http://www.broadinstitute.org/gsea/msigdb/cards/ABRAMSON_INTERACT_WITH_AIRE	-0.58375	-1.3408	0.1794	0.39812	1	0.386	0.145	0.331	0.30211	0.044
RIZKI_TUMOR_INVASIVENESS_2D_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_2D_DN	-0.31091	-1.3407	0.06579	0.39725	1	0.2	0.171	0.166	0.30176	0.044
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	124	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-0.31785	-1.3387	0.0998	0.40125	1	0.258	0.179	0.213	0.30548	0.044
ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	155	http://www.broadinstitute.org/gsea/msigdb/cards/ASTON_MAJOR_DEPRESSIVE_DISORDER_DN	-0.31798	-1.3381	0.02911	0.40204	1	0.335	0.247	0.254	0.3071	0.044
REACTOME_SYNTHESIS_OF_PC	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_PC	-0.40823	-1.338	0.1215	0.40184	1	0.235	0.126	0.206	0.30668	0.044
MCLACHLAN_DENTAL_CARIES_UP	226	http://www.broadinstitute.org/gsea/msigdb/cards/MCLACHLAN_DENTAL_CARIES_UP	-0.41195	-1.3379	0.1985	0.40139	1	0.341	0.217	0.269	0.30626	0.044
BIOCARTA_BCR_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BCR_PATHWAY	-0.37923	-1.3378	0.1192	0.40105	1	0.486	0.324	0.329	0.30617	0.044
KAMIKUBO_MYELOID_CEBPA_NETWORK	27	http://www.broadinstitute.org/gsea/msigdb/cards/KAMIKUBO_MYELOID_CEBPA_NETWORK	-0.46067	-1.3376	0.17	0.40099	1	0.222	0.119	0.196	0.30652	0.044
REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM	-0.37701	-1.3375	0.1388	0.40053	1	0.234	0.187	0.191	0.3061	0.044
REACTOME_APOPTOSIS	142	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APOPTOSIS	-0.3867	-1.3371	0.1186	0.40061	1	0.296	0.172	0.246	0.3062	0.044
KRASNOSELSKAYA_ILF3_TARGETS_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/KRASNOSELSKAYA_ILF3_TARGETS_UP	-0.51591	-1.3371	0.2088	0.40104	1	0.486	0.172	0.403	0.30661	0.044
BOCHKIS_FOXA2_TARGETS	408	http://www.broadinstitute.org/gsea/msigdb/cards/BOCHKIS_FOXA2_TARGETS	-0.28897	-1.3367	0.04167	0.40078	1	0.218	0.178	0.182	0.30579	0.044
KEGG_THYROID_CANCER	29	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_THYROID_CANCER	-0.43564	-1.3364	0.1448	0.40102	1	0.345	0.236	0.264	0.30659	0.044
WU_HBX_TARGETS_3_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_3_UP	-0.47063	-1.336	0.1176	0.40131	1	0.444	0.189	0.361	0.30657	0.044
DELYS_THYROID_CANCER_UP	435	http://www.broadinstitute.org/gsea/msigdb/cards/DELYS_THYROID_CANCER_UP	-0.32946	-1.3356	0.1468	0.4018	1	0.234	0.176	0.197	0.30741	0.044
MATSUDA_NATURAL_KILLER_DIFFERENTIATION	454	http://www.broadinstitute.org/gsea/msigdb/cards/MATSUDA_NATURAL_KILLER_DIFFERENTIATION	-0.30919	-1.3354	0.06452	0.40163	1	0.222	0.157	0.191	0.307	0.044
FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_3_DN	-0.36315	-1.3352	0.1506	0.40163	1	0.229	0.215	0.18	0.30659	0.044
NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP	-0.43217	-1.335	0.1173	0.40159	1	0.414	0.206	0.329	0.30669	0.044
LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	205	http://www.broadinstitute.org/gsea/msigdb/cards/LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER	-0.36482	-1.3346	0.1204	0.40189	1	0.473	0.302	0.333	0.30748	0.044
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	-0.48263	-1.3343	0.1541	0.40183	1	0.395	0.206	0.314	0.30707	0.044
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	87	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5	-0.32122	-1.334	0.06139	0.40205	1	0.264	0.171	0.22	0.30666	0.044
REACTOME_NOD1_2_SIGNALING_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NOD1_2_SIGNALING_PATHWAY	-0.43983	-1.3339	0.1601	0.40184	1	0.407	0.197	0.327	0.30625	0.044
SWEET_LUNG_CANCER_KRAS_UP	475	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_LUNG_CANCER_KRAS_UP	-0.30937	-1.3332	0.08949	0.40294	1	0.236	0.176	0.198	0.30851	0.044
KORKOLA_CORRELATED_WITH_POU5F1	33	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_CORRELATED_WITH_POU5F1	-0.39142	-1.3329	0.1116	0.40302	1	0.152	0.0622	0.142	0.30845	0.044
WANG_HCP_PROSTATE_CANCER	111	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_HCP_PROSTATE_CANCER	-0.33095	-1.3324	0.1366	0.40367	1	0.153	0.0928	0.14	0.30864	0.044
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	41	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	-0.41346	-1.332	0.0927	0.404	1	0.268	0.11	0.239	0.30896	0.044
DAUER_STAT3_TARGETS_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/DAUER_STAT3_TARGETS_DN	-0.55814	-1.3316	0.2041	0.40396	1	0.54	0.2	0.433	0.30906	0.044
BROCKE_APOPTOSIS_REVERSED_BY_IL6	141	http://www.broadinstitute.org/gsea/msigdb/cards/BROCKE_APOPTOSIS_REVERSED_BY_IL6	-0.3751	-1.3316	0.1457	0.40444	1	0.39	0.237	0.299	0.30946	0.044
REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC	-0.45052	-1.3307	0.1429	0.40508	1	0.231	0.103	0.207	0.30902	0.044
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-0.54773	-1.3307	0.1806	0.40544	1	0.43	0.17	0.358	0.30943	0.044
YANG_BREAST_CANCER_ESR1_BULK_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_BULK_DN	-0.5096	-1.3302	0.168	0.40553	1	0.429	0.188	0.348	0.30894	0.044
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	102	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	-0.3993	-1.3298	0.08687	0.4058	1	0.324	0.183	0.265	0.31033	0.044
PARENT_MTOR_SIGNALING_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/PARENT_MTOR_SIGNALING_DN	-0.32631	-1.3297	0.07787	0.40554	1	0.163	0.146	0.139	0.30992	0.044
KUMAR_AUTOPHAGY_NETWORK	68	http://www.broadinstitute.org/gsea/msigdb/cards/KUMAR_AUTOPHAGY_NETWORK	-0.33164	-1.3294	0.04223	0.40571	1	0.25	0.159	0.211	0.31111	0.044
PEDRIOLI_MIR31_TARGETS_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/PEDRIOLI_MIR31_TARGETS_UP	-0.28993	-1.3283	0.05988	0.40788	1	0.152	0.109	0.137	0.31395	0.044
REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS	-0.44611	-1.3282	0.1853	0.4075	1	0.346	0.215	0.272	0.31354	0.044
BIOCARTA_IL2_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL2_PATHWAY	-0.46623	-1.3276	0.1485	0.40836	1	0.65	0.324	0.44	0.31425	0.045
REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	246	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM	-0.36296	-1.3274	0.1223	0.40775	1	0.35	0.221	0.275	0.31473	0.045
HAHTOLA_SEZARY_SYNDROM_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_SEZARY_SYNDROM_DN	-0.43225	-1.3274	0.0703	0.40826	1	0.27	0.151	0.23	0.31409	0.045
BENPORATH_MYC_TARGETS_WITH_EBOX	219	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_MYC_TARGETS_WITH_EBOX	-0.27486	-1.3271	0.1576	0.40784	1	0.333	0.28	0.242	0.31432	0.045
IGLESIAS_E2F_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/IGLESIAS_E2F_TARGETS_DN	-0.51073	-1.3267	0.1394	0.40821	1	0.467	0.278	0.337	0.31557	0.045
REACTOME_ER_PHAGOSOME_PATHWAY	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ER_PHAGOSOME_PATHWAY	-0.46718	-1.3264	0.1606	0.40842	1	0.482	0.252	0.361	0.31585	0.045
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	105	http://www.broadinstitute.org/gsea/msigdb/cards/IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN	-0.3954	-1.3259	0.09696	0.4091	1	0.267	0.155	0.226	0.31544	0.045
GENTILE_UV_RESPONSE_CLUSTER_D9	26	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D9	-0.46014	-1.3257	0.1602	0.40889	1	0.269	0.15	0.229	0.31503	0.045
OUYANG_PROSTATE_CANCER_MARKERS	18	http://www.broadinstitute.org/gsea/msigdb/cards/OUYANG_PROSTATE_CANCER_MARKERS	-0.50131	-1.3255	0.1095	0.40892	1	0.389	0.129	0.339	0.31483	0.045
REACTOME_NUCLEOTIDE_EXCISION_REPAIR	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEOTIDE_EXCISION_REPAIR	-0.39056	-1.325	0.1597	0.40951	1	0.229	0.162	0.193	0.3153	0.045
DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	56	http://www.broadinstitute.org/gsea/msigdb/cards/DAWSON_METHYLATED_IN_LYMPHOMA_TCL1	-0.35338	-1.3244	0.1376	0.41039	1	0.179	0.0941	0.162	0.31806	0.045
KAUFFMANN_MELANOMA_RELAPSE_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_MELANOMA_RELAPSE_UP	-0.66846	-1.3239	0.205	0.41088	1	0.678	0.203	0.541	0.3193	0.045
KOHOUTEK_CCNT1_TARGETS	48	http://www.broadinstitute.org/gsea/msigdb/cards/KOHOUTEK_CCNT1_TARGETS	-0.37817	-1.3237	0.1705	0.41074	1	0.271	0.215	0.213	0.31889	0.044
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	28	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	-0.58393	-1.323	0.14	0.41194	1	0.429	0.187	0.349	0.31848	0.047
LIU_PROSTATE_CANCER_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_PROSTATE_CANCER_UP	-0.35398	-1.3228	0.1125	0.41166	1	0.326	0.238	0.249	0.31881	0.046
WENG_POR_TARGETS_GLOBAL_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WENG_POR_TARGETS_GLOBAL_UP	-0.42551	-1.3223	0.07117	0.41237	1	0.25	0.0833	0.229	0.32015	0.047
PID_IL1_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL1_PATHWAY	-0.41727	-1.3221	0.1383	0.41212	1	0.344	0.181	0.282	0.32008	0.047
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN	-0.4515	-1.3221	0.2086	0.4116	1	0.289	0.116	0.256	0.31967	0.045
PRAMOONJAGO_SOX4_TARGETS_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/PRAMOONJAGO_SOX4_TARGETS_UP	-0.44158	-1.3218	0.205	0.41177	1	0.451	0.262	0.333	0.32124	0.046
LIU_TARGETS_OF_VMYB_VS_CMYB_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_TARGETS_OF_VMYB_VS_CMYB_DN	-0.45992	-1.3218	0.1593	0.41142	1	0.35	0.158	0.295	0.32083	0.046
AMIT_SERUM_RESPONSE_480_MCF10A	35	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_480_MCF10A	-0.40385	-1.3215	0.08829	0.41165	1	0.4	0.213	0.315	0.32186	0.045
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN	-0.39901	-1.3214	0.1412	0.41138	1	0.31	0.161	0.26	0.32145	0.043
ST_B_CELL_ANTIGEN_RECEPTOR	40	http://www.broadinstitute.org/gsea/msigdb/cards/ST_B_CELL_ANTIGEN_RECEPTOR	-0.30439	-1.3208	0.08758	0.41226	1	0.4	0.325	0.27	0.32185	0.044
BIOCARTA_CK1_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CK1_PATHWAY	-0.46234	-1.3207	0.1762	0.41188	1	0.294	0.116	0.26	0.32145	0.043
ROSS_AML_WITH_CBFB_MYH11_FUSION	51	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_CBFB_MYH11_FUSION	-0.42508	-1.3205	0.1912	0.4118	1	0.294	0.146	0.252	0.32349	0.043
DEMAGALHAES_AGING_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/DEMAGALHAES_AGING_UP	-0.46735	-1.3204	0.1588	0.41153	1	0.3	0.118	0.265	0.32308	0.043
MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN	-0.3907	-1.3198	0.1091	0.41201	1	0.167	0.0614	0.157	0.32275	0.043
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	65	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	-0.39527	-1.3198	0.1412	0.41249	1	0.369	0.216	0.29	0.32316	0.043
BIOCARTA_NKCELLS_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NKCELLS_PATHWAY	-0.53161	-1.3197	0.1606	0.41172	1	0.471	0.218	0.368	0.32235	0.043
MURAKAMI_UV_RESPONSE_1HR_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_1HR_UP	-0.3659	-1.3196	0.1352	0.41127	1	0.353	0.276	0.256	0.32194	0.043
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	28	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6	-0.39772	-1.3196	0.1166	0.41081	1	0.25	0.0951	0.226	0.32154	0.042
PECE_MAMMARY_STEM_CELL_UP	137	http://www.broadinstitute.org/gsea/msigdb/cards/PECE_MAMMARY_STEM_CELL_UP	-0.30236	-1.3193	0.1191	0.41112	1	0.358	0.258	0.267	0.32217	0.042
SU_TESTIS	74	http://www.broadinstitute.org/gsea/msigdb/cards/SU_TESTIS	-0.53593	-1.3192	0.1455	0.41068	1	0.324	0.0931	0.295	0.32288	0.042
PID_CXCR3_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CXCR3_PATHWAY	-0.47449	-1.3188	0.1157	0.41124	1	0.326	0.175	0.269	0.32247	0.042
CASTELLANO_NRAS_TARGETS_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/CASTELLANO_NRAS_TARGETS_UP	-0.38033	-1.3185	0.1504	0.41138	1	0.25	0.136	0.217	0.32243	0.042
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	158	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.33425	-1.3184	0.1293	0.41089	1	0.278	0.197	0.225	0.32203	0.042
BIOCARTA_MPR_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MPR_PATHWAY	-0.38615	-1.3183	0.1484	0.41072	1	0.353	0.228	0.273	0.32163	0.042
PID_CMYB_PATHWAY	84	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CMYB_PATHWAY	-0.33546	-1.3182	0.1079	0.41031	1	0.31	0.222	0.242	0.32123	0.042
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	17	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2_VIA_ERCC6	-0.43424	-1.3181	0.1591	0.41008	1	0.412	0.227	0.318	0.32083	0.042
BROWNE_HCMV_INFECTION_4HR_DN	245	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_4HR_DN	-0.26802	-1.3181	0.0449	0.40961	1	0.314	0.26	0.235	0.32043	0.042
BIOCARTA_PTDINS_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PTDINS_PATHWAY	-0.41591	-1.3174	0.1956	0.41014	1	0.522	0.334	0.348	0.31964	0.039
REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_KERATAN_SULFATE_BIOSYNTHESIS	-0.35023	-1.3174	0.09256	0.41059	1	0.48	0.266	0.353	0.32003	0.042
BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	144	http://www.broadinstitute.org/gsea/msigdb/cards/BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE	-0.31323	-1.3164	0.09266	0.41185	1	0.194	0.153	0.166	0.32207	0.042
XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN	-0.63489	-1.316	0.1911	0.41223	1	0.48	0.159	0.404	0.32167	0.042
KEGG_LYSINE_DEGRADATION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LYSINE_DEGRADATION	-0.4325	-1.3159	0.1059	0.41196	1	0.432	0.218	0.338	0.32133	0.042
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	101	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-0.32421	-1.3157	0.1022	0.41188	1	0.208	0.135	0.181	0.32228	0.039
CHIBA_RESPONSE_TO_TSA_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/CHIBA_RESPONSE_TO_TSA_UP	-0.41125	-1.3157	0.167	0.41137	1	0.469	0.309	0.325	0.32188	0.039
TAVOR_CEBPA_TARGETS_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/TAVOR_CEBPA_TARGETS_DN	-0.3984	-1.3156	0.1379	0.41103	1	0.414	0.236	0.316	0.32148	0.038
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	110	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	-0.436	-1.315	0.1257	0.41202	1	0.273	0.135	0.237	0.32209	0.038
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	-0.30856	-1.3142	0.1381	0.41317	1	0.274	0.213	0.216	0.32337	0.039
WELCSH_BRCA1_TARGETS_DN	138	http://www.broadinstitute.org/gsea/msigdb/cards/WELCSH_BRCA1_TARGETS_DN	-0.32004	-1.314	0.1988	0.41327	1	0.428	0.304	0.299	0.32466	0.039
YAN_ESCAPE_FROM_ANOIKIS	24	http://www.broadinstitute.org/gsea/msigdb/cards/YAN_ESCAPE_FROM_ANOIKIS	-0.50886	-1.3137	0.1722	0.41326	1	0.417	0.163	0.349	0.32426	0.038
SANSOM_APC_TARGETS	202	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS	-0.32207	-1.3137	0.02605	0.4128	1	0.183	0.128	0.161	0.32386	0.038
AIYAR_COBRA1_TARGETS_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/AIYAR_COBRA1_TARGETS_UP	-0.43432	-1.313	0.1227	0.41377	1	0.158	0.0283	0.154	0.3248	0.038
RODRIGUES_NTN1_TARGETS_DN	153	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_NTN1_TARGETS_DN	-0.32221	-1.3129	0.1224	0.41354	1	0.288	0.205	0.23	0.3244	0.038
REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION	-0.38066	-1.3127	0.1549	0.41339	1	0.565	0.33	0.379	0.32467	0.038
KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION	-0.34126	-1.3124	0.096	0.4135	1	0.087	0.049	0.0828	0.32488	0.038
ROZANOV_MMP14_TARGETS_SUBSET	33	http://www.broadinstitute.org/gsea/msigdb/cards/ROZANOV_MMP14_TARGETS_SUBSET	-0.44389	-1.3124	0.1831	0.41317	1	0.394	0.242	0.299	0.32448	0.038
REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	62	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_NF_KAPPAB_IN_B_CELLS	-0.4446	-1.3121	0.1466	0.41325	1	0.339	0.202	0.271	0.32474	0.038
LIAN_LIPA_TARGETS_3M	57	http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_LIPA_TARGETS_3M	-0.44091	-1.3118	0.1813	0.41348	1	0.333	0.172	0.277	0.32442	0.038
PUJANA_BRCA_CENTERED_NETWORK	116	http://www.broadinstitute.org/gsea/msigdb/cards/PUJANA_BRCA_CENTERED_NETWORK	-0.57516	-1.3113	0.2094	0.41406	1	0.448	0.153	0.381	0.32607	0.038
CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	28	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY	-0.4229	-1.3113	0.1601	0.41372	1	0.321	0.135	0.278	0.32568	0.038
BILD_E2F3_ONCOGENIC_SIGNATURE	235	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_E2F3_ONCOGENIC_SIGNATURE	-0.29912	-1.311	0.08696	0.41381	1	0.149	0.107	0.134	0.32814	0.038
MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	76	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_6_7WK_DN	-0.41309	-1.3105	0.1392	0.41448	1	0.224	0.137	0.194	0.32775	0.038
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	325	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP	-0.3268	-1.309	0.1217	0.41738	1	0.298	0.212	0.238	0.33133	0.039
REACTOME_SHC_MEDIATED_SIGNALLING	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_MEDIATED_SIGNALLING	-0.59303	-1.3089	0.2171	0.41716	1	0.467	0.213	0.367	0.33093	0.039
REACTOME_DOUBLE_STRAND_BREAK_REPAIR	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOUBLE_STRAND_BREAK_REPAIR	-0.56787	-1.3088	0.1934	0.41704	1	0.227	0.0481	0.217	0.33054	0.039
GERHOLD_ADIPOGENESIS_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/GERHOLD_ADIPOGENESIS_DN	-0.41181	-1.3082	0.135	0.41777	1	0.381	0.216	0.3	0.33214	0.039
RAMASWAMY_METASTASIS_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/RAMASWAMY_METASTASIS_UP	-0.44249	-1.3081	0.1992	0.41715	1	0.429	0.24	0.327	0.33134	0.039
LOPEZ_EPITHELIOID_MESOTHELIOMA	17	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_EPITHELIOID_MESOTHELIOMA	-0.49836	-1.3081	0.155	0.41762	1	0.412	0.152	0.35	0.33174	0.039
REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HOMOLOGOUS_RECOMBINATION_REPAIR_OF_REPLICATION_INDEPENDENT_DOUBLE_STRAND_BREAKS	-0.5739	-1.308	0.1905	0.41685	1	0.25	0.0481	0.238	0.33095	0.039
BIOCARTA_NO1_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NO1_PATHWAY	-0.35114	-1.3079	0.1262	0.4166	1	0.516	0.337	0.343	0.33055	0.036
PID_BARD1_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BARD1_PATHWAY	-0.5448	-1.3078	0.1773	0.41621	1	0.483	0.169	0.402	0.33016	0.036
REACTOME_APOPTOTIC_EXECUTION_PHASE	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APOPTOTIC_EXECUTION_PHASE	-0.4344	-1.3076	0.1222	0.4162	1	0.353	0.169	0.294	0.32976	0.035
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	-0.32909	-1.3076	0.126	0.41586	1	0.432	0.277	0.314	0.33116	0.035
LANDIS_ERBB2_BREAST_TUMORS_65_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_65_DN	-0.42525	-1.3072	0.1515	0.41612	1	0.306	0.167	0.255	0.33334	0.036
RADMACHER_AML_PROGNOSIS	77	http://www.broadinstitute.org/gsea/msigdb/cards/RADMACHER_AML_PROGNOSIS	-0.33852	-1.307	0.1458	0.41616	1	0.312	0.232	0.24	0.3331	0.036
DARWICHE_PAPILLOMA_PROGRESSION_RISK	69	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_PROGRESSION_RISK	-0.30938	-1.3065	0.07536	0.41677	1	0.174	0.12	0.153	0.33271	0.036
APPEL_IMATINIB_RESPONSE	31	http://www.broadinstitute.org/gsea/msigdb/cards/APPEL_IMATINIB_RESPONSE	-0.3909	-1.3062	0.1452	0.41699	1	0.355	0.27	0.259	0.33231	0.036
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	235	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN	-0.27538	-1.3061	0.07495	0.41689	1	0.294	0.226	0.229	0.33192	0.036
LENAOUR_DENDRITIC_CELL_MATURATION_UP	112	http://www.broadinstitute.org/gsea/msigdb/cards/LENAOUR_DENDRITIC_CELL_MATURATION_UP	-0.34016	-1.305	0.1074	0.41872	1	0.17	0.132	0.148	0.3358	0.039
BROWNE_HCMV_INFECTION_14HR_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_14HR_UP	-0.38618	-1.305	0.1372	0.41823	1	0.333	0.195	0.27	0.33541	0.039
BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP	-0.5976	-1.3049	0.1808	0.41805	1	0.477	0.164	0.4	0.33501	0.039
REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	69	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RIG_I_MDA5_MEDIATED_INDUCTION_OF_IFN_ALPHA_BETA_PATHWAYS	-0.37616	-1.3045	0.126	0.41841	1	0.319	0.228	0.247	0.33538	0.039
ONDER_CDH1_TARGETS_1_DN	167	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_1_DN	-0.3902	-1.3041	0.09981	0.41887	1	0.371	0.221	0.291	0.33526	0.039
DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	345	http://www.broadinstitute.org/gsea/msigdb/cards/DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP	-0.31873	-1.3039	0.09035	0.4189	1	0.223	0.169	0.188	0.33487	0.039
PID_TCR_PATHWAY	66	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TCR_PATHWAY	-0.33676	-1.3032	0.1402	0.41987	1	0.424	0.301	0.297	0.3367	0.039
KEGG_P53_SIGNALING_PATHWAY	67	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_P53_SIGNALING_PATHWAY	-0.37941	-1.3025	0.1118	0.42093	1	0.224	0.122	0.197	0.3368	0.039
GHO_ATF5_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GHO_ATF5_TARGETS_DN	-0.50391	-1.302	0.1339	0.42163	1	0.4	0.174	0.33	0.33911	0.039
MAYBURD_RESPONSE_TO_L663536_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/MAYBURD_RESPONSE_TO_L663536_DN	-0.51007	-1.3018	0.1793	0.42153	1	0.481	0.219	0.377	0.33872	0.039
GAJATE_RESPONSE_TO_TRABECTEDIN_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/GAJATE_RESPONSE_TO_TRABECTEDIN_UP	-0.37105	-1.3017	0.1487	0.42129	1	0.359	0.219	0.281	0.34038	0.039
PID_ARF6_DOWNSTREAM_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF6_DOWNSTREAM_PATHWAY	-0.45037	-1.3016	0.1739	0.42116	1	0.6	0.225	0.465	0.33999	0.039
AMIT_EGF_RESPONSE_40_MCF10A	19	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_40_MCF10A	-0.54492	-1.3016	0.1839	0.42072	1	0.368	0.181	0.302	0.33959	0.039
LEE_LIVER_CANCER_MYC_E2F1_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_E2F1_DN	-0.31004	-1.3011	0.125	0.42125	1	0.283	0.218	0.222	0.33919	0.039
SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	466	http://www.broadinstitute.org/gsea/msigdb/cards/SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP	-0.29066	-1.3007	0.1173	0.4217	1	0.27	0.226	0.213	0.3388	0.039
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP	-0.3986	-1.3005	0.1468	0.42161	1	0.4	0.221	0.312	0.33841	0.039
RAHMAN_TP53_TARGETS_PHOSPHORYLATED	21	http://www.broadinstitute.org/gsea/msigdb/cards/RAHMAN_TP53_TARGETS_PHOSPHORYLATED	-0.51766	-1.3004	0.1861	0.42131	1	0.429	0.197	0.344	0.33801	0.039
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	162	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	-0.34877	-1.2998	0.166	0.42221	1	0.395	0.262	0.293	0.33762	0.039
PID_CXCR4_PATHWAY	102	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CXCR4_PATHWAY	-0.3157	-1.2997	0.1038	0.42194	1	0.275	0.218	0.215	0.33898	0.039
KHETCHOUMIAN_TRIM24_TARGETS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/KHETCHOUMIAN_TRIM24_TARGETS_UP	-0.49875	-1.2989	0.2092	0.42339	1	0.457	0.267	0.335	0.33859	0.039
GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	22	http://www.broadinstitute.org/gsea/msigdb/cards/GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION	-0.37541	-1.2988	0.1528	0.42309	1	0.5	0.369	0.316	0.3382	0.039
LEE_LIVER_CANCER_MYC_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_DN	-0.33332	-1.2986	0.08863	0.42305	1	0.254	0.147	0.217	0.33781	0.039
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	103	http://www.broadinstitute.org/gsea/msigdb/cards/AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-0.29147	-1.2985	0.1368	0.42262	1	0.155	0.117	0.138	0.33742	0.039
YOKOE_CANCER_TESTIS_ANTIGENS	33	http://www.broadinstitute.org/gsea/msigdb/cards/YOKOE_CANCER_TESTIS_ANTIGENS	-0.3827	-1.2984	0.1046	0.42241	1	0.303	0.139	0.261	0.33703	0.039
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP	-0.31228	-1.2978	0.05169	0.42318	1	0.118	0.0484	0.112	0.33838	0.039
ALONSO_METASTASIS_EMT_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_EMT_UP	-0.48181	-1.2974	0.1531	0.42364	1	0.314	0.113	0.279	0.33799	0.039
WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	132	http://www.broadinstitute.org/gsea/msigdb/cards/WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP	-0.43692	-1.2972	0.1811	0.42372	1	0.25	0.125	0.22	0.33867	0.039
BURTON_ADIPOGENESIS_1	33	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_1	-0.45618	-1.2965	0.2064	0.42493	1	0.182	0.062	0.171	0.33828	0.04
KEGG_DNA_REPLICATION	36	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DNA_REPLICATION	-0.57367	-1.2963	0.2102	0.4247	1	0.444	0.197	0.357	0.3379	0.039
HOEGERKORP_CD44_TARGETS_DIRECT_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/HOEGERKORP_CD44_TARGETS_DIRECT_UP	-0.39905	-1.2962	0.1902	0.42451	1	0.154	0.0668	0.144	0.33751	0.039
PID_LIS1_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LIS1_PATHWAY	-0.42831	-1.2961	0.1268	0.42384	1	0.444	0.231	0.342	0.33674	0.039
ODONNELL_METASTASIS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_METASTASIS_DN	-0.41862	-1.2961	0.1894	0.42339	1	0.417	0.243	0.316	0.33636	0.039
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP	-0.36492	-1.2961	0.1684	0.42427	1	0.441	0.275	0.32	0.33712	0.039
HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP	-0.37721	-1.2958	0.1474	0.42338	1	0.194	0.101	0.175	0.33597	0.039
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	182	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	-0.38562	-1.2956	0.1658	0.42286	1	0.236	0.108	0.212	0.33521	0.039
KIM_WT1_TARGETS_8HR_DN	117	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_8HR_DN	-0.32834	-1.2956	0.1198	0.42325	1	0.282	0.207	0.225	0.33559	0.039
REACTOME_BASE_EXCISION_REPAIR	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BASE_EXCISION_REPAIR	-0.46978	-1.2953	0.2029	0.42305	1	0.222	0.14	0.191	0.33483	0.039
REACTOME_SIGNALING_BY_ILS	101	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ILS	-0.36612	-1.2951	0.09903	0.42301	1	0.356	0.221	0.279	0.33445	0.039
REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION	-0.32127	-1.2951	0.08594	0.42255	1	0.333	0.251	0.25	0.33407	0.039
KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	22	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE	-0.41937	-1.2949	0.1616	0.42193	1	0.136	0.0603	0.128	0.33462	0.034
DASU_IL6_SIGNALING_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/DASU_IL6_SIGNALING_UP	-0.3487	-1.2949	0.1713	0.42238	1	0.293	0.277	0.212	0.335	0.039
FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	430	http://www.broadinstitute.org/gsea/msigdb/cards/FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN	-0.34682	-1.2947	0.1622	0.42214	1	0.24	0.157	0.205	0.33655	0.033
BIOCARTA_ATRBRCA_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ATRBRCA_PATHWAY	-0.57283	-1.2943	0.2046	0.42207	1	0.35	0.126	0.306	0.33624	0.033
KANG_GIST_WITH_PDGFRA_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_GIST_WITH_PDGFRA_UP	-0.40472	-1.2943	0.142	0.42253	1	0.383	0.192	0.31	0.33662	0.033
HAHTOLA_CTCL_PATHOGENESIS	15	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_CTCL_PATHOGENESIS	-0.50905	-1.2939	0.1642	0.42233	1	0.267	0.142	0.229	0.33586	0.033
REACTOME_DNA_REPAIR	103	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DNA_REPAIR	-0.43219	-1.2938	0.2058	0.42186	1	0.233	0.144	0.2	0.33511	0.033
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	59	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-0.41412	-1.2938	0.1465	0.42212	1	0.305	0.154	0.259	0.33548	0.033
BIOCARTA_AKAPCENTROSOME_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AKAPCENTROSOME_PATHWAY	-0.44903	-1.2936	0.1399	0.42179	1	0.333	0.154	0.282	0.33619	0.033
REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	79	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING	-0.30837	-1.2924	0.1423	0.42382	1	0.43	0.304	0.3	0.33897	0.033
MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN	-0.40653	-1.2923	0.2008	0.42348	1	0.25	0.17	0.208	0.33859	0.033
MENSSEN_MYC_TARGETS	51	http://www.broadinstitute.org/gsea/msigdb/cards/MENSSEN_MYC_TARGETS	-0.45789	-1.2921	0.2213	0.42363	1	0.294	0.178	0.242	0.33821	0.036
PID_ERB_GENOMIC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERB_GENOMIC_PATHWAY	-0.41706	-1.2919	0.1181	0.42355	1	0.267	0.184	0.218	0.33784	0.032
LI_WILMS_TUMOR	26	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR	-0.44491	-1.2918	0.1569	0.42328	1	0.192	0.0818	0.177	0.33746	0.032
LEE_INTRATHYMIC_T_PROGENITOR	21	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_INTRATHYMIC_T_PROGENITOR	-0.52518	-1.2915	0.1657	0.42335	1	0.333	0.114	0.296	0.33709	0.032
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-0.43505	-1.2914	0.191	0.42304	1	0.457	0.261	0.338	0.33671	0.032
LANDIS_BREAST_CANCER_PROGRESSION_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_BREAST_CANCER_PROGRESSION_UP	-0.4047	-1.2911	0.1594	0.42279	1	0.349	0.197	0.281	0.33649	0.029
QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	37	http://www.broadinstitute.org/gsea/msigdb/cards/QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2	-0.37794	-1.2911	0.1818	0.42321	1	0.243	0.18	0.2	0.33686	0.032
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN	-0.28413	-1.2902	0.1434	0.42434	1	0.182	0.166	0.152	0.33789	0.03
REACTOME_EXTENSION_OF_TELOMERES	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EXTENSION_OF_TELOMERES	-0.5196	-1.2901	0.226	0.42414	1	0.222	0.0801	0.205	0.33751	0.029
BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN	-0.51571	-1.29	0.2051	0.4236	1	0.258	0.093	0.234	0.33687	0.029
HINATA_NFKB_TARGETS_KERATINOCYTE_UP	90	http://www.broadinstitute.org/gsea/msigdb/cards/HINATA_NFKB_TARGETS_KERATINOCYTE_UP	-0.40505	-1.29	0.2081	0.42403	1	0.433	0.265	0.32	0.33724	0.029
REACTOME_SIGNALING_BY_HIPPO	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_HIPPO	-0.49292	-1.2891	0.215	0.42506	1	0.25	0.115	0.221	0.33999	0.029
BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN	-0.46606	-1.289	0.1917	0.42481	1	0.389	0.215	0.305	0.33962	0.029
REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC	-0.48419	-1.2886	0.1835	0.42515	1	0.375	0.17	0.312	0.34047	0.029
FIRESTEIN_PROLIFERATION	170	http://www.broadinstitute.org/gsea/msigdb/cards/FIRESTEIN_PROLIFERATION	-0.28722	-1.2886	0.07211	0.42428	1	0.241	0.194	0.196	0.33972	0.029
KATSANOU_ELAVL1_TARGETS_DN	143	http://www.broadinstitute.org/gsea/msigdb/cards/KATSANOU_ELAVL1_TARGETS_DN	-0.34793	-1.2886	0.09216	0.42469	1	0.287	0.185	0.235	0.34009	0.029
ST_FAS_SIGNALING_PATHWAY	62	http://www.broadinstitute.org/gsea/msigdb/cards/ST_FAS_SIGNALING_PATHWAY	-0.32541	-1.2881	0.2	0.42498	1	0.177	0.147	0.152	0.34061	0.029
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP	-0.3155	-1.2872	0.1996	0.42656	1	0.484	0.361	0.311	0.34133	0.03
BIDUS_METASTASIS_UP	208	http://www.broadinstitute.org/gsea/msigdb/cards/BIDUS_METASTASIS_UP	-0.52068	-1.2871	0.2098	0.42611	1	0.351	0.154	0.299	0.34096	0.03
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP	-0.4157	-1.2866	0.1383	0.427	1	0.357	0.236	0.273	0.34164	0.03
NOJIMA_SFRP2_TARGETS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/NOJIMA_SFRP2_TARGETS_DN	-0.51609	-1.2859	0.2132	0.42814	1	0.417	0.13	0.363	0.3418	0.031
PID_RAC1_PATHWAY	53	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RAC1_PATHWAY	-0.3468	-1.2854	0.1514	0.42869	1	0.358	0.224	0.279	0.34368	0.031
ZHANG_TLX_TARGETS_36HR_DN	183	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_36HR_DN	-0.5843	-1.2854	0.2308	0.42842	1	0.366	0.118	0.325	0.34424	0.031
LA_MEN1_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/LA_MEN1_TARGETS	-0.43736	-1.2847	0.2281	0.4294	1	0.542	0.286	0.387	0.34386	0.031
HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN	-0.40846	-1.2846	0.1663	0.42921	1	0.263	0.157	0.222	0.34349	0.031
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	152	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-0.31964	-1.2844	0.1776	0.42871	1	0.362	0.263	0.268	0.34403	0.03
PENG_GLUCOSE_DEPRIVATION_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUCOSE_DEPRIVATION_UP	-0.3538	-1.2844	0.1926	0.42911	1	0.318	0.231	0.245	0.34441	0.031
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN	-0.34433	-1.2835	0.1641	0.43011	1	0.167	0.0839	0.153	0.34543	0.033
LEE_AGING_NEOCORTEX_DN	76	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_NEOCORTEX_DN	-0.26843	-1.2833	0.1431	0.43028	1	0.395	0.321	0.269	0.3461	0.032
NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	271	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP	-0.39248	-1.2828	0.1784	0.43065	1	0.328	0.183	0.271	0.346	0.032
ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP	-0.44866	-1.2825	0.1916	0.43108	1	0.385	0.222	0.299	0.34795	0.033
BAUS_TFF2_TARGETS_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/BAUS_TFF2_TARGETS_UP	-0.36035	-1.2823	0.1572	0.43099	1	0.323	0.164	0.27	0.34757	0.033
REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING	-0.30725	-1.282	0.1743	0.4307	1	0.447	0.33	0.3	0.34682	0.033
DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	169	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN	-0.26349	-1.282	0.1077	0.43111	1	0.166	0.16	0.14	0.3472	0.033
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	111	http://www.broadinstitute.org/gsea/msigdb/cards/BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	-0.43616	-1.2816	0.1722	0.43113	1	0.288	0.184	0.236	0.34653	0.033
VALK_AML_CLUSTER_5	31	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_5	-0.43399	-1.2815	0.2194	0.43094	1	0.226	0.13	0.197	0.34616	0.033
REACTOME_HIV_INFECTION	182	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HIV_INFECTION	-0.3835	-1.2812	0.1849	0.43099	1	0.412	0.263	0.306	0.34579	0.033
GRADE_COLON_AND_RECTAL_CANCER_UP	273	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_AND_RECTAL_CANCER_UP	-0.42989	-1.2809	0.2137	0.43116	1	0.311	0.169	0.262	0.34935	0.033
MOOTHA_PGC	403	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_PGC	-0.31361	-1.2808	0.1158	0.43087	1	0.278	0.205	0.225	0.34898	0.033
REACTOME_FANCONI_ANEMIA_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FANCONI_ANEMIA_PATHWAY	-0.54634	-1.2804	0.2515	0.4313	1	0.667	0.304	0.465	0.3486	0.033
AMIT_SERUM_RESPONSE_120_MCF10A	62	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_120_MCF10A	-0.3772	-1.2799	0.2023	0.43202	1	0.339	0.264	0.25	0.34823	0.033
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	429	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP	-0.27806	-1.2798	0.1079	0.43168	1	0.247	0.198	0.201	0.34786	0.029
WELCH_GATA1_TARGETS	21	http://www.broadinstitute.org/gsea/msigdb/cards/WELCH_GATA1_TARGETS	-0.38558	-1.2797	0.1674	0.43135	1	0.286	0.254	0.213	0.34749	0.029
CROMER_METASTASIS_DN	78	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_METASTASIS_DN	-0.34008	-1.2795	0.165	0.4314	1	0.333	0.224	0.26	0.34712	0.03
ZUCCHI_METASTASIS_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/ZUCCHI_METASTASIS_UP	-0.36413	-1.2793	0.1248	0.43135	1	0.436	0.316	0.299	0.34675	0.03
AMIT_DELAYED_EARLY_GENES	17	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_DELAYED_EARLY_GENES	-0.55733	-1.2792	0.248	0.43118	1	0.529	0.262	0.391	0.34638	0.03
UEDA_PERIFERAL_CLOCK	163	http://www.broadinstitute.org/gsea/msigdb/cards/UEDA_PERIFERAL_CLOCK	-0.31931	-1.2791	0.1128	0.43084	1	0.258	0.203	0.207	0.34601	0.03
BYSTROEM_CORRELATED_WITH_IL5_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTROEM_CORRELATED_WITH_IL5_DN	-0.35754	-1.2785	0.1294	0.43167	1	0.328	0.165	0.274	0.34763	0.032
NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	145	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON	-0.42294	-1.2782	0.2571	0.4319	1	0.317	0.207	0.253	0.34786	0.031
MURATA_VIRULENCE_OF_H_PILORI	24	http://www.broadinstitute.org/gsea/msigdb/cards/MURATA_VIRULENCE_OF_H_PILORI	-0.45221	-1.2781	0.1538	0.4317	1	0.167	0.0445	0.159	0.34749	0.031
REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRIN_ALPHAIIB_BETA3_SIGNALING	-0.36144	-1.2768	0.09218	0.4341	1	0.407	0.251	0.306	0.35	0.032
REACTOME_GLUCOSE_METABOLISM	64	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCOSE_METABOLISM	-0.31721	-1.2766	0.1362	0.43397	1	0.531	0.338	0.353	0.35079	0.033
JIANG_HYPOXIA_VIA_VHL	34	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_HYPOXIA_VIA_VHL	-0.36357	-1.2761	0.213	0.43457	1	0.206	0.138	0.178	0.35138	0.032
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	223	http://www.broadinstitute.org/gsea/msigdb/cards/THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN	-0.2618	-1.276	0.09325	0.43436	1	0.22	0.191	0.179	0.35121	0.032
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	-0.61631	-1.2758	0.2514	0.43439	1	0.474	0.124	0.415	0.35187	0.031
IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	118	http://www.broadinstitute.org/gsea/msigdb/cards/IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP	-0.31993	-1.2757	0.1604	0.43406	1	0.314	0.228	0.243	0.35159	0.031
WONG_PROTEASOME_GENE_MODULE	49	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_PROTEASOME_GENE_MODULE	-0.4787	-1.2751	0.249	0.43488	1	0.449	0.206	0.357	0.352	0.032
CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP	-0.33508	-1.2746	0.2095	0.43557	1	0.176	0.118	0.156	0.35186	0.033
PID_IL2_1PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL2_1PATHWAY	-0.37865	-1.2739	0.1252	0.43659	1	0.389	0.216	0.305	0.35371	0.033
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN	-0.33923	-1.2739	0.1806	0.43624	1	0.259	0.166	0.216	0.35334	0.033
COLLER_MYC_TARGETS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/COLLER_MYC_TARGETS_UP	-0.50952	-1.2735	0.1967	0.43665	1	0.56	0.261	0.414	0.35297	0.033
PID_FRA_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FRA_PATHWAY	-0.3893	-1.2724	0.1953	0.43855	1	0.371	0.282	0.267	0.35306	0.033
PID_RAS_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RAS_PATHWAY	-0.34545	-1.2724	0.1122	0.43826	1	0.567	0.323	0.384	0.35269	0.033
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	398	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1	-0.27884	-1.2723	0.09736	0.43795	1	0.211	0.176	0.177	0.35232	0.032
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	-0.46557	-1.2719	0.1845	0.43802	1	0.592	0.279	0.427	0.35189	0.032
GEISS_RESPONSE_TO_DSRNA_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/GEISS_RESPONSE_TO_DSRNA_UP	-0.50594	-1.2719	0.1834	0.4384	1	0.486	0.221	0.379	0.35226	0.032
REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION	-0.57785	-1.2713	0.2008	0.43884	1	0.4	0.088	0.365	0.35294	0.032
HATADA_METHYLATED_IN_LUNG_CANCER_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/HATADA_METHYLATED_IN_LUNG_CANCER_DN	-0.37081	-1.271	0.09286	0.43908	1	0.0645	0.0021	0.0645	0.35403	0.032
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	71	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	-0.34724	-1.2703	0.1731	0.43998	1	0.239	0.172	0.199	0.35473	0.032
MOREIRA_RESPONSE_TO_TSA_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/MOREIRA_RESPONSE_TO_TSA_UP	-0.34789	-1.2702	0.2059	0.43985	1	0.5	0.317	0.342	0.35593	0.032
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-0.50792	-1.2699	0.2405	0.44007	1	0.435	0.221	0.34	0.35712	0.032
GENTILE_UV_RESPONSE_CLUSTER_D2	40	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D2	-0.4329	-1.2696	0.2119	0.44013	1	0.45	0.277	0.326	0.35675	0.032
REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1	-0.50462	-1.2695	0.2102	0.43986	1	0.353	0.187	0.287	0.35638	0.032
REACTOME_GLYCOLYSIS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOLYSIS	-0.36925	-1.2694	0.2008	0.43975	1	0.444	0.259	0.33	0.35601	0.032
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	97	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	-0.34385	-1.2685	0.1888	0.4412	1	0.186	0.136	0.161	0.35804	0.032
DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	220	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP	-0.40658	-1.2683	0.1601	0.44128	1	0.355	0.206	0.284	0.35985	0.032
HOLLMANN_APOPTOSIS_VIA_CD40_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLMANN_APOPTOSIS_VIA_CD40_UP	-0.34984	-1.2682	0.1948	0.44107	1	0.314	0.224	0.246	0.35948	0.032
GOLUB_ALL_VS_AML_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/GOLUB_ALL_VS_AML_UP	-0.43615	-1.2677	0.1992	0.4418	1	0.292	0.144	0.25	0.35911	0.032
WANG_SMARCE1_TARGETS_DN	353	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_SMARCE1_TARGETS_DN	-0.36273	-1.2675	0.1345	0.44167	1	0.221	0.121	0.197	0.35874	0.032
WAKASUGI_HAVE_ZNF143_BINDING_SITES	57	http://www.broadinstitute.org/gsea/msigdb/cards/WAKASUGI_HAVE_ZNF143_BINDING_SITES	-0.46516	-1.2673	0.2378	0.44167	1	0.281	0.128	0.245	0.35837	0.032
CORRE_MULTIPLE_MYELOMA_UP	66	http://www.broadinstitute.org/gsea/msigdb/cards/CORRE_MULTIPLE_MYELOMA_UP	-0.32745	-1.2671	0.1529	0.44171	1	0.106	0.0283	0.103	0.35884	0.032
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	105	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP	-0.28741	-1.267	0.1163	0.44135	1	0.2	0.151	0.171	0.35848	0.032
CROONQUIST_IL6_DEPRIVATION_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_IL6_DEPRIVATION_UP	-0.44505	-1.2668	0.1992	0.44147	1	0.158	0.0543	0.149	0.35811	0.032
SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP	-0.48469	-1.2667	0.1736	0.44118	1	0.316	0.0684	0.294	0.35774	0.032
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-0.29892	-1.2666	0.2053	0.44097	1	0.257	0.219	0.201	0.35738	0.031
REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P53_INDEPENDENT_G1_S_DNA_DAMAGE_CHECKPOINT	-0.48904	-1.2665	0.2131	0.44075	1	0.354	0.17	0.294	0.35702	0.031
REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	46	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CDK_MEDIATED_PHOSPHORYLATION_AND_REMOVAL_OF_CDC6	-0.49131	-1.2659	0.2066	0.44147	1	0.37	0.17	0.307	0.35822	0.031
REACTOME_CD28_CO_STIMULATION	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CD28_CO_STIMULATION	-0.40134	-1.2658	0.1473	0.44126	1	0.484	0.305	0.337	0.35785	0.031
LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_TARGETS_OF_PTCH1_AND_SUFU_UP	-0.33553	-1.2657	0.1407	0.44119	1	0.224	0.132	0.195	0.35749	0.031
REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM	-0.341	-1.2653	0.1571	0.44164	1	0.483	0.287	0.345	0.35712	0.031
XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	26	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR	-0.36342	-1.2652	0.2284	0.44133	1	0.269	0.221	0.21	0.35676	0.031
LE_EGR2_TARGETS_DN	104	http://www.broadinstitute.org/gsea/msigdb/cards/LE_EGR2_TARGETS_DN	-0.31204	-1.2644	0.1434	0.44254	1	0.279	0.191	0.227	0.36061	0.031
MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	16	http://www.broadinstitute.org/gsea/msigdb/cards/MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN	-0.45117	-1.2643	0.2346	0.44238	1	0.125	0.0839	0.115	0.36024	0.031
PID_SYNDECAN_4_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_4_PATHWAY	-0.42126	-1.2641	0.1536	0.44239	1	0.5	0.254	0.373	0.35988	0.031
REACTOME_SIGNALING_BY_RHO_GTPASES	110	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_RHO_GTPASES	-0.26688	-1.264	0.1255	0.44206	1	0.182	0.157	0.154	0.35951	0.031
TERAO_AOX4_TARGETS_SKIN_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/TERAO_AOX4_TARGETS_SKIN_DN	-0.45133	-1.2623	0.1743	0.44513	1	0.24	0.0583	0.226	0.36113	0.031
SANSOM_APC_TARGETS_REQUIRE_MYC	195	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_REQUIRE_MYC	-0.25885	-1.262	0.1797	0.44539	1	0.174	0.126	0.154	0.36222	0.031
MARKS_ACETYLATED_NON_HISTONE_PROTEINS	15	http://www.broadinstitute.org/gsea/msigdb/cards/MARKS_ACETYLATED_NON_HISTONE_PROTEINS	-0.37966	-1.2616	0.1946	0.44588	1	0.4	0.252	0.299	0.36185	0.031
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP	-0.40198	-1.2611	0.1677	0.44643	1	0.481	0.331	0.323	0.36319	0.031
LANDIS_ERBB2_BREAST_TUMORS_324_UP	145	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_324_UP	-0.40322	-1.2608	0.1992	0.44681	1	0.324	0.2	0.261	0.36428	0.031
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	130	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	-0.30234	-1.2605	0.1573	0.44702	1	0.115	0.0739	0.107	0.36541	0.031
ZHAN_LATE_DIFFERENTIATION_GENES_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_LATE_DIFFERENTIATION_GENES_DN	-0.4506	-1.2601	0.1502	0.44739	1	0.333	0.106	0.298	0.36533	0.031
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	104	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	-0.33178	-1.2599	0.1618	0.44729	1	0.337	0.25	0.253	0.36497	0.031
SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN	-0.46491	-1.2598	0.1236	0.44718	1	0.208	0.0829	0.191	0.3646	0.031
FOSTER_TOLERANT_MACROPHAGE_DN	395	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_TOLERANT_MACROPHAGE_DN	-0.34187	-1.2596	0.1934	0.4471	1	0.306	0.22	0.243	0.36424	0.031
COATES_MACROPHAGE_M1_VS_M2_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/COATES_MACROPHAGE_M1_VS_M2_DN	-0.31943	-1.2589	0.1361	0.44822	1	0.338	0.225	0.263	0.36552	0.031
REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/REN_ALVEOLAR_RHABDOMYOSARCOMA_UP	-0.28288	-1.2588	0.1096	0.44794	1	0.211	0.228	0.163	0.36515	0.031
REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1	-0.46712	-1.2582	0.2174	0.44893	1	0.365	0.173	0.302	0.36604	0.031
KEGG_CHEMOKINE_SIGNALING_PATHWAY	179	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CHEMOKINE_SIGNALING_PATHWAY	-0.29448	-1.2578	0.1533	0.44931	1	0.263	0.218	0.207	0.367	0.031
STONER_ESOPHAGEAL_CARCINOGENESIS_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/STONER_ESOPHAGEAL_CARCINOGENESIS_UP	-0.3599	-1.2577	0.2166	0.44899	1	0.211	0.171	0.175	0.36664	0.031
KYNG_WERNER_SYNDROM_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_WERNER_SYNDROM_DN	-0.36833	-1.2573	0.1664	0.44962	1	0.148	0.0719	0.138	0.36801	0.031
PID_HDAC_CLASSIII_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HDAC_CLASSIII_PATHWAY	-0.33894	-1.2569	0.1781	0.45004	1	0.12	0.0546	0.114	0.36815	0.033
SANA_RESPONSE_TO_IFNG_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/SANA_RESPONSE_TO_IFNG_UP	-0.49036	-1.2565	0.2481	0.45033	1	0.338	0.139	0.292	0.36846	0.033
DIRMEIER_LMP1_RESPONSE_LATE_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/DIRMEIER_LMP1_RESPONSE_LATE_UP	-0.34228	-1.2559	0.1996	0.45088	1	0.327	0.245	0.248	0.36919	0.033
IRITANI_MAD1_TARGETS_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/IRITANI_MAD1_TARGETS_DN	-0.37741	-1.2559	0.1861	0.45127	1	0.426	0.298	0.299	0.36955	0.033
BIOCARTA_SPPA_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_SPPA_PATHWAY	-0.48743	-1.2556	0.1719	0.45094	1	0.409	0.228	0.316	0.36882	0.033
THEODOROU_MAMMARY_TUMORIGENESIS	29	http://www.broadinstitute.org/gsea/msigdb/cards/THEODOROU_MAMMARY_TUMORIGENESIS	-0.35847	-1.2553	0.1331	0.45125	1	0.241	0.158	0.203	0.36998	0.033
ZHAN_MULTIPLE_MYELOMA_MF_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_MF_UP	-0.36616	-1.2549	0.1342	0.45168	1	0.209	0.148	0.179	0.37103	0.033
PID_NETRIN_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NETRIN_PATHWAY	-0.38439	-1.2547	0.1599	0.45149	1	0.438	0.263	0.323	0.37066	0.033
REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING	-0.413	-1.2545	0.1304	0.4516	1	0.286	0.157	0.241	0.37161	0.033
ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	18	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_VINBLASTINE	-0.41688	-1.2539	0.1322	0.45223	1	0.167	0.044	0.159	0.37208	0.033
DAIRKEE_CANCER_PRONE_RESPONSE_BPA	51	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_CANCER_PRONE_RESPONSE_BPA	-0.38304	-1.2532	0.1191	0.45325	1	0.275	0.189	0.223	0.3732	0.034
REACTOME_INTERFERON_SIGNALING	140	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERFERON_SIGNALING	-0.37925	-1.2527	0.1942	0.45346	1	0.371	0.22	0.291	0.37321	0.035
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-0.41804	-1.2527	0.2066	0.45386	1	0.229	0.0863	0.21	0.37357	0.036
KESHELAVA_MULTIPLE_DRUG_RESISTANCE	80	http://www.broadinstitute.org/gsea/msigdb/cards/KESHELAVA_MULTIPLE_DRUG_RESISTANCE	-0.30283	-1.2525	0.184	0.45342	1	0.162	0.131	0.142	0.37284	0.035
PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	30	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION	-0.41795	-1.252	0.2554	0.45419	1	0.3	0.212	0.237	0.37353	0.035
DANG_MYC_TARGETS_UP	139	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_MYC_TARGETS_UP	-0.38916	-1.2518	0.1914	0.45403	1	0.381	0.221	0.299	0.37406	0.034
REACTOME_IL1_SIGNALING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL1_SIGNALING	-0.39387	-1.2516	0.214	0.45405	1	0.368	0.221	0.287	0.37369	0.034
VANHARANTA_UTERINE_FIBROID_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_DN	-0.37497	-1.2508	0.2104	0.4555	1	0.397	0.255	0.296	0.37534	0.036
CAIRO_LIVER_DEVELOPMENT_DN	216	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_LIVER_DEVELOPMENT_DN	-0.26661	-1.2506	0.116	0.4555	1	0.162	0.154	0.138	0.37622	0.035
REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S	-0.37952	-1.2505	0.2224	0.45513	1	0.535	0.344	0.352	0.37585	0.035
IGLESIAS_E2F_TARGETS_UP	149	http://www.broadinstitute.org/gsea/msigdb/cards/IGLESIAS_E2F_TARGETS_UP	-0.37281	-1.2505	0.2056	0.45472	1	0.349	0.24	0.267	0.37549	0.035
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP	-0.45795	-1.2504	0.1708	0.45419	1	0.143	0.123	0.125	0.37493	0.034
KAAB_FAILED_HEART_VENTRICLE_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_FAILED_HEART_VENTRICLE_DN	-0.36909	-1.2504	0.1949	0.45452	1	0.256	0.156	0.217	0.37529	0.035
GENTILE_RESPONSE_CLUSTER_D3	58	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_RESPONSE_CLUSTER_D3	-0.45115	-1.2503	0.2167	0.45389	1	0.31	0.156	0.263	0.37456	0.034
REACTOME_REGULATORY_RNA_PATHWAYS	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATORY_RNA_PATHWAYS	-0.44568	-1.2501	0.2617	0.45379	1	0.19	0.0933	0.173	0.37496	0.034
LY_AGING_MIDDLE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/LY_AGING_MIDDLE_DN	-0.58978	-1.25	0.3077	0.45363	1	0.625	0.206	0.497	0.37459	0.034
KEGG_RNA_POLYMERASE	27	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RNA_POLYMERASE	-0.43495	-1.2496	0.1883	0.45405	1	0.37	0.239	0.282	0.37517	0.034
REACTOME_MYOGENESIS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MYOGENESIS	-0.35213	-1.2493	0.2272	0.45422	1	0.296	0.196	0.239	0.37623	0.034
DITTMER_PTHLH_TARGETS_UP	109	http://www.broadinstitute.org/gsea/msigdb/cards/DITTMER_PTHLH_TARGETS_UP	-0.38513	-1.2487	0.1936	0.45511	1	0.404	0.253	0.303	0.37671	0.035
KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY	-0.402	-1.2486	0.2108	0.4549	1	0.128	0.0445	0.122	0.37635	0.035
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	134	http://www.broadinstitute.org/gsea/msigdb/cards/COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN	-0.25369	-1.248	0.1814	0.45575	1	0.194	0.165	0.163	0.37741	0.034
KEGG_ENDOCYTOSIS	174	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ENDOCYTOSIS	-0.27576	-1.2479	0.1988	0.45565	1	0.305	0.254	0.229	0.37705	0.034
REACTOME_MRNA_SPLICING_MINOR_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_SPLICING_MINOR_PATHWAY	-0.42349	-1.2476	0.2339	0.45584	1	0.39	0.244	0.296	0.37683	0.033
SESTO_RESPONSE_TO_UV_C1	70	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C1	-0.39448	-1.2471	0.1657	0.45651	1	0.343	0.197	0.276	0.37698	0.035
FRASOR_TAMOXIFEN_RESPONSE_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_TAMOXIFEN_RESPONSE_UP	-0.32705	-1.2468	0.1699	0.45633	1	0.255	0.147	0.218	0.37709	0.034
SENESE_HDAC1_AND_HDAC2_TARGETS_UP	229	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC1_AND_HDAC2_TARGETS_UP	-0.30347	-1.2468	0.1561	0.45677	1	0.153	0.101	0.139	0.37745	0.034
LABBE_TGFB1_TARGETS_DN	103	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TGFB1_TARGETS_DN	-0.29116	-1.2465	0.1241	0.45644	1	0.194	0.151	0.166	0.37694	0.035
NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	122	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON	-0.51287	-1.2463	0.2552	0.45644	1	0.533	0.253	0.4	0.37747	0.035
QI_PLASMACYTOMA_DN	96	http://www.broadinstitute.org/gsea/msigdb/cards/QI_PLASMACYTOMA_DN	-0.29728	-1.2455	0.1704	0.45772	1	0.417	0.28	0.301	0.37987	0.035
REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_II_PRE_TRANSCRIPTION_EVENTS	-0.39695	-1.2454	0.2086	0.45763	1	0.389	0.258	0.289	0.38009	0.034
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	369	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7	-0.3198	-1.2453	0.1323	0.45731	1	0.236	0.16	0.201	0.37986	0.034
HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	154	http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_BRCA1_VS_BRCA2	-0.37194	-1.2451	0.2316	0.45723	1	0.357	0.212	0.283	0.37949	0.034
PID_ARF_3PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF_3PATHWAY	-0.48299	-1.245	0.2278	0.45699	1	0.474	0.274	0.344	0.37914	0.034
REACTOME_TIGHT_JUNCTION_INTERACTIONS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TIGHT_JUNCTION_INTERACTIONS	-0.37019	-1.2447	0.1558	0.45722	1	0.179	0.106	0.16	0.37915	0.034
THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP	-0.35059	-1.2441	0.2114	0.45816	1	0.293	0.199	0.236	0.37983	0.034
CONRAD_STEM_CELL	39	http://www.broadinstitute.org/gsea/msigdb/cards/CONRAD_STEM_CELL	-0.33021	-1.2437	0.1497	0.45878	1	0.308	0.184	0.252	0.37999	0.034
MOHANKUMAR_TLX1_TARGETS_UP	398	http://www.broadinstitute.org/gsea/msigdb/cards/MOHANKUMAR_TLX1_TARGETS_UP	-0.34007	-1.2435	0.1697	0.45876	1	0.317	0.21	0.254	0.37962	0.034
REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP	-0.48874	-1.2434	0.2678	0.45837	1	0.294	0.131	0.256	0.37926	0.033
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	76	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16	-0.3572	-1.243	0.225	0.45887	1	0.368	0.264	0.272	0.3789	0.033
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN	-0.34615	-1.2428	0.1781	0.45881	1	0.394	0.229	0.304	0.37855	0.033
PIONTEK_PKD1_TARGETS_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/PIONTEK_PKD1_TARGETS_UP	-0.3364	-1.2425	0.1486	0.45904	1	0.371	0.267	0.273	0.37936	0.033
MAHAJAN_RESPONSE_TO_IL1A_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/MAHAJAN_RESPONSE_TO_IL1A_UP	-0.32073	-1.2416	0.1622	0.46049	1	0.304	0.214	0.24	0.38096	0.033
ALFANO_MYC_TARGETS	229	http://www.broadinstitute.org/gsea/msigdb/cards/ALFANO_MYC_TARGETS	-0.30015	-1.2414	0.1553	0.46051	1	0.301	0.223	0.236	0.3806	0.033
KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	123	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP	-0.36535	-1.2413	0.2112	0.46037	1	0.276	0.159	0.234	0.38073	0.033
BROWNE_HCMV_INFECTION_14HR_DN	283	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_14HR_DN	-0.27001	-1.2407	0.149	0.4611	1	0.184	0.171	0.154	0.38155	0.033
REACTOME_G1_PHASE	34	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G1_PHASE	-0.39241	-1.2405	0.1779	0.46101	1	0.441	0.249	0.332	0.38182	0.033
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	62	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-0.37414	-1.24	0.2297	0.46181	1	0.339	0.223	0.264	0.38261	0.033
STREICHER_LSM1_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/STREICHER_LSM1_TARGETS_DN	-0.41664	-1.2399	0.2284	0.46154	1	0.263	0.162	0.221	0.38335	0.033
GAZIN_EPIGENETIC_SILENCING_BY_KRAS	23	http://www.broadinstitute.org/gsea/msigdb/cards/GAZIN_EPIGENETIC_SILENCING_BY_KRAS	-0.3988	-1.2398	0.1856	0.46119	1	0.348	0.167	0.29	0.38299	0.033
KEGG_GAP_JUNCTION	87	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GAP_JUNCTION	-0.29731	-1.2395	0.1345	0.46147	1	0.46	0.341	0.304	0.38265	0.033
BURTON_ADIPOGENESIS_5	115	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_5	-0.31604	-1.2394	0.1333	0.46125	1	0.374	0.263	0.277	0.38231	0.033
SENESE_HDAC1_TARGETS_UP	434	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC1_TARGETS_UP	-0.34489	-1.2392	0.171	0.46139	1	0.362	0.255	0.274	0.38254	0.033
KEGG_STEROID_BIOSYNTHESIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_STEROID_BIOSYNTHESIS	-0.47131	-1.2391	0.2196	0.46116	1	0.375	0.163	0.314	0.38218	0.033
REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY	-0.42483	-1.2386	0.2051	0.46165	1	0.256	0.127	0.224	0.38298	0.033
DOANE_RESPONSE_TO_ANDROGEN_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_RESPONSE_TO_ANDROGEN_UP	-0.25993	-1.2386	0.1566	0.46131	1	0.238	0.211	0.189	0.38262	0.033
PASINI_SUZ12_TARGETS_UP	107	http://www.broadinstitute.org/gsea/msigdb/cards/PASINI_SUZ12_TARGETS_UP	-0.28826	-1.2384	0.1836	0.46126	1	0.14	0.107	0.126	0.38247	0.033
LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_VAV3_PROSTATE_CARCINOGENESIS_DN	-0.40841	-1.2383	0.2066	0.46104	1	0.471	0.232	0.361	0.38217	0.033
KENNY_CTNNB1_TARGETS_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/KENNY_CTNNB1_TARGETS_DN	-0.43321	-1.238	0.2222	0.46129	1	0.314	0.205	0.25	0.38398	0.033
ALCALA_APOPTOSIS	82	http://www.broadinstitute.org/gsea/msigdb/cards/ALCALA_APOPTOSIS	-0.31817	-1.2374	0.1589	0.46229	1	0.256	0.155	0.217	0.38401	0.033
JOHNSTONE_PARVB_TARGETS_3_UP	403	http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_3_UP	-0.28112	-1.2374	0.2091	0.4619	1	0.28	0.232	0.219	0.38365	0.033
THUM_MIR21_TARGETS_HEART_DISEASE_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/THUM_MIR21_TARGETS_HEART_DISEASE_UP	-0.58581	-1.2366	0.2055	0.46311	1	0.438	0.251	0.328	0.38542	0.033
REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	69	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION	-0.39538	-1.2365	0.1992	0.46306	1	0.435	0.252	0.326	0.38506	0.033
PID_P38_MK2_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P38_MK2_PATHWAY	-0.43837	-1.2361	0.2399	0.46344	1	0.286	0.16	0.24	0.38483	0.033
KUMAR_TARGETS_OF_MLL_AF9_FUSION	390	http://www.broadinstitute.org/gsea/msigdb/cards/KUMAR_TARGETS_OF_MLL_AF9_FUSION	-0.25415	-1.2361	0.1569	0.4631	1	0.187	0.179	0.156	0.38448	0.033
BIOCARTA_BAD_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BAD_PATHWAY	-0.36837	-1.236	0.2202	0.46269	1	0.24	0.175	0.198	0.38412	0.033
REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK	-0.3208	-1.236	0.1573	0.46243	1	0.488	0.329	0.328	0.38376	0.033
KEGG_NOTCH_SIGNALING_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NOTCH_SIGNALING_PATHWAY	-0.29531	-1.2355	0.182	0.46317	1	0.34	0.298	0.239	0.38436	0.034
HOSHIDA_LIVER_CANCER_SUBCLASS_S1	231	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SUBCLASS_S1	-0.36091	-1.2354	0.2421	0.4628	1	0.329	0.219	0.259	0.384	0.033
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP	-0.29142	-1.2352	0.115	0.46298	1	0.285	0.232	0.22	0.38391	0.033
REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	73	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA1213_SIGNALLING_EVENTS	-0.28552	-1.2349	0.1699	0.46306	1	0.397	0.304	0.277	0.38356	0.033
FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	321	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_BASAL_VS_LULMINAL	-0.34447	-1.2348	0.1498	0.46287	1	0.308	0.213	0.246	0.38389	0.033
WANG_TUMOR_INVASIVENESS_UP	363	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TUMOR_INVASIVENESS_UP	-0.32695	-1.2344	0.2246	0.46334	1	0.325	0.235	0.252	0.38353	0.033
APPIERTO_RESPONSE_TO_FENRETINIDE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/APPIERTO_RESPONSE_TO_FENRETINIDE_DN	-0.34346	-1.2335	0.1078	0.46467	1	0.52	0.311	0.359	0.38537	0.034
MCLACHLAN_DENTAL_CARIES_DN	220	http://www.broadinstitute.org/gsea/msigdb/cards/MCLACHLAN_DENTAL_CARIES_DN	-0.36947	-1.2329	0.2451	0.46552	1	0.332	0.217	0.262	0.38559	0.034
GARY_CD5_TARGETS_UP	456	http://www.broadinstitute.org/gsea/msigdb/cards/GARY_CD5_TARGETS_UP	-0.2524	-1.2322	0.1517	0.46667	1	0.327	0.276	0.241	0.38531	0.034
PID_ERBB_NETWORK_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB_NETWORK_PATHWAY	-0.50735	-1.23	0.2262	0.47071	1	0.2	0.0594	0.188	0.3884	0.037
KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	15	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS	-0.54293	-1.2297	0.2372	0.47098	1	0.467	0.203	0.372	0.39021	0.037
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	147	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	-0.28017	-1.2295	0.1546	0.47099	1	0.204	0.156	0.173	0.39045	0.037
REACTOME_GLUCONEOGENESIS	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCONEOGENESIS	-0.36736	-1.2292	0.171	0.47125	1	0.594	0.335	0.396	0.39255	0.037
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	-0.29371	-1.2288	0.2082	0.47156	1	0.27	0.216	0.213	0.39302	0.037
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	129	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN	-0.3043	-1.2287	0.1536	0.47145	1	0.349	0.251	0.263	0.39293	0.037
PID_PS1_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PS1_PATHWAY	-0.30108	-1.2286	0.2257	0.47117	1	0.289	0.239	0.22	0.39258	0.037
KOBAYASHI_EGFR_SIGNALING_24HR_UP	95	http://www.broadinstitute.org/gsea/msigdb/cards/KOBAYASHI_EGFR_SIGNALING_24HR_UP	-0.31709	-1.228	0.167	0.47218	1	0.316	0.221	0.247	0.39445	0.037
LEE_LIVER_CANCER_ACOX1_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_ACOX1_UP	-0.3821	-1.2278	0.2057	0.47219	1	0.4	0.211	0.316	0.39409	0.038
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	497	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1	-0.30797	-1.2278	0.1544	0.47182	1	0.258	0.193	0.212	0.39373	0.037
REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0	-0.45594	-1.2277	0.2465	0.47147	1	0.34	0.17	0.283	0.39337	0.037
DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	138	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP	-0.27036	-1.2275	0.1737	0.47153	1	0.326	0.271	0.239	0.39412	0.037
MANTOVANI_VIRAL_GPCR_SIGNALING_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/MANTOVANI_VIRAL_GPCR_SIGNALING_DN	-0.34887	-1.2273	0.2302	0.47144	1	0.244	0.178	0.201	0.3946	0.037
SANSOM_APC_TARGETS_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_UP	-0.32828	-1.2271	0.1309	0.47156	1	0.202	0.124	0.178	0.39427	0.037
YAGI_AML_WITH_INV_16_TRANSLOCATION	406	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_WITH_INV_16_TRANSLOCATION	-0.26528	-1.2267	0.07795	0.47204	1	0.281	0.219	0.223	0.39453	0.037
REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	83	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	-0.34056	-1.2265	0.2276	0.47192	1	0.313	0.215	0.247	0.3949	0.038
HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP	-0.37957	-1.2264	0.1195	0.47165	1	0.182	0.0684	0.17	0.39454	0.035
HOSHIDA_LIVER_CANCER_SURVIVAL_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SURVIVAL_UP	-0.35868	-1.226	0.1988	0.47225	1	0.356	0.256	0.266	0.39419	0.038
REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B	-0.4997	-1.2258	0.2689	0.47207	1	0.5	0.192	0.404	0.39594	0.038
ZHANG_TLX_TARGETS_36HR_UP	211	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_36HR_UP	-0.26005	-1.2258	0.1591	0.4718	1	0.341	0.299	0.241	0.39559	0.032
OLSSON_E2F3_TARGETS_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/OLSSON_E2F3_TARGETS_UP	-0.38893	-1.2246	0.2322	0.47381	1	0.429	0.213	0.338	0.3975	0.038
ZHOU_TNF_SIGNALING_30MIN	52	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_TNF_SIGNALING_30MIN	-0.34945	-1.2244	0.2448	0.47392	1	0.481	0.311	0.332	0.39727	0.037
LIU_SMARCA4_TARGETS	59	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_SMARCA4_TARGETS	-0.34537	-1.2236	0.1719	0.47527	1	0.271	0.147	0.232	0.39788	0.038
MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	210	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_3_4WK_UP	-0.29213	-1.2231	0.2455	0.476	1	0.2	0.169	0.168	0.39862	0.037
KAUFFMANN_DNA_REPAIR_GENES	222	http://www.broadinstitute.org/gsea/msigdb/cards/KAUFFMANN_DNA_REPAIR_GENES	-0.43287	-1.2228	0.3078	0.47624	1	0.333	0.196	0.27	0.39826	0.037
HUTTMANN_B_CLL_POOR_SURVIVAL_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/HUTTMANN_B_CLL_POOR_SURVIVAL_DN	-0.43673	-1.2226	0.171	0.47579	1	0.446	0.173	0.37	0.39755	0.037
BENPORATH_NOS_TARGETS	171	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_NOS_TARGETS	-0.36047	-1.2226	0.1673	0.47621	1	0.228	0.147	0.196	0.3979	0.037
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	421	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP	-0.28406	-1.2225	0.1667	0.47555	1	0.273	0.222	0.216	0.39719	0.037
BENPORATH_OCT4_TARGETS	278	http://www.broadinstitute.org/gsea/msigdb/cards/BENPORATH_OCT4_TARGETS	-0.35426	-1.2223	0.1897	0.4755	1	0.245	0.16	0.208	0.39684	0.037
LEE_AGING_NEOCORTEX_UP	87	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_NEOCORTEX_UP	-0.30167	-1.2208	0.1956	0.47815	1	0.23	0.168	0.192	0.39987	0.038
NAKAMURA_ADIPOGENESIS_EARLY_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_ADIPOGENESIS_EARLY_UP	-0.3449	-1.2206	0.2296	0.47819	1	0.349	0.239	0.266	0.39972	0.038
JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	215	http://www.broadinstitute.org/gsea/msigdb/cards/JAATINEN_HEMATOPOIETIC_STEM_CELL_DN	-0.32161	-1.2205	0.2475	0.47801	1	0.219	0.157	0.186	0.39992	0.037
FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	320	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_APOCRINE_VS_BASAL	-0.35803	-1.2203	0.1558	0.47788	1	0.275	0.187	0.226	0.39956	0.037
MA_MYELOID_DIFFERENTIATION_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/MA_MYELOID_DIFFERENTIATION_DN	-0.33568	-1.2203	0.2405	0.47751	1	0.25	0.214	0.197	0.39921	0.037
FINETTI_BREAST_CANCER_KINOME_GREEN	16	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCER_KINOME_GREEN	-0.35894	-1.2203	0.2008	0.47713	1	0.312	0.269	0.229	0.39885	0.037
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	91	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	-0.35246	-1.2198	0.193	0.47773	1	0.308	0.211	0.244	0.39869	0.037
REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS	-0.4589	-1.2195	0.2537	0.478	1	0.158	0.0338	0.153	0.39834	0.037
REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CDT1_ASSOCIATION_WITH_THE_CDC6_ORC_ORIGIN_COMPLEX	-0.48961	-1.219	0.2664	0.47847	1	0.481	0.232	0.371	0.39846	0.037
ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	274	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_FGFR1_TARGETS_IN_PROSTATE_CANCER_MODEL_UP	-0.33951	-1.2187	0.1865	0.47876	1	0.285	0.212	0.227	0.39894	0.037
KORKOLA_TERATOMA_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_TERATOMA_UP	-0.58032	-1.2183	0.2408	0.479	1	0.5	0.214	0.393	0.39931	0.038
URS_ADIPOCYTE_DIFFERENTIATION_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/URS_ADIPOCYTE_DIFFERENTIATION_DN	-0.44699	-1.2181	0.3006	0.47914	1	0.367	0.257	0.273	0.40013	0.037
REACTOME_PHOSPHORYLATION_OF_THE_APC_C	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHOSPHORYLATION_OF_THE_APC_C	-0.52709	-1.218	0.2906	0.47906	1	0.562	0.192	0.455	0.40028	0.037
KEGG_PYRIMIDINE_METABOLISM	91	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PYRIMIDINE_METABOLISM	-0.32218	-1.2177	0.1872	0.4793	1	0.352	0.239	0.269	0.40019	0.037
ST_WNT_CA2_CYCLIC_GMP_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/ST_WNT_CA2_CYCLIC_GMP_PATHWAY	-0.32453	-1.2175	0.1929	0.4791	1	0.25	0.185	0.204	0.39983	0.037
KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	80	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION	-0.34802	-1.2166	0.1724	0.48076	1	0.262	0.158	0.222	0.40302	0.038
RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	389	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP	-0.31222	-1.2164	0.2134	0.4806	1	0.226	0.165	0.192	0.40267	0.038
HASLINGER_B_CLL_WITH_17P13_DELETION	18	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_17P13_DELETION	-0.35059	-1.2163	0.2036	0.48056	1	0.333	0.238	0.254	0.40247	0.038
GENTILE_UV_RESPONSE_CLUSTER_D7	39	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D7	-0.46242	-1.2162	0.2637	0.48029	1	0.487	0.26	0.361	0.40249	0.037
REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS	-0.36444	-1.2159	0.2402	0.48049	1	0.345	0.191	0.279	0.40308	0.038
KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	73	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY	-0.30737	-1.2154	0.229	0.48126	1	0.37	0.301	0.259	0.40322	0.038
COLLIS_PRKDC_SUBSTRATES	19	http://www.broadinstitute.org/gsea/msigdb/cards/COLLIS_PRKDC_SUBSTRATES	-0.42399	-1.2151	0.2533	0.48144	1	0.316	0.185	0.257	0.40398	0.038
MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	263	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_4_5WK_UP	-0.30346	-1.214	0.225	0.48321	1	0.236	0.202	0.19	0.40582	0.038
PID_ECADHERIN_STABILIZATION_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ECADHERIN_STABILIZATION_PATHWAY	-0.34245	-1.2139	0.1885	0.48298	1	0.381	0.209	0.302	0.40546	0.038
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	144	http://www.broadinstitute.org/gsea/msigdb/cards/SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	-0.34218	-1.2138	0.2167	0.48289	1	0.25	0.157	0.212	0.40565	0.038
WHITFIELD_CELL_CYCLE_S	150	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_S	-0.47436	-1.2134	0.2592	0.4832	1	0.313	0.126	0.276	0.4053	0.036
REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT	-0.41356	-1.213	0.2151	0.48293	1	0.312	0.198	0.251	0.40581	0.036
HUMMERICH_SKIN_CANCER_PROGRESSION_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_SKIN_CANCER_PROGRESSION_UP	-0.31829	-1.213	0.2312	0.48334	1	0.333	0.257	0.248	0.40616	0.036
RUTELLA_RESPONSE_TO_HGF_UP	399	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_UP	-0.30921	-1.213	0.2047	0.4837	1	0.308	0.227	0.242	0.40651	0.036
VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	58	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_EARLY_RESPONSE_TO_TGFB1	-0.40661	-1.2129	0.2431	0.48276	1	0.345	0.179	0.284	0.40545	0.036
REACTOME_ZINC_TRANSPORTERS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ZINC_TRANSPORTERS	-0.33836	-1.2123	0.2107	0.48346	1	0.0667	0.0121	0.0659	0.40542	0.036
JAZAG_TGFB1_SIGNALING_UP	105	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_UP	-0.31517	-1.2121	0.1104	0.48352	1	0.295	0.198	0.238	0.40507	0.036
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	-0.32986	-1.2121	0.2227	0.48324	1	0.286	0.219	0.224	0.40472	0.036
RICKMAN_HEAD_AND_NECK_CANCER_B	45	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_B	-0.40679	-1.2107	0.2064	0.48567	1	0.356	0.202	0.284	0.40799	0.038
REACTOME_SIGNALING_BY_NOTCH	95	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_NOTCH	-0.28978	-1.2103	0.2019	0.4862	1	0.274	0.236	0.21	0.40806	0.038
GERHOLD_ADIPOGENESIS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/GERHOLD_ADIPOGENESIS_UP	-0.34662	-1.2101	0.2614	0.48609	1	0.265	0.206	0.211	0.4092	0.038
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP	-0.38045	-1.2093	0.2086	0.48738	1	0.243	0.112	0.216	0.40896	0.038
REACTOME_ARMS_MEDIATED_ACTIVATION	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ARMS_MEDIATED_ACTIVATION	-0.5084	-1.2091	0.3018	0.48738	1	0.118	0.014	0.116	0.40973	0.038
YANG_MUC2_TARGETS_DUODENUM_3MO_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_MUC2_TARGETS_DUODENUM_3MO_DN	-0.42306	-1.209	0.224	0.4873	1	0.227	0.106	0.203	0.40938	0.038
GERY_CEBP_TARGETS	123	http://www.broadinstitute.org/gsea/msigdb/cards/GERY_CEBP_TARGETS	-0.32202	-1.2087	0.2147	0.48745	1	0.252	0.179	0.208	0.40934	0.038
ZUCCHI_METASTASIS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZUCCHI_METASTASIS_DN	-0.38124	-1.2082	0.246	0.48805	1	0.349	0.221	0.272	0.40981	0.038
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP	-0.31325	-1.2082	0.2272	0.48769	1	0.0882	0.0525	0.0837	0.40946	0.038
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	173	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-0.33025	-1.2079	0.2246	0.4879	1	0.312	0.236	0.24	0.40948	0.038
KAAB_FAILED_HEART_ATRIUM_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_FAILED_HEART_ATRIUM_DN	-0.31447	-1.2075	0.1776	0.4878	1	0.285	0.213	0.225	0.40878	0.036
TIAN_BHLHA15_TARGETS	15	http://www.broadinstitute.org/gsea/msigdb/cards/TIAN_BHLHA15_TARGETS	-0.4314	-1.2075	0.2302	0.48821	1	0.6	0.268	0.44	0.40913	0.038
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	63	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5	-0.30393	-1.207	0.2114	0.48848	1	0.175	0.139	0.151	0.40938	0.038
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	116	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	-0.29337	-1.207	0.2294	0.4881	1	0.0948	0.0775	0.0879	0.40903	0.038
BAKER_HEMATOPOIESIS_STAT3_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/BAKER_HEMATOPOIESIS_STAT3_TARGETS	-0.3956	-1.2067	0.2408	0.48839	1	0.312	0.206	0.248	0.40972	0.038
BIOCARTA_G1_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_G1_PATHWAY	-0.38145	-1.2064	0.2179	0.48856	1	0.25	0.0909	0.228	0.41041	0.036
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP	-0.45422	-1.2061	0.2752	0.48889	1	0.318	0.181	0.261	0.41006	0.036
BIOCARTA_GSK3_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GSK3_PATHWAY	-0.36493	-1.206	0.2663	0.48849	1	0.111	0.0709	0.103	0.40971	0.036
WINTER_HYPOXIA_METAGENE	232	http://www.broadinstitute.org/gsea/msigdb/cards/WINTER_HYPOXIA_METAGENE	-0.30674	-1.2057	0.243	0.48882	1	0.349	0.261	0.26	0.40936	0.036
REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	81	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS	-0.41036	-1.2056	0.269	0.48852	1	0.296	0.17	0.247	0.40901	0.036
REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	55	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AUTODEGRADATION_OF_CDH1_BY_CDH1_APC_C	-0.42747	-1.2056	0.262	0.48811	1	0.4	0.202	0.32	0.40866	0.036
REACTOME_HS_GAG_DEGRADATION	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HS_GAG_DEGRADATION	-0.37553	-1.2051	0.263	0.4884	1	0.25	0.169	0.208	0.40929	0.036
DURAND_STROMA_S_UP	284	http://www.broadinstitute.org/gsea/msigdb/cards/DURAND_STROMA_S_UP	-0.27692	-1.2051	0.1607	0.48877	1	0.194	0.157	0.165	0.40964	0.036
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	105	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TARGETS_OF_TGFB1_AND_WNT3A_DN	-0.30162	-1.2049	0.1904	0.48848	1	0.2	0.134	0.174	0.41033	0.036
DARWICHE_SKIN_TUMOR_PROMOTER_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SKIN_TUMOR_PROMOTER_UP	-0.27104	-1.2045	0.1911	0.48893	1	0.224	0.211	0.177	0.40998	0.036
DAZARD_UV_RESPONSE_CLUSTER_G2	29	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G2	-0.45739	-1.2044	0.2505	0.48865	1	0.414	0.224	0.321	0.4108	0.036
COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP	-0.33699	-1.2035	0.2345	0.49024	1	0.235	0.149	0.201	0.41205	0.036
MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	138	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	-0.27917	-1.2034	0.2238	0.49008	1	0.109	0.093	0.0991	0.41172	0.036
MARSON_FOXP3_TARGETS_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_TARGETS_UP	-0.3201	-1.2033	0.2782	0.48996	1	0.222	0.192	0.18	0.4114	0.036
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	-0.5544	-1.2031	0.283	0.48988	1	0.412	0.137	0.356	0.41105	0.036
LEE_LIVER_CANCER_MYC_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_UP	-0.37161	-1.203	0.18	0.48961	1	0.17	0.0623	0.16	0.4107	0.036
GENTILE_UV_RESPONSE_CLUSTER_D4	54	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D4	-0.43578	-1.2029	0.284	0.48941	1	0.463	0.246	0.35	0.41035	0.036
KANG_CISPLATIN_RESISTANCE_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_CISPLATIN_RESISTANCE_UP	-0.41648	-1.2026	0.2554	0.48966	1	0.5	0.29	0.355	0.41038	0.035
MCCABE_HOXC6_TARGETS_CANCER_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/MCCABE_HOXC6_TARGETS_CANCER_DN	-0.43675	-1.2024	0.2347	0.48983	1	0.35	0.258	0.26	0.41211	0.035
PID_TRKR_PATHWAY	62	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TRKR_PATHWAY	-0.31905	-1.2015	0.19	0.49113	1	0.355	0.224	0.276	0.41327	0.036
PID_HNF3B_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HNF3B_PATHWAY	-0.29988	-1.2005	0.2244	0.49291	1	0.111	0.0699	0.104	0.415	0.036
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN	-0.44607	-1.2003	0.2406	0.49296	1	0.32	0.148	0.273	0.41465	0.036
VERRECCHIA_RESPONSE_TO_TGFB1_C1	19	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_RESPONSE_TO_TGFB1_C1	-0.46235	-1.2002	0.2434	0.49271	1	0.211	0.0483	0.201	0.4143	0.036
SCHLOSSER_SERUM_RESPONSE_UP	125	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_SERUM_RESPONSE_UP	-0.24612	-1.2001	0.2186	0.49257	1	0.288	0.283	0.208	0.41396	0.036
VALK_AML_CLUSTER_3	31	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_3	-0.35504	-1.1999	0.1894	0.49259	1	0.194	0.0963	0.175	0.4138	0.036
BROWNE_HCMV_INFECTION_30MIN_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_30MIN_UP	-0.32188	-1.1998	0.2335	0.49237	1	0.283	0.226	0.219	0.41346	0.036
REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT	-0.35843	-1.199	0.249	0.49359	1	0.269	0.228	0.208	0.41507	0.036
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	122	http://www.broadinstitute.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-0.35828	-1.1987	0.2486	0.49391	1	0.205	0.127	0.18	0.41603	0.036
RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	115	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP	-0.33278	-1.1985	0.2347	0.4938	1	0.278	0.201	0.223	0.41568	0.036
SU_PLACENTA	30	http://www.broadinstitute.org/gsea/msigdb/cards/SU_PLACENTA	-0.33865	-1.1983	0.2315	0.49382	1	0.333	0.214	0.262	0.41539	0.036
BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	413	http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP	-0.32482	-1.1982	0.1641	0.49366	1	0.201	0.129	0.178	0.41505	0.035
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	184	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-0.42873	-1.1976	0.2773	0.49468	1	0.348	0.179	0.288	0.41742	0.036
GNATENKO_PLATELET_SIGNATURE	45	http://www.broadinstitute.org/gsea/msigdb/cards/GNATENKO_PLATELET_SIGNATURE	-0.33751	-1.1967	0.223	0.49614	1	0.156	0.0662	0.146	0.41872	0.036
PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP	-0.39221	-1.1966	0.2429	0.49605	1	0.283	0.194	0.228	0.41837	0.04
BIOCARTA_RAS_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RAS_PATHWAY	-0.38561	-1.1964	0.2379	0.49607	1	0.478	0.325	0.323	0.41802	0.036
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	99	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	-0.35258	-1.1962	0.2558	0.49607	1	0.354	0.218	0.278	0.41783	0.036
MILI_PSEUDOPODIA_CHEMOTAXIS_DN	432	http://www.broadinstitute.org/gsea/msigdb/cards/MILI_PSEUDOPODIA_CHEMOTAXIS_DN	-0.26113	-1.1961	0.2237	0.49588	1	0.257	0.217	0.205	0.41748	0.036
ST_P38_MAPK_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/ST_P38_MAPK_PATHWAY	-0.33908	-1.1958	0.2323	0.49609	1	0.389	0.301	0.272	0.41776	0.036
DARWICHE_SKIN_TUMOR_PROMOTER_DN	173	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_SKIN_TUMOR_PROMOTER_DN	-0.25414	-1.1954	0.1862	0.49651	1	0.312	0.279	0.226	0.41807	0.036
NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	54	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON	-0.40479	-1.1944	0.2421	0.49842	1	0.222	0.149	0.19	0.4195	0.04
BIOCARTA_CASPASE_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CASPASE_PATHWAY	-0.45822	-1.194	0.2846	0.49841	1	0.455	0.197	0.365	0.41997	0.04
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP	-0.33728	-1.194	0.2196	0.49872	1	0.264	0.196	0.213	0.42032	0.04
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	75	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-0.37635	-1.193	0.2902	0.50017	1	0.36	0.215	0.283	0.42229	0.04
KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	30	http://www.broadinstitute.org/gsea/msigdb/cards/KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION	-0.32563	-1.1924	0.2582	0.50122	1	0.467	0.348	0.304	0.42301	0.042
REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	46	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES	-0.41859	-1.192	0.2414	0.50154	1	0.326	0.17	0.271	0.42299	0.042
SWEET_KRAS_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_KRAS_TARGETS_DN	-0.28462	-1.192	0.2133	0.50083	1	0.274	0.253	0.205	0.42299	0.042
SESTO_RESPONSE_TO_UV_C2	52	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C2	-0.48349	-1.192	0.3024	0.50119	1	0.365	0.138	0.316	0.42318	0.042
LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_TARGETS_OF_PTCH1_AND_SUFU_DN	-0.31586	-1.1916	0.1919	0.50122	1	0.256	0.217	0.201	0.42266	0.042
REACTOME_PYRIMIDINE_METABOLISM	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PYRIMIDINE_METABOLISM	-0.36655	-1.1915	0.2375	0.50108	1	0.364	0.219	0.284	0.42231	0.042
PYEON_HPV_POSITIVE_TUMORS_UP	93	http://www.broadinstitute.org/gsea/msigdb/cards/PYEON_HPV_POSITIVE_TUMORS_UP	-0.49074	-1.1911	0.2992	0.50137	1	0.29	0.0764	0.269	0.42209	0.04
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	-0.41268	-1.1905	0.3036	0.5023	1	0.438	0.257	0.326	0.42296	0.042
KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS	-0.40335	-1.19	0.2452	0.50293	1	0.375	0.183	0.307	0.42511	0.042
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	-0.34618	-1.1898	0.2474	0.50276	1	0.128	0.0518	0.122	0.42477	0.042
PATTERSON_DOCETAXEL_RESISTANCE	28	http://www.broadinstitute.org/gsea/msigdb/cards/PATTERSON_DOCETAXEL_RESISTANCE	-0.35793	-1.189	0.2632	0.50428	1	0.214	0.155	0.181	0.42459	0.043
KANG_AR_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_AR_TARGETS_DN	-0.4892	-1.1887	0.3018	0.50447	1	0.421	0.178	0.346	0.42425	0.043
REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	-0.44879	-1.1879	0.2987	0.50577	1	0.625	0.338	0.414	0.42787	0.043
BROWNE_HCMV_INFECTION_18HR_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_18HR_UP	-0.38086	-1.1874	0.2524	0.5064	1	0.419	0.232	0.323	0.42838	0.043
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-0.3097	-1.1873	0.2528	0.50626	1	0.291	0.209	0.231	0.42803	0.043
APRELIKOVA_BRCA1_TARGETS	49	http://www.broadinstitute.org/gsea/msigdb/cards/APRELIKOVA_BRCA1_TARGETS	-0.40845	-1.1871	0.288	0.5063	1	0.224	0.112	0.2	0.4282	0.042
BROWNE_HCMV_INFECTION_30MIN_DN	137	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_30MIN_DN	-0.29101	-1.187	0.2152	0.50614	1	0.161	0.128	0.141	0.42785	0.042
PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP	-0.34172	-1.1869	0.2418	0.50592	1	0.0938	0.0216	0.0918	0.4275	0.042
RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	352	http://www.broadinstitute.org/gsea/msigdb/cards/RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN	-0.41443	-1.1868	0.3086	0.5056	1	0.241	0.124	0.214	0.42715	0.042
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	221	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1	-0.25852	-1.1863	0.1679	0.5063	1	0.213	0.18	0.176	0.42888	0.042
REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	116	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS	-0.37436	-1.186	0.2648	0.5065	1	0.483	0.287	0.346	0.42948	0.042
WU_HBX_TARGETS_2_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_2_DN	-0.44101	-1.1858	0.269	0.50637	1	0.6	0.261	0.444	0.42955	0.042
KIM_WT1_TARGETS_DN	433	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_DN	-0.39773	-1.1857	0.2713	0.50623	1	0.314	0.187	0.26	0.4292	0.042
RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP	-0.49934	-1.1854	0.3074	0.5065	1	0.5	0.29	0.355	0.43022	0.042
KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/KUNINGER_IGF1_VS_PDGFB_TARGETS_DN	-0.39283	-1.185	0.2281	0.50701	1	0.286	0.153	0.242	0.43166	0.042
HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN	-0.45298	-1.1848	0.2776	0.50695	1	0.435	0.218	0.34	0.4325	0.041
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	339	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN	-0.1905	-1.1846	0.2207	0.50697	1	0.198	0.216	0.157	0.43215	0.041
CHANG_CORE_SERUM_RESPONSE_UP	203	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CORE_SERUM_RESPONSE_UP	-0.39584	-1.184	0.2894	0.50783	1	0.404	0.229	0.314	0.43325	0.042
BIOCARTA_CXCR4_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CXCR4_PATHWAY	-0.40315	-1.1839	0.2179	0.50759	1	0.292	0.228	0.225	0.4329	0.042
REACTOME_REGULATION_OF_APOPTOSIS	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_APOPTOSIS	-0.39754	-1.1832	0.284	0.5086	1	0.464	0.287	0.332	0.43387	0.042
PID_TCR_CALCIUM_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TCR_CALCIUM_PATHWAY	-0.31645	-1.1831	0.2093	0.50813	1	0.357	0.243	0.271	0.43317	0.042
MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	113	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_5_6WK_UP	-0.31893	-1.1831	0.1543	0.50774	1	0.248	0.183	0.203	0.43282	0.042
JI_METASTASIS_REPRESSED_BY_STK11	27	http://www.broadinstitute.org/gsea/msigdb/cards/JI_METASTASIS_REPRESSED_BY_STK11	-0.35385	-1.1831	0.2453	0.50849	1	0.333	0.231	0.257	0.43352	0.042
ZWANG_DOWN_BY_2ND_EGF_PULSE	237	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_DOWN_BY_2ND_EGF_PULSE	-0.33615	-1.1824	0.2054	0.5086	1	0.278	0.157	0.237	0.43477	0.043
BIOCARTA_RARRXR_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RARRXR_PATHWAY	-0.40861	-1.1821	0.2877	0.50888	1	0.333	0.205	0.265	0.43475	0.042
PID_CDC42_PATHWAY	69	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CDC42_PATHWAY	-0.32919	-1.182	0.2564	0.50871	1	0.275	0.187	0.225	0.4344	0.042
BECKER_TAMOXIFEN_RESISTANCE_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/BECKER_TAMOXIFEN_RESISTANCE_UP	-0.3998	-1.182	0.2636	0.5084	1	0.28	0.116	0.248	0.43405	0.042
KRASNOSELSKAYA_ILF3_TARGETS_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/KRASNOSELSKAYA_ILF3_TARGETS_DN	-0.30354	-1.1815	0.2247	0.50887	1	0.31	0.232	0.238	0.4337	0.042
SANA_RESPONSE_TO_IFNG_DN	80	http://www.broadinstitute.org/gsea/msigdb/cards/SANA_RESPONSE_TO_IFNG_DN	-0.35024	-1.1813	0.2048	0.50897	1	0.362	0.222	0.283	0.43336	0.042
ASTIER_INTEGRIN_SIGNALING	55	http://www.broadinstitute.org/gsea/msigdb/cards/ASTIER_INTEGRIN_SIGNALING	-0.27832	-1.1811	0.2634	0.50897	1	0.218	0.155	0.185	0.43317	0.042
REACTOME_SIGNALING_BY_EGFR_IN_CANCER	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_EGFR_IN_CANCER	-0.28397	-1.1809	0.2244	0.50913	1	0.39	0.283	0.281	0.43346	0.042
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	111	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-0.335	-1.1807	0.2035	0.509	1	0.315	0.207	0.251	0.43311	0.042
NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	21	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON	-0.57414	-1.1804	0.3346	0.50943	1	0.429	0.195	0.345	0.43586	0.042
REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1	-0.44819	-1.1801	0.2963	0.50965	1	0.438	0.246	0.331	0.43616	0.04
BIOCARTA_PITX2_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PITX2_PATHWAY	-0.41112	-1.1798	0.264	0.50941	1	0.467	0.32	0.318	0.43547	0.039
REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G	-0.40971	-1.1798	0.2773	0.50973	1	0.3	0.17	0.249	0.43582	0.04
BROWNE_HCMV_INFECTION_20HR_UP	232	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_20HR_UP	-0.25998	-1.1791	0.1929	0.51038	1	0.254	0.222	0.2	0.43705	0.042
WILLIAMS_ESR2_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WILLIAMS_ESR2_TARGETS_UP	-0.40769	-1.179	0.2284	0.51024	1	0.346	0.163	0.29	0.4367	0.039
KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	20	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS	-0.40058	-1.1788	0.252	0.50994	1	0.45	0.29	0.32	0.4362	0.039
REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	93	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR	-0.34604	-1.1788	0.2696	0.50956	1	0.452	0.287	0.323	0.43586	0.039
WESTON_VEGFA_TARGETS_6HR	57	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS_6HR	-0.38511	-1.1788	0.2628	0.51023	1	0.351	0.224	0.273	0.43655	0.039
ABDELMOHSEN_ELAVL4_TARGETS	16	http://www.broadinstitute.org/gsea/msigdb/cards/ABDELMOHSEN_ELAVL4_TARGETS	-0.42209	-1.1786	0.2569	0.5095	1	0.5	0.209	0.396	0.43551	0.039
PID_GMCSF_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/PID_GMCSF_PATHWAY	-0.40011	-1.1782	0.2536	0.50994	1	0.333	0.213	0.263	0.43544	0.039
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	154	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-0.32084	-1.1782	0.2435	0.50969	1	0.26	0.181	0.214	0.4351	0.039
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	-0.35779	-1.1779	0.2152	0.50978	1	0.35	0.228	0.271	0.4358	0.039
RICKMAN_HEAD_AND_NECK_CANCER_A	95	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_A	-0.31777	-1.1779	0.1525	0.5094	1	0.147	0.0771	0.137	0.43546	0.039
ZHENG_IL22_SIGNALING_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_IL22_SIGNALING_UP	-0.34055	-1.1775	0.2342	0.5098	1	0.265	0.202	0.212	0.43632	0.039
GAVIN_FOXP3_TARGETS_CLUSTER_P4	95	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P4	-0.26774	-1.1768	0.166	0.51102	1	0.274	0.174	0.227	0.43653	0.039
TOOKER_GEMCITABINE_RESISTANCE_DN	121	http://www.broadinstitute.org/gsea/msigdb/cards/TOOKER_GEMCITABINE_RESISTANCE_DN	-0.36519	-1.1768	0.2565	0.51069	1	0.413	0.263	0.306	0.43619	0.039
RIGGI_EWING_SARCOMA_PROGENITOR_DN	177	http://www.broadinstitute.org/gsea/msigdb/cards/RIGGI_EWING_SARCOMA_PROGENITOR_DN	-0.32778	-1.1763	0.2019	0.51122	1	0.22	0.138	0.191	0.43641	0.039
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN	-0.33485	-1.1761	0.2344	0.51132	1	0.143	0.0621	0.134	0.43816	0.039
REACTOME_SHC_RELATED_EVENTS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC_RELATED_EVENTS	-0.49002	-1.1758	0.3266	0.51161	1	0.412	0.213	0.324	0.43865	0.039
SYED_ESTRADIOL_RESPONSE	19	http://www.broadinstitute.org/gsea/msigdb/cards/SYED_ESTRADIOL_RESPONSE	-0.40128	-1.1756	0.2682	0.51151	1	0.368	0.206	0.293	0.4383	0.039
ENK_UV_RESPONSE_EPIDERMIS_UP	277	http://www.broadinstitute.org/gsea/msigdb/cards/ENK_UV_RESPONSE_EPIDERMIS_UP	-0.24556	-1.1752	0.2046	0.51186	1	0.278	0.24	0.214	0.43859	0.039
SMITH_TERT_TARGETS_UP	142	http://www.broadinstitute.org/gsea/msigdb/cards/SMITH_TERT_TARGETS_UP	-0.37216	-1.175	0.2802	0.51191	1	0.472	0.282	0.341	0.43883	0.039
HOSHIDA_LIVER_CANCER_SUBCLASS_S2	112	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-0.36578	-1.1748	0.2998	0.51191	1	0.259	0.168	0.216	0.43848	0.039
HAHTOLA_CTCL_CUTANEOUS	25	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_CTCL_CUTANEOUS	-0.43956	-1.1748	0.2551	0.51157	1	0.32	0.129	0.279	0.43814	0.039
OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	67	http://www.broadinstitute.org/gsea/msigdb/cards/OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-0.37391	-1.1747	0.2414	0.51128	1	0.418	0.252	0.313	0.4378	0.039
LIAN_LIPA_TARGETS_6M	72	http://www.broadinstitute.org/gsea/msigdb/cards/LIAN_LIPA_TARGETS_6M	-0.36808	-1.1746	0.2879	0.51116	1	0.264	0.172	0.219	0.43764	0.039
REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE	-0.43256	-1.1743	0.3166	0.51156	1	0.352	0.17	0.292	0.43922	0.039
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	363	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN	-0.23469	-1.1738	0.2231	0.51212	1	0.231	0.2	0.188	0.4413	0.039
BIOCARTA_CDC42RAC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CDC42RAC_PATHWAY	-0.49823	-1.1737	0.2874	0.51197	1	0.533	0.224	0.414	0.441	0.039
WANG_LSD1_TARGETS_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LSD1_TARGETS_DN	-0.32194	-1.1736	0.2409	0.51178	1	0.184	0.115	0.163	0.44071	0.039
RASHI_RESPONSE_TO_IONIZING_RADIATION_1	42	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_1	-0.34876	-1.1734	0.2923	0.51165	1	0.238	0.2	0.191	0.44037	0.039
HAN_JNK_SINGALING_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_JNK_SINGALING_UP	-0.38657	-1.173	0.2766	0.51204	1	0.286	0.202	0.228	0.4402	0.039
MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_3_4WK_DN	-0.33246	-1.1729	0.2879	0.51181	1	0.206	0.16	0.173	0.43986	0.039
REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION	-0.39976	-1.1726	0.2986	0.51206	1	0.375	0.283	0.269	0.44077	0.039
REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS	-0.31205	-1.1725	0.2961	0.51181	1	0.286	0.197	0.23	0.44088	0.039
GEORGANTAS_HSC_MARKERS	64	http://www.broadinstitute.org/gsea/msigdb/cards/GEORGANTAS_HSC_MARKERS	-0.36491	-1.1722	0.2634	0.51224	1	0.328	0.209	0.26	0.44158	0.039
DOANE_BREAST_CANCER_CLASSES_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/DOANE_BREAST_CANCER_CLASSES_DN	-0.38609	-1.1721	0.2367	0.51202	1	0.156	0.0682	0.146	0.44124	0.039
BOQUEST_STEM_CELL_DN	208	http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_DN	-0.3156	-1.1719	0.2866	0.51207	1	0.274	0.224	0.214	0.4409	0.039
JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN	-0.30486	-1.1718	0.2579	0.51176	1	0.262	0.201	0.209	0.44056	0.039
TAKAO_RESPONSE_TO_UVB_RADIATION_DN	95	http://www.broadinstitute.org/gsea/msigdb/cards/TAKAO_RESPONSE_TO_UVB_RADIATION_DN	-0.34219	-1.1717	0.268	0.5117	1	0.358	0.231	0.276	0.44105	0.039
BIOCARTA_CHEMICAL_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CHEMICAL_PATHWAY	-0.38741	-1.1713	0.2653	0.51214	1	0.273	0.17	0.227	0.44098	0.039
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	-0.38325	-1.1712	0.2937	0.51207	1	0.273	0.172	0.226	0.44064	0.039
REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS	-0.4132	-1.171	0.3112	0.51197	1	0.36	0.228	0.278	0.4403	0.039
LEE_LIVER_CANCER_MYC_TGFA_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_TGFA_UP	-0.32887	-1.1708	0.2931	0.51197	1	0.356	0.254	0.266	0.43996	0.039
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP	-0.39277	-1.1708	0.2938	0.51167	1	0.324	0.202	0.259	0.43962	0.039
PID_IL3_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL3_PATHWAY	-0.33816	-1.1703	0.257	0.51194	1	0.192	0.165	0.161	0.44096	0.039
PID_RAC1_REG_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RAC1_REG_PATHWAY	-0.32867	-1.1703	0.1996	0.51221	1	0.237	0.144	0.203	0.44063	0.039
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN	-0.39075	-1.1703	0.2796	0.51159	1	0.304	0.192	0.246	0.44062	0.035
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	122	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN	-0.23971	-1.1701	0.2047	0.51141	1	0.287	0.237	0.22	0.44029	0.035
HEIDENBLAD_AMPLICON_12P11_12_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_12P11_12_UP	-0.38058	-1.1701	0.261	0.51035	1	0.375	0.226	0.291	0.43994	0.034
BECKER_TAMOXIFEN_RESISTANCE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/BECKER_TAMOXIFEN_RESISTANCE_DN	-0.44241	-1.1701	0.2647	0.51069	1	0.34	0.159	0.287	0.43961	0.035
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	247	http://www.broadinstitute.org/gsea/msigdb/cards/MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP	-0.24504	-1.1701	0.1949	0.51103	1	0.243	0.209	0.194	0.43995	0.035
KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	30	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM	-0.32871	-1.1696	0.2598	0.51104	1	0.433	0.325	0.293	0.44114	0.034
BIOCARTA_TALL1_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TALL1_PATHWAY	-0.38557	-1.1696	0.2529	0.51067	1	0.4	0.313	0.275	0.4408	0.034
LINDGREN_BLADDER_CANCER_CLUSTER_2B	372	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_2B	-0.31536	-1.1689	0.2738	0.51165	1	0.274	0.203	0.222	0.44128	0.034
NAGY_TFTC_COMPONENTS_HUMAN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NAGY_TFTC_COMPONENTS_HUMAN	-0.43493	-1.1683	0.2921	0.5126	1	0.722	0.353	0.467	0.44139	0.035
PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP	-0.33185	-1.1678	0.185	0.51322	1	0.323	0.201	0.258	0.44159	0.039
PID_NCADHERIN_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NCADHERIN_PATHWAY	-0.34115	-1.1674	0.2813	0.51369	1	0.303	0.21	0.24	0.44355	0.039
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN	-0.42364	-1.1673	0.2677	0.51339	1	0.375	0.194	0.302	0.44321	0.038
PID_NOTCH_PATHWAY	58	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NOTCH_PATHWAY	-0.30036	-1.1672	0.279	0.51323	1	0.259	0.23	0.2	0.44315	0.038
REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	50	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	-0.29428	-1.1669	0.2432	0.51346	1	0.32	0.229	0.247	0.44281	0.038
SMITH_LIVER_CANCER	42	http://www.broadinstitute.org/gsea/msigdb/cards/SMITH_LIVER_CANCER	-0.49689	-1.1669	0.3268	0.51314	1	0.381	0.157	0.322	0.44247	0.038
FRASOR_RESPONSE_TO_ESTRADIOL_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_ESTRADIOL_DN	-0.3256	-1.1668	0.2659	0.51284	1	0.241	0.155	0.204	0.44214	0.038
BURTON_ADIPOGENESIS_10	29	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_10	-0.46244	-1.1666	0.3287	0.51288	1	0.414	0.21	0.327	0.4418	0.034
PID_RB_1PATHWAY	62	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RB_1PATHWAY	-0.30351	-1.1663	0.2414	0.51317	1	0.355	0.225	0.276	0.4419	0.034
SEKI_INFLAMMATORY_RESPONSE_LPS_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/SEKI_INFLAMMATORY_RESPONSE_LPS_UP	-0.42206	-1.1655	0.3186	0.51446	1	0.24	0.158	0.203	0.44569	0.034
BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN	-0.37345	-1.1653	0.2658	0.51456	1	0.231	0.123	0.203	0.44585	0.034
HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	18	http://www.broadinstitute.org/gsea/msigdb/cards/HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2	-0.50826	-1.1652	0.3022	0.51426	1	0.278	0.0606	0.261	0.44551	0.034
BROWN_MYELOID_CELL_DEVELOPMENT_DN	124	http://www.broadinstitute.org/gsea/msigdb/cards/BROWN_MYELOID_CELL_DEVELOPMENT_DN	-0.31092	-1.1651	0.2438	0.51412	1	0.274	0.183	0.225	0.44521	0.034
REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1	-0.43468	-1.165	0.3246	0.51394	1	0.408	0.229	0.315	0.44525	0.034
BILBAN_B_CLL_LPL_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/BILBAN_B_CLL_LPL_UP	-0.31185	-1.1644	0.2392	0.51502	1	0.283	0.188	0.231	0.44589	0.034
BIOCARTA_TNFR1_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TNFR1_PATHWAY	-0.42816	-1.164	0.3247	0.51529	1	0.345	0.197	0.277	0.44609	0.034
KOINUMA_COLON_CANCER_MSI_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/KOINUMA_COLON_CANCER_MSI_UP	-0.59701	-1.164	0.3178	0.515	1	0.4	0.0567	0.378	0.44607	0.034
ELVIDGE_HYPOXIA_DN	139	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HYPOXIA_DN	-0.27792	-1.1636	0.2107	0.51538	1	0.266	0.198	0.215	0.446	0.034
CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	16	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL	-0.44803	-1.1635	0.2809	0.51493	1	0.312	0.177	0.257	0.44533	0.034
WHITFIELD_CELL_CYCLE_G1_S	132	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_G1_S	-0.39119	-1.1635	0.3478	0.51522	1	0.258	0.145	0.221	0.44566	0.034
DIRMEIER_LMP1_RESPONSE_EARLY	63	http://www.broadinstitute.org/gsea/msigdb/cards/DIRMEIER_LMP1_RESPONSE_EARLY	-0.33038	-1.1634	0.3101	0.51459	1	0.27	0.196	0.217	0.44499	0.034
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	481	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN	-0.29299	-1.1633	0.2534	0.51447	1	0.293	0.216	0.234	0.44605	0.034
SANSOM_WNT_PATHWAY_REQUIRE_MYC	57	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_WNT_PATHWAY_REQUIRE_MYC	-0.31649	-1.1633	0.2431	0.51415	1	0.298	0.184	0.244	0.44578	0.033
HAN_SATB1_TARGETS_UP	375	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_SATB1_TARGETS_UP	-0.26342	-1.1633	0.1482	0.51381	1	0.195	0.17	0.164	0.44545	0.033
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-0.48641	-1.1631	0.3631	0.51368	1	0.35	0.147	0.301	0.44512	0.033
FRASOR_RESPONSE_TO_ESTRADIOL_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/FRASOR_RESPONSE_TO_ESTRADIOL_UP	-0.34352	-1.163	0.2101	0.51353	1	0.108	0.0504	0.103	0.44487	0.033
KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM	-0.29134	-1.1626	0.2635	0.51412	1	0.432	0.303	0.301	0.44602	0.033
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP	-0.33337	-1.1626	0.2679	0.51374	1	0.288	0.186	0.236	0.44568	0.033
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	166	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-0.31172	-1.1625	0.2567	0.51365	1	0.373	0.282	0.27	0.44626	0.033
GALE_APL_WITH_FLT3_MUTATED_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GALE_APL_WITH_FLT3_MUTATED_DN	-0.34864	-1.1624	0.3022	0.51335	1	0.467	0.252	0.349	0.44593	0.033
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	183	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-0.49296	-1.1619	0.3689	0.51412	1	0.426	0.213	0.338	0.44657	0.033
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	161	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	-0.30794	-1.1617	0.2409	0.51409	1	0.242	0.149	0.207	0.44631	0.033
PID_ERBB2_ERBB3_PATHWAY	44	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB2_ERBB3_PATHWAY	-0.42373	-1.1615	0.3068	0.51399	1	0.318	0.22	0.249	0.44601	0.033
BIOCARTA_CHREBP2_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CHREBP2_PATHWAY	-0.32834	-1.1612	0.2623	0.51427	1	0.195	0.115	0.173	0.44622	0.033
GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	60	http://www.broadinstitute.org/gsea/msigdb/cards/GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11	-0.34465	-1.1611	0.2476	0.51414	1	0.4	0.253	0.3	0.44589	0.033
LEE_CALORIE_RESTRICTION_MUSCLE_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_MUSCLE_UP	-0.29007	-1.1611	0.2731	0.51383	1	0.5	0.346	0.328	0.44556	0.033
HOFMANN_CELL_LYMPHOMA_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_CELL_LYMPHOMA_UP	-0.37943	-1.161	0.2385	0.51353	1	0.479	0.216	0.376	0.44523	0.033
PROVENZANI_METASTASIS_UP	182	http://www.broadinstitute.org/gsea/msigdb/cards/PROVENZANI_METASTASIS_UP	-0.31285	-1.1606	0.2794	0.51411	1	0.28	0.213	0.222	0.446	0.033
HOUSTIS_ROS	35	http://www.broadinstitute.org/gsea/msigdb/cards/HOUSTIS_ROS	-0.35997	-1.1605	0.2667	0.51388	1	0.429	0.271	0.313	0.44567	0.033
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP	-0.4067	-1.1602	0.2854	0.51407	1	0.333	0.226	0.258	0.44534	0.033
HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP	-0.35129	-1.16	0.2659	0.51418	1	0.273	0.168	0.227	0.44501	0.033
JIANG_TIP30_TARGETS_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_TIP30_TARGETS_UP	-0.41515	-1.1593	0.2376	0.51543	1	0.2	0.0674	0.187	0.44769	0.033
REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC	-0.44077	-1.1592	0.3223	0.5152	1	0.471	0.283	0.338	0.44774	0.033
REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	-0.41961	-1.1589	0.3135	0.51498	1	0.463	0.295	0.327	0.44718	0.033
GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_ONLY_UP	-0.43293	-1.1589	0.2984	0.5153	1	0.515	0.317	0.352	0.44751	0.033
KOYAMA_SEMA3B_TARGETS_UP	266	http://www.broadinstitute.org/gsea/msigdb/cards/KOYAMA_SEMA3B_TARGETS_UP	-0.2517	-1.1587	0.1942	0.515	1	0.241	0.216	0.191	0.44724	0.033
TSENG_ADIPOGENIC_POTENTIAL_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_ADIPOGENIC_POTENTIAL_DN	-0.36136	-1.1582	0.272	0.51574	1	0.391	0.252	0.293	0.44905	0.033
WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	100	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN	-0.28471	-1.1577	0.2466	0.51636	1	0.26	0.212	0.206	0.45005	0.033
CROONQUIST_NRAS_SIGNALING_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_SIGNALING_UP	-0.3927	-1.1577	0.2835	0.51608	1	0.225	0.107	0.201	0.44972	0.033
KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	19	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSAMINOGLYCAN_DEGRADATION	-0.35505	-1.1572	0.2566	0.5166	1	0.368	0.27	0.269	0.44952	0.033
ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	17	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_NIMUSTINE	-0.42186	-1.157	0.2534	0.51679	1	0.235	0.0694	0.219	0.4497	0.033
DORSEY_GAB2_TARGETS	31	http://www.broadinstitute.org/gsea/msigdb/cards/DORSEY_GAB2_TARGETS	-0.40211	-1.1567	0.2697	0.51686	1	0.226	0.0756	0.209	0.44937	0.033
KANG_FLUOROURACIL_RESISTANCE_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_FLUOROURACIL_RESISTANCE_UP	-0.44316	-1.1566	0.3038	0.51674	1	0.333	0.141	0.286	0.4493	0.033
REACTOME_SIGNALING_BY_FGFR1_MUTANTS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR1_MUTANTS	-0.36015	-1.1563	0.2167	0.51687	1	0.103	0.0226	0.101	0.44983	0.032
YIH_RESPONSE_TO_ARSENITE_C1	23	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C1	-0.46864	-1.1562	0.3234	0.51673	1	0.435	0.184	0.355	0.45078	0.031
GHANDHI_BYSTANDER_IRRADIATION_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/GHANDHI_BYSTANDER_IRRADIATION_UP	-0.3695	-1.1561	0.2389	0.51674	1	0.312	0.165	0.262	0.45045	0.031
KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	59	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	-0.34295	-1.1557	0.2904	0.51704	1	0.305	0.196	0.246	0.4512	0.032
YAGI_AML_SURVIVAL	125	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_SURVIVAL	-0.33635	-1.1555	0.2738	0.51711	1	0.288	0.18	0.237	0.45186	0.032
SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN	-0.4732	-1.1548	0.3035	0.5184	1	0.3	0.122	0.264	0.45164	0.032
ONO_FOXP3_TARGETS_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/ONO_FOXP3_TARGETS_DN	-0.28482	-1.1545	0.2655	0.51856	1	0.195	0.127	0.171	0.45225	0.032
REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS	-0.46245	-1.1535	0.3346	0.52025	1	0.105	0.014	0.104	0.45394	0.034
GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	202	http://www.broadinstitute.org/gsea/msigdb/cards/GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP	-0.2829	-1.1534	0.2784	0.52009	1	0.233	0.176	0.193	0.4542	0.033
KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	98	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_GASTRIC_CANCER_CHEMOSENSITIVITY	-0.26072	-1.153	0.2647	0.52041	1	0.122	0.11	0.109	0.4545	0.034
ZWANG_EGF_INTERVAL_UP	90	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_INTERVAL_UP	-0.25446	-1.153	0.1599	0.52013	1	0.222	0.179	0.183	0.45417	0.032
WANG_CISPLATIN_RESPONSE_AND_XPC_DN	219	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CISPLATIN_RESPONSE_AND_XPC_DN	-0.27615	-1.1529	0.24	0.51962	1	0.288	0.229	0.224	0.45398	0.032
ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN	-0.40734	-1.1529	0.309	0.51983	1	0.267	0.156	0.225	0.45383	0.032
BASSO_CD40_SIGNALING_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/BASSO_CD40_SIGNALING_UP	-0.32389	-1.1528	0.3398	0.51901	1	0.313	0.239	0.239	0.45375	0.032
HENDRICKS_SMARCA4_TARGETS_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/HENDRICKS_SMARCA4_TARGETS_UP	-0.33832	-1.1528	0.2984	0.51936	1	0.269	0.148	0.23	0.45366	0.032
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	83	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP	-0.39115	-1.1523	0.3834	0.5195	1	0.386	0.291	0.274	0.45367	0.032
REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	122	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	-0.30578	-1.1522	0.268	0.5195	1	0.434	0.287	0.311	0.45334	0.032
RUTELLA_RESPONSE_TO_HGF_DN	225	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_HGF_DN	-0.25261	-1.1521	0.2505	0.5192	1	0.24	0.221	0.189	0.45301	0.032
DORSAM_HOXA9_TARGETS_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/DORSAM_HOXA9_TARGETS_UP	-0.38315	-1.1517	0.2934	0.51978	1	0.333	0.211	0.263	0.45442	0.032
BOYAULT_LIVER_CANCER_SUBCLASS_G2	26	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G2	-0.41762	-1.1516	0.2977	0.51957	1	0.385	0.197	0.309	0.45409	0.032
RHODES_CANCER_META_SIGNATURE	63	http://www.broadinstitute.org/gsea/msigdb/cards/RHODES_CANCER_META_SIGNATURE	-0.44753	-1.151	0.3517	0.5205	1	0.381	0.207	0.303	0.45385	0.032
REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	190	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK	-0.25057	-1.1505	0.1642	0.5207	1	0.163	0.138	0.142	0.45476	0.032
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	157	http://www.broadinstitute.org/gsea/msigdb/cards/PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-0.23257	-1.1505	0.21	0.52104	1	0.191	0.164	0.161	0.45509	0.032
HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP	-0.34733	-1.1494	0.2769	0.5226	1	0.545	0.348	0.356	0.45612	0.032
BIOCARTA_IL1R_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL1R_PATHWAY	-0.37508	-1.1489	0.2732	0.52324	1	0.312	0.196	0.251	0.45782	0.033
REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1	-0.33476	-1.1485	0.2383	0.52377	1	0.22	0.138	0.19	0.45749	0.033
KEGG_RNA_DEGRADATION	58	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RNA_DEGRADATION	-0.38665	-1.1481	0.3294	0.52431	1	0.241	0.137	0.209	0.45816	0.032
KEGG_PURINE_METABOLISM	152	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PURINE_METABOLISM	-0.26576	-1.1473	0.2342	0.52549	1	0.303	0.239	0.232	0.45955	0.033
MURAKAMI_UV_RESPONSE_6HR_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/MURAKAMI_UV_RESPONSE_6HR_DN	-0.35356	-1.147	0.2748	0.52591	1	0.238	0.116	0.211	0.45972	0.033
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	23	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS	-0.27211	-1.1466	0.2733	0.52622	1	0.304	0.253	0.228	0.46056	0.033
LEE_AGING_CEREBELLUM_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_CEREBELLUM_DN	-0.24418	-1.1463	0.2429	0.52658	1	0.171	0.147	0.146	0.46179	0.033
BURTON_ADIPOGENESIS_4	45	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_4	-0.336	-1.1457	0.2686	0.52731	1	0.267	0.138	0.23	0.46215	0.038
MOOTHA_FFA_OXYDATION	22	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_FFA_OXYDATION	-0.33496	-1.1452	0.3384	0.52809	1	0.273	0.193	0.22	0.46189	0.039
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP	-0.3374	-1.1447	0.2505	0.52878	1	0.15	0.0829	0.138	0.4625	0.039
REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP	-0.45133	-1.1443	0.3276	0.52906	1	0.235	0.127	0.206	0.46274	0.039
KEGG_TRYPTOPHAN_METABOLISM	37	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TRYPTOPHAN_METABOLISM	-0.26944	-1.1442	0.279	0.52859	1	0.297	0.206	0.236	0.46208	0.039
PENG_GLUTAMINE_DEPRIVATION_DN	326	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_GLUTAMINE_DEPRIVATION_DN	-0.35608	-1.1442	0.3468	0.52894	1	0.294	0.183	0.244	0.46241	0.039
SENESE_HDAC3_TARGETS_DN	500	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC3_TARGETS_DN	-0.25131	-1.1435	0.1847	0.52969	1	0.186	0.148	0.162	0.46198	0.039
HOEBEKE_LYMPHOID_STEM_CELL_DN	83	http://www.broadinstitute.org/gsea/msigdb/cards/HOEBEKE_LYMPHOID_STEM_CELL_DN	-0.30218	-1.1422	0.2428	0.53211	1	0.253	0.147	0.216	0.46259	0.039
BROWNE_HCMV_INFECTION_8HR_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_8HR_UP	-0.33027	-1.1421	0.2328	0.53188	1	0.23	0.156	0.195	0.46277	0.039
GRESHOCK_CANCER_COPY_NUMBER_UP	315	http://www.broadinstitute.org/gsea/msigdb/cards/GRESHOCK_CANCER_COPY_NUMBER_UP	-0.28694	-1.142	0.264	0.53178	1	0.337	0.258	0.253	0.46273	0.039
LEIN_MEDULLA_MARKERS	79	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_MEDULLA_MARKERS	-0.21817	-1.1417	0.2209	0.53205	1	0.114	0.111	0.102	0.46334	0.039
BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN	-0.35495	-1.1415	0.3272	0.53204	1	0.762	0.422	0.44	0.46348	0.039
KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	84	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	-0.31636	-1.1414	0.2749	0.53192	1	0.369	0.238	0.282	0.46315	0.038
PID_MYC_ACTIV_PATHWAY	75	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MYC_ACTIV_PATHWAY	-0.36381	-1.1412	0.354	0.53189	1	0.507	0.325	0.343	0.46329	0.038
REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS	-0.34933	-1.1407	0.3104	0.53249	1	0.161	0.0869	0.147	0.46437	0.038
LUND_SILENCED_BY_METHYLATION	15	http://www.broadinstitute.org/gsea/msigdb/cards/LUND_SILENCED_BY_METHYLATION	-0.34858	-1.1402	0.3072	0.53325	1	0.333	0.169	0.277	0.46484	0.038
DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	308	http://www.broadinstitute.org/gsea/msigdb/cards/DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP	-0.38782	-1.1399	0.2896	0.5334	1	0.344	0.198	0.279	0.46451	0.038
WANG_RECURRENT_LIVER_CANCER_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RECURRENT_LIVER_CANCER_DN	-0.36682	-1.1399	0.2602	0.53311	1	0.438	0.288	0.312	0.46418	0.038
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	80	http://www.broadinstitute.org/gsea/msigdb/cards/SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	-0.36537	-1.1371	0.3346	0.53821	1	0.35	0.223	0.273	0.4738	0.039
BROWNE_HCMV_INFECTION_48HR_UP	177	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_48HR_UP	-0.31671	-1.1371	0.2701	0.53859	1	0.254	0.155	0.216	0.47414	0.04
GAVIN_FOXP3_TARGETS_CLUSTER_P2	75	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P2	-0.3141	-1.1366	0.2726	0.53873	1	0.2	0.17	0.167	0.47418	0.04
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN	-0.32293	-1.1366	0.2682	0.53835	1	0.275	0.197	0.221	0.47384	0.04
REACTOME_DIABETES_PATHWAYS	125	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DIABETES_PATHWAYS	-0.30122	-1.1362	0.3274	0.53891	1	0.32	0.245	0.243	0.47538	0.04
GHANDHI_DIRECT_IRRADIATION_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/GHANDHI_DIRECT_IRRADIATION_DN	-0.35452	-1.1358	0.3658	0.53941	1	0.25	0.192	0.202	0.47597	0.04
KIM_WT1_TARGETS_12HR_DN	203	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_12HR_DN	-0.31205	-1.1353	0.2953	0.53998	1	0.281	0.196	0.228	0.47645	0.04
HOQUE_METHYLATED_IN_CANCER	55	http://www.broadinstitute.org/gsea/msigdb/cards/HOQUE_METHYLATED_IN_CANCER	-0.3169	-1.1353	0.2823	0.53973	1	0.273	0.189	0.222	0.47672	0.04
TERAO_AOX4_TARGETS_HG_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/TERAO_AOX4_TARGETS_HG_UP	-0.35063	-1.1351	0.2902	0.53979	1	0.214	0.134	0.186	0.47639	0.04
REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AMINE_COMPOUND_SLC_TRANSPORTERS	-0.35066	-1.135	0.2942	0.53953	1	0.259	0.248	0.195	0.47605	0.04
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN	-0.35359	-1.1347	0.3021	0.53976	1	0.212	0.111	0.189	0.47584	0.04
BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	26	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN	-0.46222	-1.1346	0.34	0.53964	1	0.385	0.176	0.317	0.4755	0.04
BURTON_ADIPOGENESIS_12	31	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_12	-0.49629	-1.1341	0.4078	0.54024	1	0.548	0.253	0.41	0.47554	0.04
DANG_MYC_TARGETS_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_MYC_TARGETS_DN	-0.28491	-1.1341	0.2814	0.53986	1	0.4	0.274	0.291	0.47521	0.04
SMID_BREAST_CANCER_ERBB2_UP	134	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_ERBB2_UP	-0.28377	-1.1336	0.2915	0.54061	1	0.269	0.204	0.215	0.47636	0.04
RIGGINS_TAMOXIFEN_RESISTANCE_DN	213	http://www.broadinstitute.org/gsea/msigdb/cards/RIGGINS_TAMOXIFEN_RESISTANCE_DN	-0.34442	-1.1331	0.3287	0.54131	1	0.343	0.206	0.274	0.47751	0.04
MEDINA_SMARCA4_TARGETS	40	http://www.broadinstitute.org/gsea/msigdb/cards/MEDINA_SMARCA4_TARGETS	-0.29537	-1.1327	0.2663	0.54171	1	0.375	0.243	0.284	0.47828	0.04
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	380	http://www.broadinstitute.org/gsea/msigdb/cards/BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP	-0.27463	-1.1321	0.2824	0.54268	1	0.339	0.258	0.256	0.47921	0.041
LIM_MAMMARY_STEM_CELL_DN	414	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_STEM_CELL_DN	-0.25548	-1.1317	0.2628	0.54309	1	0.234	0.195	0.192	0.47932	0.041
HOFMANN_CELL_LYMPHOMA_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_CELL_LYMPHOMA_DN	-0.32145	-1.1307	0.3327	0.54477	1	0.184	0.088	0.168	0.48052	0.041
UDAYAKUMAR_MED1_TARGETS_UP	129	http://www.broadinstitute.org/gsea/msigdb/cards/UDAYAKUMAR_MED1_TARGETS_UP	-0.3549	-1.1305	0.3394	0.54484	1	0.326	0.236	0.25	0.48018	0.041
PID_PI3K_PLC_TRK_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PI3K_PLC_TRK_PATHWAY	-0.36177	-1.1302	0.3353	0.54515	1	0.25	0.154	0.212	0.48063	0.041
NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/NING_CHRONIC_OBSTRUCTIVE_PULMONARY_DISEASE_UP	-0.2541	-1.1299	0.2975	0.54531	1	0.333	0.28	0.242	0.48108	0.041
REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	58	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE	-0.27979	-1.1297	0.28	0.54541	1	0.431	0.304	0.3	0.48075	0.041
REACTOME_MITOTIC_G2_G2_M_PHASES	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MITOTIC_G2_G2_M_PHASES	-0.37205	-1.1293	0.3209	0.54584	1	0.308	0.169	0.256	0.48041	0.041
PID_BETA_CATENIN_NUC_PATHWAY	77	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BETA_CATENIN_NUC_PATHWAY	-0.3092	-1.1292	0.2953	0.54556	1	0.273	0.199	0.219	0.4803	0.041
PID_REELIN_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_REELIN_PATHWAY	-0.35689	-1.1291	0.266	0.5455	1	0.214	0.0905	0.195	0.48005	0.041
CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	64	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70	-0.2856	-1.1289	0.2704	0.54553	1	0.234	0.191	0.19	0.48088	0.041
REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS	-0.29802	-1.1287	0.3069	0.54566	1	0.397	0.307	0.276	0.48076	0.041
REACTOME_UNFOLDED_PROTEIN_RESPONSE	74	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_UNFOLDED_PROTEIN_RESPONSE	-0.332	-1.1281	0.3479	0.54639	1	0.311	0.245	0.235	0.48274	0.041
MATTHEWS_AP1_TARGETS	17	http://www.broadinstitute.org/gsea/msigdb/cards/MATTHEWS_AP1_TARGETS	-0.39693	-1.1281	0.2729	0.54603	1	0.235	0.114	0.209	0.48241	0.041
PHONG_TNF_RESPONSE_NOT_VIA_P38	326	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_RESPONSE_NOT_VIA_P38	-0.2644	-1.1277	0.3131	0.54643	1	0.209	0.181	0.173	0.48332	0.041
NUTT_GBM_VS_AO_GLIOMA_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/NUTT_GBM_VS_AO_GLIOMA_UP	-0.35747	-1.1276	0.3412	0.54643	1	0.182	0.0662	0.17	0.48321	0.041
RASHI_RESPONSE_TO_IONIZING_RADIATION_4	57	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_4	-0.32602	-1.1275	0.3244	0.54618	1	0.368	0.236	0.282	0.48296	0.041
BIOCARTA_FMLP_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_FMLP_PATHWAY	-0.325	-1.1273	0.3346	0.54615	1	0.333	0.269	0.244	0.48263	0.041
WEINMANN_ADAPTATION_TO_HYPOXIA_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/WEINMANN_ADAPTATION_TO_HYPOXIA_UP	-0.37607	-1.1269	0.2713	0.54673	1	0.357	0.176	0.295	0.48392	0.041
GENTILE_UV_HIGH_DOSE_DN	299	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_HIGH_DOSE_DN	-0.34471	-1.1265	0.3327	0.54713	1	0.368	0.252	0.278	0.48459	0.04
REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY	-0.38205	-1.1262	0.2799	0.54744	1	0.176	0.0593	0.166	0.48426	0.039
PID_P75_NTR_PATHWAY	69	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P75_NTR_PATHWAY	-0.30626	-1.126	0.2658	0.54737	1	0.29	0.213	0.229	0.4844	0.039
ST_JNK_MAPK_PATHWAY	39	http://www.broadinstitute.org/gsea/msigdb/cards/ST_JNK_MAPK_PATHWAY	-0.37766	-1.1255	0.3327	0.54817	1	0.308	0.181	0.252	0.48466	0.039
PID_NFKAPPAB_CANONICAL_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NFKAPPAB_CANONICAL_PATHWAY	-0.39719	-1.1253	0.3002	0.54825	1	0.304	0.196	0.245	0.48478	0.039
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN	-0.33925	-1.1251	0.3182	0.54791	1	0.368	0.209	0.292	0.48411	0.039
VALK_AML_WITH_EVI1	22	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_EVI1	-0.35292	-1.1251	0.341	0.54823	1	0.318	0.223	0.247	0.48445	0.039
YAGI_AML_WITH_T_8_21_TRANSLOCATION	350	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_WITH_T_8_21_TRANSLOCATION	-0.23934	-1.1241	0.2416	0.54957	1	0.191	0.165	0.162	0.48641	0.039
BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP	-0.45494	-1.1239	0.3154	0.5496	1	0.4	0.184	0.327	0.48608	0.039
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	217	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	-0.28177	-1.1236	0.2888	0.54991	1	0.281	0.21	0.224	0.48666	0.039
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	113	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP	-0.28543	-1.1232	0.2994	0.55042	1	0.257	0.198	0.207	0.4875	0.039
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	166	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	-0.30753	-1.1229	0.3235	0.55063	1	0.211	0.179	0.174	0.48847	0.04
KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM	-0.42432	-1.1228	0.369	0.55044	1	0.438	0.275	0.317	0.48814	0.04
MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP	-0.4367	-1.1226	0.329	0.55048	1	0.304	0.168	0.253	0.48828	0.04
NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	122	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON	-0.27097	-1.1224	0.2703	0.5506	1	0.23	0.205	0.183	0.48839	0.04
KEGG_GLUTATHIONE_METABOLISM	50	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLUTATHIONE_METABOLISM	-0.30172	-1.1223	0.27	0.55042	1	0.24	0.122	0.211	0.48904	0.04
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	85	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	-0.27423	-1.122	0.2757	0.55025	1	0.2	0.19	0.162	0.48882	0.039
WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	27	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1	-0.31653	-1.122	0.2998	0.55049	1	0.185	0.153	0.157	0.48871	0.04
BIOCARTA_P53_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_P53_PATHWAY	-0.34723	-1.1214	0.2964	0.5512	1	0.312	0.14	0.269	0.48888	0.04
LEE_LIVER_CANCER_DENA_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_DENA_DN	-0.2716	-1.1213	0.258	0.55099	1	0.219	0.188	0.178	0.48855	0.04
DAZARD_RESPONSE_TO_UV_SCC_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_SCC_UP	-0.3677	-1.1211	0.3081	0.5509	1	0.289	0.135	0.252	0.48863	0.039
JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/JUBAN_TARGETS_OF_SPI1_AND_FLI1_DN	-0.30202	-1.1207	0.286	0.55149	1	0.284	0.205	0.227	0.48857	0.04
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	67	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN	-0.29363	-1.1206	0.3429	0.55135	1	0.224	0.188	0.182	0.48823	0.04
RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	31	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_HEMGN	-0.30672	-1.1206	0.2932	0.55099	1	0.29	0.223	0.226	0.4879	0.039
DARWICHE_PAPILLOMA_RISK_HIGH_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_HIGH_UP	-0.24208	-1.1205	0.2381	0.5508	1	0.199	0.194	0.161	0.48757	0.038
GILDEA_METASTASIS	28	http://www.broadinstitute.org/gsea/msigdb/cards/GILDEA_METASTASIS	-0.47081	-1.1204	0.348	0.55062	1	0.393	0.144	0.337	0.48724	0.038
CHIN_BREAST_CANCER_COPY_NUMBER_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/CHIN_BREAST_CANCER_COPY_NUMBER_UP	-0.41404	-1.1201	0.3204	0.5509	1	0.4	0.184	0.327	0.48814	0.039
DARWICHE_PAPILLOMA_RISK_LOW_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/DARWICHE_PAPILLOMA_RISK_LOW_UP	-0.2283	-1.1199	0.239	0.55052	1	0.288	0.27	0.211	0.48747	0.039
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	64	http://www.broadinstitute.org/gsea/msigdb/cards/SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP	-0.36061	-1.1199	0.363	0.55083	1	0.297	0.2	0.238	0.4878	0.038
SASSON_RESPONSE_TO_GONADOTROPHINS_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_GONADOTROPHINS_UP	-0.28098	-1.1188	0.3187	0.55224	1	0.371	0.236	0.284	0.48856	0.039
RICKMAN_HEAD_AND_NECK_CANCER_E	88	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_E	-0.31851	-1.1187	0.2708	0.55214	1	0.33	0.203	0.263	0.48937	0.038
HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	30	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER	-0.43064	-1.1186	0.3735	0.55207	1	0.467	0.265	0.343	0.48908	0.039
REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION	-0.39622	-1.1185	0.3183	0.5518	1	0.55	0.293	0.389	0.48875	0.039
RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP	-0.41188	-1.1182	0.3491	0.55214	1	0.8	0.33	0.537	0.4888	0.038
NUTT_GBM_VS_AO_GLIOMA_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/NUTT_GBM_VS_AO_GLIOMA_DN	-0.27722	-1.1181	0.3247	0.5519	1	0.477	0.331	0.32	0.48847	0.037
LABBE_WNT3A_TARGETS_DN	96	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_WNT3A_TARGETS_DN	-0.26876	-1.1179	0.2509	0.55189	1	0.292	0.235	0.224	0.4884	0.037
REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	174	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	-0.26705	-1.1177	0.3008	0.55211	1	0.213	0.174	0.177	0.48959	0.037
BIOCARTA_MAPK_PATHWAY	84	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MAPK_PATHWAY	-0.30887	-1.1176	0.3555	0.55187	1	0.405	0.301	0.284	0.48926	0.036
OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/OKAMOTO_LIVER_CANCER_MULTICENTRIC_OCCURRENCE_UP	-0.31188	-1.1174	0.34	0.55188	1	0.125	0.0913	0.114	0.48893	0.036
BRUECKNER_TARGETS_OF_MIRLET7A3_DN	71	http://www.broadinstitute.org/gsea/msigdb/cards/BRUECKNER_TARGETS_OF_MIRLET7A3_DN	-0.32727	-1.1171	0.3069	0.55229	1	0.254	0.158	0.214	0.48947	0.036
NAKAMURA_ADIPOGENESIS_LATE_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_ADIPOGENESIS_LATE_UP	-0.28383	-1.1168	0.2832	0.55246	1	0.19	0.126	0.167	0.48915	0.036
WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP	-0.38693	-1.1166	0.3125	0.55241	1	0.381	0.144	0.327	0.48882	0.036
ZHANG_TLX_TARGETS_DN	102	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TLX_TARGETS_DN	-0.27332	-1.1164	0.3374	0.55257	1	0.333	0.29	0.238	0.48865	0.036
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	158	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-0.33354	-1.1156	0.3624	0.55375	1	0.411	0.256	0.308	0.49021	0.036
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	-0.35416	-1.1153	0.2967	0.5541	1	0.467	0.257	0.347	0.49132	0.037
REACTOME_SIGNALING_BY_SCF_KIT	75	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_SCF_KIT	-0.32213	-1.1151	0.3083	0.55415	1	0.333	0.225	0.259	0.49124	0.036
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	-0.54963	-1.1147	0.3953	0.5546	1	0.353	0.16	0.297	0.49155	0.036
BRUNO_HEMATOPOIESIS	64	http://www.broadinstitute.org/gsea/msigdb/cards/BRUNO_HEMATOPOIESIS	-0.30011	-1.1143	0.3013	0.55504	1	0.266	0.174	0.22	0.49122	0.037
PID_ECADHERIN_NASCENT_AJ_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ECADHERIN_NASCENT_AJ_PATHWAY	-0.34838	-1.1142	0.359	0.5549	1	0.605	0.379	0.377	0.49089	0.037
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	158	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-0.30976	-1.1141	0.3077	0.55473	1	0.348	0.264	0.258	0.49107	0.037
CADWELL_ATG16L1_TARGETS_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/CADWELL_ATG16L1_TARGETS_UP	-0.30146	-1.114	0.2639	0.55454	1	0.318	0.222	0.248	0.49079	0.036
REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING	-0.48026	-1.1136	0.4083	0.55458	1	0.35	0.175	0.289	0.49122	0.036
ZHENG_GLIOBLASTOMA_PLASTICITY_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_GLIOBLASTOMA_PLASTICITY_DN	-0.30037	-1.1136	0.277	0.55488	1	0.232	0.131	0.202	0.49155	0.036
TOOKER_GEMCITABINE_RESISTANCE_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/TOOKER_GEMCITABINE_RESISTANCE_UP	-0.31635	-1.1134	0.3115	0.55457	1	0.293	0.221	0.229	0.49123	0.036
REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	61	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES	-0.39879	-1.1131	0.3314	0.55449	1	0.426	0.228	0.33	0.49154	0.036
REACTOME_HIV_LIFE_CYCLE	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HIV_LIFE_CYCLE	-0.34982	-1.1131	0.3671	0.55478	1	0.41	0.263	0.303	0.49186	0.036
PID_NFAT_3PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/PID_NFAT_3PATHWAY	-0.33155	-1.1128	0.3571	0.55481	1	0.5	0.349	0.326	0.49219	0.036
PID_IL12_2PATHWAY	61	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL12_2PATHWAY	-0.30787	-1.1123	0.3307	0.55537	1	0.311	0.257	0.232	0.49403	0.036
SAGIV_CD24_TARGETS_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/SAGIV_CD24_TARGETS_UP	-0.47048	-1.1117	0.4081	0.55617	1	0.364	0.199	0.291	0.49487	0.036
REACTOME_HS_GAG_BIOSYNTHESIS	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_HS_GAG_BIOSYNTHESIS	-0.2861	-1.1116	0.3234	0.55601	1	0.379	0.229	0.293	0.49454	0.036
HALMOS_CEBPA_TARGETS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/HALMOS_CEBPA_TARGETS_UP	-0.35406	-1.1115	0.3333	0.55579	1	0.347	0.202	0.277	0.49426	0.036
REACTOME_ADAPTIVE_IMMUNE_SYSTEM	498	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ADAPTIVE_IMMUNE_SYSTEM	-0.26209	-1.1114	0.3088	0.55563	1	0.317	0.247	0.244	0.49483	0.036
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN	-0.30603	-1.1113	0.2757	0.55539	1	0.298	0.219	0.233	0.4945	0.036
PID_IL12_STAT4_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL12_STAT4_PATHWAY	-0.38175	-1.1111	0.3333	0.55516	1	0.531	0.324	0.359	0.4939	0.036
NIELSEN_SCHWANNOMA_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_SCHWANNOMA_UP	-0.40436	-1.1111	0.3476	0.5554	1	0.294	0.186	0.24	0.49423	0.036
PID_WNT_SIGNALING_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_WNT_SIGNALING_PATHWAY	-0.34869	-1.1098	0.334	0.55742	1	0.393	0.282	0.283	0.49726	0.038
BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP	-0.39989	-1.1095	0.432	0.5576	1	0.5	0.298	0.352	0.49867	0.037
BIOCARTA_CCR3_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CCR3_PATHWAY	-0.37459	-1.1086	0.3471	0.55908	1	0.522	0.324	0.353	0.49902	0.038
MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	187	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_6_7WK_UP	-0.24064	-1.1084	0.2726	0.55898	1	0.38	0.293	0.27	0.49906	0.038
REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2	-0.4241	-1.1071	0.334	0.56135	1	0.125	0.0651	0.117	0.50114	0.038
YOSHIMURA_MAPK8_TARGETS_DN	350	http://www.broadinstitute.org/gsea/msigdb/cards/YOSHIMURA_MAPK8_TARGETS_DN	-0.29456	-1.1069	0.3491	0.56154	1	0.28	0.218	0.222	0.50119	0.038
BIOCARTA_CCR5_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CCR5_PATHWAY	-0.39541	-1.1064	0.3136	0.56215	1	0.588	0.369	0.371	0.50223	0.038
KIM_WT1_TARGETS_12HR_UP	157	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_12HR_UP	-0.25551	-1.106	0.3218	0.56264	1	0.108	0.0696	0.101	0.50291	0.038
REACTOME_MRNA_SPLICING	104	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_SPLICING	-0.35634	-1.1059	0.3508	0.56236	1	0.365	0.244	0.277	0.50258	0.038
MITSIADES_RESPONSE_TO_APLIDIN_UP	413	http://www.broadinstitute.org/gsea/msigdb/cards/MITSIADES_RESPONSE_TO_APLIDIN_UP	-0.24491	-1.1057	0.2821	0.56248	1	0.237	0.197	0.194	0.50225	0.038
SA_CASPASE_CASCADE	19	http://www.broadinstitute.org/gsea/msigdb/cards/SA_CASPASE_CASCADE	-0.38125	-1.1048	0.3625	0.56396	1	0.368	0.191	0.298	0.50319	0.039
MARTENS_BOUND_BY_PML_RARA_FUSION	431	http://www.broadinstitute.org/gsea/msigdb/cards/MARTENS_BOUND_BY_PML_RARA_FUSION	-0.22224	-1.1046	0.3209	0.56369	1	0.276	0.276	0.203	0.5036	0.038
JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/JUBAN_TARGETS_OF_SPI1_AND_FLI1_UP	-0.27419	-1.1046	0.3109	0.56405	1	0.25	0.22	0.196	0.50393	0.038
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	172	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-0.3232	-1.1041	0.357	0.56432	1	0.343	0.247	0.26	0.50327	0.038
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	105	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4	-0.30318	-1.1037	0.3055	0.56467	1	0.352	0.239	0.269	0.50294	0.038
DAUER_STAT3_TARGETS_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/DAUER_STAT3_TARGETS_UP	-0.35128	-1.1036	0.3496	0.56456	1	0.479	0.344	0.315	0.50261	0.038
PID_UPA_UPAR_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_UPA_UPAR_PATHWAY	-0.28093	-1.1035	0.3136	0.56434	1	0.214	0.218	0.168	0.50228	0.038
BURTON_ADIPOGENESIS_6	182	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_6	-0.27799	-1.1034	0.3148	0.56416	1	0.126	0.111	0.113	0.50195	0.038
DAZARD_RESPONSE_TO_UV_NHEK_UP	231	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_NHEK_UP	-0.26406	-1.1031	0.2974	0.56449	1	0.242	0.207	0.194	0.50466	0.038
LIU_SOX4_TARGETS_DN	292	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_SOX4_TARGETS_DN	-0.29736	-1.1021	0.332	0.56618	1	0.325	0.235	0.252	0.50708	0.04
MODY_HIPPOCAMPUS_PRENATAL	41	http://www.broadinstitute.org/gsea/msigdb/cards/MODY_HIPPOCAMPUS_PRENATAL	-0.37275	-1.102	0.3069	0.56601	1	0.171	0.091	0.155	0.50675	0.04
DITTMER_PTHLH_TARGETS_DN	70	http://www.broadinstitute.org/gsea/msigdb/cards/DITTMER_PTHLH_TARGETS_DN	-0.33091	-1.1017	0.3626	0.56587	1	0.3	0.204	0.239	0.50609	0.04
ZHAN_MULTIPLE_MYELOMA_HP_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_HP_UP	-0.35668	-1.1017	0.3522	0.56619	1	0.395	0.239	0.301	0.50642	0.04
BIOCARTA_ATM_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ATM_PATHWAY	-0.38855	-1.1007	0.3384	0.56762	1	0.4	0.196	0.322	0.5073	0.04
MODY_HIPPOCAMPUS_NEONATAL	35	http://www.broadinstitute.org/gsea/msigdb/cards/MODY_HIPPOCAMPUS_NEONATAL	-0.34276	-1.1006	0.3499	0.56743	1	0.514	0.316	0.352	0.50713	0.04
BURTON_ADIPOGENESIS_8	82	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_8	-0.3126	-1.1004	0.3384	0.5674	1	0.317	0.245	0.24	0.50708	0.04
HUANG_DASATINIB_RESISTANCE_UP	77	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_DASATINIB_RESISTANCE_UP	-0.40614	-1.1003	0.3825	0.56742	1	0.377	0.237	0.288	0.50688	0.04
MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	261	http://www.broadinstitute.org/gsea/msigdb/cards/MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN	-0.39398	-1.1001	0.4288	0.56738	1	0.375	0.223	0.295	0.50655	0.04
WEBER_METHYLATED_HCP_IN_SPERM_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_HCP_IN_SPERM_UP	-0.38375	-1.1001	0.375	0.56709	1	0.111	0.035	0.107	0.50622	0.039
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	75	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12	-0.35558	-1.0998	0.3074	0.56724	1	0.453	0.283	0.326	0.5059	0.04
SCHUHMACHER_MYC_TARGETS_UP	77	http://www.broadinstitute.org/gsea/msigdb/cards/SCHUHMACHER_MYC_TARGETS_UP	-0.41461	-1.0995	0.4063	0.5672	1	0.519	0.314	0.357	0.50533	0.039
HUANG_FOXA2_TARGETS_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_FOXA2_TARGETS_DN	-0.36976	-1.0995	0.3573	0.56746	1	0.2	0.0829	0.184	0.50557	0.039
HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	266	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	-0.24654	-1.0991	0.2671	0.56751	1	0.229	0.179	0.19	0.50583	0.039
WANG_TARGETS_OF_MLL_CBP_FUSION_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TARGETS_OF_MLL_CBP_FUSION_DN	-0.35031	-1.0985	0.3205	0.56853	1	0.156	0.102	0.14	0.50942	0.04
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	167	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_2G	-0.2631	-1.098	0.3401	0.56898	1	0.305	0.23	0.237	0.51003	0.04
MARKEY_RB1_CHRONIC_LOF_DN	111	http://www.broadinstitute.org/gsea/msigdb/cards/MARKEY_RB1_CHRONIC_LOF_DN	-0.27993	-1.0973	0.3036	0.57	1	0.297	0.222	0.232	0.51138	0.04
PHONG_TNF_TARGETS_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_TARGETS_UP	-0.39208	-1.097	0.3915	0.57028	1	0.344	0.224	0.268	0.51131	0.04
TIEN_INTESTINE_PROBIOTICS_24HR_DN	207	http://www.broadinstitute.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_24HR_DN	-0.30332	-1.0964	0.3589	0.57127	1	0.415	0.279	0.302	0.51098	0.041
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	-0.30684	-1.0964	0.3543	0.57091	1	0.324	0.233	0.25	0.51065	0.041
REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	93	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LATE_PHASE_OF_HIV_LIFE_CYCLE	-0.36359	-1.0961	0.3825	0.57114	1	0.43	0.263	0.318	0.5104	0.041
REACTOME_SIGNALING_BY_FGFR	107	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR	-0.24663	-1.0954	0.3276	0.57178	1	0.318	0.269	0.233	0.51168	0.041
AIYAR_COBRA1_TARGETS_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/AIYAR_COBRA1_TARGETS_DN	-0.40884	-1.0954	0.3792	0.57211	1	0.464	0.252	0.348	0.512	0.041
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	-0.44363	-1.0953	0.3936	0.57156	1	0.341	0.151	0.291	0.51135	0.041
REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES	-0.27247	-1.0951	0.2967	0.57164	1	0.121	0.149	0.103	0.51102	0.041
BLUM_RESPONSE_TO_SALIRASIB_UP	236	http://www.broadinstitute.org/gsea/msigdb/cards/BLUM_RESPONSE_TO_SALIRASIB_UP	-0.28636	-1.095	0.3484	0.57142	1	0.381	0.277	0.278	0.51069	0.04
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	125	http://www.broadinstitute.org/gsea/msigdb/cards/PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-0.34719	-1.0949	0.3685	0.5713	1	0.312	0.224	0.243	0.51036	0.04
ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	486	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP	-0.21673	-1.0947	0.2589	0.57133	1	0.198	0.178	0.166	0.51089	0.04
SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP	-0.44529	-1.0945	0.3921	0.57135	1	0.412	0.262	0.304	0.51063	0.04
REACTOME_SIGNALING_BY_FGFR_MUTANTS	43	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR_MUTANTS	-0.33093	-1.0944	0.3184	0.57126	1	0.209	0.151	0.178	0.51164	0.04
PENG_RAPAMYCIN_RESPONSE_DN	236	http://www.broadinstitute.org/gsea/msigdb/cards/PENG_RAPAMYCIN_RESPONSE_DN	-0.31769	-1.0942	0.3942	0.57097	1	0.343	0.258	0.257	0.51104	0.039
VILIMAS_NOTCH1_TARGETS_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/VILIMAS_NOTCH1_TARGETS_UP	-0.35925	-1.0942	0.4111	0.57129	1	0.314	0.275	0.228	0.51137	0.039
PIONTEK_PKD1_TARGETS_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/PIONTEK_PKD1_TARGETS_DN	-0.35471	-1.094	0.3506	0.57104	1	0.188	0.101	0.169	0.51108	0.04
HADDAD_B_LYMPHOCYTE_PROGENITOR	271	http://www.broadinstitute.org/gsea/msigdb/cards/HADDAD_B_LYMPHOCYTE_PROGENITOR	-0.26324	-1.0935	0.2745	0.57176	1	0.24	0.189	0.197	0.51224	0.04
REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS	-0.33994	-1.0933	0.3453	0.57167	1	0.24	0.187	0.195	0.51229	0.039
GENTILE_UV_RESPONSE_CLUSTER_D8	39	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D8	-0.39913	-1.0933	0.3668	0.57135	1	0.282	0.147	0.241	0.51197	0.039
HEDENFALK_BREAST_CANCER_BRACX_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/HEDENFALK_BREAST_CANCER_BRACX_UP	-0.37715	-1.093	0.389	0.57152	1	0.35	0.228	0.27	0.51254	0.039
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	63	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	-0.36812	-1.0929	0.3608	0.5713	1	0.302	0.186	0.246	0.51222	0.039
GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP	-0.31606	-1.0924	0.3075	0.57201	1	0.417	0.214	0.328	0.51283	0.039
BIOCARTA_CSK_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CSK_PATHWAY	-0.34197	-1.0921	0.3444	0.57218	1	0.136	0.0931	0.124	0.51265	0.039
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	-0.26012	-1.092	0.3035	0.57223	1	0.253	0.205	0.202	0.51233	0.039
REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_I_TRANSCRIPTION_INITIATION	-0.39711	-1.0918	0.3711	0.57211	1	0.522	0.294	0.369	0.512	0.039
BIOCARTA_PROTEASOME_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PROTEASOME_PATHWAY	-0.48329	-1.091	0.4036	0.57344	1	0.607	0.257	0.451	0.51356	0.039
JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	60	http://www.broadinstitute.org/gsea/msigdb/cards/JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN	-0.29143	-1.0909	0.3131	0.57337	1	0.383	0.275	0.278	0.51323	0.039
VANHARANTA_UTERINE_FIBROID_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_UP	-0.33543	-1.0907	0.3684	0.57327	1	0.227	0.164	0.19	0.51291	0.039
LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TARGETS_OF_TGFB1_AND_WNT3A_UP	-0.26753	-1.0906	0.3093	0.57325	1	0.343	0.25	0.258	0.5137	0.039
HAHTOLA_MYCOSIS_FUNGOIDES_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_UP	-0.3925	-1.0905	0.3058	0.57311	1	0.333	0.188	0.271	0.51406	0.039
SEIDEN_ONCOGENESIS_BY_MET	87	http://www.broadinstitute.org/gsea/msigdb/cards/SEIDEN_ONCOGENESIS_BY_MET	-0.42558	-1.0902	0.4023	0.57322	1	0.368	0.216	0.29	0.51373	0.039
KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	262	http://www.broadinstitute.org/gsea/msigdb/cards/KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES	-0.22051	-1.0899	0.2383	0.57338	1	0.191	0.168	0.16	0.51388	0.039
CHOW_RASSF1_TARGETS_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/CHOW_RASSF1_TARGETS_UP	-0.44544	-1.0898	0.3615	0.57332	1	0.185	0.0623	0.174	0.51358	0.039
REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	78	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	-0.34111	-1.0896	0.4024	0.57333	1	0.269	0.174	0.223	0.51358	0.039
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	-0.24927	-1.0893	0.3192	0.57368	1	0.308	0.219	0.241	0.51516	0.039
LINDSTEDT_DENDRITIC_CELL_MATURATION_A	64	http://www.broadinstitute.org/gsea/msigdb/cards/LINDSTEDT_DENDRITIC_CELL_MATURATION_A	-0.3514	-1.0891	0.3638	0.57366	1	0.438	0.264	0.323	0.51491	0.039
WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP	-0.31687	-1.0889	0.362	0.57326	1	0.342	0.239	0.262	0.51467	0.038
JIANG_HYPOXIA_NORMAL	295	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_HYPOXIA_NORMAL	-0.2723	-1.0889	0.3411	0.5736	1	0.285	0.212	0.227	0.51499	0.039
TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	74	http://www.broadinstitute.org/gsea/msigdb/cards/TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA	-0.33626	-1.0886	0.3679	0.5735	1	0.324	0.203	0.259	0.51498	0.038
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-0.31927	-1.0884	0.3257	0.57357	1	0.269	0.199	0.216	0.51467	0.039
MACLACHLAN_BRCA1_TARGETS_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/MACLACHLAN_BRCA1_TARGETS_DN	-0.38263	-1.0881	0.3549	0.5735	1	0.125	0.0517	0.119	0.51514	0.039
TSENG_IRS1_TARGETS_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/TSENG_IRS1_TARGETS_DN	-0.27315	-1.0881	0.3429	0.57384	1	0.323	0.255	0.242	0.51546	0.039
REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS	-0.35825	-1.0875	0.3806	0.57428	1	0.391	0.248	0.294	0.51554	0.039
REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FGFR_LIGAND_BINDING_AND_ACTIVATION	-0.38315	-1.0872	0.3938	0.57462	1	0.0909	0.0651	0.0851	0.51578	0.039
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	-0.40438	-1.0869	0.373	0.57478	1	0.526	0.283	0.377	0.5166	0.039
OZANNE_AP1_TARGETS_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/OZANNE_AP1_TARGETS_UP	-0.38438	-1.0868	0.3271	0.57465	1	0.267	0.224	0.207	0.51643	0.039
REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	121	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR_IN_DISEASE	-0.25358	-1.0865	0.3175	0.5748	1	0.174	0.154	0.147	0.5169	0.039
REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	197	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION	-0.22998	-1.0865	0.3232	0.57444	1	0.315	0.251	0.238	0.51658	0.038
SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN	-0.30944	-1.0862	0.34	0.57475	1	0.444	0.275	0.323	0.51754	0.038
BIOCARTA_SHH_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_SHH_PATHWAY	-0.4173	-1.0851	0.366	0.57664	1	0.188	0.107	0.168	0.51914	0.039
REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1	-0.4162	-1.0847	0.3794	0.57709	1	0.2	0.0665	0.187	0.52038	0.039
RODRIGUES_THYROID_CARCINOMA_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/RODRIGUES_THYROID_CARCINOMA_DN	-0.39673	-1.0846	0.3418	0.57691	1	0.292	0.167	0.244	0.52005	0.039
REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_DAI	-0.34319	-1.0845	0.3173	0.57688	1	0.167	0.107	0.149	0.52065	0.039
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	-0.29634	-1.0845	0.3378	0.57653	1	0.323	0.232	0.249	0.52033	0.039
PID_BCR_5PATHWAY	64	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BCR_5PATHWAY	-0.28106	-1.0842	0.3408	0.57684	1	0.359	0.301	0.252	0.5201	0.039
BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN	-0.29407	-1.084	0.3541	0.57682	1	0.345	0.204	0.276	0.52001	0.039
PID_PI3KCI_AKT_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PI3KCI_AKT_PATHWAY	-0.37385	-1.0839	0.375	0.57665	1	0.2	0.117	0.177	0.51998	0.039
WHITFIELD_CELL_CYCLE_M_G1	137	http://www.broadinstitute.org/gsea/msigdb/cards/WHITFIELD_CELL_CYCLE_M_G1	-0.33682	-1.0839	0.373	0.5763	1	0.387	0.258	0.289	0.51966	0.039
RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	299	http://www.broadinstitute.org/gsea/msigdb/cards/RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN	-0.2553	-1.0834	0.3018	0.57681	1	0.191	0.164	0.161	0.52015	0.039
BORCZUK_MALIGNANT_MESOTHELIOMA_UP	289	http://www.broadinstitute.org/gsea/msigdb/cards/BORCZUK_MALIGNANT_MESOTHELIOMA_UP	-0.40372	-1.0832	0.4102	0.57697	1	0.464	0.264	0.345	0.52025	0.039
BIOCARTA_CYTOKINE_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CYTOKINE_PATHWAY	-0.39818	-1.0831	0.367	0.57678	1	0.263	0.119	0.232	0.51993	0.039
BOYLAN_MULTIPLE_MYELOMA_D_DN	69	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_D_DN	-0.24472	-1.083	0.3392	0.57661	1	0.203	0.163	0.17	0.51983	0.039
ZHANG_GATA6_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_GATA6_TARGETS_DN	-0.24978	-1.0829	0.3439	0.57642	1	0.129	0.0833	0.119	0.51992	0.039
CROMER_TUMORIGENESIS_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/CROMER_TUMORIGENESIS_UP	-0.40087	-1.0824	0.4012	0.57707	1	0.322	0.164	0.27	0.52042	0.039
GEISS_RESPONSE_TO_DSRNA_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GEISS_RESPONSE_TO_DSRNA_DN	-0.39526	-1.0821	0.3573	0.57741	1	0.4	0.237	0.305	0.52071	0.039
BILD_MYC_ONCOGENIC_SIGNATURE	193	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_MYC_ONCOGENIC_SIGNATURE	-0.24576	-1.0818	0.343	0.57762	1	0.244	0.213	0.193	0.52039	0.039
REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING	-0.34774	-1.0807	0.4175	0.57933	1	0.375	0.254	0.28	0.52192	0.039
RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP	-0.43273	-1.0807	0.3878	0.57903	1	0.4	0.191	0.324	0.5216	0.039
KASLER_HDAC7_TARGETS_2_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/KASLER_HDAC7_TARGETS_2_DN	-0.32755	-1.0806	0.3618	0.57879	1	0.452	0.287	0.323	0.52128	0.039
ZHANG_BREAST_CANCER_PROGENITORS_UP	406	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_BREAST_CANCER_PROGENITORS_UP	-0.42546	-1.0799	0.4188	0.57981	1	0.374	0.185	0.31	0.52405	0.039
GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	39	http://www.broadinstitute.org/gsea/msigdb/cards/GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION	-0.30062	-1.0799	0.3667	0.57953	1	0.41	0.264	0.303	0.52373	0.039
REACTOME_RNA_POL_II_TRANSCRIPTION	95	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_II_TRANSCRIPTION	-0.34684	-1.0798	0.392	0.57935	1	0.347	0.239	0.265	0.5234	0.039
PILON_KLF1_TARGETS_UP	481	http://www.broadinstitute.org/gsea/msigdb/cards/PILON_KLF1_TARGETS_UP	-0.27139	-1.0796	0.3545	0.57943	1	0.262	0.21	0.211	0.52308	0.039
KEGG_PATHWAYS_IN_CANCER	318	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PATHWAYS_IN_CANCER	-0.2253	-1.0794	0.3353	0.57934	1	0.242	0.222	0.191	0.52297	0.039
KIM_WT1_TARGETS_8HR_UP	159	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_WT1_TARGETS_8HR_UP	-0.23589	-1.0793	0.34	0.57921	1	0.39	0.308	0.272	0.52264	0.039
NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	22	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER	-0.35175	-1.0792	0.3405	0.57899	1	0.182	0.096	0.165	0.52232	0.039
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	128	http://www.broadinstitute.org/gsea/msigdb/cards/PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	-0.26453	-1.0792	0.3496	0.57875	1	0.109	0.0763	0.102	0.522	0.039
KEGG_NON_SMALL_CELL_LUNG_CANCER	54	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NON_SMALL_CELL_LUNG_CANCER	-0.30586	-1.0789	0.3574	0.57887	1	0.463	0.329	0.311	0.52227	0.039
REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING	-0.44636	-1.0776	0.4502	0.58126	1	0.273	0.175	0.225	0.52442	0.039
ZHAN_MULTIPLE_MYELOMA_CD2_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD2_UP	-0.30317	-1.0771	0.3778	0.58181	1	0.357	0.252	0.268	0.52591	0.039
ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE	63	http://www.broadinstitute.org/gsea/msigdb/cards/ANASTASSIOU_CANCER_MESENCHYMAL_TRANSITION_SIGNATURE	-0.48827	-1.077	0.4197	0.58164	1	0.381	0.178	0.314	0.52612	0.039
IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN	-0.39754	-1.0769	0.4241	0.58146	1	0.583	0.338	0.387	0.52579	0.039
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	21	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4	-0.41482	-1.0767	0.3969	0.58144	1	0.429	0.214	0.337	0.52583	0.039
CHEN_HOXA5_TARGETS_9HR_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_HOXA5_TARGETS_9HR_DN	-0.28548	-1.0765	0.3558	0.58157	1	0.462	0.312	0.318	0.52589	0.039
KIM_PTEN_TARGETS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_PTEN_TARGETS_UP	-0.44524	-1.0765	0.3669	0.58125	1	0.444	0.176	0.366	0.52557	0.039
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	119	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	-0.32417	-1.0757	0.4049	0.58232	1	0.387	0.27	0.283	0.52652	0.039
SENESE_HDAC3_TARGETS_UP	475	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC3_TARGETS_UP	-0.31549	-1.0756	0.3562	0.58233	1	0.305	0.222	0.242	0.5264	0.039
REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	114	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTEGRATION_OF_ENERGY_METABOLISM	-0.25009	-1.0754	0.3103	0.58186	1	0.298	0.253	0.224	0.52634	0.039
ZHANG_PROLIFERATING_VS_QUIESCENT	50	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_PROLIFERATING_VS_QUIESCENT	-0.25561	-1.0754	0.3562	0.58221	1	0.28	0.21	0.222	0.52666	0.039
PARK_HSC_MARKERS	42	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_MARKERS	-0.37061	-1.0753	0.3869	0.58172	1	0.452	0.244	0.343	0.52602	0.038
KEGG_SMALL_CELL_LUNG_CANCER	82	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SMALL_CELL_LUNG_CANCER	-0.29838	-1.0752	0.379	0.58159	1	0.232	0.17	0.193	0.5257	0.038
REACTOME_MRNA_PROCESSING	149	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_PROCESSING	-0.34881	-1.0747	0.404	0.58233	1	0.389	0.249	0.294	0.52579	0.039
REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY	-0.36063	-1.0746	0.3815	0.58203	1	0.176	0.14	0.152	0.52547	0.039
WU_HBX_TARGETS_1_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_1_DN	-0.38237	-1.074	0.3577	0.58298	1	0.609	0.261	0.45	0.5274	0.039
DELASERNA_MYOD_TARGETS_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/DELASERNA_MYOD_TARGETS_DN	-0.34471	-1.074	0.3755	0.58264	1	0.2	0.121	0.176	0.52708	0.039
WANG_CLIM2_TARGETS_DN	180	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CLIM2_TARGETS_DN	-0.33891	-1.0739	0.4244	0.58216	1	0.344	0.219	0.271	0.52644	0.039
HU_ANGIOGENESIS_DN	37	http://www.broadinstitute.org/gsea/msigdb/cards/HU_ANGIOGENESIS_DN	-0.41587	-1.0739	0.4421	0.58185	1	0.297	0.179	0.245	0.52612	0.038
FERRANDO_LYL1_NEIGHBORS	15	http://www.broadinstitute.org/gsea/msigdb/cards/FERRANDO_LYL1_NEIGHBORS	-0.40059	-1.0739	0.367	0.58246	1	0.267	0.139	0.23	0.52676	0.039
ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	44	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF	-0.31992	-1.0736	0.3552	0.582	1	0.273	0.178	0.224	0.52669	0.039
ST_G_ALPHA_I_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/ST_G_ALPHA_I_PATHWAY	-0.30591	-1.0733	0.3738	0.58215	1	0.229	0.173	0.189	0.52637	0.039
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	53	http://www.broadinstitute.org/gsea/msigdb/cards/MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER	-0.33673	-1.0722	0.3681	0.58415	1	0.245	0.164	0.205	0.52891	0.039
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	49	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	-0.32568	-1.072	0.3878	0.58411	1	0.367	0.242	0.279	0.52878	0.039
REACTOME_INNATE_IMMUNE_SYSTEM	237	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INNATE_IMMUNE_SYSTEM	-0.24594	-1.0715	0.3346	0.58417	1	0.27	0.222	0.212	0.5289	0.039
MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	495	http://www.broadinstitute.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	-0.29148	-1.0715	0.3837	0.58443	1	0.309	0.225	0.244	0.52885	0.039
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	181	http://www.broadinstitute.org/gsea/msigdb/cards/BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS	-0.24493	-1.0715	0.3455	0.58473	1	0.249	0.207	0.199	0.52917	0.039
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP	-0.2564	-1.0713	0.3695	0.58413	1	0.136	0.127	0.119	0.52858	0.039
NAGASHIMA_NRG1_SIGNALING_UP	171	http://www.broadinstitute.org/gsea/msigdb/cards/NAGASHIMA_NRG1_SIGNALING_UP	-0.29573	-1.071	0.3708	0.5845	1	0.275	0.224	0.215	0.52868	0.039
TAKAO_RESPONSE_TO_UVB_RADIATION_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-0.26393	-1.0705	0.3788	0.58517	1	0.232	0.202	0.186	0.52918	0.039
MA_MYELOID_DIFFERENTIATION_UP	39	http://www.broadinstitute.org/gsea/msigdb/cards/MA_MYELOID_DIFFERENTIATION_UP	-0.25757	-1.0703	0.389	0.58523	1	0.256	0.18	0.21	0.52986	0.039
LIU_CDX2_TARGETS_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_CDX2_TARGETS_UP	-0.34694	-1.0699	0.391	0.58567	1	0.111	0.0643	0.104	0.53053	0.039
COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP	-0.32087	-1.0698	0.3938	0.58551	1	0.343	0.233	0.264	0.53021	0.039
TAVAZOIE_METASTASIS	100	http://www.broadinstitute.org/gsea/msigdb/cards/TAVAZOIE_METASTASIS	-0.2494	-1.0691	0.2939	0.5866	1	0.16	0.0861	0.147	0.53091	0.039
PID_ATF2_PATHWAY	57	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATF2_PATHWAY	-0.29725	-1.0685	0.3702	0.58743	1	0.298	0.224	0.232	0.53122	0.039
REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	-0.37608	-1.0683	0.3957	0.58737	1	0.1	0.0132	0.0988	0.5309	0.039
POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN	-0.36354	-1.0681	0.3817	0.58752	1	0.281	0.135	0.243	0.53058	0.039
REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS	-0.3805	-1.0679	0.4101	0.58742	1	0.562	0.325	0.38	0.53037	0.039
XU_GH1_AUTOCRINE_TARGETS_DN	134	http://www.broadinstitute.org/gsea/msigdb/cards/XU_GH1_AUTOCRINE_TARGETS_DN	-0.3008	-1.0675	0.3796	0.58792	1	0.239	0.202	0.192	0.53079	0.039
DASU_IL6_SIGNALING_SCAR_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/DASU_IL6_SIGNALING_SCAR_UP	-0.29709	-1.0667	0.3678	0.58925	1	0.0667	0.0147	0.0658	0.53252	0.039
CADWELL_ATG16L1_TARGETS_DN	64	http://www.broadinstitute.org/gsea/msigdb/cards/CADWELL_ATG16L1_TARGETS_DN	-0.34581	-1.0667	0.3962	0.58892	1	0.219	0.119	0.193	0.5322	0.039
BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	56	http://www.broadinstitute.org/gsea/msigdb/cards/BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN	-0.29221	-1.0666	0.3531	0.58864	1	0.321	0.184	0.263	0.53188	0.039
WEINMANN_ADAPTATION_TO_HYPOXIA_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/WEINMANN_ADAPTATION_TO_HYPOXIA_DN	-0.36777	-1.0661	0.3867	0.58943	1	0.333	0.176	0.275	0.53197	0.039
KYNG_DNA_DAMAGE_DN	193	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_DN	-0.26002	-1.066	0.398	0.58929	1	0.29	0.24	0.222	0.53165	0.039
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP	-0.30443	-1.0658	0.3833	0.58933	1	0.189	0.132	0.165	0.53278	0.039
BIOCARTA_MITOCHONDRIA_PATHWAY	21	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MITOCHONDRIA_PATHWAY	-0.36631	-1.0657	0.3926	0.5891	1	0.381	0.191	0.309	0.53252	0.039
VERRECCHIA_RESPONSE_TO_TGFB1_C2	25	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_RESPONSE_TO_TGFB1_C2	-0.40988	-1.0655	0.4043	0.58921	1	0.4	0.179	0.329	0.5322	0.038
ELVIDGE_HYPOXIA_BY_DMOG_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/ELVIDGE_HYPOXIA_BY_DMOG_DN	-0.25113	-1.0653	0.371	0.58914	1	0.224	0.184	0.183	0.53202	0.038
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-0.32852	-1.0645	0.3958	0.59052	1	0.333	0.226	0.26	0.53376	0.039
KEGG_NITROGEN_METABOLISM	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NITROGEN_METABOLISM	-0.30191	-1.0644	0.3787	0.5903	1	0.087	0.049	0.0828	0.53344	0.039
HU_ANGIOGENESIS_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/HU_ANGIOGENESIS_UP	-0.40722	-1.0642	0.3843	0.59027	1	0.35	0.244	0.265	0.53323	0.039
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	180	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.27959	-1.0641	0.4185	0.59005	1	0.211	0.169	0.177	0.53291	0.038
KONDO_PROSTATE_CANCER_WITH_H3K27ME3	184	http://www.broadinstitute.org/gsea/msigdb/cards/KONDO_PROSTATE_CANCER_WITH_H3K27ME3	-0.30073	-1.0636	0.39	0.59072	1	0.207	0.13	0.181	0.53357	0.039
PLASARI_TGFB1_TARGETS_10HR_DN	239	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_TARGETS_10HR_DN	-0.3575	-1.0632	0.3626	0.59137	1	0.276	0.163	0.233	0.53463	0.038
BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	229	http://www.broadinstitute.org/gsea/msigdb/cards/BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING	-0.26423	-1.0631	0.3595	0.59113	1	0.236	0.192	0.192	0.53431	0.038
GOUYER_TATI_TARGETS_DN	15	http://www.broadinstitute.org/gsea/msigdb/cards/GOUYER_TATI_TARGETS_DN	-0.40687	-1.063	0.375	0.59105	1	0.2	0.129	0.174	0.53461	0.038
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN	-0.3146	-1.0621	0.4167	0.59253	1	0.381	0.308	0.264	0.53605	0.039
REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM	-0.32293	-1.0616	0.3826	0.59312	1	0.0769	0.0308	0.0746	0.53654	0.039
REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI	-0.46802	-1.0614	0.4153	0.59321	1	0.353	0.172	0.293	0.53645	0.039
PID_TCPTP_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TCPTP_PATHWAY	-0.35835	-1.0611	0.404	0.59342	1	0.244	0.155	0.206	0.53774	0.039
VALK_AML_CLUSTER_8	24	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_8	-0.31822	-1.061	0.3716	0.59327	1	0.375	0.264	0.276	0.53743	0.038
BIOCARTA_ECM_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ECM_PATHWAY	-0.34659	-1.0609	0.4099	0.59303	1	0.375	0.213	0.295	0.53711	0.038
PARK_HSC_AND_MULTIPOTENT_PROGENITORS	50	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_AND_MULTIPOTENT_PROGENITORS	-0.27386	-1.0607	0.3903	0.59316	1	0.12	0.0816	0.11	0.53776	0.038
MELLMAN_TUT1_TARGETS_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/MELLMAN_TUT1_TARGETS_DN	-0.28147	-1.0607	0.3851	0.59283	1	0.174	0.112	0.155	0.53744	0.038
PID_BETA_CATENIN_DEG_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/PID_BETA_CATENIN_DEG_PATHWAY	-0.35841	-1.0601	0.4094	0.59363	1	0.278	0.184	0.227	0.53808	0.038
TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	368	http://www.broadinstitute.org/gsea/msigdb/cards/TARTE_PLASMA_CELL_VS_PLASMABLAST_UP	-0.2334	-1.0593	0.3552	0.59494	1	0.174	0.164	0.148	0.53892	0.038
BOYLAN_MULTIPLE_MYELOMA_C_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_UP	-0.30544	-1.0588	0.3843	0.59548	1	0.213	0.154	0.18	0.53989	0.038
NAKAYAMA_FRA2_TARGETS	40	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_FRA2_TARGETS	-0.38094	-1.0587	0.4178	0.5953	1	0.275	0.155	0.233	0.54072	0.038
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	71	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9	-0.29611	-1.0581	0.3403	0.59607	1	0.338	0.198	0.272	0.54124	0.038
WNT_SIGNALING	88	http://www.broadinstitute.org/gsea/msigdb/cards/WNT_SIGNALING	-0.23141	-1.0571	0.3538	0.59776	1	0.386	0.325	0.262	0.54598	0.039
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	163	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-0.27694	-1.0563	0.4	0.59912	1	0.264	0.233	0.204	0.54737	0.039
KOYAMA_SEMA3B_TARGETS_DN	382	http://www.broadinstitute.org/gsea/msigdb/cards/KOYAMA_SEMA3B_TARGETS_DN	-0.28605	-1.0561	0.3945	0.59913	1	0.28	0.198	0.228	0.54797	0.039
LIN_MELANOMA_COPY_NUMBER_UP	68	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_MELANOMA_COPY_NUMBER_UP	-0.28937	-1.0556	0.4372	0.59984	1	0.441	0.313	0.304	0.54985	0.039
KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	42	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION	-0.28061	-1.055	0.3693	0.60063	1	0.119	0.0687	0.111	0.54953	0.039
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	415	http://www.broadinstitute.org/gsea/msigdb/cards/PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN	-0.21758	-1.0549	0.3281	0.60041	1	0.195	0.18	0.163	0.54957	0.039
PID_TELOMERASE_PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TELOMERASE_PATHWAY	-0.31494	-1.0543	0.4032	0.60117	1	0.353	0.225	0.274	0.54998	0.039
KEGG_MELANOGENESIS	101	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MELANOGENESIS	-0.21624	-1.0542	0.3217	0.60118	1	0.297	0.283	0.214	0.54966	0.039
ENGELMANN_CANCER_PROGENITORS_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/ENGELMANN_CANCER_PROGENITORS_DN	-0.30866	-1.0536	0.387	0.60192	1	0.317	0.237	0.243	0.55261	0.039
RODWELL_AGING_KIDNEY_UP	444	http://www.broadinstitute.org/gsea/msigdb/cards/RODWELL_AGING_KIDNEY_UP	-0.26938	-1.0535	0.4116	0.60186	1	0.225	0.191	0.185	0.5532	0.039
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	431	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN	-0.29851	-1.0527	0.4162	0.60299	1	0.309	0.218	0.246	0.5549	0.039
GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	-0.34677	-1.0527	0.3948	0.60238	1	0.269	0.152	0.229	0.55425	0.039
WIERENGA_PML_INTERACTOME	41	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_PML_INTERACTOME	-0.29586	-1.0527	0.372	0.60264	1	0.439	0.283	0.315	0.55458	0.039
PID_ERBB1_INTERNALIZATION_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB1_INTERNALIZATION_PATHWAY	-0.38891	-1.0525	0.4555	0.60241	1	0.268	0.182	0.22	0.55441	0.039
KEGG_MELANOMA	69	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MELANOMA	-0.28779	-1.0523	0.4027	0.60245	1	0.116	0.0685	0.108	0.55454	0.039
WALLACE_JAK2_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/WALLACE_JAK2_TARGETS_UP	-0.31264	-1.0521	0.3874	0.60248	1	0.423	0.221	0.33	0.55422	0.039
CHIBA_RESPONSE_TO_TSA_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/CHIBA_RESPONSE_TO_TSA_DN	-0.45212	-1.0519	0.396	0.60258	1	0.545	0.155	0.461	0.55483	0.039
BIOCARTA_PTEN_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PTEN_PATHWAY	-0.38372	-1.0516	0.4049	0.60289	1	0.5	0.243	0.379	0.55584	0.039
KEGG_PRIMARY_IMMUNODEFICIENCY	35	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PRIMARY_IMMUNODEFICIENCY	-0.35843	-1.0514	0.4451	0.60281	1	0.4	0.295	0.282	0.55552	0.039
REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING	-0.32888	-1.0514	0.4242	0.60262	1	0.447	0.304	0.312	0.55519	0.039
BIOCARTA_EPO_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EPO_PATHWAY	-0.38581	-1.0509	0.4341	0.60305	1	0.667	0.324	0.451	0.5554	0.039
NAKAJIMA_MAST_CELL	45	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAJIMA_MAST_CELL	-0.30245	-1.0509	0.4141	0.60251	1	0.311	0.222	0.243	0.55477	0.038
HAN_SATB1_TARGETS_DN	425	http://www.broadinstitute.org/gsea/msigdb/cards/HAN_SATB1_TARGETS_DN	-0.26978	-1.0509	0.366	0.60277	1	0.294	0.218	0.234	0.55507	0.038
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN	-0.35244	-1.0508	0.402	0.60226	1	0.275	0.203	0.219	0.55445	0.038
MORI_PLASMA_CELL_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_PLASMA_CELL_UP	-0.34667	-1.0505	0.4426	0.60248	1	0.312	0.194	0.252	0.55502	0.038
DELPUECH_FOXO3_TARGETS_UP	67	http://www.broadinstitute.org/gsea/msigdb/cards/DELPUECH_FOXO3_TARGETS_UP	-0.28823	-1.0505	0.3508	0.60227	1	0.134	0.0727	0.125	0.5547	0.038
ONO_AML1_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/ONO_AML1_TARGETS_UP	-0.34588	-1.0503	0.3954	0.60232	1	0.174	0.0909	0.158	0.55438	0.038
KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	113	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION	-0.23211	-1.0501	0.3408	0.60223	1	0.248	0.218	0.195	0.55406	0.038
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	198	http://www.broadinstitute.org/gsea/msigdb/cards/PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP	-0.35313	-1.0496	0.4133	0.60297	1	0.308	0.169	0.258	0.55473	0.039
LEE_CALORIE_RESTRICTION_MUSCLE_DN	50	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_MUSCLE_DN	-0.26841	-1.049	0.3815	0.60383	1	0.18	0.162	0.151	0.55511	0.039
REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	169	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS	-0.24056	-1.0484	0.3378	0.60479	1	0.154	0.122	0.136	0.55677	0.039
REACTOME_SIGNALING_BY_NOTCH1	67	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_NOTCH1	-0.28077	-1.0482	0.4172	0.60473	1	0.269	0.228	0.208	0.5572	0.038
WINTER_HYPOXIA_UP	87	http://www.broadinstitute.org/gsea/msigdb/cards/WINTER_HYPOXIA_UP	-0.27203	-1.0481	0.4042	0.60464	1	0.437	0.34	0.289	0.55721	0.038
LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_CALORIE_RESTRICTION_NEOCORTEX_DN	-0.26199	-1.0478	0.403	0.60473	1	0.376	0.263	0.279	0.55743	0.038
IWANAGA_CARCINOGENESIS_BY_KRAS_DN	118	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_DN	-0.2386	-1.0462	0.396	0.60762	1	0.203	0.154	0.173	0.55992	0.039
ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	446	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP	-0.21053	-1.046	0.3448	0.60781	1	0.191	0.178	0.159	0.56041	0.039
OHGUCHI_LIVER_HNF4A_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/OHGUCHI_LIVER_HNF4A_TARGETS_UP	-0.33889	-1.0456	0.4179	0.60822	1	0.209	0.119	0.185	0.56025	0.039
PID_RETINOIC_ACID_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RETINOIC_ACID_PATHWAY	-0.32272	-1.0451	0.3595	0.60887	1	0.467	0.313	0.321	0.56185	0.039
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	-0.38746	-1.045	0.3942	0.60868	1	0.28	0.129	0.245	0.56188	0.039
REACTOME_REGULATION_OF_IFNA_SIGNALING	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_IFNA_SIGNALING	-0.38972	-1.0446	0.3705	0.60907	1	0.4	0.216	0.314	0.56206	0.039
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	-0.40369	-1.0446	0.4549	0.60877	1	0.467	0.274	0.339	0.56206	0.039
REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	97	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR	-0.24022	-1.0444	0.372	0.6088	1	0.165	0.154	0.14	0.56174	0.039
KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	66	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION	-0.28528	-1.0441	0.398	0.60918	1	0.152	0.11	0.135	0.56173	0.039
KEGG_CARDIAC_MUSCLE_CONTRACTION	72	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CARDIAC_MUSCLE_CONTRACTION	-0.25881	-1.0438	0.3906	0.60927	1	0.139	0.132	0.121	0.56231	0.039
PID_THROMBIN_PAR1_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/PID_THROMBIN_PAR1_PATHWAY	-0.26567	-1.0435	0.3755	0.60951	1	0.302	0.256	0.225	0.56251	0.039
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-0.35386	-1.0434	0.4121	0.60943	1	0.325	0.223	0.253	0.56316	0.039
KEGG_AXON_GUIDANCE	128	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AXON_GUIDANCE	-0.26512	-1.0431	0.3652	0.60956	1	0.258	0.211	0.204	0.56315	0.039
PID_LYSOPHOSPHOLIPID_PATHWAY	65	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LYSOPHOSPHOLIPID_PATHWAY	-0.23607	-1.043	0.405	0.60911	1	0.292	0.248	0.22	0.56292	0.039
REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES	-0.30987	-1.043	0.3989	0.60935	1	0.133	0.0522	0.127	0.56283	0.039
CHEN_LUNG_CANCER_SURVIVAL	26	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LUNG_CANCER_SURVIVAL	-0.27908	-1.0428	0.4131	0.60883	1	0.385	0.256	0.287	0.56242	0.038
ZHANG_BREAST_CANCER_PROGENITORS_DN	139	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_BREAST_CANCER_PROGENITORS_DN	-0.26441	-1.0428	0.4113	0.60913	1	0.237	0.179	0.196	0.56274	0.039
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	21	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	-0.35975	-1.0427	0.4264	0.60867	1	0.381	0.197	0.306	0.56245	0.038
GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	463	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN	-0.2355	-1.0425	0.4449	0.60859	1	0.214	0.193	0.176	0.56249	0.038
RIZKI_TUMOR_INVASIVENESS_3D_UP	199	http://www.broadinstitute.org/gsea/msigdb/cards/RIZKI_TUMOR_INVASIVENESS_3D_UP	-0.2281	-1.0423	0.3755	0.60875	1	0.261	0.223	0.205	0.56252	0.037
CHYLA_CBFA2T3_TARGETS_UP	376	http://www.broadinstitute.org/gsea/msigdb/cards/CHYLA_CBFA2T3_TARGETS_UP	-0.21625	-1.0423	0.3463	0.60845	1	0.178	0.17	0.15	0.5622	0.037
HUANG_GATA2_TARGETS_UP	142	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_GATA2_TARGETS_UP	-0.24369	-1.0421	0.3562	0.60842	1	0.331	0.238	0.253	0.56223	0.037
PID_IL27_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL27_PATHWAY	-0.30696	-1.042	0.4133	0.60833	1	0.208	0.138	0.18	0.56242	0.037
KEGG_PROSTATE_CANCER	88	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROSTATE_CANCER	-0.27661	-1.0415	0.4242	0.60885	1	0.114	0.0687	0.106	0.56338	0.038
KOHOUTEK_CCNT2_TARGETS	56	http://www.broadinstitute.org/gsea/msigdb/cards/KOHOUTEK_CCNT2_TARGETS	-0.24279	-1.0411	0.3919	0.60948	1	0.0714	0.0387	0.0688	0.56391	0.038
KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	53	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	-0.26596	-1.0407	0.351	0.60988	1	0.264	0.224	0.205	0.56443	0.038
HOLLMANN_APOPTOSIS_VIA_CD40_DN	246	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLMANN_APOPTOSIS_VIA_CD40_DN	-0.26533	-1.0402	0.3931	0.61055	1	0.321	0.252	0.243	0.56421	0.038
GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	219	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP	-0.25014	-1.0398	0.3716	0.61105	1	0.187	0.157	0.159	0.56467	0.038
SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	459	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP	-0.22455	-1.0397	0.3764	0.61084	1	0.244	0.2	0.199	0.56434	0.038
FUJII_YBX1_TARGETS_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/FUJII_YBX1_TARGETS_UP	-0.33031	-1.0396	0.4004	0.61072	1	0.25	0.139	0.215	0.56402	0.038
PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	22	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION	-0.35173	-1.0392	0.4565	0.61126	1	0.273	0.212	0.215	0.5649	0.038
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	165	http://www.broadinstitute.org/gsea/msigdb/cards/CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-0.27427	-1.0389	0.3988	0.61132	1	0.206	0.156	0.175	0.56493	0.038
SERVITJA_LIVER_HNF1A_TARGETS_DN	157	http://www.broadinstitute.org/gsea/msigdb/cards/SERVITJA_LIVER_HNF1A_TARGETS_DN	-0.22756	-1.0388	0.3665	0.61127	1	0.14	0.129	0.123	0.56539	0.038
MCDOWELL_ACUTE_LUNG_INJURY_UP	44	http://www.broadinstitute.org/gsea/msigdb/cards/MCDOWELL_ACUTE_LUNG_INJURY_UP	-0.39098	-1.0385	0.4289	0.61144	1	0.295	0.202	0.236	0.56624	0.038
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	137	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-0.25705	-1.0384	0.4214	0.61123	1	0.299	0.217	0.236	0.56627	0.038
MEISSNER_NPC_HCP_WITH_H3K27ME3	78	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_NPC_HCP_WITH_H3K27ME3	-0.31902	-1.0383	0.4514	0.61088	1	0.128	0.0812	0.118	0.56645	0.038
GUILLAUMOND_KLF10_TARGETS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/GUILLAUMOND_KLF10_TARGETS_UP	-0.28122	-1.0383	0.4137	0.61115	1	0.265	0.181	0.218	0.5663	0.038
VERHAAK_AML_WITH_NPM1_MUTATED_UP	168	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.27867	-1.0382	0.4196	0.61056	1	0.185	0.148	0.158	0.56613	0.037
KYNG_DNA_DAMAGE_UP	221	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_UP	-0.25318	-1.0381	0.4083	0.61047	1	0.204	0.161	0.172	0.56581	0.038
KRIEG_HYPOXIA_VIA_KDM3A	52	http://www.broadinstitute.org/gsea/msigdb/cards/KRIEG_HYPOXIA_VIA_KDM3A	-0.31281	-1.0375	0.4316	0.61131	1	0.25	0.172	0.207	0.56666	0.038
KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	67	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY	-0.28831	-1.0372	0.4	0.61149	1	0.0896	0.0394	0.0863	0.56634	0.038
REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE	-0.37868	-1.0371	0.4256	0.61138	1	0.32	0.247	0.241	0.56684	0.038
PID_CASPASE_PATHWAY	50	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CASPASE_PATHWAY	-0.29927	-1.037	0.4095	0.61119	1	0.3	0.197	0.241	0.56652	0.037
PID_HIF2PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HIF2PATHWAY	-0.28942	-1.0369	0.4234	0.61114	1	0.441	0.317	0.302	0.5662	0.037
CAIRO_HEPATOBLASTOMA_UP	204	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_UP	-0.3331	-1.0368	0.4082	0.61098	1	0.25	0.16	0.212	0.56588	0.037
REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING	-0.27016	-1.0362	0.386	0.61176	1	0.333	0.216	0.261	0.56638	0.038
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	-0.28079	-1.0359	0.4376	0.6121	1	0.259	0.215	0.204	0.56687	0.038
ROSS_AML_WITH_MLL_FUSIONS	72	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_WITH_MLL_FUSIONS	-0.25647	-1.0353	0.41	0.61291	1	0.194	0.163	0.163	0.5669	0.038
REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR	-0.4084	-1.0351	0.4349	0.61291	1	0.529	0.301	0.37	0.56705	0.038
MULLIGHAN_MLL_SIGNATURE_1_DN	226	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_MLL_SIGNATURE_1_DN	-0.22394	-1.035	0.3418	0.61281	1	0.181	0.171	0.152	0.56743	0.037
VALK_AML_WITH_11Q23_REARRANGED	20	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_11Q23_REARRANGED	-0.38148	-1.0347	0.4416	0.61305	1	0.3	0.196	0.242	0.56758	0.038
LANDIS_ERBB2_BREAST_TUMORS_65_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_TUMORS_65_UP	-0.43898	-1.0346	0.4719	0.61293	1	0.273	0.117	0.241	0.56726	0.038
KAYO_AGING_MUSCLE_UP	236	http://www.broadinstitute.org/gsea/msigdb/cards/KAYO_AGING_MUSCLE_UP	-0.21444	-1.0344	0.3945	0.61303	1	0.123	0.0955	0.112	0.56728	0.038
LOPES_METHYLATED_IN_COLON_CANCER_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/LOPES_METHYLATED_IN_COLON_CANCER_UP	-0.29532	-1.0341	0.4038	0.61329	1	0.296	0.276	0.215	0.56778	0.036
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	196	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN	-0.2499	-1.034	0.3961	0.61308	1	0.235	0.181	0.194	0.56746	0.036
PID_AVB3_INTEGRIN_PATHWAY	74	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AVB3_INTEGRIN_PATHWAY	-0.28596	-1.0338	0.4202	0.61315	1	0.243	0.191	0.197	0.56761	0.036
REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE	-0.32366	-1.0337	0.4012	0.61297	1	0.323	0.213	0.254	0.56845	0.036
REACTOME_RECYCLING_PATHWAY_OF_L1	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RECYCLING_PATHWAY_OF_L1	-0.3133	-1.0334	0.3984	0.61324	1	0.444	0.31	0.307	0.56854	0.036
CHENG_RESPONSE_TO_NICKEL_ACETATE	43	http://www.broadinstitute.org/gsea/msigdb/cards/CHENG_RESPONSE_TO_NICKEL_ACETATE	-0.30837	-1.0333	0.4199	0.61295	1	0.512	0.341	0.338	0.56829	0.036
NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	69	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON	-0.40839	-1.0326	0.4762	0.6141	1	0.435	0.241	0.331	0.56922	0.036
GUO_HEX_TARGETS_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/GUO_HEX_TARGETS_UP	-0.28758	-1.0322	0.43	0.61462	1	0.38	0.259	0.282	0.56959	0.037
DELACROIX_RARG_BOUND_MEF	352	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RARG_BOUND_MEF	-0.20875	-1.0319	0.4201	0.61479	1	0.165	0.175	0.138	0.56969	0.037
REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	68	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NFKB_AND_MAP_KINASES_ACTIVATION_MEDIATED_BY_TLR4_SIGNALING_REPERTOIRE	-0.27191	-1.0317	0.4198	0.61485	1	0.265	0.23	0.204	0.57094	0.036
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN	-0.44447	-1.0316	0.4343	0.61469	1	0.222	0.0409	0.213	0.57062	0.036
REACTOME_ENOS_ACTIVATION_AND_REGULATION	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ENOS_ACTIVATION_AND_REGULATION	-0.33439	-1.0314	0.3825	0.61477	1	0.263	0.17	0.219	0.57111	0.036
REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	130	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA	-0.34887	-1.0313	0.4671	0.61466	1	0.392	0.249	0.296	0.57079	0.036
WAGNER_APO2_SENSITIVITY	23	http://www.broadinstitute.org/gsea/msigdb/cards/WAGNER_APO2_SENSITIVITY	-0.32275	-1.0312	0.3788	0.61454	1	0.13	0.0669	0.122	0.57047	0.036
XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN	-0.24312	-1.0311	0.3924	0.61436	1	0.238	0.182	0.195	0.57016	0.036
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	-0.32303	-1.031	0.4108	0.61416	1	0.34	0.225	0.264	0.57052	0.036
TSAI_RESPONSE_TO_RADIATION_THERAPY	32	http://www.broadinstitute.org/gsea/msigdb/cards/TSAI_RESPONSE_TO_RADIATION_THERAPY	-0.4011	-1.031	0.4314	0.61392	1	0.312	0.17	0.26	0.57034	0.036
PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	72	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2	-0.29082	-1.0308	0.4313	0.61392	1	0.153	0.105	0.137	0.5707	0.036
KEGG_MISMATCH_REPAIR	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MISMATCH_REPAIR	-0.49515	-1.0306	0.4948	0.61393	1	0.391	0.201	0.313	0.57038	0.036
PID_THROMBIN_PAR4_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/PID_THROMBIN_PAR4_PATHWAY	-0.34908	-1.0303	0.4344	0.61409	1	0.133	0.0525	0.126	0.5708	0.036
RASHI_RESPONSE_TO_IONIZING_RADIATION_5	141	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_5	-0.22119	-1.03	0.3969	0.61444	1	0.248	0.217	0.195	0.57101	0.036
KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	96	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY	-0.29926	-1.0292	0.4	0.61561	1	0.24	0.196	0.193	0.57119	0.036
WILCOX_RESPONSE_TO_PROGESTERONE_DN	61	http://www.broadinstitute.org/gsea/msigdb/cards/WILCOX_RESPONSE_TO_PROGESTERONE_DN	-0.30641	-1.0291	0.3798	0.61517	1	0.361	0.221	0.282	0.5709	0.035
AMUNDSON_RESPONSE_TO_ARSENITE	214	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_RESPONSE_TO_ARSENITE	-0.27272	-1.0291	0.4308	0.61464	1	0.22	0.173	0.183	0.57027	0.034
LEE_RECENT_THYMIC_EMIGRANT	205	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_RECENT_THYMIC_EMIGRANT	-0.36233	-1.0291	0.4451	0.61485	1	0.283	0.161	0.239	0.57059	0.035
KASLER_HDAC7_TARGETS_1_UP	186	http://www.broadinstitute.org/gsea/msigdb/cards/KASLER_HDAC7_TARGETS_1_UP	-0.18554	-1.0291	0.3969	0.61548	1	0.301	0.285	0.217	0.57122	0.036
ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	387	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_INFLAMMATORY_RESPONSE_LPS_UP	-0.22093	-1.0287	0.3938	0.61492	1	0.199	0.178	0.166	0.56996	0.034
REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION	-0.27178	-1.0286	0.4458	0.61487	1	0.314	0.215	0.247	0.56976	0.034
MAHADEVAN_IMATINIB_RESISTANCE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_IMATINIB_RESISTANCE_DN	-0.4007	-1.0286	0.4692	0.61456	1	0.316	0.166	0.264	0.56945	0.034
RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	151	http://www.broadinstitute.org/gsea/msigdb/cards/RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN	-0.21517	-1.0284	0.3901	0.61446	1	0.219	0.226	0.17	0.56913	0.034
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	-0.40691	-1.0273	0.4297	0.6162	1	0.317	0.182	0.26	0.57117	0.035
RASHI_RESPONSE_TO_IONIZING_RADIATION_2	122	http://www.broadinstitute.org/gsea/msigdb/cards/RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.29882	-1.027	0.416	0.61648	1	0.254	0.178	0.21	0.57122	0.035
KIM_ALL_DISORDERS_CALB1_CORR_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_ALL_DISORDERS_CALB1_CORR_DN	-0.34589	-1.0268	0.4626	0.61661	1	0.0909	0.0643	0.0852	0.57218	0.035
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN	-0.28865	-1.026	0.4004	0.61783	1	0.342	0.231	0.263	0.57341	0.035
LINDVALL_IMMORTALIZED_BY_TERT_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/LINDVALL_IMMORTALIZED_BY_TERT_DN	-0.32237	-1.0258	0.4004	0.61789	1	0.354	0.221	0.277	0.57346	0.035
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	224	http://www.broadinstitute.org/gsea/msigdb/cards/OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP	-0.27187	-1.0249	0.4036	0.61951	1	0.263	0.224	0.206	0.57524	0.035
REACTOME_IL_2_SIGNALING	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL_2_SIGNALING	-0.36134	-1.0244	0.4639	0.62002	1	0.342	0.213	0.27	0.57565	0.035
RICKMAN_HEAD_AND_NECK_CANCER_C	106	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_HEAD_AND_NECK_CANCER_C	-0.28492	-1.0243	0.4115	0.61991	1	0.208	0.153	0.177	0.57563	0.035
PID_TAP63_PATHWAY	53	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TAP63_PATHWAY	-0.25113	-1.024	0.4123	0.61994	1	0.283	0.212	0.224	0.5757	0.035
VERNOCHET_ADIPOGENESIS	19	http://www.broadinstitute.org/gsea/msigdb/cards/VERNOCHET_ADIPOGENESIS	-0.33547	-1.024	0.4302	0.62022	1	0.158	0.0422	0.151	0.57601	0.035
REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INHIBITION_OF_VOLTAGE_GATED_CA2_CHANNELS_VIA_GBETA_GAMMA_SUBUNITS	-0.32016	-1.0238	0.4297	0.61998	1	0.25	0.122	0.22	0.57595	0.035
HSIAO_LIVER_SPECIFIC_GENES	238	http://www.broadinstitute.org/gsea/msigdb/cards/HSIAO_LIVER_SPECIFIC_GENES	-0.22218	-1.0234	0.3859	0.62044	1	0.252	0.24	0.193	0.57653	0.035
OHM_METHYLATED_IN_ADULT_CANCERS	27	http://www.broadinstitute.org/gsea/msigdb/cards/OHM_METHYLATED_IN_ADULT_CANCERS	-0.32452	-1.0233	0.418	0.6204	1	0.222	0.229	0.171	0.57658	0.035
SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	36	http://www.broadinstitute.org/gsea/msigdb/cards/SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM	-0.33942	-1.0232	0.4111	0.62027	1	0.333	0.25	0.25	0.57626	0.035
REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	87	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION	-0.29414	-1.0231	0.4716	0.62013	1	0.115	0.0694	0.107	0.57595	0.035
SHEPARD_BMYB_MORPHOLINO_UP	197	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_BMYB_MORPHOLINO_UP	-0.25288	-1.0225	0.4617	0.62074	1	0.132	0.0997	0.12	0.57613	0.035
CAMPS_COLON_CANCER_COPY_NUMBER_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/CAMPS_COLON_CANCER_COPY_NUMBER_DN	-0.29552	-1.0218	0.4432	0.62193	1	0.276	0.154	0.234	0.57867	0.036
BIOCARTA_NGF_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NGF_PATHWAY	-0.39305	-1.0217	0.4733	0.62162	1	0.529	0.324	0.358	0.57835	0.036
REACTOME_REGULATION_OF_INSULIN_SECRETION	87	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_INSULIN_SECRETION	-0.27023	-1.0217	0.4042	0.62129	1	0.322	0.247	0.243	0.57804	0.034
BIOCARTA_NOS1_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NOS1_PATHWAY	-0.37868	-1.0211	0.3977	0.62217	1	0.182	0.0931	0.165	0.57909	0.035
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	45	http://www.broadinstitute.org/gsea/msigdb/cards/SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6	-0.28067	-1.0204	0.4624	0.62327	1	0.267	0.222	0.208	0.5806	0.035
REACTOME_SIGNALING_BY_WNT	62	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_WNT	-0.35203	-1.0182	0.4744	0.62737	1	0.371	0.23	0.286	0.58567	0.037
LEONARD_HYPOXIA	47	http://www.broadinstitute.org/gsea/msigdb/cards/LEONARD_HYPOXIA	-0.29695	-1.0176	0.4121	0.62807	1	0.298	0.232	0.229	0.58685	0.037
FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP	-0.27421	-1.0172	0.5075	0.62854	1	0.147	0.115	0.13	0.58691	0.038
WELCSH_BRCA1_TARGETS_UP	191	http://www.broadinstitute.org/gsea/msigdb/cards/WELCSH_BRCA1_TARGETS_UP	-0.3418	-1.0167	0.4568	0.62915	1	0.335	0.218	0.264	0.5873	0.038
NABA_ECM_REGULATORS	229	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_ECM_REGULATORS	-0.23672	-1.0157	0.4491	0.63072	1	0.236	0.218	0.186	0.58882	0.038
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	77	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	-0.28485	-1.0156	0.4586	0.63056	1	0.117	0.065	0.11	0.5885	0.038
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER	-0.30485	-1.0152	0.4498	0.63102	1	0.409	0.331	0.274	0.58911	0.038
HOSHIDA_LIVER_CANCER_SUBCLASS_S3	259	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SUBCLASS_S3	-0.20027	-1.0152	0.4303	0.63083	1	0.255	0.238	0.196	0.58879	0.038
REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	73	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAF6_MEDIATED_INDUCTION_OF_NFKB_AND_MAP_KINASES_UPON_TLR7_8_OR_9_ACTIVATION	-0.28414	-1.0151	0.4558	0.63069	1	0.288	0.23	0.222	0.58854	0.038
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	-0.33183	-1.0149	0.4659	0.63063	1	0.462	0.254	0.345	0.58823	0.038
PID_IL23_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL23_PATHWAY	-0.34135	-1.0145	0.4577	0.63122	1	0.216	0.216	0.17	0.58973	0.038
TING_SILENCED_BY_DICER	29	http://www.broadinstitute.org/gsea/msigdb/cards/TING_SILENCED_BY_DICER	-0.37595	-1.0141	0.4354	0.6315	1	0.31	0.126	0.271	0.59036	0.038
ST_TUMOR_NECROSIS_FACTOR_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/ST_TUMOR_NECROSIS_FACTOR_PATHWAY	-0.32251	-1.0137	0.4334	0.63173	1	0.31	0.196	0.25	0.59075	0.037
REACTOME_SIGNALING_BY_ERBB2	97	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ERBB2	-0.26547	-1.0137	0.4654	0.63202	1	0.289	0.228	0.224	0.59107	0.038
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	163	http://www.broadinstitute.org/gsea/msigdb/cards/MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-0.37618	-1.0137	0.4675	0.63142	1	0.374	0.221	0.293	0.59051	0.037
SHEPARD_CRUSH_AND_BURN_MUTANT_UP	187	http://www.broadinstitute.org/gsea/msigdb/cards/SHEPARD_CRUSH_AND_BURN_MUTANT_UP	-0.21731	-1.0132	0.4577	0.63198	1	0.348	0.276	0.253	0.59092	0.037
GENTILE_UV_RESPONSE_CLUSTER_D6	34	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D6	-0.38291	-1.0131	0.4522	0.63184	1	0.412	0.212	0.325	0.59099	0.037
KAPOSI_LIVER_CANCER_MET_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/KAPOSI_LIVER_CANCER_MET_UP	-0.41578	-1.013	0.489	0.63178	1	0.529	0.296	0.373	0.59067	0.037
LI_INDUCED_T_TO_NATURAL_KILLER_UP	295	http://www.broadinstitute.org/gsea/msigdb/cards/LI_INDUCED_T_TO_NATURAL_KILLER_UP	-0.23564	-1.0121	0.4387	0.63316	1	0.169	0.165	0.143	0.59197	0.037
STREICHER_LSM1_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/STREICHER_LSM1_TARGETS_UP	-0.30772	-1.0118	0.4322	0.63318	1	0.279	0.158	0.235	0.59133	0.037
BURTON_ADIPOGENESIS_9	92	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_9	-0.31005	-1.0118	0.4712	0.63348	1	0.207	0.146	0.177	0.59165	0.038
GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	29	http://www.broadinstitute.org/gsea/msigdb/cards/GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP	-0.36949	-1.0102	0.4877	0.63606	1	0.345	0.224	0.268	0.59554	0.038
VISALA_AGING_LYMPHOCYTE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/VISALA_AGING_LYMPHOCYTE_DN	-0.3257	-1.009	0.4472	0.63794	1	0.316	0.217	0.247	0.59727	0.038
RIGGI_EWING_SARCOMA_PROGENITOR_UP	406	http://www.broadinstitute.org/gsea/msigdb/cards/RIGGI_EWING_SARCOMA_PROGENITOR_UP	-0.23009	-1.009	0.4487	0.63773	1	0.2	0.181	0.166	0.59695	0.038
MAHADEVAN_RESPONSE_TO_MP470_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MAHADEVAN_RESPONSE_TO_MP470_DN	-0.40718	-1.0089	0.462	0.63724	1	0.474	0.287	0.338	0.59652	0.038
SESTO_RESPONSE_TO_UV_C6	38	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C6	-0.30438	-1.0089	0.4402	0.63744	1	0.132	0.0614	0.124	0.59663	0.038
PID_CD8_TCR_DOWNSTREAM_PATHWAY	61	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CD8_TCR_DOWNSTREAM_PATHWAY	-0.28349	-1.0086	0.4181	0.63737	1	0.295	0.224	0.23	0.59687	0.038
GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	167	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP	-0.24197	-1.0085	0.4458	0.63735	1	0.168	0.136	0.146	0.59664	0.038
VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	166	http://www.broadinstitute.org/gsea/msigdb/cards/VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP	-0.34194	-1.0083	0.4774	0.63703	1	0.295	0.168	0.247	0.59639	0.038
HEIDENBLAD_AMPLICON_8Q24_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_8Q24_DN	-0.2712	-1.0083	0.4612	0.6373	1	0.405	0.341	0.267	0.59671	0.038
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	75	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN	-0.20588	-1.0082	0.4486	0.63694	1	0.267	0.219	0.209	0.59647	0.038
LIU_CMYB_TARGETS_UP	157	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_CMYB_TARGETS_UP	-0.21349	-1.0074	0.4235	0.6379	1	0.248	0.224	0.194	0.59785	0.038
REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	71	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRIF_MEDIATED_TLR3_SIGNALING	-0.25899	-1.0064	0.4588	0.63953	1	0.254	0.23	0.196	0.5986	0.038
REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS	-0.33088	-1.0062	0.499	0.63948	1	0.367	0.254	0.275	0.59867	0.038
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-0.33309	-1.0061	0.447	0.63944	1	0.297	0.194	0.24	0.59859	0.038
SILIGAN_BOUND_BY_EWS_FLT1_FUSION	45	http://www.broadinstitute.org/gsea/msigdb/cards/SILIGAN_BOUND_BY_EWS_FLT1_FUSION	-0.28051	-1.0051	0.4353	0.64103	1	0.0889	0.0279	0.0866	0.60059	0.038
HELLER_SILENCED_BY_METHYLATION_DN	101	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_SILENCED_BY_METHYLATION_DN	-0.25507	-1.0051	0.4514	0.64037	1	0.238	0.179	0.196	0.59994	0.038
OUYANG_PROSTATE_CANCER_PROGRESSION_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/OUYANG_PROSTATE_CANCER_PROGRESSION_UP	-0.36284	-1.0051	0.4743	0.64069	1	0.278	0.181	0.228	0.60026	0.038
KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	42	http://www.broadinstitute.org/gsea/msigdb/cards/KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS	-0.34376	-1.0047	0.4353	0.64073	1	0.119	0.0474	0.114	0.60007	0.038
REACTOME_MEMBRANE_TRAFFICKING	120	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MEMBRANE_TRAFFICKING	-0.25016	-1.0043	0.4862	0.64099	1	0.3	0.254	0.225	0.59979	0.038
AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	116	http://www.broadinstitute.org/gsea/msigdb/cards/AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP	-0.30804	-1.0043	0.4255	0.64115	1	0.241	0.157	0.204	0.60011	0.038
KEGG_SPLICEOSOME	121	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SPLICEOSOME	-0.3191	-1.0041	0.4861	0.64108	1	0.331	0.253	0.248	0.59991	0.038
PID_PI3KCI_PATHWAY	49	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PI3KCI_PATHWAY	-0.27504	-1.0033	0.4333	0.64216	1	0.286	0.233	0.219	0.60112	0.038
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	225	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP	-0.30894	-1.0033	0.4878	0.64185	1	0.218	0.149	0.187	0.6008	0.038
MULLIGHAN_NPM1_SIGNATURE_3_DN	156	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_SIGNATURE_3_DN	-0.2131	-1.0032	0.4621	0.64141	1	0.237	0.219	0.186	0.60016	0.038
DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	25	http://www.broadinstitute.org/gsea/msigdb/cards/DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY	-0.32982	-1.0032	0.4249	0.6416	1	0.16	0.0924	0.145	0.60048	0.038
NELSON_RESPONSE_TO_ANDROGEN_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/NELSON_RESPONSE_TO_ANDROGEN_DN	-0.39461	-1.0028	0.4459	0.64172	1	0.222	0.0536	0.21	0.60107	0.038
WANG_BARRETTS_ESOPHAGUS_UP	49	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_BARRETTS_ESOPHAGUS_UP	-0.27355	-1.0019	0.4532	0.64301	1	0.265	0.218	0.208	0.60237	0.038
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	132	http://www.broadinstitute.org/gsea/msigdb/cards/WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-0.25853	-1.0011	0.492	0.64425	1	0.356	0.257	0.266	0.60445	0.038
AMUNDSON_GAMMA_RADIATION_RESISTANCE	17	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_GAMMA_RADIATION_RESISTANCE	-0.30606	-1.0009	0.4456	0.64444	1	0.176	0.0921	0.16	0.60484	0.038
KEGG_RENIN_ANGIOTENSIN_SYSTEM	17	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RENIN_ANGIOTENSIN_SYSTEM	-0.34968	-1.0007	0.4587	0.64442	1	0.294	0.179	0.241	0.60452	0.038
LUI_THYROID_CANCER_CLUSTER_2	41	http://www.broadinstitute.org/gsea/msigdb/cards/LUI_THYROID_CANCER_CLUSTER_2	-0.27956	-0.99872	0.4161	0.64798	1	0.0976	0.0536	0.0925	0.60933	0.038
REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PLC_BETA	-0.36742	-0.99864	0.4544	0.64779	1	0.263	0.122	0.231	0.60915	0.038
KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	22	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM	-0.26054	-0.99824	0.4837	0.64827	1	0.227	0.183	0.186	0.60903	0.038
DAZARD_UV_RESPONSE_CLUSTER_G3	15	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G3	-0.39875	-0.99791	0.4451	0.64854	1	0.333	0.157	0.281	0.61007	0.038
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	82	http://www.broadinstitute.org/gsea/msigdb/cards/GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-0.30473	-0.99781	0.4489	0.64844	1	0.122	0.0917	0.111	0.60975	0.038
CORRE_MULTIPLE_MYELOMA_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/CORRE_MULTIPLE_MYELOMA_DN	-0.29409	-0.99777	0.4547	0.64816	1	0.255	0.16	0.214	0.60943	0.038
WIERENGA_STAT5A_TARGETS_DN	198	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_DN	-0.21409	-0.99755	0.4937	0.64827	1	0.116	0.115	0.104	0.6091	0.038
NELSON_RESPONSE_TO_ANDROGEN_UP	84	http://www.broadinstitute.org/gsea/msigdb/cards/NELSON_RESPONSE_TO_ANDROGEN_UP	-0.31901	-0.99746	0.4415	0.64811	1	0.357	0.244	0.271	0.60878	0.038
KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	118	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY	-0.23424	-0.99714	0.4314	0.64845	1	0.331	0.291	0.236	0.60949	0.038
LAIHO_COLORECTAL_CANCER_SERRATED_UP	108	http://www.broadinstitute.org/gsea/msigdb/cards/LAIHO_COLORECTAL_CANCER_SERRATED_UP	-0.35667	-0.99707	0.4564	0.64829	1	0.444	0.287	0.318	0.60963	0.038
HELLER_HDAC_TARGETS_DN	275	http://www.broadinstitute.org/gsea/msigdb/cards/HELLER_HDAC_TARGETS_DN	-0.21706	-0.99675	0.43	0.64856	1	0.262	0.222	0.206	0.60933	0.038
KORKOLA_YOLK_SAC_TUMOR	60	http://www.broadinstitute.org/gsea/msigdb/cards/KORKOLA_YOLK_SAC_TUMOR	-0.30963	-0.99591	0.4876	0.64986	1	0.4	0.246	0.302	0.61133	0.038
SASSON_RESPONSE_TO_FORSKOLIN_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_FORSKOLIN_UP	-0.26993	-0.99575	0.4451	0.64984	1	0.326	0.236	0.25	0.61132	0.038
ZHAN_EARLY_DIFFERENTIATION_GENES_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_EARLY_DIFFERENTIATION_GENES_DN	-0.25928	-0.99521	0.4851	0.6506	1	0.341	0.219	0.267	0.61139	0.038
KAYO_CALORIE_RESTRICTION_MUSCLE_UP	89	http://www.broadinstitute.org/gsea/msigdb/cards/KAYO_CALORIE_RESTRICTION_MUSCLE_UP	-0.23204	-0.99518	0.4326	0.6503	1	0.247	0.239	0.189	0.61107	0.038
BIOCARTA_HSP27_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HSP27_PATHWAY	-0.30245	-0.99485	0.4546	0.6506	1	0.2	0.17	0.166	0.61086	0.038
PODAR_RESPONSE_TO_ADAPHOSTIN_UP	143	http://www.broadinstitute.org/gsea/msigdb/cards/PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-0.28325	-0.99473	0.4672	0.65049	1	0.336	0.224	0.262	0.61149	0.038
DORN_ADENOVIRUS_INFECTION_48HR_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_48HR_DN	-0.29723	-0.9947	0.4973	0.6502	1	0.375	0.233	0.288	0.61117	0.038
ONDER_CDH1_TARGETS_3_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_3_DN	-0.31888	-0.99416	0.4291	0.65095	1	0.281	0.157	0.237	0.61353	0.038
DANG_REGULATED_BY_MYC_DN	240	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_REGULATED_BY_MYC_DN	-0.25835	-0.99398	0.4644	0.65095	1	0.296	0.241	0.227	0.6132	0.038
KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	255	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_HEART_ATRIUM_VS_VENTRICLE_DN	-0.26523	-0.99337	0.5298	0.65186	1	0.251	0.199	0.203	0.61525	0.038
REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	400	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSMEMBRANE_TRANSPORT_OF_SMALL_MOLECULES	-0.17348	-0.99335	0.4902	0.65155	1	0.132	0.149	0.114	0.61493	0.038
MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	201	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3	-0.23265	-0.99311	0.483	0.6517	1	0.0846	0.08	0.0784	0.61528	0.038
KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/KUROKAWA_LIVER_CANCER_CHEMOTHERAPY_DN	-0.32518	-0.99289	0.4311	0.6518	1	0.293	0.159	0.246	0.61546	0.038
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	44	http://www.broadinstitute.org/gsea/msigdb/cards/SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	-0.27273	-0.9918	0.4912	0.65362	1	0.136	0.106	0.122	0.61762	0.038
BIOCARTA_41BB_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_41BB_PATHWAY	-0.36579	-0.99168	0.4649	0.65355	1	0.294	0.196	0.237	0.6184	0.038
AMIT_EGF_RESPONSE_240_HELA	60	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_240_HELA	-0.30466	-0.99042	0.4701	0.65568	1	0.483	0.316	0.332	0.61962	0.039
AMIT_SERUM_RESPONSE_240_MCF10A	56	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_240_MCF10A	-0.29585	-0.99019	0.4461	0.65581	1	0.232	0.14	0.2	0.6193	0.039
BIOCARTA_CTLA4_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CTLA4_PATHWAY	-0.39389	-0.98965	0.483	0.6565	1	0.211	0.107	0.188	0.61988	0.039
PID_IL8_CXCR1_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL8_CXCR1_PATHWAY	-0.25291	-0.98923	0.4896	0.657	1	0.407	0.293	0.288	0.62014	0.039
PID_PDGFRB_PATHWAY	127	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PDGFRB_PATHWAY	-0.26429	-0.9888	0.4786	0.65751	1	0.331	0.251	0.249	0.62031	0.039
REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	55	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CELL_JUNCTION_ORGANIZATION	-0.25978	-0.98873	0.5248	0.65734	1	0.145	0.106	0.13	0.61999	0.039
ZHU_CMV_24_HR_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_24_HR_DN	-0.32107	-0.98872	0.4564	0.657	1	0.31	0.215	0.244	0.61967	0.039
JI_RESPONSE_TO_FSH_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/JI_RESPONSE_TO_FSH_UP	-0.29587	-0.98847	0.4742	0.65715	1	0.3	0.221	0.234	0.6225	0.039
SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP	-0.35571	-0.98834	0.4812	0.65671	1	0.294	0.254	0.22	0.62185	0.039
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	140	http://www.broadinstitute.org/gsea/msigdb/cards/WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	-0.22766	-0.98834	0.5108	0.65705	1	0.221	0.203	0.177	0.62217	0.039
NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	133	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON	-0.23792	-0.98799	0.4858	0.65705	1	0.218	0.251	0.164	0.62153	0.039
REACTOME_G_PROTEIN_ACTIVATION	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_PROTEIN_ACTIVATION	-0.31479	-0.98769	0.4652	0.65733	1	0.269	0.166	0.225	0.62194	0.038
PETRETTO_CARDIAC_HYPERTROPHY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PETRETTO_CARDIAC_HYPERTROPHY	-0.41735	-0.98751	0.499	0.65731	1	0.281	0.147	0.24	0.62162	0.038
WIERENGA_STAT5A_TARGETS_GROUP1	127	http://www.broadinstitute.org/gsea/msigdb/cards/WIERENGA_STAT5A_TARGETS_GROUP1	-0.1978	-0.98739	0.4424	0.65719	1	0.205	0.234	0.158	0.62129	0.038
HOWLIN_PUBERTAL_MAMMARY_GLAND	65	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_PUBERTAL_MAMMARY_GLAND	-0.2778	-0.98665	0.4629	0.65829	1	0.108	0.0493	0.103	0.62556	0.038
SENESE_HDAC2_TARGETS_UP	111	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC2_TARGETS_UP	-0.31071	-0.98657	0.5	0.65811	1	0.171	0.0967	0.155	0.62523	0.038
STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP	-0.26843	-0.98656	0.5084	0.65778	1	0.288	0.266	0.212	0.62491	0.038
GROSS_HYPOXIA_VIA_HIF1A_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_HIF1A_UP	-0.2957	-0.98632	0.5178	0.65792	1	0.216	0.16	0.182	0.62546	0.038
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN	-0.32991	-0.98613	0.5182	0.65794	1	0.25	0.216	0.196	0.62541	0.038
PID_FOXO_PATHWAY	49	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FOXO_PATHWAY	-0.34292	-0.98598	0.4846	0.65784	1	0.531	0.313	0.365	0.62509	0.038
LASTOWSKA_COAMPLIFIED_WITH_MYCN	42	http://www.broadinstitute.org/gsea/msigdb/cards/LASTOWSKA_COAMPLIFIED_WITH_MYCN	-0.2991	-0.98585	0.46	0.65778	1	0.167	0.122	0.147	0.62476	0.038
MATZUK_SPERMATOGONIA	23	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATOGONIA	-0.31345	-0.98549	0.4883	0.65817	1	0.13	0.0474	0.124	0.62553	0.038
AKL_HTLV1_INFECTION_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/AKL_HTLV1_INFECTION_UP	-0.33579	-0.98476	0.4378	0.65925	1	0.52	0.276	0.377	0.62626	0.038
SCIBETTA_KDM5B_TARGETS_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/SCIBETTA_KDM5B_TARGETS_UP	-0.36183	-0.98459	0.4646	0.65923	1	0.176	0.0554	0.167	0.62594	0.038
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	471	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	-0.36658	-0.98409	0.493	0.6598	1	0.308	0.195	0.252	0.62562	0.038
KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	51	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	-0.22763	-0.9838	0.4618	0.65999	1	0.118	0.0972	0.106	0.62584	0.038
KEGG_N_GLYCAN_BIOSYNTHESIS	45	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_N_GLYCAN_BIOSYNTHESIS	-0.33002	-0.98374	0.5059	0.65978	1	0.4	0.266	0.294	0.62551	0.038
PID_CDC42_REG_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CDC42_REG_PATHWAY	-0.26031	-0.98317	0.4462	0.66052	1	0.2	0.168	0.167	0.62572	0.038
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	112	http://www.broadinstitute.org/gsea/msigdb/cards/KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP	-0.26225	-0.9827	0.4805	0.6611	1	0.277	0.191	0.225	0.62547	0.038
BIOCARTA_IL7_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL7_PATHWAY	-0.35026	-0.98261	0.49	0.66092	1	0.312	0.215	0.245	0.62515	0.037
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	46	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	-0.28068	-0.98229	0.4923	0.66116	1	0.261	0.166	0.218	0.62588	0.037
BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN	-0.39208	-0.98192	0.4933	0.66157	1	0.379	0.165	0.317	0.62665	0.038
DORN_ADENOVIRUS_INFECTION_32HR_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/DORN_ADENOVIRUS_INFECTION_32HR_DN	-0.28314	-0.98154	0.5277	0.66196	1	0.359	0.233	0.276	0.62682	0.038
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	124	http://www.broadinstitute.org/gsea/msigdb/cards/ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.30355	-0.98153	0.4939	0.66164	1	0.298	0.216	0.235	0.6265	0.037
KEGG_OTHER_GLYCAN_DEGRADATION	16	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_OTHER_GLYCAN_DEGRADATION	-0.30376	-0.98128	0.4803	0.66181	1	0.188	0.13	0.163	0.62672	0.037
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN	-0.30154	-0.98121	0.495	0.66162	1	0.271	0.183	0.222	0.62752	0.037
VERHAAK_GLIOBLASTOMA_NEURAL	125	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_NEURAL	-0.25386	-0.98052	0.5077	0.66253	1	0.216	0.176	0.179	0.62828	0.037
LIU_BREAST_CANCER	28	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_BREAST_CANCER	-0.25543	-0.98027	0.45	0.66265	1	0.107	0.0901	0.0976	0.62796	0.037
ENGELMANN_CANCER_PROGENITORS_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/ENGELMANN_CANCER_PROGENITORS_UP	-0.30719	-0.98015	0.501	0.66256	1	0.267	0.194	0.215	0.62764	0.037
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	155	http://www.broadinstitute.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN	-0.23242	-0.97997	0.4564	0.66257	1	0.181	0.167	0.151	0.62732	0.037
KEGG_PROTEIN_EXPORT	23	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PROTEIN_EXPORT	-0.42706	-0.97974	0.5163	0.66272	1	0.478	0.199	0.383	0.62807	0.037
WATANABE_COLON_CANCER_MSI_VS_MSS_DN	79	http://www.broadinstitute.org/gsea/msigdb/cards/WATANABE_COLON_CANCER_MSI_VS_MSS_DN	-0.2613	-0.97962	0.4895	0.66263	1	0.215	0.152	0.183	0.62775	0.037
REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	63	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES	-0.32759	-0.97934	0.4773	0.66276	1	0.159	0.0641	0.149	0.62841	0.037
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	19	http://www.broadinstitute.org/gsea/msigdb/cards/MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17	-0.38146	-0.97927	0.5341	0.66255	1	0.474	0.249	0.356	0.62809	0.037
PID_REG_GR_PATHWAY	80	http://www.broadinstitute.org/gsea/msigdb/cards/PID_REG_GR_PATHWAY	-0.22789	-0.97918	0.4519	0.66236	1	0.238	0.215	0.187	0.62777	0.036
GAVIN_FOXP3_TARGETS_CLUSTER_P3	151	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_P3	-0.21795	-0.97907	0.4854	0.66225	1	0.179	0.169	0.149	0.62745	0.035
REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	395	http://www.broadinstitute.org/gsea/msigdb/cards/REN_ALVEOLAR_RHABDOMYOSARCOMA_DN	-0.25089	-0.9789	0.497	0.66221	1	0.332	0.264	0.248	0.62713	0.035
CHO_NR4A1_TARGETS	31	http://www.broadinstitute.org/gsea/msigdb/cards/CHO_NR4A1_TARGETS	-0.27077	-0.97883	0.4833	0.66199	1	0.258	0.219	0.202	0.6269	0.034
REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MAP_KINASE_ACTIVATION_IN_TLR_CASCADE	-0.27569	-0.97846	0.5145	0.66231	1	0.229	0.181	0.188	0.62873	0.035
REACTOME_GABA_RECEPTOR_ACTIVATION	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GABA_RECEPTOR_ACTIVATION	-0.25165	-0.97785	0.4665	0.66313	1	0.176	0.122	0.155	0.62883	0.035
SIMBULAN_UV_RESPONSE_NORMAL_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/SIMBULAN_UV_RESPONSE_NORMAL_DN	-0.28499	-0.97766	0.4821	0.66319	1	0.182	0.191	0.147	0.63024	0.035
ZHU_CMV_ALL_DN	123	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_ALL_DN	-0.30268	-0.97752	0.5143	0.66312	1	0.333	0.216	0.263	0.63001	0.035
KEGG_VIBRIO_CHOLERAE_INFECTION	54	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VIBRIO_CHOLERAE_INFECTION	-0.27558	-0.9767	0.5	0.66443	1	0.37	0.286	0.265	0.63292	0.035
GENTILE_UV_RESPONSE_CLUSTER_D1	17	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_RESPONSE_CLUSTER_D1	-0.43004	-0.97664	0.5288	0.66422	1	0.294	0.132	0.255	0.63259	0.035
ALONSO_METASTASIS_UP	188	http://www.broadinstitute.org/gsea/msigdb/cards/ALONSO_METASTASIS_UP	-0.28171	-0.9762	0.4578	0.66477	1	0.33	0.241	0.252	0.63409	0.035
WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN	-0.33711	-0.97617	0.4544	0.66449	1	0.208	0.112	0.185	0.63399	0.035
KLEIN_TARGETS_OF_BCR_ABL1_FUSION	44	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_TARGETS_OF_BCR_ABL1_FUSION	-0.27698	-0.97603	0.5233	0.66439	1	0.25	0.222	0.195	0.63367	0.034
VERHAAK_AML_WITH_NPM1_MUTATED_DN	238	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_AML_WITH_NPM1_MUTATED_DN	-0.23188	-0.97581	0.4712	0.66449	1	0.105	0.0787	0.0977	0.63344	0.034
MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	259	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP	-0.27146	-0.97576	0.518	0.66423	1	0.286	0.213	0.227	0.63312	0.034
DOUGLAS_BMI1_TARGETS_DN	305	http://www.broadinstitute.org/gsea/msigdb/cards/DOUGLAS_BMI1_TARGETS_DN	-0.2899	-0.97568	0.5089	0.66409	1	0.298	0.21	0.239	0.6328	0.034
KEGG_GLYCOLYSIS_GLUCONEOGENESIS	61	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOLYSIS_GLUCONEOGENESIS	-0.24333	-0.97541	0.4842	0.66428	1	0.279	0.258	0.207	0.63247	0.034
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN	-0.2972	-0.97539	0.5108	0.66397	1	0.298	0.214	0.235	0.63215	0.033
PID_IFNG_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IFNG_PATHWAY	-0.2905	-0.97492	0.5049	0.66456	1	0.351	0.252	0.263	0.63336	0.034
LIU_IL13_MEMORY_MODEL_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_IL13_MEMORY_MODEL_UP	-0.33595	-0.97446	0.5072	0.66516	1	0.0667	0.0165	0.0656	0.63394	0.033
PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	218	http://www.broadinstitute.org/gsea/msigdb/cards/PHONG_TNF_RESPONSE_VIA_P38_COMPLETE	-0.28975	-0.97444	0.5312	0.66487	1	0.335	0.216	0.265	0.63362	0.033
KEGG_SELENOAMINO_ACID_METABOLISM	26	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SELENOAMINO_ACID_METABOLISM	-0.25416	-0.97415	0.454	0.66507	1	0.423	0.318	0.289	0.63389	0.033
NABA_CORE_MATRISOME	272	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_CORE_MATRISOME	-0.25897	-0.9741	0.4859	0.66481	1	0.121	0.0955	0.111	0.63357	0.032
REACTOME_SIGNALLING_BY_NGF	212	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALLING_BY_NGF	-0.20352	-0.97399	0.5497	0.66467	1	0.363	0.305	0.254	0.63325	0.032
GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN	-0.3494	-0.9739	0.4962	0.66452	1	0.2	0.101	0.18	0.63293	0.032
NAKAMURA_METASTASIS	44	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_METASTASIS	-0.26518	-0.97376	0.4931	0.66445	1	0.0682	0.0173	0.0671	0.63265	0.032
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP	-0.28882	-0.97358	0.4921	0.66447	1	0.188	0.0797	0.173	0.63233	0.032
MCCABE_BOUND_BY_HOXC6	410	http://www.broadinstitute.org/gsea/msigdb/cards/MCCABE_BOUND_BY_HOXC6	-0.1916	-0.97293	0.5652	0.66539	1	0.132	0.128	0.117	0.63329	0.032
MULLIGHAN_NPM1_SIGNATURE_3_UP	319	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_SIGNATURE_3_UP	-0.25963	-0.97188	0.5311	0.66705	1	0.326	0.255	0.246	0.63546	0.033
STEGER_ADIPOGENESIS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/STEGER_ADIPOGENESIS_DN	-0.37815	-0.9715	0.4972	0.66747	1	0.391	0.28	0.282	0.63598	0.032
VALK_AML_CLUSTER_1	26	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_1	-0.32927	-0.97149	0.501	0.66715	1	0.231	0.124	0.202	0.63566	0.032
HOOI_ST7_TARGETS_UP	86	http://www.broadinstitute.org/gsea/msigdb/cards/HOOI_ST7_TARGETS_UP	-0.28455	-0.97107	0.5173	0.66761	1	0.209	0.146	0.179	0.6365	0.033
REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	59	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX	-0.27901	-0.97081	0.505	0.66778	1	0.356	0.261	0.264	0.63618	0.033
KEGG_ALZHEIMERS_DISEASE	156	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ALZHEIMERS_DISEASE	-0.22888	-0.97075	0.5288	0.66755	1	0.353	0.298	0.249	0.63648	0.033
WU_HBX_TARGETS_2_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_2_UP	-0.3513	-0.97042	0.5053	0.66785	1	0.435	0.232	0.334	0.6365	0.032
BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN	-0.27634	-0.97024	0.5032	0.6679	1	0.296	0.236	0.227	0.63829	0.032
COWLING_MYCN_TARGETS	43	http://www.broadinstitute.org/gsea/msigdb/cards/COWLING_MYCN_TARGETS	-0.29575	-0.96993	0.51	0.66818	1	0.233	0.157	0.196	0.63841	0.032
SWEET_LUNG_CANCER_KRAS_DN	423	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_LUNG_CANCER_KRAS_DN	-0.24694	-0.96989	0.4934	0.66794	1	0.229	0.196	0.187	0.63809	0.032
KEGG_APOPTOSIS	85	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_APOPTOSIS	-0.24463	-0.9697	0.5377	0.66794	1	0.2	0.196	0.161	0.638	0.032
HUMMERICH_SKIN_CANCER_PROGRESSION_DN	99	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_SKIN_CANCER_PROGRESSION_DN	-0.22764	-0.96956	0.5251	0.66787	1	0.354	0.297	0.249	0.63777	0.032
GARY_CD5_TARGETS_DN	415	http://www.broadinstitute.org/gsea/msigdb/cards/GARY_CD5_TARGETS_DN	-0.3352	-0.96939	0.5354	0.66787	1	0.306	0.204	0.248	0.63745	0.032
BERNARD_PPAPDC1B_TARGETS_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/BERNARD_PPAPDC1B_TARGETS_DN	-0.30133	-0.96921	0.5305	0.66791	1	0.273	0.151	0.232	0.63872	0.032
CARD_MIR302A_TARGETS	77	http://www.broadinstitute.org/gsea/msigdb/cards/CARD_MIR302A_TARGETS	-0.28921	-0.96914	0.501	0.66772	1	0.351	0.226	0.272	0.6384	0.032
REACTOME_SIGNALING_BY_ERBB4	87	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_ERBB4	-0.2721	-0.96861	0.5362	0.66839	1	0.333	0.228	0.258	0.63914	0.032
PID_EPHB_FWD_PATHWAY	40	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPHB_FWD_PATHWAY	-0.32004	-0.96833	0.4785	0.66858	1	0.375	0.213	0.296	0.63935	0.032
WU_HBX_TARGETS_1_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/WU_HBX_TARGETS_1_UP	-0.34441	-0.96827	0.499	0.66835	1	0.333	0.232	0.256	0.6391	0.032
REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INWARDLY_RECTIFYING_K_CHANNELS	-0.27411	-0.96793	0.542	0.66863	1	0.2	0.122	0.176	0.63925	0.032
CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	17	http://www.broadinstitute.org/gsea/msigdb/cards/CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB	-0.30448	-0.9677	0.5658	0.66876	1	0.235	0.137	0.203	0.64016	0.032
NAKAMURA_METASTASIS_MODEL_DN	42	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_METASTASIS_MODEL_DN	-0.26372	-0.96767	0.504	0.6685	1	0.262	0.242	0.199	0.63984	0.032
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	46	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8	-0.28636	-0.96758	0.5058	0.66834	1	0.283	0.2	0.227	0.63952	0.032
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	265	http://www.broadinstitute.org/gsea/msigdb/cards/PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP	-0.24089	-0.96738	0.5019	0.6684	1	0.325	0.258	0.243	0.63921	0.032
WANG_LSD1_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LSD1_TARGETS_UP	-0.32328	-0.96725	0.4572	0.66835	1	0.261	0.129	0.227	0.63889	0.032
MUNSHI_MULTIPLE_MYELOMA_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/MUNSHI_MULTIPLE_MYELOMA_UP	-0.22982	-0.96696	0.5258	0.66857	1	0.375	0.294	0.265	0.63964	0.032
HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP	-0.34304	-0.96683	0.5	0.6685	1	0.333	0.197	0.268	0.63932	0.032
RATTENBACHER_BOUND_BY_CELF1	409	http://www.broadinstitute.org/gsea/msigdb/cards/RATTENBACHER_BOUND_BY_CELF1	-0.19459	-0.96649	0.5569	0.66881	1	0.144	0.128	0.128	0.64023	0.032
MCCLUNG_DELTA_FOSB_TARGETS_8WK	46	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_DELTA_FOSB_TARGETS_8WK	-0.25329	-0.96635	0.5227	0.66877	1	0.391	0.251	0.294	0.64052	0.032
PID_ENDOTHELIN_PATHWAY	63	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ENDOTHELIN_PATHWAY	-0.25584	-0.96526	0.5248	0.67051	1	0.413	0.324	0.28	0.64219	0.032
MORI_MATURE_B_LYMPHOCYTE_UP	88	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_MATURE_B_LYMPHOCYTE_UP	-0.26129	-0.96495	0.5134	0.67085	1	0.33	0.23	0.255	0.64194	0.032
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	-0.27208	-0.96436	0.5202	0.6716	1	0.333	0.264	0.246	0.64291	0.032
BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	88	http://www.broadinstitute.org/gsea/msigdb/cards/BONCI_TARGETS_OF_MIR15A_AND_MIR16_1	-0.28939	-0.96335	0.5115	0.67317	1	0.364	0.216	0.286	0.645	0.032
GROSS_HYPOXIA_VIA_ELK3_DN	152	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_DN	-0.2922	-0.96288	0.4714	0.67366	1	0.25	0.207	0.199	0.64604	0.032
BROWNE_HCMV_INFECTION_48HR_DN	484	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_48HR_DN	-0.18927	-0.96182	0.5534	0.67536	1	0.188	0.187	0.156	0.64808	0.032
PID_RHOA_REG_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHOA_REG_PATHWAY	-0.22686	-0.96073	0.5375	0.67722	1	0.356	0.291	0.252	0.65072	0.033
NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_GIST_VS_SYNOVIAL_SARCOMA_UP	-0.39118	-0.96051	0.5396	0.67729	1	0.611	0.369	0.386	0.65132	0.032
BIOCARTA_CDMAC_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CDMAC_PATHWAY	-0.3731	-0.96008	0.509	0.67778	1	0.533	0.324	0.361	0.65147	0.033
DAZARD_UV_RESPONSE_CLUSTER_G6	146	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G6	-0.35989	-0.95985	0.538	0.67795	1	0.37	0.221	0.29	0.65229	0.033
PID_SHP2_PATHWAY	57	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SHP2_PATHWAY	-0.26826	-0.95946	0.5528	0.67841	1	0.351	0.234	0.269	0.65309	0.033
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	184	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	-0.18693	-0.95941	0.5121	0.67817	1	0.353	0.303	0.248	0.65276	0.032
KANG_DOXORUBICIN_RESISTANCE_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/KANG_DOXORUBICIN_RESISTANCE_DN	-0.42217	-0.95904	0.5658	0.67855	1	0.5	0.222	0.389	0.65278	0.032
PETROVA_PROX1_TARGETS_DN	63	http://www.broadinstitute.org/gsea/msigdb/cards/PETROVA_PROX1_TARGETS_DN	-0.28806	-0.95746	0.5341	0.68122	1	0.365	0.291	0.259	0.65496	0.035
VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	210	http://www.broadinstitute.org/gsea/msigdb/cards/VANOEVELEN_MYOGENESIS_SIN3A_TARGETS	-0.25678	-0.95734	0.5549	0.68112	1	0.324	0.257	0.243	0.65525	0.035
DORSAM_HOXA9_TARGETS_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/DORSAM_HOXA9_TARGETS_DN	-0.2667	-0.95721	0.5292	0.681	1	0.367	0.245	0.277	0.6552	0.034
GRADE_COLON_VS_RECTAL_CANCER_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_VS_RECTAL_CANCER_UP	-0.29258	-0.95706	0.5258	0.68092	1	0.355	0.238	0.271	0.65487	0.034
REACTOME_RNA_POL_III_CHAIN_ELONGATION	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_CHAIN_ELONGATION	-0.29987	-0.95665	0.491	0.68143	1	0.0625	0.0136	0.0617	0.65582	0.034
MARSON_FOXP3_TARGETS_STIMULATED_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_TARGETS_STIMULATED_UP	-0.30853	-0.95658	0.493	0.68125	1	0.321	0.209	0.255	0.65594	0.034
MA_PITUITARY_FETAL_VS_ADULT_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/MA_PITUITARY_FETAL_VS_ADULT_DN	-0.35528	-0.95651	0.5407	0.68103	1	0.389	0.244	0.294	0.65573	0.034
BIOCARTA_BIOPEPTIDES_PATHWAY	43	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_BIOPEPTIDES_PATHWAY	-0.243	-0.95607	0.5697	0.68154	1	0.419	0.332	0.28	0.6556	0.034
DAZARD_RESPONSE_TO_UV_NHEK_DN	305	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_NHEK_DN	-0.33425	-0.95606	0.5444	0.68122	1	0.328	0.221	0.259	0.65528	0.033
SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP	-0.31887	-0.95541	0.5355	0.68217	1	0.19	0.062	0.179	0.65562	0.034
IKEDA_MIR30_TARGETS_DN	27	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR30_TARGETS_DN	-0.34775	-0.95454	0.5618	0.68357	1	0.296	0.165	0.248	0.65732	0.034
REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	105	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_INSULIN_RECEPTOR	-0.2086	-0.95447	0.5822	0.68339	1	0.162	0.151	0.138	0.65699	0.034
STEIN_ESRRA_TARGETS_UP	364	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_UP	-0.24556	-0.95423	0.577	0.68351	1	0.242	0.202	0.196	0.65667	0.034
REACTOME_GABA_B_RECEPTOR_ACTIVATION	37	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GABA_B_RECEPTOR_ACTIVATION	-0.26284	-0.95341	0.5097	0.68473	1	0.189	0.122	0.166	0.65879	0.035
COLDREN_GEFITINIB_RESISTANCE_UP	80	http://www.broadinstitute.org/gsea/msigdb/cards/COLDREN_GEFITINIB_RESISTANCE_UP	-0.27971	-0.95338	0.534	0.68444	1	0.288	0.181	0.236	0.65867	0.034
PID_HEDGEHOG_2PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HEDGEHOG_2PATHWAY	-0.30263	-0.95329	0.5234	0.68428	1	0.0909	0.0121	0.0899	0.65881	0.033
PID_ALPHA_SYNUCLEIN_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ALPHA_SYNUCLEIN_PATHWAY	-0.25209	-0.95319	0.5094	0.68414	1	0.344	0.264	0.253	0.65848	0.033
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN	-0.36755	-0.95312	0.5056	0.68395	1	0.217	0.0962	0.197	0.65816	0.033
KEGG_ECM_RECEPTOR_INTERACTION	83	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ECM_RECEPTOR_INTERACTION	-0.27801	-0.95293	0.497	0.68396	1	0.205	0.178	0.169	0.65887	0.032
HILLION_HMGA1_TARGETS	86	http://www.broadinstitute.org/gsea/msigdb/cards/HILLION_HMGA1_TARGETS	-0.21852	-0.95251	0.5198	0.68442	1	0.291	0.263	0.215	0.65894	0.032
LIN_APC_TARGETS	73	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_APC_TARGETS	-0.26212	-0.95241	0.51	0.68431	1	0.205	0.179	0.169	0.65862	0.032
BOYLAN_MULTIPLE_MYELOMA_D_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_D_UP	-0.28017	-0.95216	0.5508	0.68446	1	0.232	0.134	0.201	0.65959	0.032
MCGOWAN_RSP6_TARGETS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/MCGOWAN_RSP6_TARGETS_UP	-0.27236	-0.95195	0.5248	0.68448	1	0.333	0.192	0.269	0.65927	0.032
RUAN_RESPONSE_TO_TROGLITAZONE_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/RUAN_RESPONSE_TO_TROGLITAZONE_UP	-0.27816	-0.95149	0.5081	0.68502	1	0.32	0.303	0.223	0.65927	0.032
REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA	-0.38033	-0.95136	0.5613	0.68493	1	0.391	0.237	0.299	0.65895	0.032
LU_EZH2_TARGETS_DN	365	http://www.broadinstitute.org/gsea/msigdb/cards/LU_EZH2_TARGETS_DN	-0.27966	-0.95134	0.5553	0.68465	1	0.244	0.191	0.2	0.65874	0.032
SASSON_RESPONSE_TO_FORSKOLIN_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_FORSKOLIN_DN	-0.25415	-0.95072	0.5864	0.6855	1	0.386	0.255	0.289	0.66111	0.032
KATSANOU_ELAVL1_TARGETS_UP	163	http://www.broadinstitute.org/gsea/msigdb/cards/KATSANOU_ELAVL1_TARGETS_UP	-0.21878	-0.95035	0.5254	0.6859	1	0.282	0.239	0.216	0.66115	0.032
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	159	http://www.broadinstitute.org/gsea/msigdb/cards/VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	-0.23643	-0.95004	0.5066	0.68615	1	0.157	0.152	0.134	0.66143	0.032
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN	-0.28742	-0.94981	0.5521	0.68629	1	0.329	0.219	0.258	0.66127	0.032
OUILLETTE_CLL_13Q14_DELETION_UP	70	http://www.broadinstitute.org/gsea/msigdb/cards/OUILLETTE_CLL_13Q14_DELETION_UP	-0.35207	-0.94942	0.5469	0.68669	1	0.286	0.162	0.24	0.66207	0.032
RAGHAVACHARI_PLATELET_SPECIFIC_GENES	68	http://www.broadinstitute.org/gsea/msigdb/cards/RAGHAVACHARI_PLATELET_SPECIFIC_GENES	-0.27695	-0.94934	0.5432	0.6865	1	0.265	0.205	0.211	0.66175	0.032
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	212	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP	-0.27325	-0.94863	0.5313	0.68755	1	0.236	0.176	0.196	0.66348	0.032
BIOCARTA_ACTINY_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ACTINY_PATHWAY	-0.35339	-0.94819	0.5183	0.68804	1	0.65	0.311	0.448	0.66462	0.032
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	138	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	-0.28746	-0.94773	0.5079	0.68853	1	0.283	0.208	0.225	0.66559	0.032
REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING	-0.24559	-0.94772	0.5502	0.68822	1	0.0571	0.0651	0.0535	0.66541	0.032
CHOW_RASSF1_TARGETS_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/CHOW_RASSF1_TARGETS_DN	-0.30802	-0.94761	0.543	0.68808	1	0.214	0.18	0.176	0.6656	0.032
PID_SYNDECAN_2_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_2_PATHWAY	-0.28232	-0.94688	0.5184	0.68906	1	0.344	0.222	0.268	0.66616	0.032
PID_ERA_GENOMIC_PATHWAY	61	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERA_GENOMIC_PATHWAY	-0.23338	-0.94672	0.5097	0.68904	1	0.328	0.237	0.251	0.66634	0.032
LU_AGING_BRAIN_UP	256	http://www.broadinstitute.org/gsea/msigdb/cards/LU_AGING_BRAIN_UP	-0.25154	-0.94669	0.544	0.68877	1	0.207	0.16	0.176	0.66626	0.032
REACTOME_PERK_REGULATED_GENE_EXPRESSION	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PERK_REGULATED_GENE_EXPRESSION	-0.33955	-0.94635	0.5285	0.68905	1	0.231	0.163	0.193	0.66625	0.032
KEGG_PRION_DISEASES	35	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PRION_DISEASES	-0.27762	-0.94618	0.5245	0.68899	1	0.314	0.231	0.242	0.66603	0.032
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	150	http://www.broadinstitute.org/gsea/msigdb/cards/PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	-0.23619	-0.94608	0.5728	0.68887	1	0.167	0.148	0.143	0.66571	0.032
ZHAN_MULTIPLE_MYELOMA_MS_DN	40	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_MS_DN	-0.2979	-0.94508	0.5493	0.69041	1	0.35	0.239	0.267	0.66685	0.032
REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION	-0.35119	-0.94464	0.4943	0.69094	1	0.111	0.0394	0.107	0.66726	0.032
SENESE_HDAC1_AND_HDAC2_TARGETS_DN	214	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC1_AND_HDAC2_TARGETS_DN	-0.2404	-0.94447	0.5589	0.69098	1	0.206	0.167	0.173	0.66736	0.032
PID_AP1_PATHWAY	67	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AP1_PATHWAY	-0.25802	-0.94446	0.5278	0.69066	1	0.328	0.261	0.243	0.66704	0.032
DEN_INTERACT_WITH_LCA5	25	http://www.broadinstitute.org/gsea/msigdb/cards/DEN_INTERACT_WITH_LCA5	-0.36469	-0.94425	0.5553	0.69072	1	0.36	0.184	0.294	0.66712	0.032
BAELDE_DIABETIC_NEPHROPATHY_DN	423	http://www.broadinstitute.org/gsea/msigdb/cards/BAELDE_DIABETIC_NEPHROPATHY_DN	-0.28245	-0.9436	0.548	0.69162	1	0.307	0.216	0.245	0.66889	0.032
FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_5_DN	-0.27867	-0.94348	0.5571	0.69153	1	0.279	0.181	0.229	0.66937	0.032
PID_ECADHERIN_KERATINOCYTE_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ECADHERIN_KERATINOCYTE_PATHWAY	-0.28811	-0.9431	0.5529	0.69199	1	0.25	0.209	0.198	0.66905	0.032
LINDVALL_IMMORTALIZED_BY_TERT_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/LINDVALL_IMMORTALIZED_BY_TERT_UP	-0.27077	-0.94305	0.546	0.69174	1	0.37	0.261	0.274	0.66873	0.032
FOSTER_TOLERANT_MACROPHAGE_UP	148	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_TOLERANT_MACROPHAGE_UP	-0.24439	-0.94298	0.5335	0.69156	1	0.108	0.0653	0.102	0.66841	0.032
HUPER_BREAST_BASAL_VS_LUMINAL_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/HUPER_BREAST_BASAL_VS_LUMINAL_DN	-0.29866	-0.9428	0.499	0.69155	1	0.224	0.146	0.192	0.66809	0.032
BIOCARTA_CARM_ER_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CARM_ER_PATHWAY	-0.2607	-0.94243	0.5306	0.69193	1	0.353	0.252	0.264	0.66827	0.032
KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	92	http://www.broadinstitute.org/gsea/msigdb/cards/KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3	-0.20874	-0.94207	0.5914	0.69227	1	0.0978	0.0737	0.0909	0.66795	0.032
DAZARD_RESPONSE_TO_UV_SCC_DN	116	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_RESPONSE_TO_UV_SCC_DN	-0.27263	-0.94206	0.5348	0.69196	1	0.259	0.194	0.21	0.66763	0.032
YANG_BREAST_CANCER_ESR1_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_DN	-0.39644	-0.94147	0.5722	0.69286	1	0.2	0.0713	0.186	0.66932	0.032
TIEN_INTESTINE_PROBIOTICS_6HR_DN	159	http://www.broadinstitute.org/gsea/msigdb/cards/TIEN_INTESTINE_PROBIOTICS_6HR_DN	-0.2895	-0.94126	0.5294	0.69293	1	0.289	0.2	0.233	0.6695	0.032
REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE	-0.34395	-0.94116	0.5179	0.6928	1	0.467	0.192	0.377	0.66968	0.032
DE_YY1_TARGETS_DN	91	http://www.broadinstitute.org/gsea/msigdb/cards/DE_YY1_TARGETS_DN	-0.33071	-0.94016	0.5474	0.69431	1	0.275	0.193	0.223	0.67037	0.032
ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	85	http://www.broadinstitute.org/gsea/msigdb/cards/ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION	-0.23152	-0.94011	0.5122	0.69407	1	0.212	0.229	0.164	0.67004	0.032
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	173	http://www.broadinstitute.org/gsea/msigdb/cards/LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-0.2351	-0.93982	0.5206	0.69428	1	0.208	0.2	0.168	0.66972	0.032
REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	230	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION	-0.24695	-0.93973	0.586	0.69414	1	0.313	0.229	0.244	0.67107	0.032
PID_SYNDECAN_3_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SYNDECAN_3_PATHWAY	-0.32377	-0.93942	0.5482	0.69439	1	0.125	0.0707	0.116	0.67329	0.032
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	68	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN	-0.22155	-0.93926	0.5422	0.69435	1	0.368	0.333	0.246	0.67341	0.032
JEPSEN_SMRT_TARGETS	33	http://www.broadinstitute.org/gsea/msigdb/cards/JEPSEN_SMRT_TARGETS	-0.26236	-0.93913	0.5248	0.69426	1	0.273	0.237	0.208	0.67323	0.032
GROSS_ELK3_TARGETS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_ELK3_TARGETS_DN	-0.3543	-0.93889	0.5492	0.69444	1	0.531	0.253	0.398	0.67303	0.032
LI_INDUCED_T_TO_NATURAL_KILLER_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/LI_INDUCED_T_TO_NATURAL_KILLER_DN	-0.21685	-0.93852	0.5581	0.6948	1	0.168	0.156	0.143	0.67349	0.032
PID_ILK_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ILK_PATHWAY	-0.27751	-0.93835	0.5268	0.69483	1	0.244	0.193	0.198	0.67381	0.032
QI_PLASMACYTOMA_UP	253	http://www.broadinstitute.org/gsea/msigdb/cards/QI_PLASMACYTOMA_UP	-0.20992	-0.93781	0.5248	0.69551	1	0.213	0.205	0.171	0.67399	0.032
BIOCARTA_STRESS_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_STRESS_PATHWAY	-0.31375	-0.93726	0.5127	0.69621	1	0.24	0.197	0.193	0.67437	0.032
REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_UNBLOCKING_OF_NMDA_RECEPTOR_GLUTAMATE_BINDING_AND_ACTIVATION	-0.34685	-0.93657	0.5262	0.69722	1	0.133	0.0905	0.121	0.67505	0.032
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	-0.36217	-0.93601	0.5857	0.69794	1	0.278	0.213	0.219	0.67646	0.032
DAIRKEE_CANCER_PRONE_RESPONSE_E2	28	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_CANCER_PRONE_RESPONSE_E2	-0.26016	-0.93587	0.5067	0.69791	1	0.464	0.349	0.303	0.67639	0.032
BIOCARTA_MCALPAIN_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MCALPAIN_PATHWAY	-0.2796	-0.93553	0.561	0.69823	1	0.28	0.175	0.231	0.67744	0.032
BIOCARTA_DEATH_PATHWAY	32	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_DEATH_PATHWAY	-0.29954	-0.93523	0.5387	0.6985	1	0.281	0.196	0.226	0.6784	0.032
RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP	-0.30476	-0.93499	0.5785	0.69858	1	0.216	0.128	0.189	0.67856	0.032
IGARASHI_ATF4_TARGETS_DN	88	http://www.broadinstitute.org/gsea/msigdb/cards/IGARASHI_ATF4_TARGETS_DN	-0.29116	-0.93493	0.5698	0.69836	1	0.352	0.219	0.276	0.67823	0.032
WANG_CLIM2_TARGETS_UP	234	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_CLIM2_TARGETS_UP	-0.22445	-0.9344	0.5878	0.69905	1	0.209	0.193	0.17	0.67852	0.032
REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	53	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE	-0.23266	-0.93362	0.5359	0.70028	1	0.132	0.154	0.112	0.67849	0.032
ST_ERK1_ERK2_MAPK_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/ST_ERK1_ERK2_MAPK_PATHWAY	-0.27791	-0.93359	0.5322	0.70001	1	0.516	0.325	0.349	0.67817	0.032
BILD_HRAS_ONCOGENIC_SIGNATURE	247	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_HRAS_ONCOGENIC_SIGNATURE	-0.23421	-0.93354	0.5136	0.69975	1	0.279	0.238	0.215	0.67785	0.032
KASLER_HDAC7_TARGETS_1_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/KASLER_HDAC7_TARGETS_1_DN	-0.34812	-0.93328	0.5192	0.69994	1	0.0588	0.000895	0.0588	0.67753	0.032
IWANAGA_CARCINOGENESIS_BY_KRAS_UP	160	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_UP	-0.24207	-0.93222	0.5881	0.70166	1	0.338	0.268	0.249	0.67955	0.032
CHANGOLKAR_H2AFY_TARGETS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/CHANGOLKAR_H2AFY_TARGETS_UP	-0.24367	-0.93209	0.5425	0.70161	1	0.283	0.237	0.216	0.68025	0.032
LI_CISPLATIN_RESISTANCE_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/LI_CISPLATIN_RESISTANCE_UP	-0.39845	-0.93148	0.5241	0.70244	1	0.37	0.159	0.312	0.68155	0.032
AMIT_EGF_RESPONSE_480_HELA	157	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_480_HELA	-0.19459	-0.93121	0.5576	0.70262	1	0.331	0.305	0.232	0.68163	0.032
PID_INTEGRIN3_PATHWAY	42	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN3_PATHWAY	-0.31642	-0.93078	0.5398	0.70307	1	0.238	0.178	0.196	0.68297	0.032
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	79	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2	-0.21893	-0.93057	0.6342	0.70315	1	0.215	0.186	0.176	0.683	0.032
REACTOME_INTERFERON_GAMMA_SIGNALING	52	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERFERON_GAMMA_SIGNALING	-0.34322	-0.93044	0.5549	0.70309	1	0.154	0.0512	0.146	0.68333	0.032
FALVELLA_SMOKERS_WITH_LUNG_CANCER	78	http://www.broadinstitute.org/gsea/msigdb/cards/FALVELLA_SMOKERS_WITH_LUNG_CANCER	-0.23994	-0.9302	0.5907	0.7032	1	0.231	0.191	0.187	0.68301	0.032
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	72	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	-0.21613	-0.92996	0.5633	0.70333	1	0.167	0.178	0.137	0.68268	0.032
REACTOME_TOLL_RECEPTOR_CASCADES	111	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TOLL_RECEPTOR_CASCADES	-0.22753	-0.9297	0.5637	0.7035	1	0.225	0.196	0.182	0.6831	0.032
PASINI_SUZ12_TARGETS_DN	310	http://www.broadinstitute.org/gsea/msigdb/cards/PASINI_SUZ12_TARGETS_DN	-0.28031	-0.92954	0.5509	0.70347	1	0.313	0.22	0.247	0.68313	0.032
KEGG_LONG_TERM_POTENTIATION	69	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_LONG_TERM_POTENTIATION	-0.22662	-0.92938	0.5528	0.70345	1	0.391	0.324	0.265	0.68285	0.032
ST_ADRENERGIC	35	http://www.broadinstitute.org/gsea/msigdb/cards/ST_ADRENERGIC	-0.27183	-0.92927	0.604	0.7033	1	0.0857	0.0302	0.0832	0.68279	0.032
WESTON_VEGFA_TARGETS_12HR	34	http://www.broadinstitute.org/gsea/msigdb/cards/WESTON_VEGFA_TARGETS_12HR	-0.34834	-0.92817	0.5449	0.70511	1	0.471	0.277	0.341	0.68444	0.032
VARELA_ZMPSTE24_TARGETS_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/VARELA_ZMPSTE24_TARGETS_UP	-0.24169	-0.92812	0.5081	0.70488	1	0.211	0.149	0.179	0.68411	0.032
KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	104	http://www.broadinstitute.org/gsea/msigdb/cards/KEEN_RESPONSE_TO_ROSIGLITAZONE_DN	-0.28903	-0.9279	0.5194	0.70495	1	0.212	0.118	0.187	0.68405	0.032
DAZARD_UV_RESPONSE_CLUSTER_G28	19	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G28	-0.35937	-0.92733	0.5261	0.70569	1	0.158	0.0535	0.15	0.68463	0.032
KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	94	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS	-0.21785	-0.92702	0.5743	0.70594	1	0.309	0.265	0.227	0.68459	0.032
HOSHIDA_LIVER_CANCER_SURVIVAL_DN	110	http://www.broadinstitute.org/gsea/msigdb/cards/HOSHIDA_LIVER_CANCER_SURVIVAL_DN	-0.22218	-0.92675	0.6692	0.70613	1	0.227	0.206	0.181	0.68528	0.032
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	18	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3	-0.38275	-0.92642	0.5599	0.70643	1	0.222	0.0641	0.208	0.6852	0.032
LIANG_SILENCED_BY_METHYLATION_UP	31	http://www.broadinstitute.org/gsea/msigdb/cards/LIANG_SILENCED_BY_METHYLATION_UP	-0.30682	-0.92595	0.5454	0.70702	1	0.258	0.155	0.218	0.68502	0.032
FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	100	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_4_UP	-0.21637	-0.92582	0.638	0.70692	1	0.21	0.198	0.169	0.68497	0.032
REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LOSS_OF_NLP_FROM_MITOTIC_CENTROSOMES	-0.31479	-0.92547	0.5816	0.70724	1	0.268	0.169	0.223	0.68535	0.032
BIOCARTA_AKT_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AKT_PATHWAY	-0.27168	-0.92521	0.6093	0.70741	1	0.136	0.107	0.122	0.68525	0.032
LEE_LIVER_CANCER_CIPROFIBRATE_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_CIPROFIBRATE_DN	-0.23698	-0.92476	0.6164	0.70797	1	0.246	0.218	0.193	0.6859	0.032
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	138	http://www.broadinstitute.org/gsea/msigdb/cards/PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-0.32185	-0.92417	0.5861	0.70871	1	0.275	0.174	0.229	0.68654	0.032
CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/CLIMENT_BREAST_CANCER_COPY_NUMBER_UP	-0.27122	-0.92403	0.5988	0.70865	1	0.174	0.146	0.149	0.68677	0.032
REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ADP_SIGNALLING_THROUGH_P2RY12	-0.33569	-0.92387	0.5819	0.70865	1	0.25	0.122	0.22	0.68738	0.032
BROWNE_HCMV_INFECTION_10HR_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_10HR_DN	-0.27488	-0.92347	0.5898	0.70905	1	0.278	0.191	0.225	0.6871	0.032
JAIN_NFKB_SIGNALING	73	http://www.broadinstitute.org/gsea/msigdb/cards/JAIN_NFKB_SIGNALING	-0.28946	-0.92317	0.5654	0.70927	1	0.397	0.308	0.276	0.68721	0.032
SESTO_RESPONSE_TO_UV_C0	106	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C0	-0.2714	-0.92231	0.5651	0.71059	1	0.236	0.202	0.189	0.68998	0.032
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	65	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP	-0.32158	-0.9221	0.5536	0.71064	1	0.446	0.257	0.332	0.69041	0.032
REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	47	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES	-0.3325	-0.92168	0.5611	0.71103	1	0.191	0.121	0.169	0.69035	0.032
ENK_UV_RESPONSE_EPIDERMIS_DN	495	http://www.broadinstitute.org/gsea/msigdb/cards/ENK_UV_RESPONSE_EPIDERMIS_DN	-0.20913	-0.92123	0.5876	0.71158	1	0.234	0.222	0.186	0.69003	0.032
LUCAS_HNF4A_TARGETS_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/LUCAS_HNF4A_TARGETS_UP	-0.2399	-0.92049	0.5712	0.71262	1	0.232	0.185	0.19	0.69115	0.033
PID_IL6_7_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL6_7_PATHWAY	-0.2419	-0.92046	0.562	0.71237	1	0.333	0.251	0.25	0.69083	0.032
HUMMEL_BURKITTS_LYMPHOMA_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMEL_BURKITTS_LYMPHOMA_UP	-0.30549	-0.9202	0.5884	0.71253	1	0.316	0.181	0.259	0.69051	0.032
FOSTER_KDM1A_TARGETS_UP	249	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_KDM1A_TARGETS_UP	-0.21024	-0.92008	0.5922	0.71241	1	0.221	0.194	0.18	0.69152	0.032
PID_LKB1_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LKB1_PATHWAY	-0.2314	-0.91998	0.5927	0.71227	1	0.383	0.308	0.265	0.6912	0.032
BROWNE_HCMV_INFECTION_1HR_DN	215	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_1HR_DN	-0.20416	-0.91909	0.6407	0.71367	1	0.284	0.255	0.213	0.6942	0.032
KEGG_TIGHT_JUNCTION	128	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_TIGHT_JUNCTION	-0.18529	-0.91861	0.6085	0.7142	1	0.156	0.154	0.133	0.69487	0.032
SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	114	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP	-0.23572	-0.91841	0.5832	0.71425	1	0.307	0.252	0.231	0.69471	0.032
KEGG_PEROXISOME	76	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PEROXISOME	-0.23266	-0.91819	0.6231	0.71435	1	0.145	0.113	0.129	0.69534	0.032
JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN	-0.28066	-0.91787	0.5726	0.71459	1	0.267	0.197	0.215	0.6955	0.032
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	168	http://www.broadinstitute.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	-0.21647	-0.91764	0.6483	0.71475	1	0.125	0.118	0.111	0.69605	0.032
MALONEY_RESPONSE_TO_17AAG_DN	78	http://www.broadinstitute.org/gsea/msigdb/cards/MALONEY_RESPONSE_TO_17AAG_DN	-0.31172	-0.91749	0.5648	0.71466	1	0.462	0.314	0.318	0.69573	0.032
BIOCARTA_AT1R_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AT1R_PATHWAY	-0.2769	-0.9169	0.6225	0.71516	1	0.455	0.324	0.308	0.69732	0.032
YAGI_AML_FAB_MARKERS	184	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_FAB_MARKERS	-0.25242	-0.9169	0.6057	0.71549	1	0.179	0.116	0.16	0.69765	0.032
LI_CISPLATIN_RESISTANCE_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/LI_CISPLATIN_RESISTANCE_DN	-0.31821	-0.9163	0.6306	0.71601	1	0.323	0.199	0.259	0.69823	0.032
UDAYAKUMAR_MED1_TARGETS_DN	228	http://www.broadinstitute.org/gsea/msigdb/cards/UDAYAKUMAR_MED1_TARGETS_DN	-0.21152	-0.91614	0.5664	0.71596	1	0.25	0.226	0.195	0.69878	0.032
GYORFFY_DOXORUBICIN_RESISTANCE	49	http://www.broadinstitute.org/gsea/msigdb/cards/GYORFFY_DOXORUBICIN_RESISTANCE	-0.27343	-0.91609	0.6235	0.71572	1	0.286	0.185	0.233	0.69872	0.032
ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	261	http://www.broadinstitute.org/gsea/msigdb/cards/ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN	-0.17969	-0.91575	0.6085	0.71607	1	0.169	0.177	0.14	0.69851	0.032
OKUMURA_INFLAMMATORY_RESPONSE_LPS	174	http://www.broadinstitute.org/gsea/msigdb/cards/OKUMURA_INFLAMMATORY_RESPONSE_LPS	-0.22683	-0.91493	0.6526	0.7173	1	0.241	0.186	0.198	0.69954	0.032
PID_MTOR_4PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MTOR_4PATHWAY	-0.29339	-0.91488	0.5988	0.71705	1	0.265	0.175	0.219	0.69922	0.032
LEE_NEURAL_CREST_STEM_CELL_UP	142	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_NEURAL_CREST_STEM_CELL_UP	-0.25332	-0.91483	0.5607	0.71679	1	0.19	0.159	0.161	0.6989	0.032
ZHAN_MULTIPLE_MYELOMA_UP	62	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_UP	-0.26804	-0.91437	0.5901	0.7174	1	0.323	0.209	0.256	0.69968	0.032
REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING	-0.29103	-0.91429	0.6	0.71721	1	0.222	0.122	0.195	0.69935	0.032
SEIDEN_MET_SIGNALING	19	http://www.broadinstitute.org/gsea/msigdb/cards/SEIDEN_MET_SIGNALING	-0.39043	-0.91344	0.5545	0.71845	1	0.211	0.0729	0.195	0.70072	0.033
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	134	http://www.broadinstitute.org/gsea/msigdb/cards/NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-0.31162	-0.9134	0.5862	0.71819	1	0.328	0.213	0.26	0.70059	0.033
THUM_SYSTOLIC_HEART_FAILURE_UP	395	http://www.broadinstitute.org/gsea/msigdb/cards/THUM_SYSTOLIC_HEART_FAILURE_UP	-0.26224	-0.91331	0.5888	0.71804	1	0.225	0.168	0.19	0.70071	0.033
BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	206	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP	-0.19953	-0.91315	0.5783	0.71801	1	0.0874	0.0825	0.0808	0.70047	0.033
REACTOME_ION_CHANNEL_TRANSPORT	54	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ION_CHANNEL_TRANSPORT	-0.21824	-0.9131	0.6008	0.71779	1	0.0926	0.108	0.0827	0.70015	0.032
TSUNODA_CISPLATIN_RESISTANCE_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/TSUNODA_CISPLATIN_RESISTANCE_DN	-0.29575	-0.91302	0.5901	0.71761	1	0.146	0.0955	0.132	0.70014	0.032
NABA_ECM_GLYCOPROTEINS	193	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_ECM_GLYCOPROTEINS	-0.24157	-0.91257	0.5499	0.71812	1	0.109	0.0813	0.101	0.7006	0.032
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	63	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	-0.24709	-0.91237	0.658	0.71811	1	0.206	0.148	0.176	0.70046	0.032
YAMAZAKI_TCEB3_TARGETS_UP	167	http://www.broadinstitute.org/gsea/msigdb/cards/YAMAZAKI_TCEB3_TARGETS_UP	-0.22813	-0.91149	0.5966	0.71945	1	0.228	0.189	0.186	0.7019	0.033
HILLION_HMGA1B_TARGETS	89	http://www.broadinstitute.org/gsea/msigdb/cards/HILLION_HMGA1B_TARGETS	-0.23345	-0.91123	0.6055	0.71961	1	0.258	0.228	0.2	0.70224	0.033
SENESE_HDAC2_TARGETS_DN	119	http://www.broadinstitute.org/gsea/msigdb/cards/SENESE_HDAC2_TARGETS_DN	-0.26244	-0.91122	0.6163	0.71929	1	0.176	0.12	0.156	0.70191	0.033
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-0.26109	-0.91113	0.5916	0.71912	1	0.165	0.101	0.148	0.70179	0.033
REACTOME_CGMP_EFFECTS	19	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CGMP_EFFECTS	-0.37032	-0.91088	0.5893	0.71925	1	0.368	0.247	0.278	0.70193	0.032
HARRIS_HYPOXIA	78	http://www.broadinstitute.org/gsea/msigdb/cards/HARRIS_HYPOXIA	-0.25622	-0.91065	0.5627	0.71932	1	0.372	0.264	0.275	0.70271	0.032
WINNEPENNINCKX_MELANOMA_METASTASIS_DN	43	http://www.broadinstitute.org/gsea/msigdb/cards/WINNEPENNINCKX_MELANOMA_METASTASIS_DN	-0.26899	-0.91035	0.5906	0.71952	1	0.186	0.162	0.156	0.70272	0.032
OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	258	http://www.broadinstitute.org/gsea/msigdb/cards/OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN	-0.24144	-0.91027	0.619	0.71933	1	0.252	0.205	0.202	0.70262	0.032
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	-0.3179	-0.91022	0.5651	0.7191	1	0.211	0.163	0.176	0.70229	0.032
PID_HDAC_CLASSI_PATHWAY	64	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HDAC_CLASSI_PATHWAY	-0.23097	-0.91015	0.5805	0.71889	1	0.328	0.256	0.245	0.70215	0.032
TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	254	http://www.broadinstitute.org/gsea/msigdb/cards/TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP	-0.1702	-0.90981	0.6344	0.71926	1	0.181	0.203	0.146	0.70242	0.032
COLDREN_GEFITINIB_RESISTANCE_DN	220	http://www.broadinstitute.org/gsea/msigdb/cards/COLDREN_GEFITINIB_RESISTANCE_DN	-0.24255	-0.90961	0.6148	0.7193	1	0.227	0.161	0.192	0.70223	0.032
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	65	http://www.broadinstitute.org/gsea/msigdb/cards/VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	-0.29079	-0.90955	0.5887	0.71909	1	0.292	0.2	0.234	0.70191	0.032
IVANOVSKA_MIR106B_TARGETS	86	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVSKA_MIR106B_TARGETS	-0.21765	-0.90927	0.6374	0.71927	1	0.302	0.265	0.223	0.70249	0.032
NABA_SECRETED_FACTORS	326	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_SECRETED_FACTORS	-0.23651	-0.90882	0.6268	0.71987	1	0.138	0.123	0.123	0.70236	0.032
GENTILE_UV_LOW_DOSE_DN	65	http://www.broadinstitute.org/gsea/msigdb/cards/GENTILE_UV_LOW_DOSE_DN	-0.29758	-0.90877	0.5516	0.71963	1	0.308	0.225	0.239	0.70228	0.032
FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	127	http://www.broadinstitute.org/gsea/msigdb/cards/FIGUEROA_AML_METHYLATION_CLUSTER_6_UP	-0.19262	-0.90783	0.6431	0.72107	1	0.181	0.198	0.146	0.70433	0.032
CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN	-0.27979	-0.90763	0.6121	0.7211	1	0.143	0.0849	0.131	0.70414	0.032
AMIT_SERUM_RESPONSE_40_MCF10A	31	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_40_MCF10A	-0.3686	-0.90711	0.5801	0.72163	1	0.387	0.198	0.311	0.70513	0.032
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	179	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN	-0.26079	-0.90691	0.5937	0.72167	1	0.162	0.105	0.146	0.70552	0.032
REACTOME_CELL_CELL_COMMUNICATION	116	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CELL_CELL_COMMUNICATION	-0.21077	-0.90684	0.6403	0.72148	1	0.233	0.195	0.188	0.7052	0.032
ABBUD_LIF_SIGNALING_1_UP	45	http://www.broadinstitute.org/gsea/msigdb/cards/ABBUD_LIF_SIGNALING_1_UP	-0.25544	-0.90626	0.572	0.72219	1	0.333	0.251	0.25	0.70595	0.032
DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	488	http://www.broadinstitute.org/gsea/msigdb/cards/DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	-0.27569	-0.90616	0.5604	0.72205	1	0.307	0.218	0.245	0.70563	0.032
BROWNE_HCMV_INFECTION_12HR_UP	103	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_12HR_UP	-0.24521	-0.90552	0.6397	0.72288	1	0.165	0.117	0.146	0.70638	0.032
REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_WATER_BALANCE_BY_RENAL_AQUAPORINS	-0.26575	-0.9055	0.5573	0.72258	1	0.238	0.195	0.192	0.70606	0.032
VALK_AML_CLUSTER_2	27	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_2	-0.28815	-0.90542	0.621	0.72239	1	0.296	0.165	0.248	0.70596	0.032
MAHAJAN_RESPONSE_TO_IL1A_DN	73	http://www.broadinstitute.org/gsea/msigdb/cards/MAHAJAN_RESPONSE_TO_IL1A_DN	-0.272	-0.90539	0.5564	0.72212	1	0.0959	0.0471	0.0916	0.70564	0.032
REACTOME_METABOLISM_OF_PROTEINS	417	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_PROTEINS	-0.23618	-0.90446	0.6371	0.72345	1	0.218	0.188	0.18	0.70787	0.032
JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN	-0.25759	-0.90442	0.6155	0.7232	1	0.0732	0.0493	0.0697	0.70755	0.032
HOWLIN_CITED1_TARGETS_1_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/HOWLIN_CITED1_TARGETS_1_UP	-0.28934	-0.9043	0.587	0.72309	1	0.364	0.235	0.278	0.70724	0.032
LIU_SOX4_TARGETS_UP	131	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_SOX4_TARGETS_UP	-0.26282	-0.90404	0.6066	0.72323	1	0.237	0.185	0.194	0.70786	0.032
IVANOVA_HEMATOPOIESIS_STEM_CELL	243	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_STEM_CELL	-0.20817	-0.90403	0.6732	0.72293	1	0.21	0.186	0.173	0.70754	0.032
DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	82	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	-0.31373	-0.90324	0.5594	0.72395	1	0.463	0.26	0.344	0.70832	0.032
NABA_ECM_AFFILIATED	158	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_ECM_AFFILIATED	-0.21968	-0.90226	0.6008	0.7254	1	0.209	0.221	0.164	0.70964	0.032
FINAK_BREAST_CANCER_SDPP_SIGNATURE	23	http://www.broadinstitute.org/gsea/msigdb/cards/FINAK_BREAST_CANCER_SDPP_SIGNATURE	-0.33643	-0.90195	0.5602	0.7256	1	0.13	0.0684	0.122	0.71071	0.032
LIU_COMMON_CANCER_GENES	72	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_COMMON_CANCER_GENES	-0.28777	-0.90192	0.6444	0.72533	1	0.208	0.147	0.178	0.71039	0.032
DURCHDEWALD_SKIN_CARCINOGENESIS_DN	259	http://www.broadinstitute.org/gsea/msigdb/cards/DURCHDEWALD_SKIN_CARCINOGENESIS_DN	-0.25307	-0.90187	0.654	0.72509	1	0.324	0.252	0.245	0.71007	0.032
SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	189	http://www.broadinstitute.org/gsea/msigdb/cards/SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4	-0.20063	-0.9013	0.6601	0.72585	1	0.169	0.163	0.143	0.71053	0.032
WANG_TNF_TARGETS	24	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_TNF_TARGETS	-0.31527	-0.90114	0.5955	0.72579	1	0.333	0.229	0.257	0.71087	0.032
AMIT_EGF_RESPONSE_120_HELA	66	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_120_HELA	-0.23213	-0.90097	0.5888	0.72573	1	0.273	0.264	0.201	0.71055	0.032
MARZEC_IL2_SIGNALING_DN	34	http://www.broadinstitute.org/gsea/msigdb/cards/MARZEC_IL2_SIGNALING_DN	-0.33802	-0.90079	0.6108	0.72576	1	0.294	0.15	0.25	0.71064	0.032
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN	-0.26382	-0.90049	0.5977	0.72599	1	0.316	0.236	0.242	0.71082	0.032
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	444	http://www.broadinstitute.org/gsea/msigdb/cards/CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN	-0.26557	-0.89969	0.5938	0.72719	1	0.216	0.165	0.184	0.71239	0.032
IVANOVA_HEMATOPOIESIS_MATURE_CELL	274	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_MATURE_CELL	-0.23439	-0.89956	0.6329	0.72709	1	0.219	0.157	0.187	0.71275	0.032
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	141	http://www.broadinstitute.org/gsea/msigdb/cards/GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	-0.2372	-0.89954	0.6387	0.7268	1	0.234	0.182	0.193	0.71243	0.032
LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	72	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP	-0.23042	-0.89944	0.6049	0.72665	1	0.306	0.232	0.235	0.71211	0.032
HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN	-0.27844	-0.8978	0.6797	0.72932	1	0.318	0.19	0.258	0.71561	0.033
ROZANOV_MMP14_TARGETS_UP	254	http://www.broadinstitute.org/gsea/msigdb/cards/ROZANOV_MMP14_TARGETS_UP	-0.20827	-0.89689	0.607	0.73063	1	0.287	0.246	0.219	0.71647	0.033
ROVERSI_GLIOMA_COPY_NUMBER_DN	52	http://www.broadinstitute.org/gsea/msigdb/cards/ROVERSI_GLIOMA_COPY_NUMBER_DN	-0.23733	-0.89677	0.6586	0.73053	1	0.25	0.202	0.2	0.71645	0.033
KEGG_BLADDER_CANCER	40	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BLADDER_CANCER	-0.25064	-0.89643	0.6262	0.73091	1	0.275	0.236	0.211	0.7174	0.033
GHANDHI_DIRECT_IRRADIATION_UP	99	http://www.broadinstitute.org/gsea/msigdb/cards/GHANDHI_DIRECT_IRRADIATION_UP	-0.23958	-0.89591	0.633	0.73156	1	0.222	0.179	0.183	0.71813	0.033
YANG_MUC2_TARGETS_DUODENUM_6MO_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_MUC2_TARGETS_DUODENUM_6MO_DN	-0.33474	-0.89588	0.5521	0.73129	1	0.2	0.106	0.179	0.71781	0.033
AMIT_SERUM_RESPONSE_60_MCF10A	56	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_SERUM_RESPONSE_60_MCF10A	-0.30394	-0.8954	0.6031	0.73189	1	0.268	0.164	0.224	0.71898	0.033
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP	-0.3069	-0.89536	0.6355	0.73166	1	0.111	0.0234	0.109	0.71865	0.033
HORIUCHI_WTAP_TARGETS_UP	286	http://www.broadinstitute.org/gsea/msigdb/cards/HORIUCHI_WTAP_TARGETS_UP	-0.25183	-0.89473	0.5806	0.73217	1	0.269	0.19	0.22	0.71948	0.033
BOYLAN_MULTIPLE_MYELOMA_C_DN	55	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_DN	-0.29407	-0.89473	0.6353	0.7325	1	0.236	0.141	0.204	0.7198	0.033
REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	37	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS	-0.28039	-0.89463	0.6445	0.73206	1	0.243	0.155	0.206	0.71916	0.033
LOPES_METHYLATED_IN_COLON_CANCER_DN	28	http://www.broadinstitute.org/gsea/msigdb/cards/LOPES_METHYLATED_IN_COLON_CANCER_DN	-0.2476	-0.89432	0.6375	0.73231	1	0.143	0.117	0.126	0.72017	0.033
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP	-0.37208	-0.89411	0.5939	0.73239	1	0.389	0.303	0.271	0.71985	0.032
NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	91	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER	-0.18806	-0.89392	0.6226	0.73241	1	0.297	0.286	0.213	0.71953	0.032
VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP	-0.27911	-0.89373	0.6136	0.73242	1	0.316	0.22	0.246	0.7192	0.032
BIOCARTA_NO2IL12_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NO2IL12_PATHWAY	-0.34929	-0.89243	0.6102	0.73455	1	0.125	0.0474	0.119	0.72141	0.033
CHEBOTAEV_GR_TARGETS_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/CHEBOTAEV_GR_TARGETS_DN	-0.2494	-0.89234	0.6404	0.73438	1	0.115	0.084	0.106	0.72109	0.033
GOZGIT_ESR1_TARGETS_UP	141	http://www.broadinstitute.org/gsea/msigdb/cards/GOZGIT_ESR1_TARGETS_UP	-0.21973	-0.89205	0.6958	0.73455	1	0.184	0.174	0.153	0.72118	0.033
AFFAR_YY1_TARGETS_UP	207	http://www.broadinstitute.org/gsea/msigdb/cards/AFFAR_YY1_TARGETS_UP	-0.21183	-0.89147	0.5631	0.73534	1	0.198	0.19	0.162	0.72123	0.033
HEIDENBLAD_AMPLICON_12P11_12_DN	25	http://www.broadinstitute.org/gsea/msigdb/cards/HEIDENBLAD_AMPLICON_12P11_12_DN	-0.25858	-0.89141	0.5876	0.73512	1	0.48	0.351	0.312	0.7209	0.033
QI_HYPOXIA	135	http://www.broadinstitute.org/gsea/msigdb/cards/QI_HYPOXIA	-0.21582	-0.89124	0.5918	0.73515	1	0.185	0.159	0.157	0.72116	0.033
REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION	-0.27325	-0.89109	0.5895	0.73509	1	0.0556	0.0136	0.0548	0.72095	0.033
BIOCARTA_IL2RB_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL2RB_PATHWAY	-0.25637	-0.89085	0.6779	0.73518	1	0.351	0.216	0.276	0.72101	0.033
PID_SMAD2_3NUCLEAR_PATHWAY	81	http://www.broadinstitute.org/gsea/msigdb/cards/PID_SMAD2_3NUCLEAR_PATHWAY	-0.1975	-0.89046	0.6894	0.7356	1	0.259	0.225	0.202	0.72166	0.033
ODONNELL_TFRC_TARGETS_UP	403	http://www.broadinstitute.org/gsea/msigdb/cards/ODONNELL_TFRC_TARGETS_UP	-0.19036	-0.89024	0.6502	0.7357	1	0.206	0.201	0.167	0.72182	0.033
IKEDA_MIR133_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR133_TARGETS_UP	-0.30386	-0.89016	0.5913	0.73552	1	0.349	0.222	0.272	0.72162	0.033
KEGG_NUCLEOTIDE_EXCISION_REPAIR	43	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NUCLEOTIDE_EXCISION_REPAIR	-0.28762	-0.89011	0.6108	0.73528	1	0.256	0.196	0.206	0.72137	0.033
HSIAO_HOUSEKEEPING_GENES	376	http://www.broadinstitute.org/gsea/msigdb/cards/HSIAO_HOUSEKEEPING_GENES	-0.21863	-0.89002	0.6319	0.73514	1	0.277	0.228	0.217	0.72138	0.033
ROSS_AML_OF_FAB_M7_TYPE	67	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_AML_OF_FAB_M7_TYPE	-0.2556	-0.88956	0.6104	0.73572	1	0.194	0.158	0.164	0.72136	0.033
REACTOME_AXON_GUIDANCE	242	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AXON_GUIDANCE	-0.19885	-0.88919	0.5868	0.73612	1	0.351	0.301	0.248	0.72269	0.033
IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	334	http://www.broadinstitute.org/gsea/msigdb/cards/IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN	-0.20244	-0.88868	0.6986	0.73667	1	0.24	0.207	0.192	0.72319	0.033
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	95	http://www.broadinstitute.org/gsea/msigdb/cards/CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-0.23741	-0.8885	0.6817	0.73667	1	0.232	0.202	0.185	0.72362	0.033
CHANDRAN_METASTASIS_UP	200	http://www.broadinstitute.org/gsea/msigdb/cards/CHANDRAN_METASTASIS_UP	-0.28329	-0.88833	0.5492	0.73668	1	0.245	0.195	0.199	0.72379	0.033
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	131	http://www.broadinstitute.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	-0.21069	-0.88827	0.7069	0.73646	1	0.221	0.169	0.185	0.72347	0.033
SESTO_RESPONSE_TO_UV_C5	46	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C5	-0.30772	-0.88812	0.5758	0.73642	1	0.37	0.226	0.287	0.72365	0.033
RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	73	http://www.broadinstitute.org/gsea/msigdb/cards/RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP	-0.23985	-0.88807	0.5984	0.73618	1	0.288	0.224	0.224	0.72355	0.032
OSMAN_BLADDER_CANCER_UP	385	http://www.broadinstitute.org/gsea/msigdb/cards/OSMAN_BLADDER_CANCER_UP	-0.2829	-0.88794	0.6215	0.7361	1	0.281	0.194	0.229	0.7235	0.032
HONMA_DOCETAXEL_RESISTANCE	33	http://www.broadinstitute.org/gsea/msigdb/cards/HONMA_DOCETAXEL_RESISTANCE	-0.25648	-0.88776	0.6161	0.73611	1	0.364	0.24	0.277	0.72318	0.032
XU_CREBBP_TARGETS_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/XU_CREBBP_TARGETS_UP	-0.27409	-0.88755	0.5848	0.7362	1	0.348	0.288	0.248	0.72385	0.032
STAMBOLSKY_BOUND_BY_MUTATED_TP53	17	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_BOUND_BY_MUTATED_TP53	-0.25679	-0.88735	0.6198	0.73626	1	0.294	0.216	0.231	0.72378	0.032
YANG_BREAST_CANCER_ESR1_LASER_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/YANG_BREAST_CANCER_ESR1_LASER_DN	-0.32216	-0.88715	0.666	0.73632	1	0.388	0.179	0.319	0.7247	0.032
KEGG_BUTANOATE_METABOLISM	33	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BUTANOATE_METABOLISM	-0.26434	-0.88688	0.6544	0.73647	1	0.303	0.206	0.241	0.72438	0.032
BIOCARTA_PML_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PML_PATHWAY	-0.21314	-0.88682	0.6362	0.73625	1	0.412	0.299	0.289	0.72406	0.032
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	16	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	-0.29675	-0.88655	0.598	0.73646	1	0.375	0.205	0.298	0.72423	0.032
MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	153	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MCV6_LCP_WITH_H3K4ME3	-0.20553	-0.8864	0.6406	0.73641	1	0.176	0.182	0.145	0.72391	0.032
LEE_LIVER_CANCER_CIPROFIBRATE_UP	55	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_CIPROFIBRATE_UP	-0.22141	-0.88631	0.6985	0.73624	1	0.255	0.181	0.209	0.72359	0.032
BROWNE_HCMV_INFECTION_1HR_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_1HR_UP	-0.24212	-0.88628	0.6952	0.73598	1	0.439	0.301	0.307	0.72376	0.029
AMIT_EGF_RESPONSE_60_HELA	44	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_60_HELA	-0.29157	-0.88568	0.5748	0.7367	1	0.341	0.259	0.253	0.72443	0.029
STEIN_ESRRA_TARGETS_DN	101	http://www.broadinstitute.org/gsea/msigdb/cards/STEIN_ESRRA_TARGETS_DN	-0.21659	-0.88559	0.6248	0.73658	1	0.238	0.213	0.188	0.72411	0.029
REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	197	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION	-0.24378	-0.88538	0.6308	0.73662	1	0.284	0.202	0.229	0.72409	0.029
LIN_NPAS4_TARGETS_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_NPAS4_TARGETS_DN	-0.21094	-0.885	0.6042	0.737	1	0.355	0.32	0.242	0.72426	0.029
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	482	http://www.broadinstitute.org/gsea/msigdb/cards/STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN	-0.22085	-0.88485	0.6364	0.73693	1	0.251	0.218	0.2	0.72422	0.029
REACTOME_COMPLEMENT_CASCADE	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_COMPLEMENT_CASCADE	-0.32371	-0.88451	0.5846	0.73724	1	0.25	0.193	0.202	0.72511	0.029
REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	29	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT	-0.39305	-0.88427	0.5746	0.73742	1	0.586	0.263	0.433	0.72507	0.029
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP	-0.27589	-0.88331	0.637	0.73886	1	0.25	0.206	0.199	0.72752	0.029
PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY	-0.35132	-0.88287	0.6019	0.73929	1	0.314	0.181	0.258	0.72842	0.029
PID_ERBB1_DOWNSTREAM_PATHWAY	105	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ERBB1_DOWNSTREAM_PATHWAY	-0.25822	-0.88242	0.6465	0.73983	1	0.39	0.305	0.272	0.72946	0.029
REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	-0.23185	-0.88118	0.6267	0.74175	1	0.098	0.0669	0.0917	0.73072	0.029
PID_IL2_PI3K_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IL2_PI3K_PATHWAY	-0.25436	-0.88091	0.6562	0.74193	1	0.212	0.131	0.184	0.73197	0.029
JIANG_AGING_CEREBRAL_CORTEX_UP	35	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_AGING_CEREBRAL_CORTEX_UP	-0.29943	-0.88034	0.6066	0.74265	1	0.257	0.185	0.21	0.73176	0.029
SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	331	http://www.broadinstitute.org/gsea/msigdb/cards/SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	-0.2817	-0.88028	0.6055	0.74243	1	0.227	0.168	0.191	0.73167	0.029
REACTOME_STRIATED_MUSCLE_CONTRACTION	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_STRIATED_MUSCLE_CONTRACTION	-0.28073	-0.88003	0.6357	0.74254	1	0.259	0.189	0.211	0.73209	0.032
YAGI_AML_WITH_T_9_11_TRANSLOCATION	121	http://www.broadinstitute.org/gsea/msigdb/cards/YAGI_AML_WITH_T_9_11_TRANSLOCATION	-0.21614	-0.87971	0.6719	0.74277	1	0.24	0.215	0.189	0.73225	0.032
BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	260	http://www.broadinstitute.org/gsea/msigdb/cards/BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D	-0.16383	-0.8797	0.8282	0.74247	1	0.158	0.168	0.133	0.73193	0.032
ONO_AML1_TARGETS_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/ONO_AML1_TARGETS_DN	-0.23686	-0.87957	0.618	0.74242	1	0.154	0.116	0.136	0.73194	0.029
SMIRNOV_RESPONSE_TO_IR_2HR_DN	53	http://www.broadinstitute.org/gsea/msigdb/cards/SMIRNOV_RESPONSE_TO_IR_2HR_DN	-0.35241	-0.87953	0.6412	0.74217	1	0.358	0.21	0.284	0.73162	0.029
URS_ADIPOCYTE_DIFFERENTIATION_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/URS_ADIPOCYTE_DIFFERENTIATION_UP	-0.208	-0.87942	0.6626	0.74205	1	0.365	0.297	0.257	0.7313	0.029
YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	249	http://www.broadinstitute.org/gsea/msigdb/cards/YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN	-0.18877	-0.87922	0.8116	0.74205	1	0.237	0.218	0.187	0.73136	0.029
REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES	-0.3099	-0.87897	0.6162	0.7422	1	0.312	0.222	0.243	0.73184	0.028
BIOCARTA_COMP_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_COMP_PATHWAY	-0.37132	-0.87829	0.6198	0.74312	1	0.389	0.214	0.306	0.73256	0.028
PID_HES_HEY_PATHWAY	47	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HES_HEY_PATHWAY	-0.19464	-0.87826	0.6272	0.74286	1	0.191	0.23	0.148	0.7328	0.028
KEGG_DRUG_METABOLISM_OTHER_ENZYMES	40	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_DRUG_METABOLISM_OTHER_ENZYMES	-0.24023	-0.87769	0.6484	0.74358	1	0.325	0.234	0.249	0.73316	0.028
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	66	http://www.broadinstitute.org/gsea/msigdb/cards/MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN	-0.23296	-0.87759	0.5938	0.74345	1	0.212	0.182	0.174	0.73342	0.028
BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN	-0.20353	-0.87756	0.664	0.74317	1	0.149	0.16	0.125	0.7331	0.028
ZHU_CMV_8_HR_DN	52	http://www.broadinstitute.org/gsea/msigdb/cards/ZHU_CMV_8_HR_DN	-0.27348	-0.87754	0.6335	0.74288	1	0.365	0.216	0.287	0.73307	0.028
SHIN_B_CELL_LYMPHOMA_CLUSTER_5	17	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_5	-0.29851	-0.87636	0.5936	0.74472	1	0.471	0.324	0.318	0.73643	0.028
DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	36	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN	-0.27798	-0.8755	0.6175	0.74597	1	0.333	0.252	0.25	0.73727	0.028
DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	176	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN	-0.19513	-0.87549	0.6386	0.74567	1	0.153	0.157	0.13	0.73695	0.028
REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS	-0.29831	-0.87479	0.6178	0.74661	1	0.412	0.271	0.3	0.73751	0.028
REACTOME_INSULIN_RECEPTOR_RECYCLING	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INSULIN_RECEPTOR_RECYCLING	-0.29526	-0.87442	0.6365	0.74699	1	0.174	0.0869	0.159	0.73856	0.028
IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	499	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR	-0.2121	-0.87403	0.7495	0.74736	1	0.214	0.197	0.176	0.73914	0.028
KEGG_PYRUVATE_METABOLISM	39	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PYRUVATE_METABOLISM	-0.25317	-0.87386	0.6931	0.74734	1	0.231	0.16	0.194	0.73882	0.028
BIOCARTA_TOLL_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TOLL_PATHWAY	-0.24576	-0.87275	0.6382	0.74902	1	0.243	0.196	0.196	0.74086	0.028
TRAYNOR_RETT_SYNDROM_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/TRAYNOR_RETT_SYNDROM_UP	-0.27998	-0.87265	0.6764	0.74886	1	0.214	0.118	0.189	0.74064	0.028
KEGG_ABC_TRANSPORTERS	44	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ABC_TRANSPORTERS	-0.23919	-0.8726	0.6115	0.74862	1	0.114	0.0861	0.104	0.74031	0.028
HE_PTEN_TARGETS_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/HE_PTEN_TARGETS_UP	-0.33907	-0.87147	0.6461	0.75034	1	0.188	0.0977	0.169	0.74291	0.028
REACTOME_SIGNALING_BY_PDGF	117	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_PDGF	-0.22423	-0.87127	0.6811	0.7504	1	0.385	0.309	0.267	0.74287	0.028
FOSTER_KDM1A_TARGETS_DN	199	http://www.broadinstitute.org/gsea/msigdb/cards/FOSTER_KDM1A_TARGETS_DN	-0.16282	-0.87107	0.6762	0.75043	1	0.201	0.235	0.155	0.74255	0.028
MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	50	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6	-0.27975	-0.8709	0.6134	0.7504	1	0.42	0.302	0.294	0.74255	0.028
KEGG_GLIOMA	64	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLIOMA	-0.22922	-0.87072	0.695	0.75044	1	0.438	0.329	0.294	0.74262	0.028
BIOCARTA_IL12_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL12_PATHWAY	-0.28561	-0.87071	0.635	0.75013	1	0.2	0.119	0.176	0.7423	0.028
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	76	http://www.broadinstitute.org/gsea/msigdb/cards/HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP	-0.26547	-0.8705	0.6718	0.75017	1	0.211	0.129	0.184	0.74226	0.028
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	79	http://www.broadinstitute.org/gsea/msigdb/cards/HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	-0.24453	-0.87046	0.6379	0.74992	1	0.266	0.181	0.218	0.74207	0.028
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN	-0.24833	-0.87026	0.6076	0.74994	1	0.267	0.259	0.198	0.74174	0.028
PID_AMB2_NEUTROPHILS_PATHWAY	41	http://www.broadinstitute.org/gsea/msigdb/cards/PID_AMB2_NEUTROPHILS_PATHWAY	-0.2405	-0.86925	0.6463	0.75151	1	0.293	0.264	0.216	0.74276	0.028
MIKKELSEN_MEF_LCP_WITH_H3K4ME3	122	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_MEF_LCP_WITH_H3K4ME3	-0.19929	-0.86893	0.6096	0.75178	1	0.213	0.218	0.167	0.74296	0.028
ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	17	http://www.broadinstitute.org/gsea/msigdb/cards/ZEMBUTSU_SENSITIVITY_TO_CYCLOPHOSPHAMIDE	-0.31927	-0.86832	0.6385	0.7525	1	0.353	0.197	0.283	0.74418	0.028
WANG_MLL_TARGETS	279	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_MLL_TARGETS	-0.19248	-0.86824	0.6864	0.75233	1	0.24	0.218	0.19	0.74386	0.028
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	56	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP	-0.24638	-0.86755	0.6228	0.75329	1	0.214	0.187	0.175	0.74492	0.028
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP	-0.30599	-0.86751	0.6213	0.75303	1	0.235	0.145	0.201	0.7446	0.028
MATZUK_MALE_REPRODUCTION_SERTOLI	28	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_MALE_REPRODUCTION_SERTOLI	-0.26797	-0.867	0.6779	0.75366	1	0.25	0.169	0.208	0.74579	0.028
BROWNE_HCMV_INFECTION_16HR_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_16HR_DN	-0.22409	-0.86595	0.6798	0.75525	1	0.298	0.224	0.232	0.7469	0.029
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN	-0.23865	-0.86547	0.6615	0.75582	1	0.235	0.162	0.198	0.74732	0.029
ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	210	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF	-0.25993	-0.86469	0.5941	0.7569	1	0.29	0.224	0.227	0.74802	0.029
SUNG_METASTASIS_STROMA_UP	107	http://www.broadinstitute.org/gsea/msigdb/cards/SUNG_METASTASIS_STROMA_UP	-0.29168	-0.86465	0.6238	0.75666	1	0.336	0.257	0.251	0.74772	0.029
KAMIKUBO_MYELOID_MN1_NETWORK	19	http://www.broadinstitute.org/gsea/msigdb/cards/KAMIKUBO_MYELOID_MN1_NETWORK	-0.29688	-0.86401	0.6859	0.75744	1	0.316	0.209	0.25	0.74906	0.029
KEGG_FATTY_ACID_METABOLISM	41	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_FATTY_ACID_METABOLISM	-0.20886	-0.86306	0.6431	0.75881	1	0.22	0.206	0.174	0.75067	0.029
PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	328	http://www.broadinstitute.org/gsea/msigdb/cards/PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP	-0.17877	-0.86265	0.7951	0.75929	1	0.265	0.249	0.202	0.75154	0.029
SU_THYMUS	19	http://www.broadinstitute.org/gsea/msigdb/cards/SU_THYMUS	-0.32147	-0.86234	0.6479	0.75951	1	0.211	0.114	0.187	0.75183	0.029
KEGG_PANCREATIC_CANCER	69	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PANCREATIC_CANCER	-0.25375	-0.86191	0.6972	0.75996	1	0.13	0.0909	0.119	0.75173	0.029
MORI_IMMATURE_B_LYMPHOCYTE_UP	50	http://www.broadinstitute.org/gsea/msigdb/cards/MORI_IMMATURE_B_LYMPHOCYTE_UP	-0.2619	-0.86165	0.6175	0.76003	1	0.4	0.282	0.288	0.75226	0.029
MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP	-0.21045	-0.86139	0.6326	0.76017	1	0.256	0.253	0.192	0.75216	0.029
STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	48	http://www.broadinstitute.org/gsea/msigdb/cards/STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP	-0.26277	-0.86138	0.6869	0.75985	1	0.417	0.284	0.299	0.75184	0.029
GROSS_HYPOXIA_VIA_HIF1A_DN	106	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_HYPOXIA_VIA_HIF1A_DN	-0.21373	-0.86078	0.7041	0.76058	1	0.264	0.245	0.2	0.75266	0.029
WANG_LMO4_TARGETS_DN	332	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LMO4_TARGETS_DN	-0.2778	-0.86075	0.6582	0.76032	1	0.355	0.237	0.275	0.75234	0.029
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	112	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP	-0.27992	-0.86065	0.6466	0.76013	1	0.304	0.212	0.24	0.75202	0.029
KEGG_MAPK_SIGNALING_PATHWAY	260	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_MAPK_SIGNALING_PATHWAY	-0.16787	-0.86064	0.7247	0.75984	1	0.296	0.293	0.211	0.75173	0.029
BIOCARTA_VIP_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_VIP_PATHWAY	-0.29451	-0.86055	0.6499	0.75971	1	0.296	0.269	0.217	0.75141	0.029
GALE_APL_WITH_FLT3_MUTATED_UP	54	http://www.broadinstitute.org/gsea/msigdb/cards/GALE_APL_WITH_FLT3_MUTATED_UP	-0.33105	-0.86006	0.6556	0.76029	1	0.278	0.192	0.225	0.75266	0.029
CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	448	http://www.broadinstitute.org/gsea/msigdb/cards/CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5	-0.23105	-0.85943	0.6529	0.7611	1	0.205	0.174	0.173	0.75363	0.029
KARLSSON_TGFB1_TARGETS_DN	197	http://www.broadinstitute.org/gsea/msigdb/cards/KARLSSON_TGFB1_TARGETS_DN	-0.21392	-0.85925	0.6994	0.76106	1	0.218	0.178	0.181	0.75394	0.029
CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	37	http://www.broadinstitute.org/gsea/msigdb/cards/CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY	-0.24914	-0.85907	0.6857	0.76106	1	0.216	0.163	0.181	0.7541	0.029
KARLSSON_TGFB1_TARGETS_UP	121	http://www.broadinstitute.org/gsea/msigdb/cards/KARLSSON_TGFB1_TARGETS_UP	-0.2674	-0.85882	0.6667	0.76118	1	0.314	0.222	0.245	0.75414	0.029
REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	-0.26938	-0.85868	0.627	0.76112	1	0.156	0.122	0.137	0.75381	0.029
KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	88	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION	-0.21152	-0.85859	0.748	0.76098	1	0.239	0.215	0.188	0.7536	0.029
PID_EPHA_FWDPATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_EPHA_FWDPATHWAY	-0.2314	-0.85782	0.66	0.76186	1	0.324	0.251	0.243	0.75568	0.029
PID_HIV_NEF_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HIV_NEF_PATHWAY	-0.27954	-0.85766	0.6162	0.76181	1	0.265	0.197	0.213	0.75578	0.028
BOYLAN_MULTIPLE_MYELOMA_C_D_DN	237	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_C_D_DN	-0.20954	-0.85733	0.6877	0.76201	1	0.19	0.166	0.16	0.75593	0.028
DAZARD_UV_RESPONSE_CLUSTER_G4	20	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G4	-0.26908	-0.85715	0.6707	0.76204	1	0.4	0.302	0.279	0.75584	0.028
OSADA_ASCL1_TARGETS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/OSADA_ASCL1_TARGETS_UP	-0.21827	-0.85703	0.6982	0.76193	1	0.217	0.199	0.175	0.75552	0.028
CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	231	http://www.broadinstitute.org/gsea/msigdb/cards/CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	-0.21073	-0.85689	0.6712	0.76185	1	0.277	0.232	0.215	0.7557	0.028
BAE_BRCA1_TARGETS_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/BAE_BRCA1_TARGETS_DN	-0.26887	-0.85652	0.6704	0.76219	1	0.419	0.297	0.295	0.75594	0.028
VERHAAK_GLIOBLASTOMA_PRONEURAL	170	http://www.broadinstitute.org/gsea/msigdb/cards/VERHAAK_GLIOBLASTOMA_PRONEURAL	-0.20011	-0.85637	0.7249	0.76213	1	0.165	0.148	0.141	0.75562	0.028
CROONQUIST_STROMAL_STIMULATION_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/CROONQUIST_STROMAL_STIMULATION_UP	-0.33228	-0.85608	0.6333	0.7623	1	0.254	0.202	0.203	0.75538	0.028
CAIRO_HEPATOBLASTOMA_DN	257	http://www.broadinstitute.org/gsea/msigdb/cards/CAIRO_HEPATOBLASTOMA_DN	-0.16041	-0.85544	0.8214	0.76313	1	0.222	0.225	0.174	0.75613	0.028
MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	131	http://www.broadinstitute.org/gsea/msigdb/cards/MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP	-0.26073	-0.85515	0.7221	0.76334	1	0.282	0.211	0.224	0.75722	0.028
LIU_LIVER_CANCER	37	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_LIVER_CANCER	-0.22682	-0.85488	0.6398	0.76352	1	0.243	0.203	0.194	0.75715	0.028
MARSON_FOXP3_TARGETS_DN	52	http://www.broadinstitute.org/gsea/msigdb/cards/MARSON_FOXP3_TARGETS_DN	-0.21482	-0.85461	0.6952	0.76369	1	0.269	0.183	0.22	0.75701	0.028
WEI_MIR34A_TARGETS	139	http://www.broadinstitute.org/gsea/msigdb/cards/WEI_MIR34A_TARGETS	-0.23252	-0.85402	0.6673	0.76438	1	0.324	0.249	0.244	0.75739	0.028
REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE	-0.21938	-0.85189	0.688	0.76784	1	0.111	0.0791	0.102	0.76116	0.029
FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	313	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL	-0.21228	-0.85176	0.7889	0.76775	1	0.256	0.208	0.205	0.76083	0.029
ZWANG_EGF_INTERVAL_DN	199	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_INTERVAL_DN	-0.17734	-0.85163	0.7211	0.76769	1	0.241	0.24	0.185	0.76097	0.028
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	145	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-0.22323	-0.8514	0.6954	0.76781	1	0.303	0.221	0.238	0.76072	0.028
CHEN_LIVER_METABOLISM_QTL_CIS	89	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_LIVER_METABOLISM_QTL_CIS	-0.25432	-0.85138	0.6857	0.76751	1	0.225	0.177	0.186	0.7604	0.028
REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR	-0.30789	-0.85115	0.6634	0.7676	1	0.222	0.122	0.195	0.76023	0.028
DELACROIX_RAR_TARGETS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RAR_TARGETS_UP	-0.24818	-0.85046	0.6252	0.76855	1	0.17	0.161	0.143	0.7615	0.028
REACTOME_METAL_ION_SLC_TRANSPORTERS	22	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METAL_ION_SLC_TRANSPORTERS	-0.25717	-0.84958	0.7047	0.76972	1	0.0909	0.0374	0.0876	0.76297	0.028
BIOCARTA_LAIR_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_LAIR_PATHWAY	-0.34375	-0.84853	0.6635	0.77084	1	0.312	0.218	0.245	0.76432	0.028
REACTOME_PLATELET_HOMEOSTASIS	75	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLATELET_HOMEOSTASIS	-0.2174	-0.84853	0.6977	0.77117	1	0.253	0.23	0.196	0.76465	0.028
CHENG_IMPRINTED_BY_ESTRADIOL	103	http://www.broadinstitute.org/gsea/msigdb/cards/CHENG_IMPRINTED_BY_ESTRADIOL	-0.16491	-0.84743	0.7349	0.77236	1	0.194	0.22	0.152	0.76542	0.028
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	91	http://www.broadinstitute.org/gsea/msigdb/cards/GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN	-0.27118	-0.84714	0.7264	0.77253	1	0.363	0.224	0.282	0.76528	0.028
REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	164	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS	-0.24806	-0.84699	0.6762	0.77247	1	0.14	0.121	0.124	0.76558	0.028
ENK_UV_RESPONSE_KERATINOCYTE_DN	476	http://www.broadinstitute.org/gsea/msigdb/cards/ENK_UV_RESPONSE_KERATINOCYTE_DN	-0.27443	-0.84688	0.6505	0.77203	1	0.294	0.211	0.236	0.76531	0.028
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	47	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	-0.2116	-0.84688	0.6953	0.77236	1	0.34	0.28	0.246	0.76564	0.028
BILD_SRC_ONCOGENIC_SIGNATURE	60	http://www.broadinstitute.org/gsea/msigdb/cards/BILD_SRC_ONCOGENIC_SIGNATURE	-0.27767	-0.84651	0.6443	0.77232	1	0.333	0.253	0.25	0.76562	0.028
LIEN_BREAST_CARCINOMA_METAPLASTIC	34	http://www.broadinstitute.org/gsea/msigdb/cards/LIEN_BREAST_CARCINOMA_METAPLASTIC	-0.35782	-0.84619	0.6174	0.77253	1	0.176	0.0493	0.168	0.76574	0.028
REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	36	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER	-0.27129	-0.84614	0.6773	0.7723	1	0.167	0.101	0.15	0.76566	0.028
MEISSNER_BRAIN_HCP_WITH_H3K4ME2	16	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K4ME2	-0.31382	-0.84592	0.659	0.77239	1	0.25	0.201	0.2	0.76615	0.028
GROSS_ELK3_TARGETS_UP	26	http://www.broadinstitute.org/gsea/msigdb/cards/GROSS_ELK3_TARGETS_UP	-0.24364	-0.84577	0.7485	0.77234	1	0.192	0.121	0.169	0.76672	0.028
BURTON_ADIPOGENESIS_7	47	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_7	-0.27084	-0.84492	0.6707	0.77347	1	0.319	0.178	0.263	0.76739	0.028
LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	15	http://www.broadinstitute.org/gsea/msigdb/cards/LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED	-0.35373	-0.8449	0.677	0.77316	1	0.6	0.298	0.421	0.76707	0.028
SPIRA_SMOKERS_LUNG_CANCER_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/SPIRA_SMOKERS_LUNG_CANCER_UP	-0.3604	-0.84398	0.7175	0.77444	1	0.25	0.118	0.221	0.76908	0.028
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	107	http://www.broadinstitute.org/gsea/msigdb/cards/LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	-0.23648	-0.84362	0.7101	0.77474	1	0.215	0.16	0.181	0.76876	0.028
REACTOME_OPIOID_SIGNALLING	76	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OPIOID_SIGNALLING	-0.20617	-0.84334	0.7628	0.77494	1	0.211	0.189	0.171	0.76872	0.028
PID_RXR_VDR_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RXR_VDR_PATHWAY	-0.23114	-0.84328	0.6551	0.7747	1	0.346	0.301	0.242	0.76843	0.028
BIOCARTA_P38MAPK_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_P38MAPK_PATHWAY	-0.26268	-0.84289	0.6802	0.7751	1	0.237	0.179	0.195	0.76886	0.028
PID_VEGFR1_2_PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/PID_VEGFR1_2_PATHWAY	-0.22526	-0.84277	0.7054	0.775	1	0.471	0.324	0.319	0.7692	0.028
PID_LYMPH_ANGIOGENESIS_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/PID_LYMPH_ANGIOGENESIS_PATHWAY	-0.31668	-0.84275	0.6267	0.7747	1	0.32	0.178	0.263	0.76887	0.028
CHEN_HOXA5_TARGETS_9HR_UP	212	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_HOXA5_TARGETS_9HR_UP	-0.28436	-0.84275	0.6628	0.77438	1	0.363	0.26	0.271	0.76855	0.028
REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	28	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS	-0.345	-0.84099	0.6772	0.77708	1	0.571	0.282	0.411	0.77147	0.028
DAZARD_UV_RESPONSE_CLUSTER_G1	64	http://www.broadinstitute.org/gsea/msigdb/cards/DAZARD_UV_RESPONSE_CLUSTER_G1	-0.24567	-0.84056	0.7289	0.77751	1	0.156	0.103	0.141	0.77125	0.028
BRUINS_UVC_RESPONSE_EARLY_LATE	293	http://www.broadinstitute.org/gsea/msigdb/cards/BRUINS_UVC_RESPONSE_EARLY_LATE	-0.21796	-0.83984	0.7434	0.77846	1	0.208	0.178	0.173	0.77171	0.028
CHEBOTAEV_GR_TARGETS_UP	72	http://www.broadinstitute.org/gsea/msigdb/cards/CHEBOTAEV_GR_TARGETS_UP	-0.23275	-0.8396	0.6862	0.77855	1	0.278	0.199	0.223	0.77217	0.028
ROZANOV_MMP14_TARGETS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/ROZANOV_MMP14_TARGETS_DN	-0.26316	-0.83932	0.6917	0.77866	1	0.25	0.169	0.208	0.77263	0.028
LEE_LIVER_CANCER_MYC_TGFA_DN	62	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER_MYC_TGFA_DN	-0.22133	-0.83808	0.7778	0.78039	1	0.226	0.199	0.181	0.77484	0.028
SASSON_RESPONSE_TO_GONADOTROPHINS_DN	87	http://www.broadinstitute.org/gsea/msigdb/cards/SASSON_RESPONSE_TO_GONADOTROPHINS_DN	-0.24086	-0.83752	0.7227	0.78107	1	0.241	0.189	0.196	0.77537	0.028
FAELT_B_CLL_WITH_VH3_21_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/FAELT_B_CLL_WITH_VH3_21_DN	-0.25604	-0.83746	0.6771	0.78082	1	0.319	0.232	0.245	0.77518	0.028
BIOCARTA_PYK2_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PYK2_PATHWAY	-0.2652	-0.8372	0.7276	0.78097	1	0.517	0.324	0.35	0.77486	0.028
MATZUK_SPERMATID_DIFFERENTIATION	37	http://www.broadinstitute.org/gsea/msigdb/cards/MATZUK_SPERMATID_DIFFERENTIATION	-0.24407	-0.83672	0.7479	0.78145	1	0.162	0.0569	0.153	0.77631	0.028
HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN	-0.22602	-0.83648	0.7441	0.78152	1	0.188	0.133	0.163	0.77628	0.028
CHEN_PDGF_TARGETS	17	http://www.broadinstitute.org/gsea/msigdb/cards/CHEN_PDGF_TARGETS	-0.3111	-0.83635	0.6451	0.78145	1	0.412	0.213	0.324	0.77619	0.028
REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS	-0.28399	-0.83621	0.736	0.78138	1	0.267	0.207	0.212	0.7761	0.028
REACTOME_DARPP_32_EVENTS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DARPP_32_EVENTS	-0.25265	-0.83617	0.7026	0.78112	1	0.167	0.116	0.147	0.77577	0.028
RAO_BOUND_BY_SALL4_ISOFORM_B	489	http://www.broadinstitute.org/gsea/msigdb/cards/RAO_BOUND_BY_SALL4_ISOFORM_B	-0.22135	-0.8358	0.7808	0.78141	1	0.256	0.22	0.203	0.7759	0.028
MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP	-0.30492	-0.83541	0.6948	0.78171	1	0.32	0.224	0.248	0.77622	0.028
MCCABE_HOXC6_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/MCCABE_HOXC6_TARGETS_DN	-0.30471	-0.8353	0.7409	0.78158	1	0.105	0.0456	0.101	0.77607	0.028
LEIN_MIDBRAIN_MARKERS	80	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_MIDBRAIN_MARKERS	-0.18622	-0.83504	0.7232	0.78168	1	0.125	0.117	0.111	0.77612	0.028
WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	54	http://www.broadinstitute.org/gsea/msigdb/cards/WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP	-0.28089	-0.83425	0.615	0.78275	1	0.185	0.134	0.161	0.77724	0.028
WANG_METHYLATED_IN_BREAST_CANCER	35	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_METHYLATED_IN_BREAST_CANCER	-0.26412	-0.83411	0.6627	0.78272	1	0.457	0.343	0.301	0.77713	0.028
REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	38	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NUCLEAR_SIGNALING_BY_ERBB4	-0.2411	-0.83403	0.7665	0.78251	1	0.316	0.206	0.251	0.7768	0.028
FORTSCHEGGER_PHF8_TARGETS_UP	252	http://www.broadinstitute.org/gsea/msigdb/cards/FORTSCHEGGER_PHF8_TARGETS_UP	-0.24815	-0.83336	0.7126	0.78335	1	0.238	0.173	0.199	0.77757	0.028
CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN	-0.36141	-0.83243	0.6478	0.78462	1	0.286	0.178	0.235	0.77863	0.028
VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	38	http://www.broadinstitute.org/gsea/msigdb/cards/VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1	-0.24893	-0.83233	0.6506	0.78446	1	0.289	0.257	0.215	0.7783	0.028
WANG_RECURRENT_LIVER_CANCER_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_RECURRENT_LIVER_CANCER_UP	-0.37135	-0.83209	0.6721	0.78453	1	0.35	0.176	0.289	0.77848	0.028
LIN_NPAS4_TARGETS_UP	153	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_NPAS4_TARGETS_UP	-0.2162	-0.83173	0.7562	0.78485	1	0.157	0.134	0.137	0.779	0.028
REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	26	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS	-0.3485	-0.83153	0.6959	0.78487	1	0.192	0.0656	0.18	0.77896	0.028
YIH_RESPONSE_TO_ARSENITE_C3	35	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C3	-0.23736	-0.83021	0.7731	0.78684	1	0.486	0.318	0.332	0.78179	0.028
LEE_DOUBLE_POLAR_THYMOCYTE	24	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_DOUBLE_POLAR_THYMOCYTE	-0.27773	-0.82965	0.6889	0.78743	1	0.125	0.045	0.119	0.78201	0.028
REACTOME_METABOLISM_OF_MRNA	211	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_MRNA	-0.24592	-0.82954	0.716	0.78732	1	0.227	0.187	0.187	0.78168	0.028
BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/BOYLAN_MULTIPLE_MYELOMA_PCA3_UP	-0.25219	-0.82952	0.7769	0.78703	1	0.203	0.148	0.173	0.78136	0.028
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	75	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	-0.25147	-0.82925	0.7241	0.78717	1	0.32	0.212	0.253	0.78149	0.028
TSUNODA_CISPLATIN_RESISTANCE_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/TSUNODA_CISPLATIN_RESISTANCE_UP	-0.36538	-0.8292	0.6653	0.78691	1	0.267	0.135	0.231	0.78123	0.028
PID_INTEGRIN1_PATHWAY	66	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN1_PATHWAY	-0.279	-0.82901	0.6126	0.7869	1	0.364	0.307	0.253	0.78091	0.028
REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	177	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_G_ALPHA_I_SIGNALLING_EVENTS	-0.21834	-0.82869	0.7008	0.78708	1	0.124	0.122	0.11	0.78084	0.028
TRACEY_RESISTANCE_TO_IFNA2_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/TRACEY_RESISTANCE_TO_IFNA2_DN	-0.25322	-0.82867	0.6765	0.78679	1	0.355	0.271	0.259	0.781	0.028
DANG_REGULATED_BY_MYC_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/DANG_REGULATED_BY_MYC_UP	-0.24678	-0.82808	0.7137	0.78743	1	0.296	0.254	0.221	0.78235	0.028
ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	477	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF	-0.19028	-0.82759	0.7471	0.78793	1	0.245	0.221	0.195	0.78279	0.028
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	183	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-0.27911	-0.82609	0.6838	0.79016	1	0.295	0.225	0.23	0.78512	0.028
MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	18	http://www.broadinstitute.org/gsea/msigdb/cards/MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23	-0.30963	-0.8257	0.7138	0.79055	1	0.5	0.297	0.352	0.78588	0.028
KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	57	http://www.broadinstitute.org/gsea/msigdb/cards/KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN	-0.19984	-0.82521	0.7336	0.79104	1	0.246	0.251	0.184	0.78665	0.028
INGRAM_SHH_TARGETS_DN	58	http://www.broadinstitute.org/gsea/msigdb/cards/INGRAM_SHH_TARGETS_DN	-0.227	-0.82413	0.7633	0.79255	1	0.155	0.146	0.133	0.79011	0.028
REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	79	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MYD88_MAL_CASCADE_INITIATED_ON_PLASMA_MEMBRANE	-0.22411	-0.82397	0.7832	0.79249	1	0.253	0.23	0.195	0.78978	0.028
REACTOME_GLOBAL_GENOMIC_NER_GG_NER	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLOBAL_GENOMIC_NER_GG_NER	-0.25345	-0.82395	0.675	0.7922	1	0.188	0.162	0.157	0.7895	0.028
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	55	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	-0.22994	-0.82384	0.695	0.79207	1	0.164	0.203	0.131	0.78917	0.028
ROME_INSULIN_TARGETS_IN_MUSCLE_UP	416	http://www.broadinstitute.org/gsea/msigdb/cards/ROME_INSULIN_TARGETS_IN_MUSCLE_UP	-0.21693	-0.8238	0.721	0.7918	1	0.264	0.216	0.211	0.78885	0.028
REACTOME_GLUCOSE_TRANSPORT	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLUCOSE_TRANSPORT	-0.28448	-0.82376	0.6869	0.79153	1	0.429	0.275	0.311	0.78852	0.028
PID_ATM_PATHWAY	34	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ATM_PATHWAY	-0.28845	-0.82368	0.7398	0.79128	1	0.294	0.142	0.253	0.7882	0.028
IKEDA_MIR1_TARGETS_UP	53	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR1_TARGETS_UP	-0.3053	-0.82318	0.6856	0.79178	1	0.226	0.121	0.199	0.78794	0.028
PID_FAS_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FAS_PATHWAY	-0.28255	-0.82311	0.6937	0.79158	1	0.189	0.143	0.162	0.78785	0.028
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	311	http://www.broadinstitute.org/gsea/msigdb/cards/GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN	-0.16777	-0.82298	0.6126	0.79148	1	0.286	0.299	0.203	0.78777	0.028
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	78	http://www.broadinstitute.org/gsea/msigdb/cards/LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP	-0.20528	-0.82286	0.775	0.79138	1	0.128	0.107	0.115	0.78803	0.028
MCCLUNG_DELTA_FOSB_TARGETS_2WK	44	http://www.broadinstitute.org/gsea/msigdb/cards/MCCLUNG_DELTA_FOSB_TARGETS_2WK	-0.24809	-0.82165	0.6764	0.79317	1	0.182	0.154	0.154	0.78925	0.028
WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	39	http://www.broadinstitute.org/gsea/msigdb/cards/WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2	-0.20174	-0.82073	0.721	0.79444	1	0.436	0.342	0.287	0.79084	0.028
RIZ_ERYTHROID_DIFFERENTIATION_6HR	39	http://www.broadinstitute.org/gsea/msigdb/cards/RIZ_ERYTHROID_DIFFERENTIATION_6HR	-0.25348	-0.82062	0.701	0.79432	1	0.0769	0.0504	0.0732	0.791	0.028
KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	105	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY	-0.20802	-0.82035	0.7407	0.79444	1	0.352	0.301	0.247	0.791	0.028
EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	50	http://www.broadinstitute.org/gsea/msigdb/cards/EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION	-0.24383	-0.82008	0.6544	0.79458	1	0.2	0.188	0.163	0.79159	0.028
UEDA_CENTRAL_CLOCK	87	http://www.broadinstitute.org/gsea/msigdb/cards/UEDA_CENTRAL_CLOCK	-0.20459	-0.8199	0.7893	0.79455	1	0.241	0.203	0.193	0.79128	0.028
MANTOVANI_NFKB_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/MANTOVANI_NFKB_TARGETS_UP	-0.26799	-0.81922	0.6441	0.79534	1	0.186	0.163	0.156	0.79189	0.028
JIANG_AGING_HYPOTHALAMUS_UP	46	http://www.broadinstitute.org/gsea/msigdb/cards/JIANG_AGING_HYPOTHALAMUS_UP	-0.26074	-0.81861	0.6722	0.7961	1	0.37	0.264	0.272	0.79231	0.028
WANG_LMO4_TARGETS_UP	341	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_LMO4_TARGETS_UP	-0.22874	-0.81829	0.7366	0.79629	1	0.191	0.154	0.163	0.79295	0.028
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	63	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	-0.21783	-0.81818	0.7774	0.79614	1	0.349	0.241	0.266	0.7931	0.028
BROWNE_HCMV_INFECTION_4HR_UP	52	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_4HR_UP	-0.26131	-0.81767	0.7538	0.79672	1	0.462	0.255	0.344	0.79342	0.028
HENDRICKS_SMARCA4_TARGETS_DN	49	http://www.broadinstitute.org/gsea/msigdb/cards/HENDRICKS_SMARCA4_TARGETS_DN	-0.24519	-0.81752	0.7121	0.79664	1	0.0612	0.0314	0.0594	0.79372	0.028
SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN	-0.30039	-0.81724	0.6716	0.79683	1	0.211	0.16	0.177	0.7938	0.028
FIRESTEIN_CTNNB1_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/FIRESTEIN_CTNNB1_PATHWAY	-0.25162	-0.8168	0.728	0.79721	1	0.242	0.185	0.198	0.79348	0.028
BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN	-0.32387	-0.81574	0.651	0.79869	1	0.471	0.259	0.349	0.79531	0.028
BIOCARTA_CREB_PATHWAY	27	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CREB_PATHWAY	-0.26545	-0.81511	0.7329	0.79946	1	0.148	0.128	0.129	0.79609	0.028
ROSS_LEUKEMIA_WITH_MLL_FUSIONS	73	http://www.broadinstitute.org/gsea/msigdb/cards/ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-0.23475	-0.81486	0.7515	0.7995	1	0.0822	0.0423	0.0789	0.79597	0.028
SCHOEN_NFKB_SIGNALING	33	http://www.broadinstitute.org/gsea/msigdb/cards/SCHOEN_NFKB_SIGNALING	-0.34027	-0.81467	0.6839	0.79948	1	0.394	0.222	0.307	0.79752	0.028
BRUECKNER_TARGETS_OF_MIRLET7A3_UP	103	http://www.broadinstitute.org/gsea/msigdb/cards/BRUECKNER_TARGETS_OF_MIRLET7A3_UP	-0.22362	-0.81436	0.7336	0.79966	1	0.184	0.159	0.156	0.79802	0.028
LEE_EARLY_T_LYMPHOCYTE_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_EARLY_T_LYMPHOCYTE_DN	-0.24185	-0.81385	0.7146	0.8002	1	0.216	0.159	0.182	0.79798	0.028
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	154	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-0.29786	-0.81326	0.6654	0.80088	1	0.331	0.218	0.26	0.79932	0.028
RAO_BOUND_BY_SALL4	218	http://www.broadinstitute.org/gsea/msigdb/cards/RAO_BOUND_BY_SALL4	-0.20384	-0.81311	0.8369	0.80079	1	0.197	0.159	0.167	0.79925	0.028
BIOCARTA_VEGF_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_VEGF_PATHWAY	-0.2689	-0.81234	0.6874	0.80174	1	0.448	0.318	0.306	0.79995	0.028
WOO_LIVER_CANCER_RECURRENCE_UP	102	http://www.broadinstitute.org/gsea/msigdb/cards/WOO_LIVER_CANCER_RECURRENCE_UP	-0.25626	-0.81232	0.7442	0.80147	1	0.235	0.19	0.191	0.79963	0.028
REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	64	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	-0.19871	-0.81171	0.7149	0.80214	1	0.281	0.254	0.21	0.80062	0.027
MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	381	http://www.broadinstitute.org/gsea/msigdb/cards/MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP	-0.20039	-0.81135	0.7817	0.80244	1	0.281	0.23	0.219	0.8011	0.027
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	132	http://www.broadinstitute.org/gsea/msigdb/cards/LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-0.25534	-0.81104	0.7337	0.80262	1	0.159	0.129	0.139	0.8016	0.027
LANG_MYB_FAMILY_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/LANG_MYB_FAMILY_TARGETS	-0.30191	-0.81027	0.7241	0.8036	1	0.31	0.181	0.254	0.80168	0.027
PID_KIT_PATHWAY	52	http://www.broadinstitute.org/gsea/msigdb/cards/PID_KIT_PATHWAY	-0.22698	-0.80983	0.7679	0.80397	1	0.346	0.247	0.261	0.80273	0.027
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	141	http://www.broadinstitute.org/gsea/msigdb/cards/IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-0.21883	-0.80969	0.7617	0.80384	1	0.397	0.316	0.273	0.80297	0.027
HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	98	http://www.broadinstitute.org/gsea/msigdb/cards/HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN	-0.25787	-0.80951	0.7359	0.8038	1	0.296	0.172	0.246	0.80285	0.027
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	117	http://www.broadinstitute.org/gsea/msigdb/cards/STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-0.24308	-0.80928	0.6961	0.80386	1	0.248	0.204	0.198	0.80264	0.027
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	76	http://www.broadinstitute.org/gsea/msigdb/cards/SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-0.26758	-0.80919	0.7332	0.80371	1	0.316	0.189	0.257	0.80313	0.027
REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING	-0.27982	-0.80917	0.6901	0.80343	1	0.16	0.0869	0.146	0.8028	0.027
AZARE_STAT3_TARGETS	23	http://www.broadinstitute.org/gsea/msigdb/cards/AZARE_STAT3_TARGETS	-0.31394	-0.80899	0.7333	0.8034	1	0.304	0.191	0.247	0.80262	0.027
BIOCARTA_TPO_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TPO_PATHWAY	-0.27755	-0.80871	0.7352	0.80357	1	0.304	0.213	0.24	0.80314	0.027
LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	54	http://www.broadinstitute.org/gsea/msigdb/cards/LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN	-0.19829	-0.80864	0.7635	0.80334	1	0.296	0.28	0.214	0.80281	0.027
MARTIN_INTERACT_WITH_HDAC	44	http://www.broadinstitute.org/gsea/msigdb/cards/MARTIN_INTERACT_WITH_HDAC	-0.22514	-0.80831	0.752	0.80359	1	0.25	0.196	0.201	0.80274	0.027
PID_MET_PATHWAY	79	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MET_PATHWAY	-0.23174	-0.80765	0.7694	0.80439	1	0.316	0.255	0.236	0.80316	0.027
SANSOM_APC_TARGETS_DN	352	http://www.broadinstitute.org/gsea/msigdb/cards/SANSOM_APC_TARGETS_DN	-0.1634	-0.80764	0.75	0.80409	1	0.264	0.295	0.189	0.80284	0.027
KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	39	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS	-0.21053	-0.80741	0.7339	0.80413	1	0.256	0.224	0.199	0.80311	0.027
MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	349	http://www.broadinstitute.org/gsea/msigdb/cards/MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN	-0.20348	-0.80738	0.7843	0.80387	1	0.226	0.205	0.182	0.80279	0.027
VERNELL_RETINOBLASTOMA_PATHWAY_DN	22	http://www.broadinstitute.org/gsea/msigdb/cards/VERNELL_RETINOBLASTOMA_PATHWAY_DN	-0.27852	-0.80701	0.7308	0.80415	1	0.0909	0.0343	0.0879	0.80318	0.026
BIOCARTA_HIVNEF_PATHWAY	56	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HIVNEF_PATHWAY	-0.2375	-0.80635	0.6994	0.8049	1	0.25	0.197	0.201	0.80443	0.027
AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	280	http://www.broadinstitute.org/gsea/msigdb/cards/AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP	-0.17945	-0.80533	0.7534	0.80624	1	0.264	0.264	0.197	0.80595	0.027
MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	35	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED	-0.25155	-0.80458	0.75	0.80717	1	0.114	0.0774	0.106	0.80694	0.027
BIOCARTA_RAC1_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RAC1_PATHWAY	-0.26564	-0.80445	0.765	0.80706	1	0.227	0.127	0.199	0.80668	0.027
KEGG_SPHINGOLIPID_METABOLISM	38	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_SPHINGOLIPID_METABOLISM	-0.19941	-0.80397	0.7712	0.80754	1	0.289	0.263	0.214	0.80691	0.027
SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	159	http://www.broadinstitute.org/gsea/msigdb/cards/SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP	-0.23062	-0.80333	0.7538	0.80829	1	0.264	0.218	0.208	0.80799	0.027
REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SIGNALING_BY_FGFR1_FUSION_MUTANTS	-0.30806	-0.80297	0.7892	0.80853	1	0.222	0.139	0.191	0.8085	0.027
DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	245	http://www.broadinstitute.org/gsea/msigdb/cards/DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP	-0.2058	-0.8025	0.7767	0.80897	1	0.257	0.228	0.2	0.80853	0.027
KEGG_INSULIN_SIGNALING_PATHWAY	136	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_INSULIN_SIGNALING_PATHWAY	-0.16885	-0.8024	0.8631	0.80879	1	0.426	0.338	0.284	0.80821	0.027
BIOCARTA_TNFR2_PATHWAY	18	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TNFR2_PATHWAY	-0.27971	-0.8016	0.6905	0.80983	1	0.389	0.311	0.268	0.81043	0.027
REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	33	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT	-0.23128	-0.80115	0.7627	0.81023	1	0.0909	0.0654	0.0851	0.81043	0.027
PID_MYC_PATHWAY	24	http://www.broadinstitute.org/gsea/msigdb/cards/PID_MYC_PATHWAY	-0.31784	-0.801	0.6814	0.81016	1	0.292	0.216	0.229	0.81011	0.026
SCHEIDEREIT_IKK_INTERACTING_PROTEINS	58	http://www.broadinstitute.org/gsea/msigdb/cards/SCHEIDEREIT_IKK_INTERACTING_PROTEINS	-0.18854	-0.80085	0.7776	0.81005	1	0.414	0.297	0.291	0.80978	0.026
REACTOME_PLC_BETA_MEDIATED_EVENTS	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PLC_BETA_MEDIATED_EVENTS	-0.24307	-0.80058	0.7698	0.81018	1	0.357	0.283	0.256	0.8104	0.026
SWEET_KRAS_ONCOGENIC_SIGNATURE	87	http://www.broadinstitute.org/gsea/msigdb/cards/SWEET_KRAS_ONCOGENIC_SIGNATURE	-0.22523	-0.8005	0.7628	0.80998	1	0.276	0.228	0.214	0.81007	0.026
MIZUSHIMA_AUTOPHAGOSOME_FORMATION	18	http://www.broadinstitute.org/gsea/msigdb/cards/MIZUSHIMA_AUTOPHAGOSOME_FORMATION	-0.28016	-0.80029	0.7686	0.81004	1	0.167	0.0977	0.15	0.81036	0.026
CHANG_CORE_SERUM_RESPONSE_DN	195	http://www.broadinstitute.org/gsea/msigdb/cards/CHANG_CORE_SERUM_RESPONSE_DN	-0.19781	-0.79943	0.7653	0.81109	1	0.164	0.146	0.141	0.81213	0.026
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP	-0.27138	-0.79806	0.8045	0.81304	1	0.389	0.24	0.296	0.81449	0.026
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	156	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN	-0.16509	-0.79759	0.824	0.81346	1	0.0705	0.0763	0.0655	0.81479	0.026
REACTOME_CIRCADIAN_CLOCK	51	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CIRCADIAN_CLOCK	-0.20643	-0.79754	0.7661	0.81323	1	0.275	0.228	0.212	0.81446	0.026
NIELSEN_LEIOMYOSARCOMA_CNN1_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_CNN1_DN	-0.30914	-0.79743	0.7004	0.81307	1	0.25	0.0997	0.225	0.81465	0.026
BIOCARTA_MYOSIN_PATHWAY	31	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MYOSIN_PATHWAY	-0.20065	-0.79608	0.7816	0.81489	1	0.0968	0.061	0.091	0.81572	0.027
ZHAN_MULTIPLE_MYELOMA_LB_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_LB_UP	-0.18632	-0.79597	0.7538	0.81476	1	0.238	0.254	0.178	0.81539	0.027
KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	243	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION	-0.20116	-0.79571	0.788	0.81487	1	0.169	0.17	0.141	0.81597	0.027
YANAGIHARA_ESX1_TARGETS	29	http://www.broadinstitute.org/gsea/msigdb/cards/YANAGIHARA_ESX1_TARGETS	-0.30603	-0.79533	0.7714	0.81478	1	0.345	0.157	0.291	0.8165	0.026
STAEGE_EWING_FAMILY_TUMOR	28	http://www.broadinstitute.org/gsea/msigdb/cards/STAEGE_EWING_FAMILY_TUMOR	-0.23344	-0.79533	0.7954	0.8151	1	0.0714	0.0472	0.0681	0.81682	0.027
NIELSEN_LIPOSARCOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LIPOSARCOMA_DN	-0.28386	-0.79473	0.765	0.81537	1	0.158	0.0924	0.143	0.81681	0.027
CHIBA_RESPONSE_TO_TSA	45	http://www.broadinstitute.org/gsea/msigdb/cards/CHIBA_RESPONSE_TO_TSA	-0.20945	-0.7943	0.7324	0.81578	1	0.422	0.293	0.299	0.81688	0.027
AMIT_EGF_RESPONSE_120_MCF10A	41	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_120_MCF10A	-0.20113	-0.79362	0.7694	0.81654	1	0.293	0.264	0.216	0.81892	0.027
TIAN_TNF_SIGNALING_VIA_NFKB	27	http://www.broadinstitute.org/gsea/msigdb/cards/TIAN_TNF_SIGNALING_VIA_NFKB	-0.30536	-0.79325	0.6892	0.81679	1	0.259	0.196	0.209	0.81869	0.027
BIOCARTA_CERAMIDE_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CERAMIDE_PATHWAY	-0.27832	-0.7931	0.7284	0.81669	1	0.455	0.352	0.295	0.81861	0.027
LIU_TARGETS_OF_VMYB_VS_CMYB_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_TARGETS_OF_VMYB_VS_CMYB_UP	-0.28918	-0.79281	0.7357	0.81684	1	0.176	0.131	0.153	0.81899	0.027
BROWNE_HCMV_INFECTION_20HR_DN	98	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_20HR_DN	-0.26269	-0.79265	0.7274	0.81678	1	0.265	0.227	0.206	0.81886	0.026
TERAO_AOX4_TARGETS_SKIN_UP	36	http://www.broadinstitute.org/gsea/msigdb/cards/TERAO_AOX4_TARGETS_SKIN_UP	-0.27119	-0.79258	0.7929	0.8166	1	0.222	0.166	0.186	0.8187	0.026
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN	-0.25362	-0.79238	0.7343	0.81659	1	0.105	0.0494	0.1	0.81873	0.027
BIOCARTA_IGF1MTOR_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IGF1MTOR_PATHWAY	-0.29985	-0.79205	0.7464	0.81676	1	0.2	0.117	0.177	0.81882	0.027
REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN	-0.26271	-0.7913	0.8047	0.81765	1	0.519	0.313	0.356	0.82017	0.027
JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	37	http://www.broadinstitute.org/gsea/msigdb/cards/JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER	-0.28697	-0.79104	0.7388	0.81775	1	0.27	0.184	0.221	0.82014	0.026
SESTO_RESPONSE_TO_UV_C8	71	http://www.broadinstitute.org/gsea/msigdb/cards/SESTO_RESPONSE_TO_UV_C8	-0.26648	-0.79075	0.7174	0.81788	1	0.183	0.155	0.155	0.82039	0.026
LIN_MELANOMA_COPY_NUMBER_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/LIN_MELANOMA_COPY_NUMBER_DN	-0.24363	-0.79045	0.7398	0.81802	1	0.282	0.165	0.236	0.82063	0.026
VALK_AML_WITH_CEBPA	35	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_WITH_CEBPA	-0.18979	-0.79023	0.7574	0.81804	1	0.371	0.324	0.251	0.82093	0.026
CAMPS_COLON_CANCER_COPY_NUMBER_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/CAMPS_COLON_CANCER_COPY_NUMBER_UP	-0.17694	-0.78991	0.8111	0.81821	1	0.0488	0.043	0.0468	0.82122	0.026
BIOCARTA_IL6_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_IL6_PATHWAY	-0.25039	-0.78957	0.7593	0.81839	1	0.45	0.324	0.304	0.82104	0.026
BARIS_THYROID_CANCER_DN	59	http://www.broadinstitute.org/gsea/msigdb/cards/BARIS_THYROID_CANCER_DN	-0.22551	-0.78957	0.8419	0.81807	1	0.322	0.266	0.237	0.82072	0.025
HAMAI_APOPTOSIS_VIA_TRAIL_DN	169	http://www.broadinstitute.org/gsea/msigdb/cards/HAMAI_APOPTOSIS_VIA_TRAIL_DN	-0.19046	-0.78947	0.6667	0.81788	1	0.178	0.201	0.143	0.82039	0.025
NGUYEN_NOTCH1_TARGETS_DN	85	http://www.broadinstitute.org/gsea/msigdb/cards/NGUYEN_NOTCH1_TARGETS_DN	-0.22002	-0.7893	0.7718	0.81785	1	0.118	0.0935	0.107	0.8209	0.025
BIOCARTA_RELA_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_RELA_PATHWAY	-0.29331	-0.78927	0.6742	0.81762	1	0.312	0.313	0.215	0.82058	0.025
WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	54	http://www.broadinstitute.org/gsea/msigdb/cards/WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER	-0.28075	-0.78879	0.7143	0.81806	1	0.148	0.0808	0.136	0.82058	0.025
KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	307	http://www.broadinstitute.org/gsea/msigdb/cards/KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN	-0.19678	-0.78856	0.7476	0.81812	1	0.186	0.175	0.155	0.82102	0.025
KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	43	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION	-0.26894	-0.78829	0.7109	0.81824	1	0.302	0.206	0.24	0.82142	0.025
WANG_SMARCE1_TARGETS_UP	269	http://www.broadinstitute.org/gsea/msigdb/cards/WANG_SMARCE1_TARGETS_UP	-0.23981	-0.78763	0.749	0.81896	1	0.245	0.174	0.205	0.82251	0.025
WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN	-0.28379	-0.78727	0.8506	0.81918	1	0.167	0.0829	0.153	0.82219	0.025
CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	35	http://www.broadinstitute.org/gsea/msigdb/cards/CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY	-0.23488	-0.78665	0.8155	0.8199	1	0.2	0.139	0.173	0.82265	0.025
BIOCARTA_HER2_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HER2_PATHWAY	-0.31158	-0.78656	0.7382	0.81971	1	0.591	0.324	0.4	0.82233	0.025
PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	50	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ANGIOPOIETIN_RECEPTOR_PATHWAY	-0.208	-0.78569	0.783	0.82072	1	0.22	0.185	0.18	0.82387	0.025
MALONEY_RESPONSE_TO_17AAG_UP	40	http://www.broadinstitute.org/gsea/msigdb/cards/MALONEY_RESPONSE_TO_17AAG_UP	-0.19696	-0.78561	0.7443	0.82054	1	0.25	0.257	0.186	0.82354	0.025
LANDEMAINE_LUNG_METASTASIS	21	http://www.broadinstitute.org/gsea/msigdb/cards/LANDEMAINE_LUNG_METASTASIS	-0.31124	-0.7855	0.7668	0.82038	1	0.19	0.07	0.177	0.82322	0.025
HUMMERICH_BENIGN_SKIN_TUMOR_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/HUMMERICH_BENIGN_SKIN_TUMOR_DN	-0.26998	-0.78523	0.7183	0.82047	1	0.5	0.38	0.31	0.82311	0.025
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	180	http://www.broadinstitute.org/gsea/msigdb/cards/LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	-0.2182	-0.78483	0.7763	0.82079	1	0.106	0.0972	0.096	0.8239	0.025
SMID_BREAST_CANCER_NORMAL_LIKE_UP	441	http://www.broadinstitute.org/gsea/msigdb/cards/SMID_BREAST_CANCER_NORMAL_LIKE_UP	-0.19716	-0.7846	0.8015	0.82083	1	0.145	0.148	0.126	0.82407	0.025
BIOCARTA_FAS_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_FAS_PATHWAY	-0.31873	-0.78419	0.7016	0.82109	1	0.4	0.254	0.299	0.82411	0.025
LIM_MAMMARY_LUMINAL_MATURE_DN	96	http://www.broadinstitute.org/gsea/msigdb/cards/LIM_MAMMARY_LUMINAL_MATURE_DN	-0.23566	-0.78401	0.7267	0.82108	1	0.135	0.118	0.12	0.82387	0.025
REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE	-0.27312	-0.78383	0.7485	0.82106	1	0.375	0.247	0.283	0.82375	0.025
REACTOME_DAG_AND_IP3_SIGNALING	31	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DAG_AND_IP3_SIGNALING	-0.21154	-0.78368	0.7808	0.82095	1	0.355	0.283	0.255	0.82395	0.025
INGRAM_SHH_TARGETS_UP	123	http://www.broadinstitute.org/gsea/msigdb/cards/INGRAM_SHH_TARGETS_UP	-0.20154	-0.78349	0.7888	0.82092	1	0.26	0.22	0.204	0.82364	0.025
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	113	http://www.broadinstitute.org/gsea/msigdb/cards/DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	-0.1923	-0.78316	0.7866	0.82115	1	0.133	0.129	0.116	0.8243	0.025
BOUDOUKHA_BOUND_BY_IGF2BP2	103	http://www.broadinstitute.org/gsea/msigdb/cards/BOUDOUKHA_BOUND_BY_IGF2BP2	-0.19617	-0.78213	0.7863	0.82237	1	0.214	0.179	0.176	0.82601	0.025
REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_RIBONUCLEOPROTEINS_INTO_THE_HOST_NUCLEUS	-0.36479	-0.78187	0.672	0.82247	1	0.625	0.282	0.449	0.82628	0.025
PID_ARF6_TRAFFICKING_PATHWAY	49	http://www.broadinstitute.org/gsea/msigdb/cards/PID_ARF6_TRAFFICKING_PATHWAY	-0.21507	-0.78032	0.7977	0.82456	1	0.224	0.175	0.186	0.82905	0.025
MA_PITUITARY_FETAL_VS_ADULT_UP	28	http://www.broadinstitute.org/gsea/msigdb/cards/MA_PITUITARY_FETAL_VS_ADULT_UP	-0.26299	-0.77944	0.7788	0.82564	1	0.107	0.0614	0.101	0.83051	0.025
RODWELL_AGING_KIDNEY_NO_BLOOD_UP	206	http://www.broadinstitute.org/gsea/msigdb/cards/RODWELL_AGING_KIDNEY_NO_BLOOD_UP	-0.23683	-0.77868	0.7813	0.82653	1	0.243	0.191	0.198	0.83123	0.025
PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	45	http://www.broadinstitute.org/gsea/msigdb/cards/PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1	-0.22746	-0.77831	0.7274	0.82681	1	0.4	0.277	0.29	0.83093	0.025
REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	134	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NGF_SIGNALLING_VIA_TRKA_FROM_THE_PLASMA_MEMBRANE	-0.16745	-0.77745	0.9232	0.82786	1	0.306	0.283	0.221	0.83207	0.025
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	390	http://www.broadinstitute.org/gsea/msigdb/cards/SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP	-0.25742	-0.77725	0.8714	0.82787	1	0.3	0.199	0.244	0.83175	0.025
RAMALHO_STEMNESS_DN	71	http://www.broadinstitute.org/gsea/msigdb/cards/RAMALHO_STEMNESS_DN	-0.1994	-0.77725	0.7525	0.82755	1	0.268	0.217	0.21	0.83143	0.025
REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT	-0.26133	-0.7769	0.737	0.82774	1	0.5	0.297	0.352	0.83172	0.025
ONDER_CDH1_TARGETS_2_UP	247	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_TARGETS_2_UP	-0.23447	-0.77617	0.7206	0.8285	1	0.243	0.203	0.196	0.83311	0.025
KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	125	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	-0.18986	-0.77599	0.8569	0.82846	1	0.352	0.301	0.247	0.83279	0.025
LEE_METASTASIS_AND_RNA_PROCESSING_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_METASTASIS_AND_RNA_PROCESSING_UP	-0.30711	-0.77298	0.821	0.83275	1	0.588	0.261	0.435	0.83673	0.026
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	148	http://www.broadinstitute.org/gsea/msigdb/cards/CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	-0.16881	-0.77265	0.7798	0.83294	1	0.176	0.172	0.146	0.83654	0.026
HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	23	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY	-0.30082	-0.77071	0.7201	0.83551	1	0.304	0.195	0.245	0.83954	0.027
MADAN_DPPA4_TARGETS	41	http://www.broadinstitute.org/gsea/msigdb/cards/MADAN_DPPA4_TARGETS	-0.22417	-0.77005	0.841	0.83614	1	0.0732	0.0499	0.0696	0.83975	0.027
ZHENG_RESPONSE_TO_ARSENITE_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_RESPONSE_TO_ARSENITE_UP	-0.30827	-0.76933	0.753	0.83699	1	0.312	0.159	0.263	0.84138	0.027
LIU_NASOPHARYNGEAL_CARCINOMA	65	http://www.broadinstitute.org/gsea/msigdb/cards/LIU_NASOPHARYNGEAL_CARCINOMA	-0.18032	-0.76885	0.8537	0.83739	1	0.431	0.313	0.296	0.84125	0.027
REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS	-0.25383	-0.76847	0.8055	0.83763	1	0.176	0.0794	0.163	0.84092	0.027
RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	29	http://www.broadinstitute.org/gsea/msigdb/cards/RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN	-0.23361	-0.76808	0.7794	0.83794	1	0.138	0.11	0.123	0.8409	0.027
REACTOME_REGULATION_OF_SIGNALING_BY_CBL	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_SIGNALING_BY_CBL	-0.29218	-0.768	0.8125	0.83771	1	0.389	0.251	0.292	0.84091	0.027
REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_	-0.29681	-0.76763	0.7685	0.83796	1	0.2	0.128	0.174	0.84234	0.027
DELACROIX_RAR_TARGETS_DN	23	http://www.broadinstitute.org/gsea/msigdb/cards/DELACROIX_RAR_TARGETS_DN	-0.24132	-0.76738	0.8225	0.83803	1	0.261	0.202	0.208	0.84253	0.026
ZWANG_EGF_PERSISTENTLY_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/ZWANG_EGF_PERSISTENTLY_UP	-0.29388	-0.76726	0.7912	0.83789	1	0.156	0.0833	0.143	0.84254	0.026
KYNG_DNA_DAMAGE_BY_UV	62	http://www.broadinstitute.org/gsea/msigdb/cards/KYNG_DNA_DAMAGE_BY_UV	-0.21828	-0.76697	0.8494	0.83798	1	0.0806	0.0487	0.0769	0.84298	0.026
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	27	http://www.broadinstitute.org/gsea/msigdb/cards/BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP	-0.23829	-0.76692	0.6986	0.83773	1	0.259	0.214	0.204	0.84277	0.026
BHAT_ESR1_TARGETS_VIA_AKT1_UP	273	http://www.broadinstitute.org/gsea/msigdb/cards/BHAT_ESR1_TARGETS_VIA_AKT1_UP	-0.15431	-0.76611	0.8141	0.83862	1	0.139	0.187	0.114	0.8428	0.026
DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	84	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	-0.28746	-0.76565	0.716	0.83896	1	0.5	0.294	0.354	0.84352	0.026
BIOCARTA_FCER1_PATHWAY	38	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_FCER1_PATHWAY	-0.25042	-0.76535	0.7854	0.83912	1	0.421	0.324	0.285	0.84359	0.026
WEBER_METHYLATED_ICP_IN_FIBROBLAST	22	http://www.broadinstitute.org/gsea/msigdb/cards/WEBER_METHYLATED_ICP_IN_FIBROBLAST	-0.26906	-0.7651	0.796	0.83915	1	0.318	0.196	0.256	0.84327	0.026
GRADE_COLON_CANCER_DN	31	http://www.broadinstitute.org/gsea/msigdb/cards/GRADE_COLON_CANCER_DN	-0.24615	-0.76473	0.8388	0.83938	1	0.29	0.291	0.206	0.84372	0.026
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	181	http://www.broadinstitute.org/gsea/msigdb/cards/GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	-0.17748	-0.76305	0.8372	0.84153	1	0.271	0.25	0.204	0.84567	0.026
BIOCARTA_EGF_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EGF_PATHWAY	-0.25037	-0.76214	0.8051	0.84251	1	0.517	0.332	0.346	0.84688	0.026
TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	64	http://www.broadinstitute.org/gsea/msigdb/cards/TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN	-0.26184	-0.76145	0.7853	0.84322	1	0.0938	0.0284	0.0913	0.84801	0.026
GAVIN_FOXP3_TARGETS_CLUSTER_T7	95	http://www.broadinstitute.org/gsea/msigdb/cards/GAVIN_FOXP3_TARGETS_CLUSTER_T7	-0.21203	-0.76127	0.7996	0.84316	1	0.358	0.292	0.254	0.84775	0.026
REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN	-0.32549	-0.75994	0.7406	0.84485	1	0.542	0.263	0.4	0.84844	0.026
REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	90	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION	-0.19265	-0.75902	0.9091	0.84589	1	0.244	0.225	0.19	0.84913	0.027
AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	94	http://www.broadinstitute.org/gsea/msigdb/cards/AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G	-0.22271	-0.75896	0.7168	0.84567	1	0.255	0.241	0.194	0.8488	0.026
REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	49	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_AQUAPORIN_MEDIATED_TRANSPORT	-0.21978	-0.75817	0.756	0.84653	1	0.143	0.122	0.126	0.84949	0.027
MAINA_VHL_TARGETS_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/MAINA_VHL_TARGETS_DN	-0.28482	-0.75812	0.8106	0.84626	1	0.389	0.259	0.288	0.84916	0.026
BROWNE_HCMV_INFECTION_16HR_UP	218	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_16HR_UP	-0.23916	-0.75788	0.8324	0.84631	1	0.17	0.131	0.149	0.84883	0.026
WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	55	http://www.broadinstitute.org/gsea/msigdb/cards/WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2	-0.23242	-0.75778	0.774	0.84612	1	0.127	0.0967	0.115	0.84851	0.026
GALLUZZI_PERMEABILIZE_MITOCHONDRIA	43	http://www.broadinstitute.org/gsea/msigdb/cards/GALLUZZI_PERMEABILIZE_MITOCHONDRIA	-0.20724	-0.75702	0.7876	0.84686	1	0.326	0.255	0.243	0.85021	0.027
BROWNE_HCMV_INFECTION_12HR_DN	97	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_12HR_DN	-0.20803	-0.7564	0.856	0.84746	1	0.34	0.243	0.259	0.85084	0.027
HWANG_PROSTATE_CANCER_MARKERS	28	http://www.broadinstitute.org/gsea/msigdb/cards/HWANG_PROSTATE_CANCER_MARKERS	-0.20705	-0.75627	0.8515	0.84733	1	0.321	0.261	0.238	0.85051	0.026
REACTOME_TIE2_SIGNALING	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TIE2_SIGNALING	-0.32096	-0.75523	0.78	0.84856	1	0.353	0.185	0.288	0.85227	0.026
DIRMEIER_LMP1_RESPONSE_LATE_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/DIRMEIER_LMP1_RESPONSE_LATE_DN	-0.24551	-0.75442	0.75	0.84942	1	0.167	0.118	0.147	0.85377	0.026
CHOI_ATL_CHRONIC_VS_ACUTE_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/CHOI_ATL_CHRONIC_VS_ACUTE_DN	-0.31796	-0.75428	0.7551	0.84929	1	0.556	0.345	0.364	0.85365	0.026
FARMER_BREAST_CANCER_CLUSTER_6	16	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_6	-0.31115	-0.75416	0.7335	0.84918	1	0.25	0.151	0.212	0.85332	0.026
BIOCARTA_ERK_PATHWAY	26	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_ERK_PATHWAY	-0.22919	-0.75387	0.7954	0.84927	1	0.269	0.228	0.208	0.853	0.026
SCHRAMM_INHBA_TARGETS_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/SCHRAMM_INHBA_TARGETS_DN	-0.25945	-0.7528	0.833	0.85047	1	0.0417	0.000467	0.0417	0.85451	0.026
FINETTI_BREAST_CANCERS_KINOME_GRAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/FINETTI_BREAST_CANCERS_KINOME_GRAY	-0.35008	-0.75214	0.7357	0.85114	1	0.2	0.0575	0.189	0.85559	0.026
NIELSEN_LEIOMYOSARCOMA_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_LEIOMYOSARCOMA_DN	-0.23132	-0.75125	0.8015	0.85215	1	0.294	0.246	0.222	0.85728	0.027
KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	76	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM	-0.18537	-0.75089	0.9234	0.85239	1	0.158	0.166	0.132	0.85766	0.026
PID_IGF1_PATHWAY	30	http://www.broadinstitute.org/gsea/msigdb/cards/PID_IGF1_PATHWAY	-0.25936	-0.74944	0.875	0.85412	1	0.233	0.131	0.203	0.85862	0.027
WILENSKY_RESPONSE_TO_DARAPLADIB	29	http://www.broadinstitute.org/gsea/msigdb/cards/WILENSKY_RESPONSE_TO_DARAPLADIB	-0.24552	-0.7489	0.7896	0.85457	1	0.379	0.279	0.274	0.85908	0.027
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	120	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-0.21243	-0.74871	0.8601	0.85456	1	0.342	0.264	0.253	0.85878	0.026
KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	242	http://www.broadinstitute.org/gsea/msigdb/cards/KAAB_HEART_ATRIUM_VS_VENTRICLE_UP	-0.15882	-0.74682	0.9265	0.85692	1	0.314	0.304	0.221	0.86083	0.027
WENDT_COHESIN_TARGETS_UP	32	http://www.broadinstitute.org/gsea/msigdb/cards/WENDT_COHESIN_TARGETS_UP	-0.34852	-0.74562	0.8024	0.85835	1	0.344	0.172	0.285	0.86257	0.027
ONDER_CDH1_SIGNALING_VIA_CTNNB1	78	http://www.broadinstitute.org/gsea/msigdb/cards/ONDER_CDH1_SIGNALING_VIA_CTNNB1	-0.27337	-0.74514	0.7341	0.85872	1	0.346	0.221	0.27	0.86377	0.027
ZHENG_BOUND_BY_FOXP3	471	http://www.broadinstitute.org/gsea/msigdb/cards/ZHENG_BOUND_BY_FOXP3	-0.21079	-0.74507	0.8435	0.8585	1	0.223	0.192	0.184	0.86344	0.027
REACTOME_L1CAM_INTERACTIONS	83	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_L1CAM_INTERACTIONS	-0.19363	-0.74375	0.8471	0.86011	1	0.325	0.282	0.234	0.86495	0.027
BIOCARTA_TH1TH2_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TH1TH2_PATHWAY	-0.30026	-0.7437	0.7622	0.85986	1	0.263	0.153	0.223	0.86462	0.027
KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	131	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS	-0.22486	-0.74325	0.7922	0.8602	1	0.351	0.227	0.273	0.86524	0.027
SHIPP_DLBCL_CURED_VS_FATAL_DN	44	http://www.broadinstitute.org/gsea/msigdb/cards/SHIPP_DLBCL_CURED_VS_FATAL_DN	-0.18617	-0.74324	0.8455	0.85988	1	0.205	0.189	0.166	0.86491	0.027
REACTOME_METABOLISM_OF_RNA	252	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_METABOLISM_OF_RNA	-0.23263	-0.74296	0.8192	0.86001	1	0.242	0.192	0.197	0.86458	0.027
REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	-0.24978	-0.74202	0.8039	0.86107	1	0.118	0.0931	0.107	0.86578	0.027
REACTOME_RAP1_SIGNALLING	16	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RAP1_SIGNALLING	-0.25724	-0.7406	0.8302	0.86275	1	0.562	0.371	0.354	0.86807	0.027
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII	-0.28644	-0.73982	0.773	0.86352	1	0.133	0.0905	0.121	0.86947	0.027
ST_T_CELL_SIGNAL_TRANSDUCTION	44	http://www.broadinstitute.org/gsea/msigdb/cards/ST_T_CELL_SIGNAL_TRANSDUCTION	-0.20494	-0.73978	0.7818	0.86326	1	0.386	0.324	0.262	0.86914	0.027
REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA	-0.18549	-0.73927	0.875	0.86363	1	0.235	0.228	0.182	0.86892	0.027
ZHOU_TNF_SIGNALING_4HR	54	http://www.broadinstitute.org/gsea/msigdb/cards/ZHOU_TNF_SIGNALING_4HR	-0.2185	-0.73895	0.8227	0.86377	1	0.333	0.292	0.236	0.8688	0.027
BROWNE_HCMV_INFECTION_24HR_DN	143	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_24HR_DN	-0.21606	-0.73805	0.8091	0.86479	1	0.196	0.167	0.164	0.87049	0.027
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	65	http://www.broadinstitute.org/gsea/msigdb/cards/MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP	-0.2179	-0.73758	0.8117	0.8651	1	0.308	0.228	0.238	0.87072	0.027
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	159	http://www.broadinstitute.org/gsea/msigdb/cards/BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-0.20379	-0.7371	0.7797	0.86545	1	0.302	0.249	0.228	0.872	0.027
REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	25	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER	-0.24068	-0.73689	0.7873	0.8654	1	0.08	0.0553	0.0756	0.87221	0.027
OKAWA_NEUROBLASTOMA_1P36_31_DELETION	22	http://www.broadinstitute.org/gsea/msigdb/cards/OKAWA_NEUROBLASTOMA_1P36_31_DELETION	-0.28205	-0.73675	0.7442	0.86526	1	1	0.718	0.282	0.87187	0.027
REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	48	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM	-0.29295	-0.73575	0.7056	0.86629	1	0.479	0.268	0.351	0.87203	0.027
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	15	http://www.broadinstitute.org/gsea/msigdb/cards/VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	-0.27989	-0.73493	0.8668	0.86713	1	0.133	0.03	0.129	0.87305	0.027
REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	40	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_IL_3_5_AND_GM_CSF_SIGNALING	-0.24235	-0.73414	0.8379	0.86781	1	0.325	0.213	0.256	0.87405	0.027
ZHAN_MULTIPLE_MYELOMA_LB_DN	39	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_LB_DN	-0.26233	-0.73246	0.7466	0.86979	1	0.308	0.172	0.255	0.87626	0.027
KIM_GLIS2_TARGETS_UP	79	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_GLIS2_TARGETS_UP	-0.26975	-0.73234	0.7565	0.86961	1	0.19	0.129	0.166	0.87593	0.027
BIOCARTA_GATA3_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GATA3_PATHWAY	-0.25392	-0.73168	0.82	0.87015	1	0.312	0.243	0.237	0.87631	0.027
KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	67	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	-0.25944	-0.73075	0.7734	0.87107	1	0.239	0.155	0.202	0.8781	0.027
KEGG_GALACTOSE_METABOLISM	25	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GALACTOSE_METABOLISM	-0.17448	-0.72952	0.9168	0.87242	1	0.04	0.0196	0.0393	0.87971	0.027
PID_FAK_PATHWAY	58	http://www.broadinstitute.org/gsea/msigdb/cards/PID_FAK_PATHWAY	-0.24709	-0.72937	0.8113	0.87229	1	0.414	0.257	0.308	0.87955	0.027
BARRIER_COLON_CANCER_RECURRENCE_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/BARRIER_COLON_CANCER_RECURRENCE_DN	-0.20769	-0.72932	0.8008	0.87205	1	0.316	0.244	0.239	0.87922	0.027
BIOCARTA_NFAT_PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_NFAT_PATHWAY	-0.17309	-0.72914	0.8887	0.87198	1	0.204	0.243	0.154	0.87889	0.027
PID_HDAC_CLASSII_PATHWAY	33	http://www.broadinstitute.org/gsea/msigdb/cards/PID_HDAC_CLASSII_PATHWAY	-0.22002	-0.7291	0.8577	0.8717	1	0.303	0.252	0.227	0.87855	0.027
BIOCARTA_PDGF_PATHWAY	29	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PDGF_PATHWAY	-0.24261	-0.72837	0.8205	0.87238	1	0.517	0.332	0.346	0.87907	0.027
NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	324	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON	-0.15562	-0.72807	0.7996	0.87247	1	0.117	0.151	0.101	0.87911	0.027
VARELA_ZMPSTE24_TARGETS_DN	38	http://www.broadinstitute.org/gsea/msigdb/cards/VARELA_ZMPSTE24_TARGETS_DN	-0.20376	-0.72678	0.8964	0.87392	1	0.237	0.174	0.196	0.88029	0.027
ABE_INNER_EAR	47	http://www.broadinstitute.org/gsea/msigdb/cards/ABE_INNER_EAR	-0.17981	-0.72642	0.8598	0.87409	1	0.0426	0.0186	0.0418	0.88054	0.027
BOQUEST_STEM_CELL_UP	253	http://www.broadinstitute.org/gsea/msigdb/cards/BOQUEST_STEM_CELL_UP	-0.22631	-0.72624	0.8256	0.87401	1	0.178	0.137	0.155	0.88058	0.027
KEGG_PPAR_SIGNALING_PATHWAY	68	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PPAR_SIGNALING_PATHWAY	-0.17234	-0.72566	0.9346	0.87448	1	0.147	0.165	0.123	0.88123	0.027
BAELDE_DIABETIC_NEPHROPATHY_UP	82	http://www.broadinstitute.org/gsea/msigdb/cards/BAELDE_DIABETIC_NEPHROPATHY_UP	-0.1828	-0.72508	0.8902	0.8749	1	0.183	0.215	0.144	0.88163	0.027
HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	18	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_MUTATED_VH_GENES	-0.30699	-0.72412	0.8636	0.87591	1	0.278	0.146	0.237	0.88303	0.027
BARIS_THYROID_CANCER_UP	23	http://www.broadinstitute.org/gsea/msigdb/cards/BARIS_THYROID_CANCER_UP	-0.26039	-0.724	0.762	0.87575	1	0.348	0.231	0.268	0.88272	0.027
REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	45	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LIPID_DIGESTION_MOBILIZATION_AND_TRANSPORT	-0.17255	-0.72396	0.8276	0.87547	1	0.422	0.321	0.287	0.88239	0.027
PID_P53_REGULATION_PATHWAY	59	http://www.broadinstitute.org/gsea/msigdb/cards/PID_P53_REGULATION_PATHWAY	-0.24498	-0.72282	0.8081	0.8766	1	0.475	0.327	0.32	0.88372	0.026
BILANGES_SERUM_SENSITIVE_VIA_TSC1	23	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_SENSITIVE_VIA_TSC1	-0.23644	-0.72186	0.8063	0.87755	1	0.217	0.224	0.169	0.88519	0.027
SHIN_B_CELL_LYMPHOMA_CLUSTER_2	29	http://www.broadinstitute.org/gsea/msigdb/cards/SHIN_B_CELL_LYMPHOMA_CLUSTER_2	-0.17743	-0.7199	0.8586	0.87973	1	0.345	0.306	0.24	0.88754	0.027
KEGG_HEMATOPOIETIC_CELL_LINEAGE	82	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_HEMATOPOIETIC_CELL_LINEAGE	-0.19658	-0.71968	0.8427	0.87967	1	0.171	0.162	0.143	0.88783	0.027
REACTOME_ACTIVATION_OF_GENES_BY_ATF4	23	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ACTIVATION_OF_GENES_BY_ATF4	-0.25544	-0.71926	0.8182	0.87989	1	0.217	0.219	0.17	0.88823	0.027
MCDOWELL_ACUTE_LUNG_INJURY_DN	48	http://www.broadinstitute.org/gsea/msigdb/cards/MCDOWELL_ACUTE_LUNG_INJURY_DN	-0.17813	-0.71845	0.8498	0.88066	1	0.333	0.321	0.227	0.88806	0.027
NAKAMURA_CANCER_MICROENVIRONMENT_UP	21	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAMURA_CANCER_MICROENVIRONMENT_UP	-0.25994	-0.71835	0.7776	0.88045	1	0.238	0.178	0.196	0.88772	0.027
NADLER_HYPERGLYCEMIA_AT_OBESITY	58	http://www.broadinstitute.org/gsea/msigdb/cards/NADLER_HYPERGLYCEMIA_AT_OBESITY	-0.16418	-0.71679	0.87	0.88221	1	0.172	0.175	0.143	0.89027	0.027
HASLINGER_B_CLL_WITH_11Q23_DELETION	21	http://www.broadinstitute.org/gsea/msigdb/cards/HASLINGER_B_CLL_WITH_11Q23_DELETION	-0.34471	-0.71642	0.8162	0.88233	1	0.333	0.146	0.285	0.8906	0.026
TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/TCGA_GLIOBLASTOMA_COPY_NUMBER_UP	-0.25905	-0.71617	0.8218	0.8823	1	0.408	0.244	0.31	0.89047	0.027
TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	30	http://www.broadinstitute.org/gsea/msigdb/cards/TCGA_GLIOBLASTOMA_COPY_NUMBER_DN	-0.24565	-0.71577	0.829	0.8825	1	0.133	0.0923	0.121	0.89052	0.027
LEE_LIVER_CANCER	45	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_LIVER_CANCER	-0.20182	-0.71532	0.8558	0.88271	1	0.0667	0.0633	0.0626	0.89084	0.027
YIH_RESPONSE_TO_ARSENITE_C4	16	http://www.broadinstitute.org/gsea/msigdb/cards/YIH_RESPONSE_TO_ARSENITE_C4	-0.25144	-0.71485	0.8023	0.88299	1	0.562	0.301	0.393	0.89061	0.026
RODWELL_AGING_KIDNEY_NO_BLOOD_DN	140	http://www.broadinstitute.org/gsea/msigdb/cards/RODWELL_AGING_KIDNEY_NO_BLOOD_DN	-0.21227	-0.7144	0.9315	0.88325	1	0.179	0.159	0.151	0.89058	0.026
REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE	-0.20832	-0.71398	0.9136	0.88342	1	0.125	0.102	0.112	0.89083	0.026
BIOCARTA_TCR_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_TCR_PATHWAY	-0.18644	-0.71346	0.852	0.88377	1	0.378	0.324	0.256	0.89165	0.026
BIOCARTA_KERATINOCYTE_PATHWAY	45	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_KERATINOCYTE_PATHWAY	-0.20038	-0.71186	0.8223	0.88552	1	0.4	0.329	0.269	0.8928	0.026
KIM_HYPOXIA	25	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_HYPOXIA	-0.2462	-0.71161	0.7767	0.88547	1	0.32	0.21	0.253	0.89246	0.026
GUTIERREZ_MULTIPLE_MYELOMA_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/GUTIERREZ_MULTIPLE_MYELOMA_DN	-0.28073	-0.71025	0.7917	0.8868	1	0.219	0.116	0.194	0.89359	0.026
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	-0.1712	-0.71019	0.8912	0.88654	1	0.0752	0.0829	0.0693	0.89325	0.026
MILI_PSEUDOPODIA_HAPTOTAXIS_UP	492	http://www.broadinstitute.org/gsea/msigdb/cards/MILI_PSEUDOPODIA_HAPTOTAXIS_UP	-0.26153	-0.71015	0.7936	0.88626	1	0.307	0.204	0.249	0.89321	0.026
KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	30	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM	-0.20161	-0.70996	0.8707	0.88617	1	0.1	0.103	0.0898	0.89299	0.026
REACTOME_ENDOGENOUS_STEROLS	15	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_ENDOGENOUS_STEROLS	-0.25324	-0.70825	0.8293	0.88796	1	0.0667	0.0294	0.0647	0.89487	0.026
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	33	http://www.broadinstitute.org/gsea/msigdb/cards/BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN	-0.21004	-0.70822	0.8588	0.88766	1	0.121	0.117	0.107	0.89453	0.026
NIELSEN_SYNOVIAL_SARCOMA_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_SYNOVIAL_SARCOMA_DN	-0.32325	-0.7069	0.8619	0.88891	1	0.579	0.291	0.411	0.89572	0.026
BIOCARTA_PAR1_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_PAR1_PATHWAY	-0.17673	-0.70524	0.8919	0.89063	1	0.216	0.228	0.167	0.89735	0.026
CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	74	http://www.broadinstitute.org/gsea/msigdb/cards/CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP	-0.16481	-0.70516	0.8725	0.89041	1	0.0811	0.088	0.0742	0.89702	0.026
IKEDA_MIR30_TARGETS_UP	115	http://www.broadinstitute.org/gsea/msigdb/cards/IKEDA_MIR30_TARGETS_UP	-0.25406	-0.70456	0.8635	0.89082	1	0.287	0.188	0.234	0.89717	0.026
CAFFAREL_RESPONSE_TO_THC_UP	33	http://www.broadinstitute.org/gsea/msigdb/cards/CAFFAREL_RESPONSE_TO_THC_UP	-0.2693	-0.70442	0.8356	0.89067	1	0.485	0.301	0.34	0.89702	0.026
REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_REGULATION_OF_HYPOXIA_INDUCIBLE_FACTOR_HIF_BY_OXYGEN	-0.19068	-0.70415	0.8426	0.89066	1	0.333	0.259	0.247	0.89675	0.026
REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR	-0.26373	-0.704	0.835	0.89051	1	0.118	0.0905	0.107	0.89643	0.026
PID_INTEGRIN5_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/PID_INTEGRIN5_PATHWAY	-0.29102	-0.70387	0.8103	0.89034	1	0.529	0.307	0.367	0.8961	0.026
LABBE_TGFB1_TARGETS_UP	97	http://www.broadinstitute.org/gsea/msigdb/cards/LABBE_TGFB1_TARGETS_UP	-0.19421	-0.70365	0.8377	0.89026	1	0.32	0.271	0.234	0.89623	0.025
VANTVEER_BREAST_CANCER_BRCA1_DN	41	http://www.broadinstitute.org/gsea/msigdb/cards/VANTVEER_BREAST_CANCER_BRCA1_DN	-0.24184	-0.7025	0.8067	0.89129	1	0.317	0.222	0.247	0.89773	0.025
KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/KEEN_RESPONSE_TO_ROSIGLITAZONE_UP	-0.19183	-0.7017	0.8767	0.89192	1	0.342	0.291	0.243	0.89814	0.025
WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	51	http://www.broadinstitute.org/gsea/msigdb/cards/WATTEL_AUTONOMOUS_THYROID_ADENOMA_DN	-0.23001	-0.70151	0.8327	0.89182	1	0.157	0.135	0.136	0.89879	0.025
GESERICK_TERT_TARGETS_DN	21	http://www.broadinstitute.org/gsea/msigdb/cards/GESERICK_TERT_TARGETS_DN	-0.29215	-0.69923	0.7566	0.89424	1	0.238	0.239	0.181	0.90098	0.026
KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	68	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	-0.21161	-0.6985	0.835	0.89478	1	0.353	0.309	0.245	0.90181	0.026
NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	17	http://www.broadinstitute.org/gsea/msigdb/cards/NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_DN	-0.23851	-0.69822	0.864	0.89477	1	0.118	0.106	0.105	0.9016	0.024
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	72	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	-0.19098	-0.69821	0.9061	0.89445	1	0.25	0.216	0.197	0.90127	0.024
FERRARI_RESPONSE_TO_FENRETINIDE_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/FERRARI_RESPONSE_TO_FENRETINIDE_UP	-0.28898	-0.69744	0.792	0.89505	1	0.182	0.0736	0.169	0.90219	0.026
AMIT_EGF_RESPONSE_40_HELA	41	http://www.broadinstitute.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_40_HELA	-0.24802	-0.69395	0.8043	0.89887	1	0.268	0.224	0.209	0.90545	0.026
REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	44	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION	-0.18063	-0.69202	0.866	0.90076	1	0.227	0.228	0.176	0.90748	0.026
BIOCARTA_HCMV_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_HCMV_PATHWAY	-0.23533	-0.69166	0.8439	0.90085	1	0.235	0.213	0.185	0.90732	0.026
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	22	http://www.broadinstitute.org/gsea/msigdb/cards/HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP	-0.24587	-0.69083	0.8446	0.90141	1	0.0909	0.0684	0.0848	0.90849	0.026
DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	16	http://www.broadinstitute.org/gsea/msigdb/cards/DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP	-0.22414	-0.69009	0.849	0.90192	1	0.188	0.202	0.15	0.90899	0.026
ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	61	http://www.broadinstitute.org/gsea/msigdb/cards/ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP	-0.17227	-0.68991	0.9336	0.90177	1	0.311	0.275	0.226	0.90896	0.024
MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	210	http://www.broadinstitute.org/gsea/msigdb/cards/MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	-0.19611	-0.68942	0.834	0.90202	1	0.21	0.199	0.169	0.90866	0.026
REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX	-0.23785	-0.68935	0.8384	0.90177	1	0.296	0.218	0.232	0.90832	0.023
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	51	http://www.broadinstitute.org/gsea/msigdb/cards/CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-0.20993	-0.68906	0.831	0.90175	1	0.373	0.266	0.274	0.90814	0.023
REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM	-0.29498	-0.68794	0.8252	0.9027	1	0.294	0.174	0.243	0.90891	0.023
REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	30	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE	-0.21177	-0.68696	0.9428	0.90344	1	0.0667	0.0395	0.0641	0.91031	0.025
BILANGES_SERUM_SENSITIVE_VIA_TSC2	39	http://www.broadinstitute.org/gsea/msigdb/cards/BILANGES_SERUM_SENSITIVE_VIA_TSC2	-0.24739	-0.68587	0.8299	0.90429	1	0.359	0.257	0.267	0.91105	0.025
KEGG_PARKINSONS_DISEASE	116	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_PARKINSONS_DISEASE	-0.18413	-0.6858	0.8941	0.90404	1	0.319	0.282	0.23	0.91071	0.023
NAGASHIMA_EGF_SIGNALING_UP	57	http://www.broadinstitute.org/gsea/msigdb/cards/NAGASHIMA_EGF_SIGNALING_UP	-0.25764	-0.68483	0.7695	0.90474	1	0.316	0.303	0.221	0.91182	0.023
PID_TRAIL_PATHWAY	28	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TRAIL_PATHWAY	-0.24741	-0.68152	0.8889	0.90806	1	0.0714	0.0311	0.0693	0.9154	0.026
CHOI_ATL_STAGE_PREDICTOR	40	http://www.broadinstitute.org/gsea/msigdb/cards/CHOI_ATL_STAGE_PREDICTOR	-0.2823	-0.68106	0.8502	0.90824	1	0.4	0.235	0.306	0.91559	0.026
LU_IL4_SIGNALING	91	http://www.broadinstitute.org/gsea/msigdb/cards/LU_IL4_SIGNALING	-0.20165	-0.68105	0.8849	0.90791	1	0.286	0.25	0.215	0.91525	0.026
RUIZ_TNC_TARGETS_UP	148	http://www.broadinstitute.org/gsea/msigdb/cards/RUIZ_TNC_TARGETS_UP	-0.20644	-0.68008	0.8887	0.90868	1	0.291	0.246	0.22	0.91637	0.026
MOOTHA_HUMAN_MITODB_6_2002	419	http://www.broadinstitute.org/gsea/msigdb/cards/MOOTHA_HUMAN_MITODB_6_2002	-0.17832	-0.68003	0.9343	0.9084	1	0.239	0.221	0.189	0.91604	0.026
REACTOME_RNA_POL_III_TRANSCRIPTION	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_RNA_POL_III_TRANSCRIPTION	-0.223	-0.67867	0.8426	0.90954	1	0.25	0.26	0.185	0.91757	0.026
GU_PDEF_TARGETS_UP	71	http://www.broadinstitute.org/gsea/msigdb/cards/GU_PDEF_TARGETS_UP	-0.21673	-0.6777	0.8352	0.9103	1	0.197	0.164	0.165	0.91801	0.026
SHEN_SMARCA2_TARGETS_DN	330	http://www.broadinstitute.org/gsea/msigdb/cards/SHEN_SMARCA2_TARGETS_DN	-0.16461	-0.67555	0.8686	0.91221	1	0.148	0.185	0.123	0.91923	0.026
REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	20	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_INSULIN_SYNTHESIS_AND_PROCESSING	-0.27107	-0.67389	0.8426	0.91366	1	0.5	0.305	0.348	0.92197	0.026
GOLDRATH_HOMEOSTATIC_PROLIFERATION	164	http://www.broadinstitute.org/gsea/msigdb/cards/GOLDRATH_HOMEOSTATIC_PROLIFERATION	-0.21144	-0.67376	0.9063	0.91347	1	0.22	0.175	0.182	0.92173	0.026
LEIN_ASTROCYTE_MARKERS	42	http://www.broadinstitute.org/gsea/msigdb/cards/LEIN_ASTROCYTE_MARKERS	-0.17777	-0.67222	0.8697	0.91474	1	0.31	0.291	0.22	0.92315	0.026
PID_TGFBR_PATHWAY	54	http://www.broadinstitute.org/gsea/msigdb/cards/PID_TGFBR_PATHWAY	-0.22866	-0.67164	0.8546	0.91498	1	0.407	0.267	0.299	0.92311	0.026
PID_PDGFRA_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/PID_PDGFRA_PATHWAY	-0.23683	-0.67055	0.8665	0.9158	1	0.211	0.181	0.172	0.92332	0.026
DAIRKEE_TERT_TARGETS_DN	117	http://www.broadinstitute.org/gsea/msigdb/cards/DAIRKEE_TERT_TARGETS_DN	-0.18587	-0.67046	0.9605	0.91554	1	0.325	0.275	0.237	0.92323	0.026
TOMIDA_METASTASIS_UP	25	http://www.broadinstitute.org/gsea/msigdb/cards/TOMIDA_METASTASIS_UP	-0.23128	-0.66986	0.8457	0.91581	1	0.28	0.257	0.208	0.92388	0.026
VALK_AML_CLUSTER_15	30	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_15	-0.19871	-0.66822	0.8588	0.91717	1	0.467	0.321	0.317	0.92569	0.026
REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	83	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	-0.19272	-0.66679	0.8227	0.91822	1	0.193	0.179	0.159	0.92694	0.026
SUMI_HNF4A_TARGETS	32	http://www.broadinstitute.org/gsea/msigdb/cards/SUMI_HNF4A_TARGETS	-0.21726	-0.66568	0.8986	0.91894	1	0.156	0.132	0.136	0.9274	0.026
PID_CONE_PATHWAY	22	http://www.broadinstitute.org/gsea/msigdb/cards/PID_CONE_PATHWAY	-0.23827	-0.66485	0.8122	0.91947	1	0.182	0.166	0.152	0.92785	0.026
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	37	http://www.broadinstitute.org/gsea/msigdb/cards/CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	-0.22815	-0.66433	0.8524	0.91965	1	0.162	0.119	0.143	0.92791	0.026
MEISSNER_BRAIN_HCP_WITH_H3K27ME3	258	http://www.broadinstitute.org/gsea/msigdb/cards/MEISSNER_BRAIN_HCP_WITH_H3K27ME3	-0.17564	-0.66242	0.78	0.92113	1	0.0736	0.0997	0.067	0.92934	0.026
REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY	-0.30309	-0.66147	0.8126	0.92168	1	0.542	0.263	0.4	0.92973	0.026
BIOCARTA_LONGEVITY_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_LONGEVITY_PATHWAY	-0.25904	-0.6597	0.8654	0.92309	1	0.2	0.131	0.174	0.93135	0.026
NOJIMA_SFRP2_TARGETS_UP	30	http://www.broadinstitute.org/gsea/msigdb/cards/NOJIMA_SFRP2_TARGETS_UP	-0.21509	-0.6593	0.8474	0.92314	1	0.233	0.181	0.191	0.93124	0.026
BIOCARTA_WNT_PATHWAY	25	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_WNT_PATHWAY	-0.20043	-0.65907	0.8337	0.92303	1	0.24	0.22	0.187	0.93128	0.026
AKL_HTLV1_INFECTION_DN	67	http://www.broadinstitute.org/gsea/msigdb/cards/AKL_HTLV1_INFECTION_DN	-0.2326	-0.65823	0.898	0.92354	1	0.179	0.143	0.154	0.93174	0.026
KIM_MYC_AMPLIFICATION_TARGETS_UP	193	http://www.broadinstitute.org/gsea/msigdb/cards/KIM_MYC_AMPLIFICATION_TARGETS_UP	-0.20098	-0.65676	0.9562	0.9246	1	0.233	0.193	0.19	0.93248	0.026
WONG_MITOCHONDRIA_GENE_MODULE	216	http://www.broadinstitute.org/gsea/msigdb/cards/WONG_MITOCHONDRIA_GENE_MODULE	-0.1993	-0.65527	0.9079	0.92567	1	0.264	0.219	0.208	0.93365	0.026
JOHNSTONE_PARVB_TARGETS_2_DN	319	http://www.broadinstitute.org/gsea/msigdb/cards/JOHNSTONE_PARVB_TARGETS_2_DN	-0.2377	-0.65396	0.8658	0.92649	1	0.216	0.153	0.185	0.93447	0.025
PLASARI_TGFB1_TARGETS_10HR_UP	195	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_TARGETS_10HR_UP	-0.15723	-0.65253	0.8777	0.92748	1	0.226	0.267	0.167	0.9353	0.026
DALESSIO_TSA_RESPONSE	21	http://www.broadinstitute.org/gsea/msigdb/cards/DALESSIO_TSA_RESPONSE	-0.26405	-0.65152	0.8878	0.92815	1	0.429	0.252	0.321	0.93606	0.026
BIOCARTA_CD40_PATHWAY	15	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CD40_PATHWAY	-0.24427	-0.65049	0.8918	0.92876	1	0.2	0.196	0.161	0.93658	0.025
BIOCARTA_AGR_PATHWAY	36	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AGR_PATHWAY	-0.16909	-0.65004	0.9674	0.92879	1	0.194	0.181	0.159	0.93684	0.025
COLLIS_PRKDC_REGULATORS	15	http://www.broadinstitute.org/gsea/msigdb/cards/COLLIS_PRKDC_REGULATORS	-0.20609	-0.64992	0.8844	0.92855	1	0.4	0.251	0.3	0.93656	0.025
REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	21	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_LIGAND_GATED_ION_CHANNEL_TRANSPORT	-0.20857	-0.6498	0.83	0.92831	1	0.19	0.211	0.15	0.93631	0.025
LEE_AGING_MUSCLE_UP	42	http://www.broadinstitute.org/gsea/msigdb/cards/LEE_AGING_MUSCLE_UP	-0.20821	-0.64906	0.8873	0.92868	1	0.143	0.147	0.122	0.9367	0.025
CHANDRAN_METASTASIS_TOP50_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/CHANDRAN_METASTASIS_TOP50_DN	-0.1716	-0.64803	0.9069	0.92927	1	0.178	0.204	0.142	0.937	0.025
BIOCARTA_GPCR_PATHWAY	35	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GPCR_PATHWAY	-0.21618	-0.64772	0.8919	0.9292	1	0.371	0.324	0.251	0.93713	0.025
TIAN_TNF_SIGNALING_NOT_VIA_NFKB	21	http://www.broadinstitute.org/gsea/msigdb/cards/TIAN_TNF_SIGNALING_NOT_VIA_NFKB	-0.2515	-0.64653	0.8583	0.92996	1	0.333	0.252	0.25	0.93786	0.025
BIOCARTA_SPRY_PATHWAY	17	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_SPRY_PATHWAY	-0.23307	-0.64641	0.8443	0.92973	1	0.529	0.329	0.355	0.93752	0.022
HUANG_FOXA2_TARGETS_UP	43	http://www.broadinstitute.org/gsea/msigdb/cards/HUANG_FOXA2_TARGETS_UP	-0.23061	-0.64511	0.955	0.93064	1	0.372	0.257	0.277	0.93798	0.022
VALK_AML_CLUSTER_7	27	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_7	-0.20939	-0.6428	0.8521	0.93244	1	0.222	0.172	0.184	0.94054	0.023
RAMALHO_STEMNESS_UP	198	http://www.broadinstitute.org/gsea/msigdb/cards/RAMALHO_STEMNESS_UP	-0.21695	-0.64091	0.869	0.93379	1	0.207	0.177	0.172	0.94133	0.026
MOREIRA_RESPONSE_TO_TSA_DN	18	http://www.broadinstitute.org/gsea/msigdb/cards/MOREIRA_RESPONSE_TO_TSA_DN	-0.22639	-0.64023	0.9216	0.934	1	0.389	0.29	0.276	0.94157	0.025
REACTOME_MRNA_3_END_PROCESSING	32	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_MRNA_3_END_PROCESSING	-0.24767	-0.63949	0.8202	0.93431	1	0.406	0.299	0.285	0.94198	0.024
REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	41	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CLEAVAGE_OF_GROWING_TRANSCRIPT_IN_THE_TERMINATION_REGION_	-0.23766	-0.63647	0.8482	0.93648	1	0.317	0.237	0.242	0.9449	0.025
KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	25	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS	-0.24238	-0.6334	0.8831	0.93878	1	0.16	0.122	0.141	0.94748	0.025
BIOCARTA_MET_PATHWAY	37	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_MET_PATHWAY	-0.23228	-0.6329	0.9272	0.9389	1	0.27	0.213	0.213	0.94764	0.025
GABRIELY_MIR21_TARGETS	281	http://www.broadinstitute.org/gsea/msigdb/cards/GABRIELY_MIR21_TARGETS	-0.24465	-0.63173	0.8622	0.93956	1	0.295	0.232	0.229	0.94783	0.025
FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	24	http://www.broadinstitute.org/gsea/msigdb/cards/FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN	-0.1726	-0.63131	0.9004	0.93955	1	1	0.828	0.173	0.94797	0.025
KEGG_RETINOL_METABOLISM	51	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_RETINOL_METABOLISM	-0.1754	-0.62905	0.9672	0.94104	1	0.137	0.144	0.118	0.94944	0.025
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	60	http://www.broadinstitute.org/gsea/msigdb/cards/HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-0.18576	-0.62198	0.9152	0.94599	1	0.15	0.156	0.127	0.95393	0.025
CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN	-0.16796	-0.62149	0.9663	0.94601	1	0.421	0.335	0.28	0.95399	0.025
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	67	http://www.broadinstitute.org/gsea/msigdb/cards/ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-0.20936	-0.62094	0.9109	0.94608	1	0.299	0.255	0.223	0.95421	0.025
KEGG_ONE_CARBON_POOL_BY_FOLATE	17	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_ONE_CARBON_POOL_BY_FOLATE	-0.23139	-0.61662	0.9044	0.94884	1	0.118	0.0654	0.11	0.95596	0.025
BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	24	http://www.broadinstitute.org/gsea/msigdb/cards/BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP	-0.17141	-0.6165	0.9813	0.94858	1	0.0833	0.0721	0.0774	0.95582	0.025
PID_S1P_META_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/PID_S1P_META_PATHWAY	-0.17962	-0.61543	0.9377	0.949	1	0.25	0.242	0.19	0.95639	0.025
KANNAN_TP53_TARGETS_UP	58	http://www.broadinstitute.org/gsea/msigdb/cards/KANNAN_TP53_TARGETS_UP	-0.15518	-0.61499	0.9805	0.94899	1	0.172	0.197	0.139	0.95619	0.025
SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	25	http://www.broadinstitute.org/gsea/msigdb/cards/SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER	-0.18717	-0.61464	0.8972	0.94891	1	0.16	0.207	0.127	0.95588	0.025
KEGG_WNT_SIGNALING_PATHWAY	147	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_WNT_SIGNALING_PATHWAY	-0.12669	-0.6143	0.9941	0.94882	1	0.32	0.324	0.217	0.95607	0.023
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	74	http://www.broadinstitute.org/gsea/msigdb/cards/NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN	-0.16174	-0.61322	0.9224	0.94923	1	0.149	0.189	0.121	0.95612	0.024
TOMLINS_PROSTATE_CANCER_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/TOMLINS_PROSTATE_CANCER_UP	-0.20928	-0.61272	0.936	0.94921	1	0.105	0.0739	0.0976	0.95607	0.024
BIOCARTA_GLEEVEC_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_GLEEVEC_PATHWAY	-0.21617	-0.61271	0.9314	0.94887	1	0.522	0.325	0.353	0.95573	0.023
FARMER_BREAST_CANCER_CLUSTER_5	19	http://www.broadinstitute.org/gsea/msigdb/cards/FARMER_BREAST_CANCER_CLUSTER_5	-0.28874	-0.6118	0.8044	0.94916	1	0.368	0.22	0.288	0.95604	0.018
SCHRAETS_MLL_TARGETS_DN	32	http://www.broadinstitute.org/gsea/msigdb/cards/SCHRAETS_MLL_TARGETS_DN	-0.19686	-0.61025	0.8998	0.94991	1	0.0625	0.0434	0.0599	0.95663	0.018
SINGH_NFE2L2_TARGETS	15	http://www.broadinstitute.org/gsea/msigdb/cards/SINGH_NFE2L2_TARGETS	-0.23182	-0.60984	0.9621	0.94986	1	0.267	0.222	0.207	0.95657	0.018
HARRIS_BRAIN_CANCER_PROGENITORS	42	http://www.broadinstitute.org/gsea/msigdb/cards/HARRIS_BRAIN_CANCER_PROGENITORS	-0.17153	-0.60695	0.9012	0.95149	1	0.0476	0.0206	0.0467	0.95826	0.02
WIKMAN_ASBESTOS_LUNG_CANCER_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/WIKMAN_ASBESTOS_LUNG_CANCER_UP	-0.23807	-0.60481	0.9644	0.9526	1	0.294	0.198	0.236	0.95928	0.021
REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION	-0.19398	-0.60063	0.9365	0.95503	1	0.375	0.338	0.249	0.9616	0.022
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	17	http://www.broadinstitute.org/gsea/msigdb/cards/GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP	-0.22003	-0.599	0.9286	0.95575	1	0.412	0.275	0.299	0.96262	0.021
REACTOME_COLLAGEN_FORMATION	56	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_COLLAGEN_FORMATION	-0.18616	-0.59746	0.8695	0.9564	1	0.179	0.178	0.147	0.96305	0.019
MIKKELSEN_NPC_HCP_WITH_H3K27ME3	330	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_NPC_HCP_WITH_H3K27ME3	-0.1566	-0.59738	0.9356	0.9561	1	0.097	0.12	0.0864	0.96273	0.017
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	36	http://www.broadinstitute.org/gsea/msigdb/cards/UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	-0.23597	-0.5935	0.8611	0.95822	1	0.278	0.224	0.216	0.96447	0.017
PECE_MAMMARY_STEM_CELL_DN	133	http://www.broadinstitute.org/gsea/msigdb/cards/PECE_MAMMARY_STEM_CELL_DN	-0.1977	-0.59319	0.9459	0.95805	1	0.233	0.188	0.19	0.96425	0.017
BIOCARTA_AMI_PATHWAY	20	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_AMI_PATHWAY	-0.18949	-0.59294	0.9158	0.95784	1	0.05	0.0283	0.0486	0.9639	0.017
ZIRN_TRETINOIN_RESPONSE_UP	20	http://www.broadinstitute.org/gsea/msigdb/cards/ZIRN_TRETINOIN_RESPONSE_UP	-0.23308	-0.59292	0.9301	0.95751	1	0.4	0.276	0.29	0.96356	0.017
SPIRA_SMOKERS_LUNG_CANCER_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/SPIRA_SMOKERS_LUNG_CANCER_DN	-0.261	-0.59279	0.9594	0.95725	1	0.2	0.143	0.171	0.96338	0.017
REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	27	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CREB_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_RAS	-0.18818	-0.59143	0.9778	0.95768	1	0.111	0.0905	0.101	0.96375	0.015
VILIMAS_NOTCH1_TARGETS_DN	19	http://www.broadinstitute.org/gsea/msigdb/cards/VILIMAS_NOTCH1_TARGETS_DN	-0.20688	-0.58513	0.8861	0.96111	1	1	0.793	0.207	0.96714	0.017
GAURNIER_PSMD4_TARGETS	66	http://www.broadinstitute.org/gsea/msigdb/cards/GAURNIER_PSMD4_TARGETS	-0.21775	-0.58494	0.8962	0.96088	1	0.0758	0.0442	0.0726	0.9668	0.016
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	19	http://www.broadinstitute.org/gsea/msigdb/cards/HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	-0.21681	-0.57951	0.9283	0.9637	1	0.579	0.354	0.374	0.96985	0.016
DE_YY1_TARGETS_UP	18	http://www.broadinstitute.org/gsea/msigdb/cards/DE_YY1_TARGETS_UP	-0.18591	-0.57779	0.9376	0.96432	1	0.111	0.108	0.0992	0.9704	0.017
KEGG_BETA_ALANINE_METABOLISM	22	http://www.broadinstitute.org/gsea/msigdb/cards/KEGG_BETA_ALANINE_METABOLISM	-0.16995	-0.57676	0.959	0.9645	1	0.455	0.339	0.301	0.97069	0.016
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	59	http://www.broadinstitute.org/gsea/msigdb/cards/BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	-0.20658	-0.57621	0.98	0.96445	1	0.271	0.2	0.218	0.97046	0.016
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	35	http://www.broadinstitute.org/gsea/msigdb/cards/ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN	-0.16917	-0.5747	0.9632	0.96486	1	0.0571	0.054	0.0541	0.97075	0.013
VALK_AML_CLUSTER_9	35	http://www.broadinstitute.org/gsea/msigdb/cards/VALK_AML_CLUSTER_9	-0.15485	-0.56806	0.9409	0.96792	1	0.143	0.171	0.119	0.97341	0.014
REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	17	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS	-0.21154	-0.56798	0.9025	0.9676	1	1	0.789	0.211	0.97306	0.01
ROESSLER_LIVER_CANCER_METASTASIS_DN	47	http://www.broadinstitute.org/gsea/msigdb/cards/ROESSLER_LIVER_CANCER_METASTASIS_DN	-0.17123	-0.56754	0.9843	0.96747	1	0.34	0.285	0.244	0.97272	0.01
REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	24	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION	-0.26199	-0.56696	0.936	0.96741	1	0.5	0.312	0.345	0.97278	0.008
NABA_COLLAGENS	44	http://www.broadinstitute.org/gsea/msigdb/cards/NABA_COLLAGENS	-0.18765	-0.56074	0.8936	0.96995	1	0.318	0.298	0.224	0.97523	0.012
BURTON_ADIPOGENESIS_PEAK_AT_2HR	50	http://www.broadinstitute.org/gsea/msigdb/cards/BURTON_ADIPOGENESIS_PEAK_AT_2HR	-0.19827	-0.55834	0.8767	0.9707	1	0.08	0.062	0.0752	0.97591	0.008
IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	20	http://www.broadinstitute.org/gsea/msigdb/cards/IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN	-0.17721	-0.54395	0.9598	0.97639	1	0.3	0.244	0.227	0.98129	0.01
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	64	http://www.broadinstitute.org/gsea/msigdb/cards/YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-0.16156	-0.53709	0.9778	0.9786	1	0.297	0.27	0.217	0.98331	0.016
BIOCARTA_EIF_PATHWAY	16	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_EIF_PATHWAY	-0.19488	-0.5197	0.9724	0.98408	1	0.438	0.3	0.307	0.98817	0.033
REACTOME_GLYCOSPHINGOLIPID_METABOLISM	35	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_GLYCOSPHINGOLIPID_METABOLISM	-0.13494	-0.51501	0.9859	0.98513	1	0.229	0.27	0.167	0.98874	0.035
REACTOME_TRNA_AMINOACYLATION	42	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_TRNA_AMINOACYLATION	-0.18983	-0.50885	0.969	0.98651	1	0.405	0.317	0.277	0.98987	0.035
NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	112	http://www.broadinstitute.org/gsea/msigdb/cards/NIKOLSKY_BREAST_CANCER_16P13_AMPLICON	-0.13868	-0.49413	0.8521	0.98973	1	0.00893	0.000156	0.00897	0.99298	0.052
PID_RHODOPSIN_PATHWAY	23	http://www.broadinstitute.org/gsea/msigdb/cards/PID_RHODOPSIN_PATHWAY	-0.16631	-0.48898	0.984	0.99043	1	0.217	0.247	0.164	0.9933	0.05
MIKKELSEN_ES_ICP_WITH_H3K27ME3	40	http://www.broadinstitute.org/gsea/msigdb/cards/MIKKELSEN_ES_ICP_WITH_H3K27ME3	-0.16292	-0.48667	0.9863	0.99054	1	0.075	0.0818	0.069	0.99333	0.042
SAGIV_CD24_TARGETS_DN	45	http://www.broadinstitute.org/gsea/msigdb/cards/SAGIV_CD24_TARGETS_DN	-0.13503	-0.48429	0.996	0.99068	1	0.178	0.197	0.143	0.99343	0.029
BIOCARTA_CALCINEURIN_PATHWAY	19	http://www.broadinstitute.org/gsea/msigdb/cards/BIOCARTA_CALCINEURIN_PATHWAY	-0.14902	-0.47094	0.9856	0.9926	1	0.263	0.269	0.192	0.99491	0.037
REACTOME_DEADENYLATION_OF_MRNA	18	http://www.broadinstitute.org/gsea/msigdb/cards/REACTOME_DEADENYLATION_OF_MRNA	-0.19084	-0.44689	0.9826	0.99552	1	0.222	0.182	0.182	0.99714	0.103
PLASARI_TGFB1_TARGETS_1HR_UP	34	http://www.broadinstitute.org/gsea/msigdb/cards/PLASARI_TGFB1_TARGETS_1HR_UP	-0.15532	-0.42847	0.9784	0.99692	1	0.235	0.252	0.176	0.99819	0.142
BROWNE_HCMV_INFECTION_2HR_UP	38	http://www.broadinstitute.org/gsea/msigdb/cards/BROWNE_HCMV_INFECTION_2HR_UP	-0.13351	-0.41496	1	0.99754	1	0.158	0.196	0.127	0.99858	0.111
WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	21	http://www.broadinstitute.org/gsea/msigdb/cards/WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION	-0.13895	-0.36782	0.9958	0.99916	1	0.952	0.718	0.269	0.99954	0.408
